<SEC-DOCUMENT>0001213900-24-076981.txt : 20240909
<SEC-HEADER>0001213900-24-076981.hdr.sgml : 20240909
<ACCEPTANCE-DATETIME>20240909171015
ACCESSION NUMBER:		0001213900-24-076981
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		26
CONFORMED PERIOD OF REPORT:	20240905
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Unregistered Sales of Equity Securities
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240909
DATE AS OF CHANGE:		20240909

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Andretti Acquisition Corp. II
		CENTRAL INDEX KEY:			0002025341
		STANDARD INDUSTRIAL CLASSIFICATION:	BLANK CHECKS [6770]
		ORGANIZATION NAME:           	05 Real Estate & Construction
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-42268
		FILM NUMBER:		241287958

	BUSINESS ADDRESS:	
		STREET 1:		7615 ZIONSVILLE ROAD
		CITY:			INDIANAPOLIS
		STATE:			IN
		ZIP:			46268
		BUSINESS PHONE:		2057398649

	MAIL ADDRESS:	
		STREET 1:		7615 ZIONSVILLE ROAD
		CITY:			INDIANAPOLIS
		STATE:			IN
		ZIP:			46268
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ea0213830-8k_andretti2.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:us-roles="http://fasb.org/us-roles/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:POLEU="http://andretti.com/20240905">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02C_US%2DGAAP%2D2023 -->
<!-- Field: Set; Name: xdx; ID: xdx_036_POLEU_andretti.com_20240905 -->
<!-- Field: Set; Name: xdx; ID: xdx_04E_20240905_20240905 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_051_edei%2D%2DCurrentFiscalYearEndDate_%2D%2DLS0xMi0zMQ== -->
<!-- Field: Set; Name: xdx; ID: xdx_05B_edei%2D%2DEntityCentralIndexKey_0002025341 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2024-09-05" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2024-09-05" id="Fact000004" name="dei:CurrentFiscalYearEndDate">--12-31</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2024-09-05" id="Fact000005" name="dei:EntityCentralIndexKey">0002025341</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="poleu-20240905.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2024-09-05">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0002025341</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-09-05</xbrli:startDate>
        <xbrli:endDate>2024-09-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-09-052024-09-05_custom_UnitsEachConsistingOfOneClassOrdinaryShareAndOnehalfOfOneRedeemableWarrantMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0002025341</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">POLEU:UnitsEachConsistingOfOneClassOrdinaryShareAndOnehalfOfOneRedeemableWarrantMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-09-05</xbrli:startDate>
        <xbrli:endDate>2024-09-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-09-052024-09-05_custom_ClassOrdinarySharesParValue0.0001PerShareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0002025341</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">POLEU:ClassOrdinarySharesParValue0.0001PerShareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-09-05</xbrli:startDate>
        <xbrli:endDate>2024-09-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-09-052024-09-05_custom_WarrantsEachWholeWarrantExercisableForOneClassOrdinaryShareAtExercisePriceOf11.50PerShareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0002025341</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">POLEU:WarrantsEachWholeWarrantExercisableForOneClassOrdinaryShareAtExercisePriceOf11.50PerShareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-09-05</xbrli:startDate>
        <xbrli:endDate>2024-09-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Washington,
D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FORM
<span id="xdx_90D_edei--DocumentType_c20240905__20240905_zYMGmb6KHLR1"><ix:nonNumeric contextRef="AsOf2024-09-05" id="Fact000010" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CURRENT
REPORT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PURSUANT
TO SECTION 13 OR 15(d)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>OF
THE SECURITIES EXCHANGE ACT OF 1934</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Date
of Report (Date of earliest event reported): <span id="xdx_906_edei--DocumentPeriodEndDate_c20240905__20240905_znDomQtlRWe8"><ix:nonNumeric contextRef="AsOf2024-09-05" format="ixt:datemonthdayyearen" id="Fact000011" name="dei:DocumentPeriodEndDate">September 5, 2024</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_902_edei--EntityRegistrantName_c20240905__20240905_z0d1nJzsL9E5"><ix:nonNumeric contextRef="AsOf2024-09-05" id="Fact000012" name="dei:EntityRegistrantName">Andretti
Acquisition Corp. II</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Exact
name of registrant as specified in its charter)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_908_edei--EntityIncorporationStateCountryCode_c20240905__20240905_zGxUBRUymf8k"><ix:nonNumeric contextRef="AsOf2024-09-05" format="ixt-sec:edgarprovcountryen" id="Fact000013" name="dei:EntityIncorporationStateCountryCode">Cayman
    Islands</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_909_edei--EntityFileNumber_c20240905__20240905_zoYj4UDuobqh"><ix:nonNumeric contextRef="AsOf2024-09-05" id="Fact000014" name="dei:EntityFileNumber">001-42268</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_902_edei--EntityTaxIdentificationNumber_c20240905__20240905_zTTP79cXw29b"><ix:nonNumeric contextRef="AsOf2024-09-05" id="Fact000015" name="dei:EntityTaxIdentificationNumber">98-1792547</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(State
    or other jurisdiction</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>of
    incorporation)</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Commission
    File Number)</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(IRS
    Employer</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Identification
    No.)</b></span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90A_edei--EntityAddressAddressLine1_c20240905__20240905_zdunQRmS0ZUg"><ix:nonNumeric contextRef="AsOf2024-09-05" id="Fact000016" name="dei:EntityAddressAddressLine1">7615
Zionsville Road</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_909_edei--EntityAddressCityOrTown_c20240905__20240905_z9XE5fS1nPT6"><ix:nonNumeric contextRef="AsOf2024-09-05" id="Fact000017" name="dei:EntityAddressCityOrTown">Indianapolis</ix:nonNumeric></span>,
<span id="xdx_908_edei--EntityAddressStateOrProvince_c20240905__20240905_zjinjdEKJEmf"><ix:nonNumeric contextRef="AsOf2024-09-05" format="ixt-sec:stateprovnameen" id="Fact000018" name="dei:EntityAddressStateOrProvince">Indiana</ix:nonNumeric></span> <span id="xdx_907_edei--EntityAddressPostalZipCode_c20240905__20240905_z4gEYOqnm9Db"><ix:nonNumeric contextRef="AsOf2024-09-05" id="Fact000019" name="dei:EntityAddressPostalZipCode">46268</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Address
of principal executive offices, including zip code)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Registrant&#8217;s
telephone number, including area code: (<span id="xdx_90D_edei--CityAreaCode_c20240905__20240905_zqPSUcHXNdS7"><ix:nonNumeric contextRef="AsOf2024-09-05" id="Fact000020" name="dei:CityAreaCode">317</ix:nonNumeric></span>) <span id="xdx_909_edei--LocalPhoneNumber_c20240905__20240905_zIbtE2TqKPX4"><ix:nonNumeric contextRef="AsOf2024-09-05" id="Fact000021" name="dei:LocalPhoneNumber">872-2700</ix:nonNumeric></span> </b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Not
Applicable</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Former
name or former address, if changed since last report)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_edei--WrittenCommunications_c20240905__20240905_zFLVm8P9axeh"><ix:nonNumeric contextRef="AsOf2024-09-05" format="ixt:booleanfalse" id="Fact000022" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Written communications
    pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_edei--SolicitingMaterial_c20240905__20240905_zh8zFp7V2Rrg"><ix:nonNumeric contextRef="AsOf2024-09-05" format="ixt:booleanfalse" id="Fact000023" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
    material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_edei--PreCommencementTenderOffer_c20240905__20240905_zBS9G4C8hApi"><ix:nonNumeric contextRef="AsOf2024-09-05" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_edei--PreCommencementIssuerTenderOffer_c20240905__20240905_zKXxM51XZrA2"><ix:nonNumeric contextRef="AsOf2024-09-05" format="ixt:booleanfalse" id="Fact000025" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pre-commencement
    communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities
registered pursuant to Section 12(b) of the Act:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title
    of each class</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading
                                                                                                       Symbol(s)</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
    of each exchange</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>on
    which registered</b></span></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_edei--Security12bTitle_c20240905__20240905__us-gaap--StatementClassOfStockAxis__custom--UnitsEachConsistingOfOneClassOrdinaryShareAndOnehalfOfOneRedeemableWarrantMember_z0EWQfTnO1nj"><ix:nonNumeric contextRef="From2024-09-052024-09-05_custom_UnitsEachConsistingOfOneClassOrdinaryShareAndOnehalfOfOneRedeemableWarrantMember" id="Fact000026" name="dei:Security12bTitle">Units,
    each consisting of one Class A ordinary share and one-half of one redeemable warrant</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90E_edei--TradingSymbol_c20240905__20240905__us-gaap--StatementClassOfStockAxis__custom--UnitsEachConsistingOfOneClassOrdinaryShareAndOnehalfOfOneRedeemableWarrantMember_zGBKGC0cAE8c"><ix:nonNumeric contextRef="From2024-09-052024-09-05_custom_UnitsEachConsistingOfOneClassOrdinaryShareAndOnehalfOfOneRedeemableWarrantMember" id="Fact000027" name="dei:TradingSymbol">POLEU</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    <span id="xdx_900_edei--SecurityExchangeName_c20240905__20240905__us-gaap--StatementClassOfStockAxis__custom--UnitsEachConsistingOfOneClassOrdinaryShareAndOnehalfOfOneRedeemableWarrantMember_zs63Pnq72q4g"><ix:nonNumeric contextRef="From2024-09-052024-09-05_custom_UnitsEachConsistingOfOneClassOrdinaryShareAndOnehalfOfOneRedeemableWarrantMember" format="ixt-sec:exchnameen" id="Fact000028" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Stock Market LLC</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_edei--Security12bTitle_c20240905__20240905__us-gaap--StatementClassOfStockAxis__custom--ClassOrdinarySharesParValue0.0001PerShareMember_zyApLmXFGNgi"><ix:nonNumeric contextRef="From2024-09-052024-09-05_custom_ClassOrdinarySharesParValue0.0001PerShareMember" id="Fact000029" name="dei:Security12bTitle">Class
    A ordinary shares, par value $0.0001 per share</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90E_edei--TradingSymbol_c20240905__20240905__us-gaap--StatementClassOfStockAxis__custom--ClassOrdinarySharesParValue0.0001PerShareMember_zi9jQ9kauml9"><ix:nonNumeric contextRef="From2024-09-052024-09-05_custom_ClassOrdinarySharesParValue0.0001PerShareMember" id="Fact000030" name="dei:TradingSymbol">POLE</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    <span id="xdx_909_edei--SecurityExchangeName_c20240905__20240905__us-gaap--StatementClassOfStockAxis__custom--ClassOrdinarySharesParValue0.0001PerShareMember_zSheya08dVI7"><ix:nonNumeric contextRef="From2024-09-052024-09-05_custom_ClassOrdinarySharesParValue0.0001PerShareMember" format="ixt-sec:exchnameen" id="Fact000031" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Stock Market LLC</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_edei--Security12bTitle_c20240905__20240905__us-gaap--StatementClassOfStockAxis__custom--WarrantsEachWholeWarrantExercisableForOneClassOrdinaryShareAtExercisePriceOf11.50PerShareMember_zHyEkEXxDbP4"><ix:nonNumeric contextRef="From2024-09-052024-09-05_custom_WarrantsEachWholeWarrantExercisableForOneClassOrdinaryShareAtExercisePriceOf11.50PerShareMember" id="Fact000032" name="dei:Security12bTitle">Warrants,
    each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_90A_edei--TradingSymbol_c20240905__20240905__us-gaap--StatementClassOfStockAxis__custom--WarrantsEachWholeWarrantExercisableForOneClassOrdinaryShareAtExercisePriceOf11.50PerShareMember_zctP6Qz3uLMi"><ix:nonNumeric contextRef="From2024-09-052024-09-05_custom_WarrantsEachWholeWarrantExercisableForOneClassOrdinaryShareAtExercisePriceOf11.50PerShareMember" id="Fact000033" name="dei:TradingSymbol">POLEW</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    <span id="xdx_902_edei--SecurityExchangeName_c20240905__20240905__us-gaap--StatementClassOfStockAxis__custom--WarrantsEachWholeWarrantExercisableForOneClassOrdinaryShareAtExercisePriceOf11.50PerShareMember_zOYCFUnmgCLi"><ix:nonNumeric contextRef="From2024-09-052024-09-05_custom_WarrantsEachWholeWarrantExercisableForOneClassOrdinaryShareAtExercisePriceOf11.50PerShareMember" format="ixt-sec:exchnameen" id="Fact000034" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Stock Market LLC</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
growth company <span id="xdx_90A_edei--EntityEmergingGrowthCompany_c20240905__20240905_ztuo40oKCyTe"><ix:nonNumeric contextRef="AsOf2024-09-05" format="ixt:booleantrue" id="Fact000035" name="dei:EntityEmergingGrowthCompany">&#9746;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <span id="xdx_90B_edei--EntityExTransitionPeriod_c20240905__20240905_zOR6UUcDwSr5"><ix:nonNumeric contextRef="AsOf2024-09-05" format="ixt:booleanfalse" id="Fact000036" name="dei:EntityExTransitionPeriod">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item&#8201;1.01.
Entry into a Material Definitive Agreement.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">On September 9, 2024, Andretti
Acquisition Corp. II (the &#8220;<span style="text-decoration: underline">Company</span>&#8221;) consummated its initial public offering
(&#8220;<span style="text-decoration: underline">IPO</span>&#8221;), which consisted of 23,000,000 units (the &#8220;<span style="text-decoration: underline">Units</span>&#8221;),
including the exercise in full by the underwriter of an option to purchase up to 3,000,000 Units at the offering price to cover over-allotments.
The Units were sold at a price of $10.00 per Unit, generating gross proceeds to the Company of $230,000,000. Each Unit consists of one
Class A ordinary share, par value $0.0001 per share (the &#8220;<span style="text-decoration: underline">Class A Ordinary Shares</span>&#8221;),
of the Company, and one-half of one redeemable warrant (each, a &#8220;<span style="text-decoration: underline">Warrant</span>&#8221;)
of the Company, with each whole Warrant entitling the holder thereof to purchase one Class A Ordinary Share for $11.50 per share.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">In connection with the IPO, the
Company entered into the following agreements, forms of which were previously filed as exhibits to the Registration Statement:</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An Underwriting Agreement,
    dated September 5, 2024, by and between the Company and BTIG, LLC,  a copy of which
    is attached as Exhibit 1.1 hereto and incorporated herein by reference.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A Warrant Agreement, dated
    September 5, 2024, by and between the Company and Continental Stock Transfer &amp; Trust Company, as warrant agent, a copy of which
    is attached as Exhibit 4.1 hereto and incorporated herein by reference.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An Investment Management
    Trust Agreement, dated September 5, 2024, by and between the Company and Continental Stock Transfer &amp; Trust Company, as trustee,
    a copy of which is attached as Exhibit 10.1 hereto and incorporated herein by reference.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A Registration Rights Agreement,
    dated September 5, 2024, by and among the Company and certain security holders, a copy of which is attached as Exhibit 10.2 hereto
    and incorporated herein by reference.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    Private Placement Units Purchase Agreement, dated September 5, 2024 (the &#8220;<span style="text-decoration: underline">Sponsor
    Private Placement Units Purchase Agreement</span>&#8221;), by and between the Company and Andretti Sponsor II LLC (the &#8220;<span style="text-decoration: underline">Sponsor</span>&#8221;), a copy of which
is attached as Exhibit 10.3 hereto and incorporated herein by reference.&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
    Private Placement Units Purchase Agreement, dated September 5, 2024 (the &#8220;<span style="text-decoration: underline">BTIG
    Private Placement Units Purchase Agreement</span>&#8221; and, together with the Sponsor Private Placement Units Purchase Agreement, the &#8220;Private Placement Units Purchase Agreements&#8221;), by and between the Company and BTIG, LLC, a copy of which is attached as
    Exhibit 10.4 hereto and incorporated herein by reference.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A Letter Agreement, dated
    September 5, 2024, by and among the Company, its officers, its directors and the Sponsor, a copy of which is attached as Exhibit
    10.5 hereto and incorporated herein by reference.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An Administrative Services
    Agreement, dated September 5, 2024, by and between the Company and the Sponsor, a copy of which is attached as Exhibit 10.6 hereto
    and incorporated herein by reference.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="width: 0.25in; font-size: 10pt">&#160;</td>
    <td style="width: 0.25in; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="text-align: justify; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indemnity Agreement, dated September 5, 2024, by and among the Company and each Director and executive officers of the Company, a copy of form of which is attached as Exhibit 10.7 hereto and incorporated herein by reference.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item&#8201;3.02.
Unregistered Sales of Equity Securities.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in">Simultaneously with the closing
of the IPO, pursuant to the Private Placement Units Purchase Agreements, the Company completed the private placement of an aggregate of
760,000 units (the &#8220;<span style="text-decoration: underline">Private Placement Units</span>&#8221;) to the Sponsor and BTIG, LLC, the representative of the underwriters,
at $10.00 per Unit, each Unit consisting of one Class A Ordinary Share and one-half of one redeemable Warrant, each whole Warrant exercisable
to purchase one Class A Ordinary Share of the Company. Of those 760,000 Private Placement Units, the Sponsor purchased 450,000 Private
Placement Units and BTIG, LLC purchased 310,000 Private Placement Units. The Warrants contained in the Private Placement Units are identical
to the Warrants included in the Units sold in the IPO, except as otherwise disclosed in the Registration Statement. No underwriting discounts
or commissions were paid with respect to such sale. The issuance of the Private Placement Units was made pursuant to the exemption from
registration contained in Section 4(a)(2) of the Securities Act of 1933, as amended.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"></p>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 5.02.&#160;Departure of Directors or Certain Officers; Election
of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">On September 5, 2024, in connection with the IPO,
Zakary C. Brown, James W. Keyes, Cassandra S. Lee, Gerald D. Putnam and John J. Romanelli (the &#8220;<span style="text-decoration: underline">New Directors</span>&#8221; and,
collectively with William J. Sandbrook and Michael M. Andretti, the &#8220;<span style="text-decoration: underline">Directors</span>&#8221;) were appointed to the board of directors
of the Company (the &#8220;<span style="text-decoration: underline">Board</span>&#8221;). Effective September 5, 2024, each of Cassandra S.&#160;Lee, Gerald D.&#160;Putnam and
John J.&#160;Romanelli was appointed to the Board&#8217;s Audit Committee with Cassandra S. Lee serving as chair of the Audit Committee.
Each of Zakary C.&#160;Brown, James&#160;W.&#160;Keyes and Gerald D.&#160;Putnam was appointed to the Board&#8217;s Compensation Committee,
with Gerald D. Brown serving as chair of the Compensation Committee.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.25in">On September 5, 2024, the Company entered into indemnity
agreements with each of the Directors and William M. Brown, its chief executive officer, that require the Company to indemnify each of
them to the fullest extent permitted by applicable law and to advance expenses incurred as a result of any proceeding against them as
to which they could be indemnified. The foregoing summary of the indemnity agreements does not purport to be complete and is subject to,
and qualified in its entirety by, the full text of the form of indemnity agreement, which is filed as Exhibits 10.7 to this Current Report
on Form 8-K and incorporated in this Item 5.02 by reference.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item&#8201;5.03.
Amendments to Certificate of Incorporation or Bylaws; Change in Fiscal Year.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 5, 2024, in connection with the IPO, the Company filed its amended and restated memorandum and articles of association (the
&#8220;<span style="text-decoration: underline">Amended and Restated Memorandum and Articles of Association</span>&#8221;) with the Cayman Islands Registrar of Companies, which
was effective on September 5, 2024. The terms of the Amended and Restated Memorandum and Articles of Association are set forth in the
Registration Statement and are incorporated herein by reference. A copy of the Amended and Restated Memorandum and Articles of Association
is attached as Exhibit 3.1 hereto and incorporated herein by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item&#8201;8.01.
Other Events.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
total of $231,150,000, comprised of the proceeds from the IPO and the sale of the Private Placement Units (which amount includes
$9,775,000 of the underwriter&#8217;s deferred discount), was placed in a U.S.-based trust account maintained by Continental Stock
Transfer &amp; Trust Company, acting as trustee. Except with respect to interest earned on the funds in the trust account that may
be released to the Company to pay its taxes and for winding up and dissolution expenses, the funds held in the trust account will
not be released from the trust account until the earliest of (i) the completion of the Company&#8217;s initial business combination,
(ii) the redemption of the Company&#8217;s public shares if it is unable to complete its initial business combination within 24
months from the closing of the IPO (or by such earlier liquidation date as the Company&#8217;s board of directors may approve),
subject to applicable law, and (iii) the redemption of the Company&#8217;s public shares properly submitted in connection with a
shareholder vote to amend the Company&#8217;s Amended and Restated Memorandum and Articles of Association to modify the substance or
timing of its obligation to redeem 100% of the Company&#8217;s public shares if it has not consummated an initial business
combination within 24 months from the closing of the IPO or with respect to any other material provisions relating to
shareholders&#8217; rights or pre-initial business combination activity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 5, 2024, the Company issued a press release announcing the pricing of the IPO, a copy of which is attached as Exhibit 99.1
to this Current Report on Form 8-K.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 9, 2024, the Company issued a press release announcing the closing of the IPO, a copy of which is attached as Exhibit 99.2
to this Current Report on Form 8-K.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></p>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Item&#8201;9.01
Financial Statements and Exhibits.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
Exhibits</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following exhibits are being filed herewith:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 9%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit
    No.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 90%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea021383001ex1-1_andretti2.htm">Underwriting Agreement, dated September 5, 2024, by and between the Company and BTIG, LLC, as representative of the several underwriters.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea021383001ex3-1_andretti2.htm">Amended and Restated Memorandum and Articles of Association of the Company.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea021383001ex4-1_andretti2.htm">Warrant Agreement, dated September 5, 2024, by and between the Company and Continental Stock Transfer &amp; Trust Company, as warrant agent.</a>    </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea021383001ex10-1_andretti2.htm">Investment Management Trust Agreement, September 5, 2024, by and between the Company and Continental Stock Transfer &amp; Trust Company, as trustee.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea021383001ex10-2_andretti2.htm">Registration Rights Agreement, dated September 5, 2024, by and among the Company and certain security holders.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea021383001ex10-3_andretti2.htm">Private Placement Units Purchase Agreement, dated September 5, 2024, by and between the Company and the Sponsor.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea021383001ex10-4_andretti2.htm">Private Placement Units Purchase Agreement, dated September 5, 2024, by and between the Company and the Sponsor.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea021383001ex10-5_andretti2.htm">Letter Agreement, dated September 5, 2024, by and among the Company, its officers, directors, and the Sponsor.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.6</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea021383001ex10-6_andretti2.htm">Administrative Services Agreement, dated September 5, 2024, by and between the Company and&#160;&#160;Andretti Sponsor II LLC.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top">10.7</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><a href="ea021383001ex10-7_andretti2.htm">Form of Indemnity Agreement</a></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea021383001ex99-1_andretti2.htm">Press Release, dated September 5, 2024.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.2</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea021383001ex99-2_andretti2.htm">Press Release, dated September 9, 2024.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover
    Page Interactive Data File (embedded within the Inline XBRL document).</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></p>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SIGNATURE</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="3" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ANDRETTI ACQUISITION CORP. II</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    William M. Brown</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 60%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 4%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 31%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">William
    M. Brown</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dated: September 9, 2024</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- 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 -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>ea021383001ex1-1_andretti2.htm
<DESCRIPTION>UNDERWRITING AGREEMENT, DATED SEPTEMBER 5, 2024, BY AND BETWEEN THE COMPANY AND BTIG, LLC, AS REPRESENTATIVE OF THE SEVERAL UNDERWRITERS
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 1.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B><I>&nbsp;</I></B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Underwriting Agreement<BR>
between<BR>
Andretti Acquisition Corp. II<BR>
and<BR>
BTIG, LLC<BR>
Dated September 5, 2024<BR>
(the &ldquo;Agreement&rdquo;)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">ANDRETTI ACQUISITION CORP. II<FONT STYLE="font-size: 10pt"><BR>
</FONT><BR>
UNDERWRITING AGREEMENT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">New York, New York<BR>
September 5, 2024</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">BTIG, LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">65 E. 55<SUP>th</SUP> Street</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">New York, New York 10022</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>As Representative of the Underwriters</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>named on <U>Schedule A</U> hereto</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The undersigned, Andretti
Acquisition Corp. II, a Cayman Islands exempted company (the &ldquo;<B>Company</B>&rdquo;), hereby confirms its agreement with BTIG, LLC
(&ldquo;<B>BTIG</B>&rdquo; or the &ldquo;<B>Representative</B>&rdquo;) and with the other underwriters named on Schedule A hereto (if
any), for which the Representative is acting as representative (the Representative and such other underwriters being collectively referred
to herein as the &ldquo;<B>Underwriters</B>&rdquo; or, each underwriter individually, an &ldquo;<B>Underwriter,</B>&rdquo; provided that,
if only BTIG is listed on such Schedule A, any references to the Underwriters shall refer exclusively to BTIG) as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">1.&nbsp;<U>Purchase
and Sale of Securities</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">1.1&nbsp;<U>Firm
Securities</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">1.1.1&nbsp;<U>Purchase
of Firm Units</U>. On the basis of the representations and warranties contained herein, but subject to the terms and conditions herein
set forth, the Company agrees to issue and sell to the several Underwriters, severally and not jointly, and the Underwriters agree to
purchase from the Company, severally and not jointly, an aggregate of 20,000,000 units (the &ldquo;<B>Firm Units</B>&rdquo;), ratably
in accordance with the number of Firm Units set forth opposite the name of such Underwriter in Schedule A attached hereto, at a purchase
price (net of discounts and commissions, excluding Deferred Underwriting Commission (as defined below)) of $9.80 per Firm Unit. The Firm
Units are to be offered initially to the public (the &ldquo;<B>Offering</B>&rdquo;) at the offering price of $10.00 per Firm Unit. Each
Firm Unit consists of one Class A ordinary share, of $0.0001 par value, of the Company (the &ldquo;<B>Class A Ordinary Shares</B>&rdquo;)
and one-half of one redeemable warrant (the &ldquo;<B>Warrants</B>&rdquo;). The Class A Ordinary Shares and the Warrants included in the
Firm Units will trade separately on the 52<SUP>nd</SUP> day following the date hereof unless the Representative determines to allow earlier
separate trading. Notwithstanding the immediately preceding sentence, in no event will the Class A Ordinary Shares and the Warrants included
in the Firm Units trade separately until (i)&nbsp;the Company has filed with the U.S. Securities and Exchange Commission (the &ldquo;<B>Commission</B>&rdquo;)
a Current Report on Form 8-K that includes an audited balance sheet reflecting the Company&rsquo;s receipt of the proceeds of the Offering
and the Unit Private Placement (as defined in <U>Section 1.4.2</U>) and updated financial information with respect to any proceeds the
Company receives from the exercise of the Over-allotment Option (defined below) if such option is exercised prior to the filing of the
Current Report on Form 8-K and (ii) the Company has filed with the Commission a Current Report on Form 8-K and issued a press release
announcing when such separate trading will begin. Each whole Warrant entitles its holder to purchase one Class A Ordinary Share for $11.50
per share, subject to adjustment, commencing 30 days after the consummation by the Company of a merger, share exchange, asset acquisition,
share purchase, reorganization, or similar business combination with one or more businesses (the &ldquo;<B>Business Combination</B>&rdquo;)
and expiring on the five year anniversary of the consummation by the Company of its initial Business Combination, or earlier upon redemption
or liquidation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">1.1.2&nbsp;<U>Payment
and Delivery</U>. Delivery and payment for the Firm Units shall be made at 10:00 a.m., New York City time, on the first Business Day (as
defined below) following the commencement of trading of the Firm Units, or at such earlier time as shall be agreed upon by the Representative
and the Company, at the offices of DLA Piper LLP (US), counsel to the Underwriters (&ldquo;<B>DLA Piper</B>&rdquo;), or at such other
place as shall be agreed upon by the Representative and the Company. The hour and date of delivery and payment for the Firm Units is called
the &ldquo;<B>Closing Date</B>.&rdquo; Payment for the Firm Units shall be made on the Closing Date by wire transfer in Federal (same
day) funds, payable as follows: $201,000,000 of the proceeds received by the Company for the Firm Units and the sale of Private Placement
Units (as defined in <U>Section 1.4.2</U>) shall be deposited in the trust account (&ldquo;<B>Trust Account</B>&rdquo;) established by
the Company for the benefit of the Public Shareholders (as defined below), as described in the Registration Statement (as defined in <U>Section
2.1.1</U>) pursuant to the terms of an Investment Management Trust Agreement (the &ldquo;<B>Trust Agreement</B>&rdquo;) between the Company
and Continental Stock Transfer &amp; Trust Company (&ldquo;<B>Continental</B>&rdquo;). The funds deposited in the Trust Account shall
include an aggregate of $8,500,000 ($0.425 per Firm Unit), payable to the Underwriters as Deferred Underwriting Commission, in accordance
with <U>Section 1.3</U> hereof. The remaining proceeds (less commissions and actual expense payments or other fees payable pursuant to
this Agreement), if any, shall be paid to the order of the Company upon delivery to the Representative of certificates (in form and substance
reasonably satisfactory to the Representative) representing the Firm Units (or through the facilities of the Depository Trust Company
(&ldquo;<B>DTC</B>&rdquo;)) for the account of the Underwriters. The Firm Units shall be registered in such name or names and in such
authorized denominations as the Representative may request in writing at least two full Business Days prior to the Closing Date. The Company
will permit the Representative to examine and package the Firm Units for delivery, at least one full Business Day prior to the Closing
Date. The Company shall not be obligated to sell or deliver any of the Firm Units except upon tender of payment by the Representative
for all the Firm Units. As used herein, the term &ldquo;<B>Public Shareholders</B>&rdquo; means the holders of Class A Ordinary Shares
sold as part of the Units in the Offering or acquired in the aftermarket, including the Sponsor (defined below), any member of the Sponsor
or any officer or director of the Company, to the extent, he, she or it acquires such Class A Ordinary Shares in the aftermarket (and
solely with respect to such Class A Ordinary Shares). &ldquo;<B>Business Day</B>&rdquo; means any day other than Saturday, Sunday or other
day on which commercial banks in The City of New York are authorized or required by law to remain closed; <U>provided</U>, <U>however</U>,
for clarification, commercial banks shall not be deemed to be authorized or required by law to remain closed due to &ldquo;stay at home&rdquo;,
&ldquo;shelter-in-place&rdquo;, &ldquo;non-essential employee&rdquo; or any other similar orders or restrictions or the closure of any
physical branch locations at the direction of any governmental authority so long as the electronic funds transfer systems (including for
wire transfers) of commercial banks in The City of New York are generally are open for use by customers on such day.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">1.2&nbsp;<U>Over-Allotment
Option</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">1.2.1&nbsp;<U>Option
Units</U>. The Underwriters are hereby granted an option (the &ldquo;<B>Over-allotment Option</B>&rdquo;) to purchase, ratably in accordance
with the number of Firm Units to be purchased by each of them, up to an additional 3,000,000 units (the &ldquo;<B>Option Units</B>&rdquo;),
the net proceeds of which, together with the proceeds of the Option Private Placement Units (as defined below), will be deposited in the
Trust Account, for the purposes of covering any over-allotments in connection with the distribution and sale of the Firm Units. Such Option
Units shall be identical in all respects to the Firm Units and shall be sold at the same purchase price per Firm Unit to be paid by the
Underwriters to the Company. The Firm Units and the Option Units are hereinafter collectively referred to as the &ldquo;<B>Units</B>,&rdquo;
and the Units, the Class&nbsp;A Ordinary Shares, the Warrants included in the Units and the Class A Ordinary Shares issuable upon exercise
of the Warrants are hereinafter referred to collectively as the &ldquo;<B>Public Securities</B>.&rdquo; No Option Units shall be sold
or delivered unless the Firm Units previously have been, or simultaneously are, sold and delivered. The right to purchase the Option Units,
or any portion thereof, may be exercised from time to time and to the extent not previously exercised may be surrendered and terminated
at any time upon notice by the Representative to the Company. The purchase price to be paid for each Option Unit will be the price set
forth in <U>Section 1.2.3</U> hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-family: Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">1.2.2&nbsp;<U>Exercise
of Option</U>. The Over-allotment Option granted pursuant to <U>Section 1.2.1</U> hereof may be exercised by the Representative as to
all (at any time) or any part (from time to time) of the Option Units within 45 days after the effective date (&ldquo;<B>Effective Date</B>&rdquo;)
of the Registration Statement (as defined in <U>Section 2.1.1</U> hereof). The Underwriters will not be under any obligation to purchase
any Option Units prior to the exercise of the Over-allotment Option. The Over-allotment Option granted hereby may be exercised by the
giving of oral notice to the Company by the Representative, which must be confirmed in accordance with <U>Section 10.1</U> herein setting
forth the number of Option Units to be purchased and the date and time for delivery of and payment for the Option Units (the &ldquo;<B>Option
Closing Date</B>&rdquo;), which will not be later than five full Business Days after the date of the notice or such other time and in
such other manner as shall be agreed upon by the Company and the Representative, at the offices of DLA Piper or at such other place (including
remotely by facsimile or other electronic transmission) as shall be agreed upon by the Company and the Representative. If such delivery
and payment for the Option Units does not occur on the Closing Date, the Option Closing Date will be as set forth in the notice. Upon
exercise of the Over-allotment Option, the Company will become obligated to convey to the Underwriters, and, subject to the terms and
conditions set forth herein, the Underwriters will become obligated to purchase, the number of Option Units specified in such notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">1.2.3&nbsp;<U>Payment
and Delivery</U>. Payment for the Option Units shall be made on the Option Closing Date by wire transfer in Federal (same day) funds,
payable as follows: $9.80 per Option Unit shall be deposited in the Trust Account pursuant to the Trust Agreement upon delivery to the
Representative of certificates (in form and substance satisfactory to the Representative) representing the Option Units (or through the
facilities of DTC) for the account of the Representative. The amount of the payments for the Option Units to be deposited in the Trust
Account will include $0.425 per Option Unit (up to $1,275,000), payable to the Underwriters, as Deferred Underwriting Commission, in accordance
with <U>Section 1.3</U> hereof. The certificates representing the Option Units to be delivered will be in such denominations and registered
in such names as the Representative requests in writing not less than two full Business Days prior to the Closing Date or the Option Closing
Date, as the case may be. The Company shall not be obligated to sell or deliver the Option Units except upon tender of payment by the
Underwriters for applicable Option Units.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">1.3&nbsp;<U>Deferred
Underwriting Commission</U>. The Representative agrees that 4.25% of the gross proceeds from the sale of the Firm Units ($8,500,000) and
4.25% of the gross proceeds from the sale of the Option Units (up to $1,275,000) (collectively, the &ldquo;<B>Deferred Underwriting Commission</B>&rdquo;),
will be deposited and held in the Trust Account and payable directly from the Trust Account, without accrued interest, to the Representative
for its own account upon consummation of the Company&rsquo;s initial Business Combination. In the event that the Company is unable to
consummate a Business Combination and Continental, as the trustee of the Trust Account (in this context, the &ldquo;<B>Trustee</B>&rdquo;),
commences liquidation of the Trust Account as provided in the Trust Agreement, the Representative agrees that: (i)&nbsp;the Representative
shall forfeit any rights or claims to the Deferred Underwriting Commission, including any accrued interest thereon; and (ii)&nbsp;the
Deferred Underwriting Commission, together with all other amounts on deposit in the Trust Account, shall be distributed on a pro-rata
basis among the Public Shareholders. Any Deferred Underwriting Commissions will be fully earned by each Underwriter upon the payment of
the purchase price for the Units purchased by such underwriter on the closing of the Offering (including payment of the purchase price
of any Option Units) and will be paid if and when the Company consummates its Business Combination, without any further conditions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-family: Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">1.4&nbsp;<U>Private
Placements</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">1.4.1&nbsp;<U>Founder
Shares</U>. In May 2024, Andretti Sponsor II LLC, a Delaware limited liability company (the &ldquo;<B>Sponsor</B>&rdquo;), purchased from
the Company 5,750,000 Class B ordinary shares (the &ldquo;<B>Founder Shares</B>&rdquo;), for an aggregate consideration of $25,000 paid
to cover certain offering costs, in a private placement exempt from registration under the Securities Act of 1933, as amended (the &ldquo;<B>Act</B>&rdquo;),
pursuant to Section&nbsp;4(a)(2) of the Act. No underwriting discounts, commissions, or placement fees have been or will be payable in
connection with the purchase of Founder Shares. Except as described in the Registration Statement, none of the Founder Shares may be sold,
assigned or transferred by the Sponsor until the earlier of: (i) one year after the consummation of a Business Combination; or (ii) subsequent
to the consummation of such Business Combination, (x) when the last reported sale price of the Company&rsquo;s Class A Ordinary Shares
equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and
the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after consummation of the Business Combination
or (y) the date on which the Company completes a liquidation, merger, share exchange, reorganization or other similar transaction that
results in all of the Company&rsquo;s shareholders having the right to exchange their ordinary shares for cash, securities or other property.
The holders of Founder Shares shall have no right to any liquidating distributions with respect to any portion of the Founder Shares in
the event the Company fails to consummate a Business Combination. The holders of the Founder Shares shall not have redemption rights with
respect to the Founder Shares. In the event that the Over-allotment Option is not exercised in full, the Sponsor will be required to forfeit
such number of Founder Shares (up to 750,000 Founder Shares) such that the Founder Shares then outstanding will comprise 20% of the issued
and outstanding shares of the Company after giving effect to the Offering and exercise, if any, of the Over-allotment Option.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">1.4.2&nbsp;<U>Unit
Private Placement</U>. Simultaneously with the Closing Date, the Sponsor and the Representative will purchase from the Company pursuant
to the Purchase Agreements (as defined in <U>Section 2.21.2</U> hereof), 700,000 private placement units (450,000 units to be purchased
by the Sponsor and 250,000 to be purchased by the Representative), at a purchase price of $10.00 per unit (the &ldquo;<B>Private Placement
Units</B>&rdquo;) in a private placement intended to be exempt from registration under Act, pursuant to Section 4(a)(2) of the Act. Simultaneously
with the Option Closing Date (if any), the Representative will purchase from the Company pursuant to the Representative Purchase Agreement
up to an additional 60,000 Private Placement Units, at a purchase price of $10.00 per Private Placement Unit in a private placement intended
to be exempt from registration under the Act, pursuant to Section 4(a)(2) of the Act (the &ldquo;<B>Option Private Placement Units</B>&rdquo;).
The Private Placement Units and Option Private Placement Units, if any, are substantially identical to the Firm Units, subject to certain
exceptions. The private placement of the Private Placement Units and the Option Private Placement Units, if any, is referred to herein
as the &ldquo;<B>Unit Private Placement</B>.&rdquo; None of the Private Placement Units, the Option Private Placement Units, the Class
A Ordinary Shares (the &ldquo;<B>Private Placement Shares</B>&rdquo;) or the warrants (the &ldquo;<B>Private Placement Warrants</B>&rdquo;)
forming a part of the Private Placement Units and the Option Private Placement Units, or the Class A Ordinary Shares issuable upon exercise
of the Private Placement Warrants may be sold, assigned or transferred by the purchasers or their permitted transferees until 30&nbsp;days
after consummation of a Business Combination. Certain proceeds from the sale of the Private Placement Units and certain of the proceeds
from the sale of the Option Private Placement Units, if any, shall be deposited into the Trust Account. In addition, for as long as any
Private Placement Units, Option Private Placement Units, underlying Private Placement Shares and underlying Private Placement Warrants
are held by the Representative or its designees or affiliates, such Private Placement Units, Option Private Placement Units, the underlying
Private Placement Shares, the underlying Private Placement Warrants and the Class A Ordinary Shares issuable upon exercise of the Private
Placement Warrants, will be subject to the lock-up and registration rights limitations imposed by FINRA Rule 5110 and may not be exercised
after five years from the effective date of the Registration Statement (as defined herein).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-family: Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">1.4.3&nbsp;The
Private Placement Units, the Option Private Placement Units, if any, the Private Placement Shares, the Private Placement Warrants and
the Class A Ordinary Shares issuable upon exercise of the Private Placement Warrants included in the Private Placement Units and the Option
Private Placement Units, if any, are hereinafter referred to collectively as the &ldquo;<B>Placement Securities</B>.&rdquo; No underwriting
discounts, commissions or placement fees have been or will be payable in connection with the Placement Securities. The Public Securities,
the Placement Securities and the Founder Shares are hereinafter referred to collectively as the &ldquo;<B>Securities</B>.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">1.5&nbsp;<U>Working
Capital</U>. Upon consummation of the Offering, it is intended that approximately $1,250,000 (or $1,100,000 if the Over-allotment Option
is exercised in full) of the Offering proceeds and the Unit Private Placement will be released to the Company and held outside of the
Trust Account to fund the working capital requirements of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">1.6&nbsp;<U>Interest
Income</U>. Prior to the Company&rsquo;s consummation of a Business Combination or the Company&rsquo;s liquidation, interest earned on
the Trust Account may be released to the Company from the Trust Account in accordance with the terms of the Trust Agreement to pay any
taxes incurred by the Company and up to $100,000 for dissolution expenses, all as more fully described in the Prospectus (as defined below).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">2.&nbsp;<U>Representations
and Warranties of the Company</U>. The Company represents and warrants to the Underwriters as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.1&nbsp;<U>Filing
of Registration Statement</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">2.1.1&nbsp;<U>Pursuant
to the Act</U>. The Company has filed with the Commission a registration statement and an amendment or amendments thereto, on Form S-1
(File No. 333-280552), including any related preliminary prospectus (&ldquo;<B>Preliminary Prospectus</B>&rdquo;), including any prospectus
that is included in the Registration Statement immediately prior to the effectiveness of the Registration Statement, for the registration
of the Units (and the Class A Ordinary Shares and the Warrants included in the Units) under the Act, which registration statement and
amendment or amendments have been prepared by the Company in conformity with the requirements of the Act, and the rules and regulations
(the &ldquo;<B>Regulations</B>&rdquo;) of the Commission under the Act. The conditions for use of Form S-1 to register the Offering under
the Act, as set forth in the General Instructions to such Form, have been satisfied. Except as the context may otherwise require, such
registration statement, as amended, on file with the Commission at the time the registration statement becomes effective (including the
prospectus, financial statements, schedules, exhibits and all other documents filed as a part thereof or incorporated therein and all
information deemed to be a part thereof as of such time pursuant to Rule 430A of the Regulations), is hereinafter called the &ldquo;<B>Registration
Statement</B>,&rdquo; and the form of the final prospectus dated the Effective Date included in the Registration Statement (or, if applicable,
the form of final prospectus containing information permitted to be omitted at the time of effectiveness by Rule 430A of the Regulations,
filed by the Company with the Commission pursuant to Rule 424 of the Regulations), is hereinafter called the &ldquo;<B>Prospectus</B>.&rdquo;
For purposes of this Agreement, &ldquo;<B>Time of Sale</B>,&rdquo; as used in the Act, means 5:00 p.m. New York City time, on the date
of this Agreement. Prior to the Time of Sale, the Company prepared a Preliminary Prospectus, which was included in the Registration Statement
filed on August 22, 2024, for distribution by the Underwriter (such Preliminary Prospectus used most recently prior to the Time of Sale,
the &ldquo;<B>Sale Preliminary Prospectus</B>&rdquo;). If the Company has filed, or is required pursuant to the terms hereof to file,
a Registration Statement pursuant to Rule 462(b) under the Act registering additional securities or an amendment to such Registration
Statement (a &ldquo;<B>Rule 462(b) Registration Statement</B>&rdquo;), then, unless otherwise specified, any reference herein to the term
&ldquo;<B>Registration Statement</B>&rdquo; shall be deemed to include such Rule 462(b) Registration Statement. Other than the Rule 462(b)
Registration Statement, which, if filed, becomes effective upon filing, no other document with respect to the Registration Statement has
been filed with the Commission. All of the Public Securities have been registered for public sale under the Act pursuant to the Registration
Statement or, if any Rule 462(b) Registration Statement is filed, will be duly registered for public sale under the Act with the filing
of such Rule 462(b) Registration Statement. The Registration Statement has been declared effective by the Commission on the date hereof.
If, subsequent to the date of this Agreement, the Company or the Representative determines that at the Time of Sale, the Sale Preliminary
Prospectus includes an untrue statement of a material fact or omits a statement of material fact necessary to make the statements therein,
in light of the circumstances under which they were made, not misleading and the Company and the Representative agree to provide an opportunity
to purchasers of the Units to terminate their old purchase contracts and enter into new purchase contracts, then the Sale Preliminary
Prospectus will be deemed to include any additional information available to purchasers at the time of entry into the first such new purchase
contract.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-family: Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">2.1.2&nbsp;<U>Pursuant
to the Exchange Act</U>. The Company has filed with the Commission a Registration Statement on Form 8-A (File No. 001-42268) providing
for the registration under the Securities Exchange Act of 1934, as amended (the &ldquo;<B>Exchange Act</B>&rdquo;), of the Units, the
Class A Ordinary Shares and the Warrants. The registration of the Units, Class A Ordinary Shares and the Warrants under the Exchange Act
has been declared effective by the Commission on the date hereof and the Units, the Class A Ordinary Shares and the Warrants have been
registered pursuant to Section 12(b) of the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">2.1.3&nbsp;<U>No
Stop Orders, Etc</U>. Neither the Commission nor, to the Company&rsquo;s knowledge, assuming reasonable inquiry, any federal, state, or
other regulatory authority has issued any order or threatened to issue any order preventing or suspending the use of the Registration
Statement, any Preliminary Prospectus, the Sale Preliminary Prospectus, or Prospectus or any part thereof, or has instituted or, to the
Company&rsquo;s knowledge, assuming reasonable inquiry, threatened to institute any proceedings with respect to such an order.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.2&nbsp;<U>Disclosures
in Registration Statement</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">2.2.1 <U>10b-5 Representation</U>.
At the time of effectiveness of the Registration Statement (or at the time of any post-effective amendment to the Registration Statement)
and at all times subsequent thereto up to the Closing Date and the Option Closing Date, if any, the Registration Statement, the Sale Preliminary
Prospectus and the Prospectus did and will, in all material respects, conform to the requirements of the Act and the Regulations. The
Registration Statement, as of the Effective Date, did not, and the amendments and supplements thereto, as of their respective dates, will
not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein, or necessary to
make the statements therein, not misleading. The Prospectus, as of its date and the Closing Date or the Option Closing Date, as the case
may be, did not, and the amendments and supplements thereto, as of their respective dates, will not, include any untrue statement of a
material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under
which they were made, not misleading. The Sale Preliminary Prospectus, as of the Time of Sale (or such subsequent Time of Sale pursuant
to <U>Section 2.1.1</U>), did not include any untrue statement of a material fact or omit to state a material fact necessary in order
to make the statements therein, in the light of the circumstances under which they were made, not misleading. When any Preliminary Prospectus
or the Sale Preliminary Prospectus was first filed with the Commission (whether filed as part of the Registration Statement for the registration
of the Public Securities or any amendment thereto or pursuant to Rule 424(a) of the Regulations) and when any amendment thereof or supplement
thereto was first filed with the Commission, such Preliminary Prospectus or the Sale Preliminary Prospectus and any amendments thereof
and supplements thereto complied or will have been corrected in the Sale Preliminary Prospectus and the Prospectus to comply in all material
respects with the applicable provisions of the Act and the Regulations and did not and will not contain an untrue statement of a material
fact or omit to state any material fact required to be stated therein or necessary in order to make the statements therein, in the light
of the circumstances under which they were made, not misleading. The representation and warranty made in this <U>Section 2.2.1</U> does
not apply to statements made or statements omitted in reliance upon and in conformity with written information furnished to the Company
with respect to the Underwriters by the Underwriters expressly for use in the Registration Statement, the Sale Preliminary Prospectus
or the Prospectus or any amendment thereof or supplement thereto. The parties acknowledge and agree that such information provided by
or on behalf of the Underwriters consists solely of the following: the names of the Underwriters, the information with respect to stabilizing
transactions contained in the fifteenth, sixteenth, seventeenth and eighteenth paragraphs of the section entitled &ldquo;Underwriting&rdquo;
and the identity of counsel to the Underwriters contained in the section entitled &ldquo;Legal Matters&rdquo; (such information, collectively,
the &ldquo;<B>Underwriters&rsquo; Information</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-family: Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">2.2.2&nbsp;<U>Disclosure
of Agreements</U>. The agreements and documents described in the Registration Statement, the Sale Preliminary Prospectus and the Prospectus
conform to the descriptions thereof contained therein in all material respects and there are no agreements or other documents required
to be described in the Registration Statement, the Sale Preliminary Prospectus or the Prospectus or to be filed with the Commission as
exhibits to the Registration Statement, that have not been so described or filed. Each agreement or other instrument (however characterized
or described) to which the Company is a party or by which its property or business is or may be bound or affected and (i)&nbsp;that is
referred to in the Registration Statement, Sale Preliminary Prospectus or the Prospectus or attached as an exhibit thereto, or (ii)&nbsp;that
is material to the Company&rsquo;s business, has been duly authorized and validly executed by the Company, is in full force and effect
and is enforceable against the Company and, to the Company&rsquo;s knowledge, assuming reasonable inquiry, the other parties thereto,
in accordance with its terms, except (x)&nbsp;as such enforceability may be limited by bankruptcy, insolvency, reorganization or similar
laws affecting creditors&rsquo; rights generally, (y)&nbsp;as enforceability of any indemnification or contribution provision may be limited
under the foreign, federal and state securities laws, and (z)&nbsp;that the remedy of specific performance and injunctive and other forms
of equitable relief may be subject to the equitable defenses and to the discretion of the court before which any proceeding therefor may
be brought, and no such agreement or instrument has been assigned by the Company, and neither the Company nor, to the Company&rsquo;s
knowledge, assuming reasonable inquiry, any other party is in breach or default thereunder and, to the Company&rsquo;s knowledge, assuming
reasonable inquiry, no event has occurred that, with the lapse of time or the giving of notice, or both, would constitute a breach or
default thereunder. To the Company&rsquo;s knowledge, assuming reasonable inquiry, the performance by the Company of the material provisions
of such agreements or instruments will not result in a violation of any existing applicable law, rule, regulation, judgment, order or
decree of any governmental agency or court, domestic or foreign, having jurisdiction over the Company or any of its assets or businesses,
including, without limitation, those relating to environmental laws and regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">2.2.3&nbsp;<U>Prior
Securities Transactions</U>. No securities of the Company have been sold by the Company or by or on behalf of, or for the benefit of,
any person or persons controlling, controlled by, or under common control with the Company since the date of the Company&rsquo;s formation,
except as disclosed in the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">2.2.4&nbsp;<U>Regulations</U>.
The disclosures in the Registration Statement, the Sale Preliminary Prospectus, and Prospectus concerning the effects of federal, foreign,
state, and local regulation on the Company&rsquo;s business as currently contemplated are correct in all material respects and do not
omit to state a material fact necessary to make the statements therein, in the light of the circumstances in which they were made, not
misleading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.3&nbsp;<U>Changes
After Dates in Registration Statement</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-family: Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">2.3.1&nbsp;<U>No
Material Adverse Change</U>. Since the respective dates as of which information is given in the Registration Statement, the Sale Preliminary
Prospectus and the Prospectus, except as otherwise specifically stated therein, (i)&nbsp;there has been no material adverse change in
the condition, financial or otherwise, or business prospects of the Company, (ii)&nbsp;there have been no material transactions entered
into by the Company, other than as contemplated pursuant to this Agreement, (iii)&nbsp;no member of the Company&rsquo;s board of directors
(the &ldquo;<B>Board of Directors</B>&rdquo;) or management has resigned from any position with the Company, other than a change in the
title of such officer, and (iv)&nbsp;no event or occurrence has taken place which materially impairs, or would likely materially impair,
with the passage of time, the ability of the members of the Board of Directors or management to act in their capacities with the Company
as described in the Registration Statement, the Sale Preliminary Prospectus and the Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">2.3.2&nbsp;<U>Recent
Securities Transactions</U>. Subsequent to the respective dates as of which information is given in the Registration Statement, the Sale
Preliminary Prospectus and the Prospectus, and except as may otherwise be indicated or contemplated herein or therein, the Company has
not (i)&nbsp;issued any securities or incurred any liability or obligation, direct or contingent, for borrowed money; or (ii)&nbsp;declared
or paid any dividend or made any other distribution on or in respect to its share capital.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.4&nbsp;<U>Independent
Accountants</U>. To the Company&rsquo;s knowledge, assuming reasonable inquiry, Withum Smith+Brown, PC (&ldquo;<B>Withum</B>&rdquo;),
whose report is filed with the Commission as part of, and is included in, the Registration Statement, the Sale Preliminary Prospectus,
and the Prospectus, is an independent registered public accounting firm as required by the Act, the Regulations and the Public Company
Accounting Oversight Board (the &ldquo;<B>PCAOB</B>&rdquo;), including the rules and regulations promulgated by such entity. To the Company&rsquo;s
knowledge, assuming reasonable inquiry, Withum is currently registered with the PCAOB. Withum has not, during the periods covered by the
financial statements included in the Registration Statement, the Sale Preliminary Prospectus and the Prospectus, provided to the Company
any non-audit services, as such term is used in Section 10A(g) of the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.5&nbsp;<U>Financial
Statements; Statistical Data</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">2.5.1&nbsp;<U>Financial
Statements</U>. The financial statements, including the notes thereto and supporting schedules (if any) included in the Registration Statement,
the Sale Preliminary Prospectus and the Prospectus fairly present the financial position, the results of operations and the cash flows
of the Company at the dates and for the periods to which they apply; such financial statements have been prepared in conformity with United
States generally accepted accounting principles (&ldquo;<B>GAAP</B>&rdquo;), consistently applied throughout the periods involved; and
the supporting schedules included in the Registration Statement, the Sale Preliminary Prospectus and the Prospectus present fairly the
information required to be stated therein in conformity with the Regulations. No other financial statements or supporting schedules are
required to be included or incorporated by reference in the Registration Statement, the Sale Preliminary Prospectus or the Prospectus.
The Registration Statement, the Sale Preliminary Prospectus and the Prospectus disclose all material off-balance sheet transactions, arrangements,
obligations (including contingent obligations), and other relationships of the Company with unconsolidated entities or other persons that
may have a material current or future effect on the Company&rsquo;s financial condition, changes in financial condition, results of operations,
liquidity, capital expenditures, capital resources, or significant components of revenues or expenses. There are no pro forma or as adjusted
financial statements that are required to be included in the Registration Statement, the Sale Preliminary Prospectus and the Prospectus
in accordance with Regulation&nbsp;S-X or Form&nbsp;10 that have not been included as required.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">2.5.2&nbsp;<U>Statistical
Data</U>. The statistical, industry-related and market-related data included in the Registration Statement, the Sale Preliminary Prospectus,
and/or the Prospectus are based on or derived from sources that the Company reasonably and in good faith believes are reliable and accurate,
and such data materially agree with the sources from which they are derived.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-family: Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.6&nbsp;<U>Authorized Capital;
Options</U>. The Company had at the date or dates indicated in each of the Registration Statement, the Sale Preliminary Prospectus, and
the Prospectus, as the case may be, duly authorized, issued and outstanding capitalization as set forth in the Registration Statement,
the Sale Preliminary Prospectus, and the Prospectus. Based on the assumptions stated in the Registration Statement, the Sale Preliminary
Prospectus, and the Prospectus, the Company will have on the Closing Date or on the Option Closing Date, as the case may be, the adjusted
share capitalization set forth therein. Except as set forth in, or contemplated by the Registration Statement, the Sale Preliminary Prospectus
and the Prospectus, on the Effective Date and on the Closing Date or Option Closing Date, as the case may be, there will be no options,
warrants, or other rights to purchase or otherwise acquire any authorized but unissued Class A Ordinary Shares or any security convertible
into Class A Ordinary Shares, or any contracts or commitments to issue or sell Class A Ordinary Shares or any such options, warrants,
rights or convertible securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.7&nbsp;<U>Valid
Issuance of Securities</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">2.7.1&nbsp;<U>Outstanding
Securities</U>. All issued and outstanding securities of the Company issued prior to the transactions contemplated by this Agreement have
been duly authorized and validly issued and are fully paid and non-assessable; the holders thereof have no rights of rescission with respect
thereto, and are not subject to personal liability by reason of being such holders; and none of such securities was issued in violation
of the preemptive rights of any holders of any security of the Company or similar contractual rights granted by the Company. The authorized
and outstanding securities of the Company conform in all material respects to all statements relating thereto contained in the Registration
Statement, the Sale Preliminary Prospectus and the Prospectus. All offers and sales and any transfers of the outstanding securities of
the Company were at all relevant times either registered under the Act and the applicable state securities or Blue Sky laws or, based
in part on the representations and warranties of the purchasers of such securities, exempt from such registration requirements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">2.7.2&nbsp;<U>Securities
Sold Pursuant to this Agreement</U>. The Securities have been duly authorized and reserved for issuance and when issued and paid for in
accordance with this Agreement and registered in the Company&rsquo;s register of members, will be validly issued, fully paid and non-assessable;
the holders thereof are not and will not be subject to personal liability by reason of being such holders; the Securities are not and
will not be subject to the preemptive rights of any holders of any security of the Company or similar contractual rights granted by the
Company; and all corporate action required to be taken for the authorization, issuance and sale of the Securities has been duly and validly
taken. The form of certificates for the Securities conform to the corporate law of the jurisdiction of the Company&rsquo;s incorporation
and applicable securities laws. The Securities conform in all material respects to the descriptions thereof contained in the Registration
Statement, the Sale Preliminary Prospectus and the Prospectus, as the case may be. When paid for and issued, the Warrants will constitute
valid and binding obligations of the Company to issue the number and type of securities of the Company called for thereby in accordance
with the terms thereof and such Warrants are enforceable against the Company in accordance with their respective terms, except: (i) as
such enforceability may be limited by bankruptcy, insolvency, reorganization or similar laws affecting creditors&rsquo; rights generally;
(ii) as enforceability of any indemnification or contribution provision may be limited under foreign, federal and state securities laws;
and (iii) that the remedy of specific performance and injunctive and other forms of equitable relief may be subject to the equitable defenses
and to the discretion of the court before which any proceeding therefor may be brought. The Class A Ordinary Shares issuable upon exercise
of the Warrants have been reserved for issuance upon the exercise of the Warrants and upon payment of the consideration therefor, and
when issued in accordance with the terms thereof such Class A Ordinary Shares will be duly and validly authorized, validly issued, fully
paid and non-assessable, and the holders thereof are not and will not be subject to personal liability by reason of being such holders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-family: Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">2.7.3&nbsp;<U>Placement
Securities</U>. The Private Placement Warrants included in the Private Placement Units constitute valid and binding obligations of the
Company to issue the number and type of securities of the Company called for thereby in accordance with the terms thereof, and are, or
will be, enforceable against the Company in accordance with their respective terms, except: (i)&nbsp;as such enforceability may be limited
by bankruptcy, insolvency, reorganization or similar laws affecting creditors&rsquo; rights generally; (ii)&nbsp;as enforceability of
any indemnification or contribution provision may be limited under federal and state securities laws; and (iii)&nbsp;that the remedy of
specific performance and injunctive and other forms of equitable relief may be subject to the equitable defenses and to the discretion
of the court before which any proceeding therefor may be brought. The Class A Ordinary Shares issuable upon exercise of the Private Placement
Warrants included in the Private Placement Units have been reserved for issuance and, when issued in accordance with the terms of the
Private Placement Warrants included in the Private Placement Units and registered in the Company&rsquo;s register of members, will be
duly and validly authorized, validly issued and upon payment therefor, fully paid and non-assessable, and the holders thereof are not
and will not be subject to personal liability by reason of being such holders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">2.7.4&nbsp;<U>No
Integration</U>. Neither the Company nor any of its affiliates has, prior to the date hereof, made any offer or sale of any securities
which are required to be or may be &ldquo;integrated&rdquo; pursuant to the Act or the Regulations with the Offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.8&nbsp;<U>Registration
Rights of Third Parties</U>. Except as set forth in the Registration Statement, the Sale Preliminary Prospectus and the Prospectus, no
holders of any securities of the Company or any rights exercisable for or convertible or exchangeable into securities of the Company have
the right to require the Company to register any such securities of the Company under the Act or to include any such securities in a registration
statement to be filed by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.9&nbsp;<U>Validity
and Binding Effect of Agreements</U>. This Agreement, the Warrant Agreement (as defined in <U>Section 2.23</U>), the Trust Agreement,
the Services Agreement (as defined in <U>Section 2.21.3</U>), the Registration Rights Agreement (as defined in <U>Section 2.21.4</U>)
and the Purchase Agreements (collectively, the &ldquo;<B>Transaction Documents</B>&rdquo;) have been duly and validly authorized by the
Company and, when executed and delivered, will constitute the valid and binding agreements of the Company, enforceable against the Company
in accordance with their respective terms, except: (i)&nbsp;as such enforceability may be limited by bankruptcy, insolvency, reorganization
or similar laws affecting creditors&rsquo; rights generally, (ii)&nbsp;as enforceability of any indemnification or contribution provision
may be limited under the foreign, federal, and state securities laws, and (iii)&nbsp;that the remedy of specific performance and injunctive
and other forms of equitable relief may be subject to the equitable defenses and to the discretion of the court before which any proceeding
therefor may be brought.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.10&nbsp;<U>No
Conflicts, Etc</U>. The execution, delivery, and performance by the Company of the Transaction Documents, the consummation by the Company
of the transactions herein and therein contemplated and the compliance by the Company with the terms hereof and thereof do not and will
not, with or without the giving of notice or the lapse of time or both: (i)&nbsp;result in a breach or violation of, or conflict with
any of the terms and provisions of, or constitute a default under, or result in the creation, modification, termination or imposition
of any lien, charge or encumbrance upon any property or assets of the Company pursuant to the terms of any agreement, obligation, condition,
covenant or instrument to which the Company is a party or bound or to which its property is subject except pursuant to the Trust Agreement
(ii)&nbsp;result in any violation of the provisions of the amended and restated memorandum and articles of association of the Company
(collectively, the &ldquo;<B>Charter Documents</B>&rdquo;); or (iii)&nbsp;violate any existing applicable statute, law, rule, regulation,
judgment, order or decree of any governmental agency or court, domestic or foreign, having jurisdiction over the Company or any of its
properties, assets or business constituted as of the date hereof; except in the case of clauses (i) and (iii) above for any such conflict,
breach or violation that would not, individually or in the aggregate, be reasonably expected to have a Material Adverse Effect (as defined
below).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-family: Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.11&nbsp;<U>No
Defaults; Violations</U>. No default or violation exists in the due performance and observance of any term, covenant or condition of any
license, contract, indenture, mortgage, deed of trust, note, loan or credit agreement, or any other agreement or instrument evidencing
an obligation for borrowed money, or any other agreement or instrument to which the Company is a party or by which the Company may be
bound or to which any of the properties or assets of the Company is subject, except for any such default or violation that would not,
individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. The Company is not in violation of any term
or provision of its Charter Documents or in violation of any franchise, license, permit, applicable law, rule, regulation, judgment or
decree of any governmental agency or court, domestic or foreign, having jurisdiction over the Company or any of its properties or businesses,
except for any such violation that would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.12&nbsp;<U>Corporate
Power; Licenses; Consents</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">2.12.1&nbsp;<U>Conduct
of Business</U>. The Company has all requisite corporate power and authority, and has all necessary authorizations, approvals, orders,
licenses, certificates and permits of and from all governmental regulatory officials and bodies that it needs as of the date hereof to
conduct its business purpose as described in the Registration Statement, the Sale Preliminary Prospectus and the Prospectus, except where
the failure to would not reasonably be expected to have a Material Adverse Effect. The disclosures in the Registration Statement, the
Sale Preliminary Prospectus and the Prospectus concerning the effects of foreign, federal, state and local regulation on this Offering
and the Company&rsquo;s business purpose as currently contemplated are correct in all material respects and do not omit to state a material
fact required to be stated therein or necessary in order to make the statements therein, in light of the circumstances under which they
were made, not misleading. Since its formation, the Company has conducted no business and has incurred no liabilities other than in connection
with and in furtherance of this Offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">2.12.2&nbsp;<U>Transactions
Contemplated Herein</U>. The Company has all requisite corporate power and authority to enter into the Transaction Documents and to carry
out the provisions and conditions hereof and thereof, and all consents, authorizations, approvals and orders required in connection herewith
and therewith have been obtained. No consent, authorization, or order of, and no filing with, any court, government agency or other body,
foreign or domestic, is required for the valid issuance, sale, and delivery, of the Securities and the consummation of the transactions
and agreements contemplated by the Transaction Documents and as contemplated by the Registration Statement, the Sale Preliminary Prospectus
and the Prospectus, except with respect to applicable foreign, federal and state securities laws, the rules of the Nasdaq Stock Market
(&ldquo;<B>Nasdaq</B>&rdquo;) and the rules and regulations promulgated by the Financial Industry Regulatory Authority (&ldquo;<B>FINRA</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.13&nbsp;<U>D&amp;O
Questionnaires</U>. To the Company&rsquo;s knowledge, assuming reasonable inquiry, all information contained in the questionnaires (&ldquo;<B>Questionnaires</B>&rdquo;)
completed by each of the Company&rsquo;s officers, directors and shareholders (&ldquo;<B>Insiders</B>&rdquo;) and provided to the Representative
and their counsel and the biographies of the Insiders contained in the Registration Statement, Sale Preliminary Prospectus and the Prospectus
(to the extent a biography is contained) is true and correct in all material respects and the Company has not become aware of any information
which would cause the information disclosed in the Questionnaires completed by each Insider to become inaccurate, incorrect or incomplete
in any material respect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.14&nbsp;<U>Litigation;
Governmental Proceedings</U>. There is no action, suit, proceeding, inquiry, arbitration, investigation, litigation or governmental proceeding
pending, or to the Company&rsquo;s knowledge, assuming reasonable inquiry, threatened against or involving the Company or, to the Company&rsquo;s
knowledge, assuming reasonable inquiry, any Insider or any shareholder or member of an Insider that would be reasonably expected to have
a Material Adverse Effect, that has not been disclosed, that is required to be disclosed, in the Registration Statement, the Sale Preliminary
Prospectus or the Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-family: Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.15&nbsp;<U>Good
Standing</U>. The Company has been duly incorporated and is validly existing as an exempted company and is in good standing under the
laws of its jurisdiction of incorporation. The Company is duly qualified to do business and is in good standing as a foreign corporation
in each jurisdiction in which its ownership or lease of property or the conduct of business requires such qualification, except where
the failure to qualify would not have a material adverse effect on the condition (financial or otherwise), earnings, assets, prospects,
business, operations or properties of the Company, whether or not arising from transactions in the ordinary course of business (a &ldquo;<B>Material
Adverse Effect</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.16&nbsp;<U>No
Contemplation of a Business Combination</U>. The Company has not selected any specific Business Combination target (each a &ldquo;<B>Target
Business</B>&rdquo;) and it has not, nor has anyone on its behalf, initiated any substantive discussions, directly or indirectly, with
any Target Business regarding a Business Combination with the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.17&nbsp;<U>Transactions
Requiring Disclosure to FINRA</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">2.17.1&nbsp;<U>Finder&rsquo;s
Fees</U>. There are no claims, payments, arrangements, agreements or understandings relating to the payment of a finder&rsquo;s, consulting
or origination fee by the Company or any Insider with respect to the sale of the Securities hereunder or any other arrangements, agreements
or understandings of the Company or to the Company&rsquo;s knowledge, assuming reasonable inquiry, any Insider that may affect the Underwriters&rsquo;
compensation, as determined by FINRA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">2.17.2&nbsp;<U>Payments
Within 180 Days</U>. The Company has not made any direct or indirect payments (in cash, securities or otherwise) to: (i) any person, as
a finder&rsquo;s fee, consulting fee or otherwise, in consideration of such person raising capital for the Company or introducing to the
Company persons who raised or provided capital to the Company; or (ii) any participating member, as defined in FINRA Rule 5110, with respect
to the Offering (&ldquo;<B>Participating Member</B>&rdquo;), within the 180-day period prior to the initial filing of the Registration
Statement, other than the prior payments to the Representative in connection with the Offering. The Company has not issued any warrants
or other securities, or granted any options, directly or indirectly, to any Participating Member within the 180-day period prior to the
initial filing date of the Registration Statement. No person to whom securities of the Company have been privately issued within the 180-day
period prior to the initial filing date of the Registration Statement has any relationship or affiliation or association with any Participating
Member. Except with respect to the Representative in connection with the Offering, the Company has not entered into any agreement or arrangement
(including, without limitation, any consulting agreement or any other type of agreement) during the 180-day period prior to the initial
filing date of the Registration Statement with the Commission, which arrangement or agreement provides for the receipt of any &ldquo;underwriting
compensation&rdquo; as defined in FINRA Rule 5110.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">2.17.3&nbsp;<U>FINRA
Affiliation</U>. No officer or director or any direct or indirect beneficial owner (including the Insiders) of any class of the Company&rsquo;s
unregistered securities (whether debt or equity, registered or unregistered, regardless of the time acquired or the source from which
derived) has any direct or indirect affiliation or association with any Participating Member (as determined in accordance with the rules
and regulations of FINRA). The Company will advise the Representative and DLA Piper if it learns that any officer or director or any direct
or indirect beneficial owner (including the Insiders) is or becomes an affiliate or associated person of a Participating Member.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">2.17.4&nbsp;<U>Share
Ownership</U>. No officer or director or any direct or indirect beneficial owner (including the Insiders) of any class of the Company&rsquo;s
unregistered securities is an owner of shares or other securities of any Participating Member (other than securities purchased on the
open market).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-family: Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">2.17.5&nbsp;<U>Loans</U>.
No officer or director or any direct or indirect beneficial owner (including the Insiders) of any class of the Company&rsquo;s unregistered
securities has made a subordinated loan to any Participating Member.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">2.17.6&nbsp;<U>Proceeds
of the Offering</U>. No proceeds from the sale of the Public Securities (excluding underwriting compensation), the Private Placement Units
or Option Private Placement Units, if any, will be paid to any Participating Member, except as specifically authorized herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">2.17.7&nbsp;<U>Conflicts
of Interest</U>. To the Company&rsquo;s knowledge, assuming reasonable inquiry, no Participating Member has a conflict of interest with
the Company. For this purpose, a &ldquo;<B>conflict of interest</B>&rdquo; exists when a Participating Member and/or its associated persons,
parent or affiliates in the aggregate beneficially own 10% or more of the Company&rsquo;s outstanding subordinated debt or common equity,
or 10% or more of the Company&rsquo;s preferred equity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.18&nbsp;<U>Taxes</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">2.18.1&nbsp;There
are no transfer taxes or other similar fees or charges under U.S. federal law or the laws of any U.S. state or any political subdivision
of the United States, required to be paid in connection with the execution and delivery of this Agreement or the issuance or sale by the
Company of the Public Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">2.18.2&nbsp;The
Company has filed all U.S. federal, state and local tax returns required to be filed with taxing authorities prior to the date hereof
in a timely manner or has duly obtained extensions of time for the filing thereof (except in any case in which the failure so to file
would not reasonably be expected to have a Material Adverse Effect). The Company has paid all taxes shown as due on such returns that
were filed and has paid all taxes imposed on it and any other assessment, fine or penalty levied against it, to the extent that any of
the foregoing is due and payable or as would not be reasonably expected to have a Material Adverse Effect. The Company has made appropriate
provisions in the applicable financial statements referred to in <U>Section&nbsp;2.5.1</U> above in respect of all federal, state, local
and foreign income taxes for all current or prior periods as to which the tax liability of the Company has not been finally determined.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.19&nbsp;<U>Foreign
Corrupt Practices Act; Anti-Money Laundering; Patriot Act</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">2.19.1&nbsp;<U>Foreign
Corrupt Practices Act</U>. Neither the Company nor to the Company&rsquo;s knowledge, assuming reasonable inquiry, any of the Insiders
or any other person acting on behalf of the Company has, directly or indirectly, given or agreed to give any money, gift or similar benefit
(other than legal price concessions to customers in the ordinary course of business) to any customer, supplier, employee or agent of a
customer or supplier, or official or employee of any governmental agency or instrumentality of any government (domestic or foreign) or
any political party or candidate for office (domestic or foreign) or other person who was, is, or may be in a position to help or hinder
the business of the Company (or assist it in connection with any actual or proposed transaction) that (i)&nbsp;might subject the Company
to any damage or penalty in any civil, criminal or governmental litigation or proceeding, (ii)&nbsp;if not given in the past, might have
had a Material Adverse Effect, or (iii)&nbsp;if not continued in the future, might adversely affect the assets, business or operations
of the Company. The Company has taken reasonable steps to ensure that its accounting controls and procedures are sufficient to cause the
Company to comply in all material respects with the Foreign Corrupt Practices Act of 1977, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">2.19.2&nbsp;<U>Currency
and Foreign Transactions Reporting Act</U>. The operations of the Company are and have been conducted at all times in compliance with
(i)&nbsp;the requirements of the U.S. Treasury Department Office of Foreign Asset Control and (ii)&nbsp;applicable financial recordkeeping
and reporting requirements of the Currency and Foreign Transaction Reporting Act of 1970, as amended, including the Money Laundering Control
Act of 1986, as amended, the rules and regulations thereunder and any related or similar money laundering statutes, rules, regulations
or guidelines, issued, administered or enforced by any Federal governmental agency (collectively, the &ldquo;<B>Money Laundering Laws</B>&rdquo;)
and no action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company
with respect to the Money Laundering Laws is pending or, to the Company&rsquo;s knowledge, assuming reasonable inquiry, threatened.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-family: Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">2.19.3&nbsp;<U>Patriot
Act</U>. Neither the Company nor to the Company&rsquo;s knowledge, assuming reasonable inquiry, any Insider has violated the Bank Secrecy
Act of 1970, as amended, or Uniting and Strengthening of America by Providing Appropriate Tools Required to Intercept and Obstruct Terrorism
(USA PATRIOT ACT) Act of 2001, and/or the rules and regulations promulgated under any such law, or any successor law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.20&nbsp;<U>Officers&rsquo;
Certificate</U>. Any certificate signed by any duly authorized officer of the Company in connection with the Offering and delivered to
the Representative or to DLA Piper shall be deemed a representation and warranty by the Company to the Underwriters as to the matters
covered thereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.21&nbsp;<U>Agreements
With Insiders</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">2.21.1&nbsp;<U>Insider
Letter</U>. On the date of this Agreement, the Company will cause to be duly executed and delivered to the Underwriters a legally binding
and enforceable agreement (except (i)&nbsp;as such enforceability may be limited by bankruptcy, insolvency, reorganization or similar
laws affecting creditors&rsquo; rights generally, (ii)&nbsp;as enforceability of any indemnification, contribution or non-compete provision
may be limited under foreign, federal and state securities laws, and (iii)&nbsp;that the remedy of specific performance and injunctive
and other forms of equitable relief may be subject to the equitable defenses and to the discretion of the court before which any proceeding
therefor may be brought), a form of which is annexed as an exhibit to the Registration Statement (the &ldquo;<B>Insider Letter</B>&rdquo;),
pursuant to which each of the Insiders of the Company agree to certain matters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">2.21.2&nbsp;<U>Purchase
Agreements</U>. On the date of this Agreement, the Company and the Sponsor have executed and delivered to the Underwriters a Private Placement
Units Purchase Agreement, the form of which is annexed as an exhibit to the Registration Statement (the &ldquo;<B>Sponsor Purchase Agreement</B>&rdquo;),
pursuant to which the Sponsor will, among other things, on the Closing Date, consummate the purchase of and deliver the purchase price
for the Private Placement Units to be sold to the Sponsor as described in <U>Section 1.4.2,</U> and as provided for in such Sponsor Purchase
Agreement. The Company and the Representative shall have executed and delivered a Private Placement Units Purchase Agreement, the form
of which is annexed as an exhibit to the Registration Statement (the &ldquo;<B>Representative Purchase Agreement</B>&rdquo; and together
with the Sponsor Purchase Agreement, the &ldquo;<B>Purchase Agreements</B>&rdquo;), pursuant to which the Representative will, among other
things, on the Closing Date and Option Closing Date, if any, consummate the purchase of and deliver the purchase price for the Private
Placement Units to be sold to the Representative as described in <U>Section 1.4.2</U> and as provided for in such Representative Purchase
Agreement. Pursuant to the Purchase Agreements, (i) each of the Sponsor and the Representative have waived any and all rights and claims
they may have to any proceeds, and any interest thereon, held in the Trust Account in respect of the Private Placement Units, and (ii)
certain of the proceeds from the sale of the Private Placement Units and certain of the proceeds from the sale of the Option Private Placement
Units, if any, will be deposited by the Company in the Trust Account in accordance with the terms of the Trust Agreement on the Closing
Date and Option Closing Date (if any) as provided for in the Purchase Agreements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">2.21.3&nbsp;<U>Services
Agreement</U>. On the date of this Agreement (a) the Company and the Sponsor have executed and delivered to the Underwriters an Administrative
Services Agreement, the form of which is annexed as an exhibit to the Registration Statement (the &ldquo;<B>Services Agreement</B>&rdquo;),
pursuant to which the Sponsor will provide office space, utilities, secretarial and administrative services to the Company, for which
the Company will pay the Sponsor $2,500 per month until the completion of the Business Combination and (b) the Company has approved payments
to William M. Brown, for his services as Chief Executive Officer of the Company, of $12,500 per month starting on the Effective Date and
continuing until the earliest of (x) the completion of the Business Combination, (y) the liquidation of the Company and (z) the date that
is 24 months following the Effective Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-family: Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">2.21.4&nbsp;<U>Registration
Rights Agreement</U>. On the date of this Agreement, the Company, the Sponsor, the Representative and other holders of the Founder Shares,
if any, entered into and delivered to the Underwriters a Registration Rights Agreement (the &ldquo;<B>Registration Rights Agreement</B>&rdquo;)
substantially in the form annexed as an exhibit to the Registration Statement, whereby such parties will be entitled to certain registration
rights with respect to the securities they hold or may hold, as set forth in such Registration Rights Agreement and described more fully
in the Registration Statement, the Sale Preliminary Prospectus and the Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">2.21.5&nbsp;<U>Loans</U>.
The Sponsor has agreed to make loans to the Company in the aggregate amount of up to $400,000 (the &ldquo;<B>Insider Loans</B>&rdquo;)
pursuant to a promissory note, as amended, substantially in the form annexed as an exhibit to the Registration Statement. The Insider
Loans do not bear any interest and are repayable by the Company on the earlier of December 31, 2024 or the consummation of the Offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.22&nbsp;<U>Investment
Management Trust Agreement</U>. On the date of this Agreement, the Company has entered into and delivered to the Underwriters the Trust
Agreement with respect to certain proceeds of the Offering and the Unit Private Placement substantially in the form annexed as an exhibit
to the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.23&nbsp;<U>Warrant
Agreement</U>. On the date of this Agreement, the Company has entered into and delivered to the Underwriters a warrant agreement with
respect to the Warrants underlying the Units and the Private Placement Warrants included in the Private Placement Units and certain other
warrants that may be issued by the Company with Continental substantially in the form filed as an exhibit to the Registration Statement
(the &ldquo;<B>Warrant Agreement</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.24&nbsp;<U>No
Existing Non-Competition Agreements</U>. No Insider is subject to any non-competition agreement or non-solicitation agreement with any
employer or prior employer which could materially affect his ability to be an employee, officer and/or director of the Company, except
as disclosed in the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.25&nbsp;<U>Investments</U>.
No more than 45% of the &ldquo;value&rdquo; (as defined in Section 2(a)(41) of the Investment Company Act of 1940, as amended (the &ldquo;<B>Investment
Company Act</B>&rdquo;)) of the Company&rsquo;s total assets consist of, and no more than 45% of the Company&rsquo;s net income after
taxes is derived from, securities other than &ldquo;Government Securities&rdquo; (as defined in Section 2(a)(16) of the Investment Company
Act) or money market funds meeting the conditions of Rule 2a-7 of the Investment Company Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.26&nbsp;<U>Investment
Company Act</U>. The Company is not required, and upon the issuance and sale of the Securities as herein contemplated and the application
of the net proceeds therefrom as described in the Sale Preliminary Prospectus and Prospectus will not be required, to register as an &ldquo;investment
company&rdquo; under the Investment Company Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.27&nbsp;<U>Subsidiaries</U>.
The Company does not own an interest in any corporation, partnership, limited liability company, joint venture, trust or other business
entity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-family: Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.28&nbsp;<U>Related
Party Transactions</U>. No relationship, direct or indirect, exists between or among the Company, on the one hand, and any Insider, on
the other hand, which is required by the Act, the Exchange Act or the Regulations to be described in the Registration Statement, the Sale
Preliminary Prospectus and the Prospectus which is not so described as required. There are no outstanding loans, advances (except normal
advances for business expenses in the ordinary course of business), or guarantees of indebtedness by the Company to or for the benefit
of any of the officers or directors of the Company or any of their respective family members, except as disclosed in the Registration
Statement, the Sale Preliminary Prospectus and Prospectus. The Company has not extended or maintained credit, arranged for the extension
of credit, or renewed an extension of credit, in the form of a personal loan to or for any director or officer of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.29&nbsp;<U>No
Influence</U>. The Company has not offered, or caused the Underwriters to offer, the Firm Units to any person or entity with the intention
of unlawfully influencing: (a)&nbsp;a customer or supplier of the Company or any affiliate of the Company to alter the customer&rsquo;s
or supplier&rsquo;s level or type of business with the Company or such affiliate or (b)&nbsp;a journalist or publication to write or publish
favorable information about the Company or any such affiliate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.30&nbsp;<U>Sarbanes-Oxley</U>.
The Company is, or on the Closing Date will be, in material compliance with the provisions of the Sarbanes-Oxley Act of 2002, as amended
(the &ldquo;<B>Sarbanes-Oxley Act</B>&rdquo;), and the rules and regulations promulgated thereunder and related or similar rules or regulations
promulgated by any governmental or self-regulatory entity or agency, that are applicable to it as of the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.31&nbsp;<U>Distribution
of Offering Material by the Company</U>. The Company has not distributed and will not distribute, prior to the later of the Closing Date
and the completion of the distribution of the Units, any offering material in connection with the offering and sale of the Units other
than the Sale Preliminary Prospectus and the Prospectus, in each case as supplemented and amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.32&nbsp;<U>Listing
on Nasdaq</U>. The Public Securities have been authorized for listing, subject to official notice of issuance and evidence of satisfactory
distribution, on Nasdaq, and the Company knows of no reason or set of facts that is likely to adversely affect such authorization.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.33&nbsp;<U>Board
of Directors</U>. As of the Effective Date, the Board of Directors of the Company will be comprised of the persons set forth as &ldquo;Directors&rdquo;
or &ldquo;Director nominees&rdquo; under the heading of the Sale Preliminary Prospectus and the Prospectus captioned &ldquo;Management.&rdquo;
As of the Effective Date, the qualifications of the persons serving as board members and the overall composition of the board will comply
with the Sarbanes-Oxley Act and the rules promulgated thereunder and the rules of Nasdaq that are, in each case, applicable to the Company.
As of the Effective Date, the Company will have an Audit Committee that satisfies the applicable requirements under the Sarbanes-Oxley
Act and the rules promulgated thereunder and the rules of Nasdaq.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.34&nbsp;<U>Emerging
Growth Company</U>. From its formation through the date hereof, the Company has been and is an &ldquo;emerging growth company,&rdquo;
as defined in Section&nbsp;2(a) of the Act (an &ldquo;<B>Emerging Growth Company</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.35&nbsp;<U>No
Disqualification Events</U>. Neither the Company, nor any of its predecessors or any affiliated issuer, nor any director, executive officer,
or other officer of the Company participating in the Offering, nor any beneficial owner of 20% or more of the Company&rsquo;s outstanding
voting equity securities, calculated on the basis of voting power, nor any promoter (as that term is defined in Rule&nbsp;405 under the
Act) connected with the Company in any capacity at the time of sale (each, a &ldquo;<B>Company Covered Person</B>&rdquo; and, together,
&ldquo;<B>Company Covered Persons</B>&rdquo;) is subject to any of the &ldquo;Bad Actor&rdquo; disqualifications described in Rule&nbsp;506(d)(1)(i)
to (viii) under the Act (a &ldquo;<B>Disqualification Event</B>&rdquo;), except for a Disqualification Event covered by Rule&nbsp;506(d)(2)
or (d)(3). The Company has exercised reasonable care to determine whether any Company Covered Person is subject to a Disqualification
Event. The Company has complied, to the extent applicable, with its disclosure obligations under Rule&nbsp;506(e), and has furnished to
the Representative a copy of any disclosures provided thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-family: Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">2.36&nbsp;<U>Free-Writing
Prospectus and Testing-the-Waters</U>. The Company has not made any offer relating to the Public Securities that would constitute an issuer
free writing prospectus, as defined in Rule&nbsp;433 under the Act, or that would otherwise constitute a &ldquo;free writing prospectus&rdquo;
as defined in Rule&nbsp;405. The Company: (a)&nbsp;has not engaged in any Testing-the-Waters Communication other than Testing-the-Waters
Communications with the consent of the Representative with entities that are qualified institutional buyers within the meaning of Rule&nbsp;144A
under the Act or institutions that are accredited investors within the meaning of Rule&nbsp;501 under the Act and (b)&nbsp;has not authorized
anyone to engage in Testing-the-Waters Communications other than its officers and the Representative and individuals engaged by the Representative.
The Company has not distributed any written Testing-the-Waters Communications other than those listed on Schedule B hereto. &ldquo;<B>Testing-the-Waters
Communication</B>&rdquo; means any oral or written communication with potential investors undertaken in reliance on Section&nbsp;5(d)
of the Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">3.&nbsp;<U>Covenants
of the Company</U>. The Company covenants and agrees as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">3.1&nbsp;<U>Amendments
to Registration Statement</U>. The Company will deliver to the Representative, prior to filing, any amendment or supplement to the Registration
Statement, any Preliminary Prospectus or the Prospectus proposed to be filed after the Effective Date and the Company shall not file any
such amendment or supplement to which the Representative reasonably objects in writing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">3.2&nbsp;<U>Federal
Securities Laws</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">3.2.1&nbsp;<U>Compliance</U>.
During the time when a Prospectus is required to be delivered under the Act, the Company will use its best efforts to comply with all
requirements imposed upon it by the Act, the Regulations, and the Exchange Act, and by the regulations under the Exchange Act, as from
time to time in force, so far as necessary to permit the continuance of sales of or dealings in the Securities in accordance with the
provisions hereof and the Sale Preliminary Prospectus and the Prospectus. If at any time when a Prospectus relating to the Securities
is required to be delivered under the Act, any event shall have occurred as a result of which, in the opinion of counsel for the Company
or counsel for the Representative, the Prospectus, as then amended or supplemented, includes an untrue statement of a material fact or
omits to state any material fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances
under which they were made, not misleading, or if it is necessary at any time to amend or supplement the Prospectus to comply with the
Act, the Company will notify the Representative promptly and prepare and file with the Commission, subject to <U>Section&nbsp;3.1</U>
hereof, an appropriate amendment or supplement in accordance with Section 10 of the Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">3.2.2&nbsp;<U>Filing
of Final Prospectus</U>. The Company will file the Prospectus (in form and substance satisfactory to the Representative) with the Commission
pursuant to the requirements of Rule&nbsp;424 of the Regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">3.2.3&nbsp;<U>Exchange
Act Registration</U>. The Company will use its best efforts to maintain the registration of the Class A Ordinary Shares (or any successor
security for which Class&nbsp;A Ordinary Shares are exchangeable in connection with a Business Combination) under the provisions of the
Exchange Act (except in connection with a going-private transaction) for a period of five years from the Effective Date, or until the
Company is required to be liquidated or is acquired, if earlier, or, in the case of the Warrants, until the Warrants expire and are no
longer exercisable or have been exercised or redeemed in full. The Company will not deregister the Public Securities under the Exchange
Act without the prior written consent of the Representative prior to the earlier of the Company&rsquo;s liquidation or the Business Combination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">3.2.4&nbsp;<U>Exchange
Act Filings</U>. From the Effective Date until the earlier of the Company&rsquo;s initial Business Combination, or its liquidation and
dissolution, the Company shall timely file with the Commission via the Electronic Data Gathering, Analysis and Retrieval System (&ldquo;<B>EDGAR</B>&rdquo;)
such statements and reports as are required to be filed by a company registered under Section&nbsp;12(b) of the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-family: Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">3.2.5&nbsp;<U>Sarbanes-Oxley
Compliance</U>. As soon as it is legally required to do so, the Company shall take all actions necessary to obtain and thereafter maintain
material compliance with each applicable provision of the Sarbanes-Oxley Act and the rules and regulations promulgated thereunder and
related or similar rules and regulations promulgated by any other governmental or self-regulatory entity or agency with jurisdiction over
the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">3.3&nbsp;<U>Free-Writing
Prospectus</U>. The Company agrees that it will not make any offer relating to the Public Securities that would constitute an issuer free
writing prospectus, as defined in Rule&nbsp;433 under the Act, or that would otherwise constitute a &ldquo;free writing prospectus&rdquo;
as defined in Rule&nbsp;405, without the prior consent of the Representative.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">3.4&nbsp;<U>Delivery
to Underwriters of Prospectuses</U>. The Company will deliver to the Underwriters, without charge and from time to time during the period
when the Prospectus is required to be delivered under the Act or the Exchange Act, such number of copies of each Preliminary Prospectus
and the Prospectus as the Underwriters may reasonably request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">3.5&nbsp;<U>Effectiveness
and Events Requiring Notice to the Representative</U>. The Company will use its reasonable best efforts to cause the Registration Statement
to remain effective and will notify the Representative as promptly as reasonably possible and confirm the notice in writing: (i)&nbsp;of
the effectiveness of the Registration Statement and any amendment thereto; (ii)&nbsp;of the issuance by the Commission of any stop order
suspending the effectiveness of the Registration Statement or any post-effective amendment thereto or preventing or suspending the use
of any Preliminary Prospectus or the Prospectus or of the initiation, or the threatening, of any proceeding for that purpose; (iii)&nbsp;of
the issuance by any foreign or state securities commission of any proceedings for the suspension of the qualification of the Public Securities
for offering or sale in any jurisdiction or of the initiation, or the threatening, of any proceeding for that purpose; (iv)&nbsp;of the
mailing and delivery to the Commission for filing of any amendment or supplement to the Registration Statement or Prospectus; (v)&nbsp;of
the receipt of any comments or request for any additional information from the Commission; and (vi)&nbsp;of the happening of any event
that, in the reasonable judgment of the Company, makes any statement of a material fact made in the Registration Statement or the Prospectus
untrue or that requires the making of any changes in the Registration Statement or the Prospectus in order to make the statements therein,
and in light of the circumstances under which they were made, not misleading. If the Commission or any foreign or state securities commission
shall enter a stop order or suspend such qualification at any time, the Company will make every reasonable effort to obtain promptly the
lifting of such order.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">3.6&nbsp;<U>Affiliated
Transactions</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">3.6.1&nbsp;<U>Business
Combinations</U>. The Company will not consummate a Business Combination with any entity that is affiliated with any Insider unless (i)&nbsp;the
Company or a committee of independent and disinterested members of its board of directors obtains an opinion from an independent investment
banking firm or another independent entity that commonly renders valuation opinions that the Business Combination is fair to the Company
from a financial point of view and (ii)&nbsp;a majority of the Company&rsquo;s disinterested and independent directors (if there are any)
approve such transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">3.6.2&nbsp;<U>Compensation
to Insiders</U>. Except as disclosed in the Prospectus, the Company shall not pay any of the Insiders or any of their affiliates any fees
or compensation from the Company, for services rendered to the Company prior to, or in connection with, the consummation of a Business
Combination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-family: Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">3.7&nbsp;<U>Reports
to the Representative</U>. For a period from the Effective Date until such time when the Company either completes its Business Combination
or is required to be liquidated, the Company will furnish to the Representative and its counsel copies of such financial statements and
other periodic and special reports as the Company from time to time furnishes generally to holders of any class of its securities, and
promptly furnish to the Representative: (i)&nbsp;a copy of each periodic report the Company files with the Commission, (ii)&nbsp;a copy
of every press release and every news item and article with respect to the Company or its affairs that was released by the Company, (iii)&nbsp;a
copy of each current Report on Form 8-K or Schedules 13D, 13G, 14D-1 or 13E-4 received or prepared by the Company, (iv)&nbsp;two copies
of each registration statement filed by the Company with the Commission under the Act, and (v)&nbsp;such additional documents and information
with respect to the Company and the affairs of any future subsidiaries of the Company as the Representative may from time to time reasonably
request; <U>provided</U> the Representative shall sign, if requested by the Company, a Regulation FD compliant confidentiality agreement
which is reasonably acceptable to the Representative and their counsel in connection with the Representative receipt of such information.
Documents filed with the Commission pursuant to its EDGAR system shall be deemed to have been delivered to the Representative pursuant
to this Section.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">3.8&nbsp;<U>Transfer
Agent</U>. For a period from the Effective Date until such time when the Company either completes its Business Combination or is required
to be liquidated, the Company shall retain a transfer agent and warrant agent acceptable to the Representative. Continental is acceptable
to the Representative.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">3.9&nbsp;<U>Payment
of Expenses</U>. The Company hereby agrees to pay on each of the Closing Date and the Option Closing Date, if any, to the extent not paid
at Closing Date, all Company expenses incident to the performance of the obligations of the Company under this Agreement, including but
not limited to (i)&nbsp;the Company&rsquo;s legal and accounting fees and disbursements, (ii)&nbsp;the preparation, printing, filing,
mailing and delivery (including the payment of postage with respect to such mailing) of the Registration Statement, the Preliminary Sale
Prospectus and the Prospectus, including any pre- or post-effective amendments or supplements thereto, and the printing and mailing of
this Agreement and related documents, including the cost of all copies thereof and any amendments thereof or supplements thereto supplied
to the Underwriters in quantities as may be required by the Underwriters, (iii)&nbsp;fees incurred in connection with conducting background
checks of the Company&rsquo;s management team, not to exceed $2,500 per person (in the case investigations and background checks in U.S.
jurisdictions) and $3,000 per person (in the case of investigations and background checks in non-U.S. jurisdictions), (iv)&nbsp;the preparation,
printing, engraving, issuance and delivery of the Units, the Class A Ordinary Shares and the Warrants included in the Units, including
any transfer or other taxes payable thereon, (v)&nbsp;filing fees incurred in registering the Offering with FINRA, (vi)&nbsp;fees, costs
and expenses incurred in listing the Securities on Nasdaq or such other share exchanges as the Company and the Underwriter together determine,
(vii)&nbsp;all fees and disbursements of the transfer and warrant agent, (viii)&nbsp;reasonable expenses from all participants (including
the Underwriters) associated with &ldquo;due diligence&rdquo; and &ldquo;road show&rdquo; meetings arranged by the Representative and
any presentations made available by way of a net roadshow, including without limitation trips for the Company&rsquo;s management to meet
with prospective investors, all travel, food and lodging expenses associated with such trips incurred by the Company or such management;
(ix)&nbsp;the documented fees of the Representative&rsquo;s legal counsel <FONT STYLE="background-color: white">incurred in connection
with the review and qualification of the Offering by FINRA</FONT> (which amount shall not exceed $15,000); (x)<FONT STYLE="font-size: 10pt">&nbsp;</FONT>the
cost of Ipreo database charges; and (xi)&nbsp;all other costs and expenses customarily borne by an issuer incident to the performance
of its obligations hereunder which are not otherwise specifically provided for in this <U>Section 3.9</U>, <U>provided</U> that such expenses
have been pre-approved by the Company or the Sponsor (including any advance for such out-of-pocket costs, and not including any costs
referred to in clause (iii) above) and <U>further provided</U> that the maximum reimbursement to the Underwriters under this section shall
not exceed $65,000. If the Offering is consummated, the Representative may deduct from the net proceeds of the Offering payable to the
Company on the Closing Date the expenses set forth above (which shall be mutually agreed upon between the Company and the Representative
prior to Closing) to be paid by the Company to the Representative and others. If the Offering is not consummated for any reason other
than a breach by the Underwriters of their obligations hereunder, the expenses set forth above paid by the Representative, shall, so long
as they have first been pre-approved by the Sponsor or the Company, be reimbursed by the Sponsor or the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-family: Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">In addition, the Company agrees
to pay for the reasonable and documented costs and expenses reasonably incurred by the Underwriters in connection with the Business Combination,
including the fees and expenses of their legal counsel, to the extent provided for in <U>Section 3.32</U> hereof (which shall not exceed
an amount to be mutually agreed upon by the Company and the Representative at such time).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">3.10&nbsp;<U>Application
of Net Proceeds</U>. The Company will apply the net proceeds from the Offering and Unit Private Placement received by it in a manner materially
consistent with the application described under the caption &ldquo;Use of Proceeds&rdquo; in the Prospectus.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">3.11&nbsp;<U>Delivery
of Earnings Statements to Security Holders</U>. The Company will make generally available to its security holders as soon as practicable,
but not later than the first day of the fifteenth full calendar month following the Effective Date, an earnings statement (which need
not be certified by independent public or independent certified public accountants unless required by the Act or the Regulations, but
which shall satisfy the provisions of Rule&nbsp;158(a) under Section 11(a) of the Act) covering a period of at least twelve consecutive
months beginning after the Effective Date. Any financial statements filed or furnished on the Commission&rsquo;s EDGAR website will be
considered to be generally available to security holders for purposes of this <U>Section&nbsp;3.11</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">3.12&nbsp;<U>Notice
to the Representative or FINRA</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">3.12.1&nbsp;<U>Notice
to the Representative</U>. For a period of 60 days after the date of the Prospectus, in the event any person or entity (regardless of
any FINRA affiliation or association) is engaged, in writing, to assist the Company in its search for a Target Business or to provide
any other services in connection therewith, the Company will provide the following to the Representative prior to the consummation of
the Business Combination: (i)&nbsp;complete details of all services and copies of agreements governing such services; and (ii)&nbsp;justification
as to why the person or entity providing the merger and acquisition services should not be considered a Participating Member with respect
to the Offering. The Company also agrees that, if required by law, proper disclosure of such arrangement or potential arrangement will
be made in the tender offer documents or proxy statement which the Company will file with the Commission in connection with the Business
Combination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">3.12.2&nbsp;<U>FINRA</U>.
The Company shall advise the Representative (who shall make an appropriate filing with FINRA) if it is aware that any 10% or greater shareholder
of the Company becomes a Participating Member.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">3.12.3&nbsp;<U>Broker/Dealer</U>.
In the event the Company intends to register as a broker/dealer, merge with or acquire a registered broker/dealer, or otherwise become
a member of FINRA, it shall promptly notify FINRA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">3.13&nbsp;<U>Stabilization</U>.
Neither the Company, nor to its knowledge, assuming reasonable inquiry, any of its employees, directors or shareholders (without the consent
of the Representative) has taken or will take, directly or indirectly, any action designed to or that has constituted or that might reasonably
be expected to cause or result in, under the Exchange Act, or otherwise, stabilization or manipulation of the price of any security of
the Company to facilitate the sale or resale of the Units.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">3.14&nbsp;<U>Intentionally
Omitted</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-family: Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">3.15&nbsp;<U>Payment
of Deferred Underwriting Commission on Business Combination</U>. Upon the consummation of the Company&rsquo;s initial Business Combination,
the Company agrees that it will cause the Trustee to pay the Deferred Underwriting Commission directly from the Trust Account to the Representative,
in accordance with <U>Section 1.3</U>. The Representative shall have no claim to payment of any interest earned on the portion of the
proceeds held in the Trust Account representing the Deferred Underwriting Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">3.16&nbsp;<U>Internal
Controls</U>. The Company will maintain a system of internal accounting controls sufficient to provide reasonable assurances that: (i)&nbsp;transactions
are executed in accordance with management&rsquo;s general or specific authorization, (ii)&nbsp;transactions are recorded as necessary
in order to permit preparation of financial statements in accordance with GAAP and to maintain accountability for assets, (iii)&nbsp;access
to assets is permitted only in accordance with management&rsquo;s general or specific authorization, and (iv)&nbsp;the recorded accountability
for assets is compared with existing assets at reasonable intervals and appropriate action is taken with respect to any differences.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">3.17&nbsp;<U>Accountants</U>.
Until the earlier of five years from the Effective Date or until such earlier time upon which the Company is required to be liquidated,
the Company shall retain Withum or another nationally recognized independent registered public accounting firm.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">3.18&nbsp;<U>Form
8-K</U>. The Company shall, on or prior to the date hereof, retain its independent registered public accounting firm to audit the balance
sheet of the Company as of the Closing Date (&ldquo;<B>Audited Financial Statements</B>&rdquo;) reflecting the receipt by the Company
of the proceeds of the Offering and the Unit Private Placement. Within four Business Days after the Closing Date, the Company shall file
a Current Report on Form 8-K with the Commission, which report shall contain the Company&rsquo;s Audited Financial Statements. Additionally,
upon the Company&rsquo;s receipt of the proceeds from the exercise of all or any portion of the Over-allotment Option provided for in
<U>Section 1.2</U> hereof, the Company shall promptly, but not later than four business days after the receipt of such proceeds, file
a Current Report on Form&nbsp;8-K with the Commission, which report shall disclose the Company&rsquo;s sale of the Option Units and its
receipt of the proceeds therefrom, unless the receipt of such proceeds are reflected in the Current Report on Form&nbsp;8-K referenced
in the immediately prior sentence.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">3.19&nbsp;<U>Corporate
Proceedings</U>. All corporate proceedings and other legal matters necessary to carry out the provisions of this Agreement and the transactions
contemplated hereby shall have been done to the reasonable satisfaction of DLA Piper.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">3.20&nbsp;<U>Investment
Company</U>. <FONT STYLE="background-color: white">The Company shall cause the proceeds of the Offering to be held in the Trust Account
to be invested only as provided for in the Trust Agreement and disclosed in the Prospectus. The Company will conduct its business in a
manner so that it will not become subject to the Investment Company Act. Furthermore, once the Company consummates a Business Combination,
it shall be engaged in a business other than that of investing, reinvesting, owning, holding or trading securities</FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">3.21&nbsp;<U>Amendments
to Charter Documents</U>. The Company covenants and agrees, that prior to its initial Business Combination it will not seek to amend or
modify its Charter Documents, except as set forth therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">3.22&nbsp;<U>Press
Releases</U>. The Company agrees that it will not issue press releases or engage in any other publicity, without the Representative&rsquo;s
prior written consent (not to be unreasonably delayed, conditioned or withheld), for a period of 25 days after the Closing Date. Notwithstanding
the foregoing, in no event shall the Company be prohibited from issuing any press releases or engaging in any other publicity required
by law, except that including the name of any Underwriter therein shall require the prior written consent of such Underwriter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-family: Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">3.23&nbsp;<U>Insurance</U>.
The Company will maintain directors&rsquo; and officers&rsquo; insurance (including, without limitation, insurance covering the Company,
its directors and officers for liabilities or losses arising in connection with this Offering, including, without limitation, liabilities
or losses arising under the Act, the Exchange Act, the Regulations and any applicable foreign securities laws) until the consummation
of the Company&rsquo;s Business Combination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">3.24&nbsp;<U>Electronic
Prospectus</U>. The Company shall cause to be prepared and delivered to the Underwriters, at the Company&rsquo;s expense, promptly, but
in no event later than two Business Days from the effective date of this Agreement, an Electronic Prospectus to be used by the Underwriters
in connection with the Offering. As used herein, the term &ldquo;<B>Electronic Prospectus</B>&rdquo; means a form of prospectus, and any
amendment or supplement thereto, that meets each of the following conditions: (i) it shall be encoded in an electronic format, satisfactory
to the Representative, that may be transmitted electronically by the Underwriters to offerees and purchasers of the Units for at least
the period during which a prospectus relating to the Units is required to be delivered under the Act; (ii) it shall disclose the same
information as the paper prospectus and prospectus filed pursuant to EDGAR, except to the extent that graphic and image material cannot
be disseminated electronically, in which case such graphic and image material shall be replaced in the electronic prospectus with a fair
and accurate narrative description or tabular representation of such material, as appropriate; and (iii) it shall be in or convertible
into a paper format or an electronic format, satisfactory to the Representative, that will allow recipients thereof to store and have
continuously ready access to the prospectus at any future time, without charge to such recipients (other than any fee charged for subscription
to the Internet as a whole and for on-line time).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">3.25&nbsp;<U>Private
Placement Proceeds</U>. On or prior to the Closing Date and each Option Closing Date, if any, the Company shall have caused the applicable
proceeds from the Unit Private Placement and certain of the proceeds from the sale of the Option Private Placement Units, if any, to be
deposited into the Trust Account in accordance with the Purchase Agreements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">3.26&nbsp;<U>Future
Financings</U>. The Company agrees that neither it, nor any successor or subsidiary of the Company, will consummate any public or private
equity or debt financing prior to the consummation of a Business Combination, unless all investors in such financing expressly waive,
in writing, any rights in or claims against the Trust Account with respect to such financing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">3.27&nbsp;<U>Amendments
to Agreements</U>. Prior to the consummation of the Business Combination, the Company shall not amend, modify or otherwise change the
Trust Agreement or any Insider Letter without the prior written consent of the Representative, which will not be unreasonably delayed,
conditioned or withheld.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">3.28&nbsp;<U>Maintenance
of Nasdaq Listing</U>. Until the consummation of a Business Combination, the Company will use its commercially reasonable efforts to maintain
the listing of the Public Securities on Nasdaq or a national securities exchange acceptable to the Representative.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">3.29&nbsp;<U>Reservation
of Shares</U>. The Company will reserve and keep available that maximum number of its authorized but unissued securities which are issuable
upon exercise of the Warrants and the Private Placement Warrants included in the Private Placement Units outstanding from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">3.30&nbsp;<U>Notice
of Disqualification Events</U>. The Company will notify the Representative in writing, prior to the Closing Date, of (i) any Disqualification
Event relating to any Company Covered Person and (ii) any event that would, with the passage of time, become a Disqualification Event
relating to any Company Covered Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-family: Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">3.31&nbsp;<U>Clear
Market</U>. For a period of 180 days after the date of the Prospectus, the Company will not (i) offer, sell, contract to sell, pledge
or grant any option to purchase or otherwise dispose of, directly or indirectly, or submit to, or file with, the Commission a registration
statement under the Act relating to, any Units, Class A Ordinary Shares, Founder Shares, Warrants or any securities convertible into or
exercisable or exchangeable for any Class A Ordinary Shares or Founder Shares or publicly disclose the intention to undertake any of the
foregoing, or (ii) enter into any swap or other arrangement that transfers, in whole or in part, any of the economic consequences of ownership
of any Units, Class A Ordinary Shares, Founder Shares, Warrants or any securities convertible into, or exercisable, or exchangeable for,
Class&nbsp;A Ordinary Shares or Founder Shares owned, whether any such transaction described in clause (i) or (ii) above is to be settled
by delivery of such securities, in cash or otherwise, without the prior written consent of the Representative, except, in each case, that
the Company may (a) issue and sell the Private Placement Units, (b) issue and sell the Option Units on exercise of the option provided
for in <U>Section 1.2.2</U> hereof (if any), (c) register with the Commission pursuant to the Registration Rights Agreement, the resale
of the Founder Shares, the Private Placement Units and warrants that may be issued upon conversion of working capital loans (and any Class
A Ordinary Shares issuable upon exercise of the Private Placement Warrants underlying the Private Placement Units or warrants issued upon
conversion of working capital loans and upon conversion of the Founder Shares) and (d) issue securities in connection with a Business
Combination. However, the preceding clauses (i) and (ii) shall not apply to the forfeiture of any Founder Shares pursuant to their terms
or any transfer of Founder Shares to any current or future independent director of the Company (as long as such current or future independent
director transferee is subject to the terms of the Insider Letter applicable to directors and officers at the time of such transfer; and
as long as, to the extent any reporting obligation under Section 16 of the Exchange Act is triggered as a result of such transfer, any
related filing includes a practical explanation as to the nature of the transfer). The Representative in its sole discretion may release
or waive the transfer restrictions set forth herein at any time without notice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">3.32&nbsp;In
connection with the initial Business Combination, the Company shall, if requested by the Underwriters, (i)&nbsp;provide, or cause the
target of the initial Business Combination to provide, to the Underwriters and their representatives, customary documentation, including
(A)&nbsp;all financial and other records, including any financial forecasts or projections, (B)&nbsp;pertinent corporate documents, (C)&nbsp;material
contracts, (D)&nbsp;documents and information contained in the virtual data room used in connection with the initial Business Combination,
and (E) any other information, certifications or documentation reasonably requested by the Underwriters and their representatives with
respect to the parties to the Business Combination Agreement, in each case, with reasonable advance opportunity to review the foregoing;
(ii) cause appropriate officers, directors and employees of the parties to the Business Combination Agreement, and cause representatives
of the Company&rsquo;s and the initial Business Combination target&rsquo;s accountants and auditors, to participate in any due diligence
sessions reasonably requested by the Underwriters in connection with the initial Business Combination; and (iii)&nbsp;provide, and in
the case of the target of the initial Business Combination, cause to provide, customary comfort letters, legal opinions and negative assurance
letters, in form and substance reasonably satisfactory to the Underwriters, each dated as of the effective date of the registration statement
(if applicable), statutory prospectus, prospectus or proxy statement filed in connection with the initial Business Combination and as
of the date of the shareholder vote to approve the initial Business Combination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">3.33&nbsp;The
Company shall include in any Business Combination agreement (i)&nbsp;a covenant for the assignment and assumption, by the public entity
resulting from the Business Combination, of all of the Company&rsquo;s indemnification obligations under Section 5 hereof and (ii)&nbsp;that
the Underwriters may rely on the representations and warranties contained therein as if they were a party thereto.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">3.34&nbsp;In
connection with the initial Business Combination, the Company shall use commercially reasonable efforts to cause the target of the initial
Business Combination to execute and deliver to the Representative a joinder agreement, in form and substance reasonably satisfactory to
the Representative, pursuant to which it shall join this Agreement as a signatory and a party for purposes of being subject to <U>Section
3.32</U> hereof, and as a result, the Company&rsquo;s obligations to cause the Target to take such actions shall cease to be of force
or effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-family: Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">3.35&nbsp;The
Company acknowledges and agrees that nothing in this Agreement shall be interpreted to obligate the Underwriters to take any action, or
to refrain from taking any action, in connection with the Business Combination and any such actions will be undertaken by each Underwriter,
in respect of itself, in its sole discretion and only pursuant to a separate, definitive written agreement between such Underwriter and
the Company or another Registrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">3.36&nbsp;The
Company shall (i)&nbsp;(A)&nbsp;provide the Underwriters and their representatives with notice of filing of, and a reasonable advance
opportunity to review and comment on, any registration statement, statutory prospectus, prospectus, proxy statement, tender offer document
or offering document, including exhibits and financial statements included or incorporated by reference therein or any amendment or supplement
thereto, to be filed with or furnished to the Commission in connection with the initial Business Combination (each, a &ldquo;<B>Business
Combination Disclosure Document</B>&rdquo;), prior to each such filing, and not permit the filing thereof without the prior written consent
of the Underwriters, (B)&nbsp;provide each Underwriter and its representatives a reasonable advance opportunity to review and comment
on any publicly-disseminated document that names or describes such Underwriter, whether or not such document is filed, (C)&nbsp;give reasonable
consideration to accepting any comments made by the Underwriters and their representatives in respect of such Business Combination Disclosure
Documents, and (D)&nbsp;consider in good faith including in any such filing, document or response all comments reasonably proposed by
the Underwriters and their representatives;&nbsp;<U>provided</U> that any information naming or describing an Underwriter must be in a
form and content reasonably satisfactory to such Underwriter; and (ii)&nbsp;upon the request by the Underwriters, promptly file an amendment
to any Business Combination Disclosure Document, filed in connection with the initial Business Combination, to correct any information
to the extent that such information shall have become false or misleading in any material respect, or to correct any material omissions
therefrom.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">4.&nbsp;<U>Conditions
of Underwriters&rsquo; Obligations</U>. The obligations of the Underwriters to purchase and pay for the Units, as provided herein, shall
be subject to the continuing accuracy of the representations and warranties of the Company as of the date hereof and as of each of the
Closing Date and the Option Closing Date, if any, to the accuracy of the statements of officers of the Company made pursuant to the provisions
hereof and to the performance in all material respects by the Company of its obligations hereunder and to the following conditions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">4.1&nbsp;<U>Regulatory
Matters</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">4.1.1&nbsp;<U>Effectiveness
of Registration Statement</U>. The Registration Statement shall have become effective not later than 4:00 p.m., New York time, on the
date of this Agreement or such later date and time as shall be consented to in writing by the Representative.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">4.1.2&nbsp;<U>FINRA
Clearance</U>. By the Effective Date, the Underwriters shall have received a letter of no objections from FINRA as to the terms and arrangements
and the amount of compensation allowable or payable to the Underwriters as described in the Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">4.1.3&nbsp;<U>No
Commission Stop Order</U>. At the Closing Date, the Commission has not issued any order or threatened to issue any order preventing or
suspending the use of any Preliminary Prospectus, the Prospectus or any part thereof, and has not instituted or, to the Company&rsquo;s
knowledge, assuming reasonable inquiry, threatened to institute any proceedings with respect to such an order.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">4.1.4&nbsp;<U>Approval
for Listing on Nasdaq</U>. The Securities shall have been approved for listing on Nasdaq, subject to official notice of issuance and evidence
of satisfactory distribution, satisfactory evidence of which shall have been provided to the Representative.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-family: Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">4.2&nbsp;<U>Company
Counsel Matters</U>.</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">4.2.1&nbsp;<U>Closing
Date and Option Closing Date Opinions of U.S. Counsel</U>. On the Closing Date and the Option Closing Date, if any, the Representative
shall have received the favorable opinion and negative assurance statement of Ellenoff Grossman &amp; Schole LLP, dated the Closing Date
or the Option Closing Date, as the case may be, addressed to the Representative as representative for the several Underwriters and in
form and substance satisfactory to the Representative and DLA Piper, as well as the favorable opinion and negative assurance letter of
DLA Piper, dated the Closing Date or the Option Closing Date, as the case may be, addressed to the Representative for the several Underwriters
and in form and substance satisfactory to the Representative.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">4.2.2&nbsp;<U>Closing
Date and Option Closing Date Opinions of Cayman Counsel</U>. On the Closing Date and the Option Closing Date, if any, the Representative
shall have received the favorable opinion of <FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maples and Calder
(Cayman) LLP</FONT>, dated the Closing Date or the Option Closing Date, as the case may be, addressed to the Representative as representative
for the several Underwriters and in form and substance satisfactory to the Representative and DLA Piper.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">4.2.3&nbsp;<U>Reliance</U>.
In rendering such opinion, such counsel may rely as to matters of fact, to the extent they deem proper, on certificates or other written
statements of officers of the Company and officers of departments of various jurisdictions having custody of documents respecting the
corporate existence or good standing of the Company; <U>provided</U> that copies of any such statements or certificates shall be delivered
to the Representative&rsquo;s counsel if requested. The opinion of counsel for the Company shall include a statement to the effect that
it may be relied upon by counsel for the Underwriters in its opinion delivered to the Underwriters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">4.3&nbsp;<U>Comfort
Letter</U>. At the time this Agreement is executed, and at the Closing Date and Option Closing Date, if any, the Representative shall
have received a letter, addressed to the Representative as representative for the several Underwriters and in form and substance satisfactory
in all respects (including the non-material nature of the changes or decreases, if any, referred to in <U>Section 4.3.3</U> below) to
the Representative from Withum dated, respectively, as of the date of this Agreement and as of the Closing Date and Option Closing Date,
if any:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">4.3.1&nbsp;Confirming
that they are independent accountants with respect to the Company within the meaning of the Act and the applicable Regulations;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">4.3.2&nbsp;Stating
that in their opinion the financial statements of the Company included in the Registration Statement, the Sale Preliminary Prospectus
and the Prospectus comply as to form in all material respects with the applicable accounting requirements of the Act and the published
Regulations thereunder;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">4.3.3&nbsp;Stating
that, on the basis of their review, a reading of the latest available minutes of the shareholders and Board of Directors and the various
committees of the Board of Directors, consultations with officers and other employees of the Company responsible for financial and accounting
matters and other specified procedures and inquiries, or at a date not later than five days prior to the Effective Date, Closing Date
or Option Closing Date, as the case may be, there was any change in the share capital or long-term debt of the Company, or any decrease
in the shareholders&rsquo; equity of the Company as compared with amounts shown in the May 28, 2024 balance sheet included in the Registration
Statement, the Sale Preliminary Prospectus and the Prospectus, other than as set forth in or contemplated by the Registration Statement,
the Sale Preliminary Prospectus and the Prospectus;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">4.3.4&nbsp;Setting
forth, at a date not later than five days prior to the Effective Date, the amount of liabilities of the Company (including a break-down
of commercial papers and notes payable to banks);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-family: Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">4.3.5&nbsp;Stating
that they have compared specific dollar amounts, numbers of shares, percentages of revenues and earnings, statements and other financial
information pertaining to the Company set forth in the Registration Statement, the Sale Preliminary Prospectus and the Prospectus in each
case to the extent that such amounts, numbers, percentages, statements and information may be derived from the general accounting records,
including work sheets, of the Company and excluding any questions requiring an interpretation by legal counsel, with the results obtained
from the application of specified readings, inquiries and other appropriate procedures (which procedures do not constitute an examination
in accordance with generally accepted auditing standards) set forth in the letter and found them to be in agreement; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">4.3.6&nbsp;Statements
as to such other matters incident to the transaction contemplated hereby as the Representative or DLA Piper may reasonably request, including
that Withum is registered with the Public Company Accounting Oversight Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">4.4&nbsp;<U>Officers&rsquo;
Certificates</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">4.4.1&nbsp;<U>Officers&rsquo;
Certificate</U>. At each of the Closing Date and the Option Closing Date, if any, the Representative shall have received a certificate
of the Company signed by the Chairman of the Board, the Chief Executive Officer or the President, and the Chief Financial Officer or General
Counsel of the Company, or any similar or equivalent officer of the Company (in their capacities as such), dated the Closing Date or the
Option Closing Date, as the case may be, respectively, to the effect that the Company has performed in all material respects all covenants
and complied with all conditions required by this Agreement to be performed or complied with by the Company prior to and as of the Closing
Date, or the Option Closing Date, as the case may be, and that the conditions set forth in <U>Section 4</U> hereof have been satisfied
as of such date and that, as of the Closing Date and the Option Closing Date, as the case may be, the representations and warranties of
the Company set forth in <U>Section 2</U> hereof are true and correct. In addition, the Representative will have received such other and
further certificates of officers of the Company (in their capacities as such) as the Representative may reasonably request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">4.4.2&nbsp;<U>Chief
Executive&rsquo;s Certificate</U>. At each of the Closing Date and the Option Closing Date, if any, the Representative shall have received
a certificate of the Company signed by the General Counsel or Chief Executive Officer of the Company, dated the Closing Date or the Option
Closing Date, as the case may be, respectively, certifying (i)&nbsp;that the Charter Documents are true and complete, have not been modified
and are in full force and effect, (ii)&nbsp;that the resolutions of the Company&rsquo;s Board of Directors relating to the Offering are
in full force and effect and have not been modified, (iii)&nbsp;as to the accuracy and completeness of all correspondence between the
Company or its counsel and the Commission, (iv)&nbsp;as to the accuracy and completeness of all correspondence between the Company or
its counsel and Nasdaq, (v)<FONT STYLE="font-size: 10pt">&nbsp;</FONT>as to the accuracy and completeness, to the Company&rsquo;s knowledge
(assuming reasonable inquiry) of the certificates specified in <U>Section 4.4.1</U> hereof, and (vi)&nbsp;as to the incumbency of the
officers of the Company. The documents referred to in such certificate shall be attached to such certificate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">4.5&nbsp;<U>No
Material Changes</U>. Prior to and on each of the Closing Date and the Option Closing Date, if any, (i)&nbsp;there shall have been no
material adverse change or development involving a prospective material adverse change in the condition or prospects or the business activities,
financial or otherwise, of the Company from the latest dates as of which such condition is set forth in the Registration Statement and
the Prospectus, (ii)&nbsp;no action, suit or proceeding, at law or in equity, shall have been pending or threatened against the Company
or any Insider before or by any court or federal, foreign or state commission, board or other administrative agency wherein an unfavorable
decision, ruling or finding may materially adversely affect the business, operations, or financial condition or income of the Company,
except as set forth in the Registration Statement and the Prospectus, (iii)&nbsp;no stop order shall have been issued under the Act and
no proceedings therefor shall have been initiated or, to the Company&rsquo;s knowledge, assuming reasonable inquiry, threatened by the
Commission, and (iv)&nbsp;the Registration Statement, the Sale Preliminary Prospectus and the Prospectus and any amendments or supplements
thereto shall contain all material statements which are required to be stated therein in accordance with the Act and the Regulations and
shall conform in all material respects to the requirements of the Act and the Regulations, and neither the Registration Statement, the
Sale Preliminary Prospectus nor the Prospectus nor any amendment or supplement thereto shall contain any untrue statement of a material
fact or omit to state any material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances
under which they were made, not misleading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-family: Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">4.6&nbsp;<U>Delivery
of Agreements</U>. On the Effective Date, the Company shall have delivered to the Representative executed copies of the Transaction Documents
and all of the Insider Letters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">5.&nbsp;<U>Indemnification</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">5.1&nbsp;<U>Indemnification
of the Underwriters</U>. Subject to the conditions set forth below, the Company agrees to indemnify and hold harmless each of the Underwriters
and their affiliates, and each dealer selected by the Underwriters that participates in the offer and sale of the Securities (each a &ldquo;<B>Selected
Dealer</B>&rdquo;) and each of their respective directors, officers, agents, partners, members and employees and each person, if any,
who controls within the meaning of Section 15&nbsp;of the Act or Section&nbsp;20(a) of the Exchange Act (&ldquo;<B>Controlling Person</B>&rdquo;)
any Underwriter, against any and all loss, liability, claim, damage and expense whatsoever as incurred to which they or any of them may
become subject under the Act, the Exchange Act or any other statute or at common law or otherwise or under the laws of foreign countries,
arising out of or based upon any untrue statement or alleged untrue statement of a material fact contained in (i)&nbsp;the Registration
Statement, the Business Combination Disclosure Documents, any Preliminary Prospectus including the Sale Preliminary Prospectus or the
Prospectus (as from time to time each may be amended and supplemented, including, but not limited to any information deemed to be a part
thereof pursuant to Rule 430A, Rule 430B or Rule 430C); (ii)&nbsp;any materials or information provided to investors by, or with the approval
of, the Company in connection with the marketing of the offering of the Securities, including any &ldquo;road show&rdquo; or investor
presentations made to investors by the Company (whether in person or electronically); (iii)&nbsp;any application or other document or
written communication (in this <U>Section 5</U>, collectively called &ldquo;<B>application</B>&rdquo;) executed by the Company or based
upon written information furnished by the Company in any jurisdiction in order to qualify the Public Securities under the securities laws
thereof or filed with the Commission, any foreign or state securities commission or agency, the Nasdaq Global Market, the Nasdaq Capital
Market, the Nasdaq Global Select Market, the New York Stock Exchange, any other securities exchange or the Over-the-Counter Bulletin Board
(the &ldquo;<B>OTCBB</B>&rdquo;); or (iv)&nbsp;any post-effective amendments to the Registration Statement or Prospectus or new Registration
Statement or Prospectus filed by the Company with the Commission, any state securities commission or agency, OTCBB or any securities exchange;
or (v)&nbsp;the omission or alleged omission from the Registration Statement, the Business Combination Disclosure Documents, any Preliminary
Prospectus including the Sale Preliminary Prospectus or the Prospectus or subsequent filing by the Company under clause (iv) of a material
fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were
made, not misleading, and to reimburse each Underwriter, its affiliates, each Selected Dealer and each of their respective directors,
officers, partners, agents, members and employees and each Controlling Person, if any, for any and all reasonable expenses (including
the reasonable fees and disbursements of counsel chosen by the Underwriters) as such expenses are incurred by each Underwriter, its affiliates,
such Selected Dealer or each of their respective directors, officers, partners, agents, members and employees or such Controlling Person
in connection with investigating, defending, settling, compromising or paying any such loss, claim damage, liability, expense or action,
whether or not any such person is a party to any such claim or action and including any and all reasonable legal and other expenses incurred
in giving testimony or furnishing documents in response to a subpoena or otherwise; <U>provided</U>, <U>however</U>, that the foregoing
agreement shall not apply to any loss, claim, damage, liability or expenses to the extent, but only to the extent, arising out of or based
upon (vi)&nbsp;any untrue statement or alleged untrue statement or omission or alleged omission made in reliance upon and in conformity
with written information furnished to the Company with respect to an Underwriter by or on behalf of such Underwriter expressly for use
in the Registration Statement, any Preliminary Prospectus including the Sale Preliminary Prospectus or the Prospectus, or any amendment
or supplement thereof, or in any application, as the case may be, or the jurisdictions listed in the section entitled &ldquo;Underwriting&rdquo;
in the Registration Statement, any Preliminary Prospectus including the Sale Preliminary Prospectus or the Prospectus, or any amendment
or supplement thereof, as the case may be; (y)&nbsp;the use of the Sale Preliminary Prospectus or Prospectus in violation of any stop
order or other notice received by the Underwriters indicating the then current Prospectus is not to be used in connection with the sale
of any Securities or (z) &nbsp;the Underwriters otherwise failing in its prospectus delivery obligations. The Company agrees promptly
to notify the Representative of the commencement of any litigation or proceedings against the Company or any of its officers, directors
or Controlling Persons in connection with the issue and sale of the Securities or in connection with the Registration Statement, the Sale
Preliminary Prospectus or the Prospectus. The indemnity agreement set forth in this <U>Section 5.1</U> shall be in addition to any liabilities
that the Company may otherwise have.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-family: Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">5.2&nbsp;<U>Indemnification
of the Company</U>. Each Underwriter, severally and not jointly, agrees to indemnify and hold harmless the Company, its directors, its
officers who signed the Registration Statement and each Controlling Person of the Company, if any, against any and all loss, liability,
claim, damage and expense described in the foregoing indemnity from the Company to the Underwriter, as incurred, but only with respect
to untrue statements or omissions, or alleged untrue statements or omissions made in the Registration Statement, any Preliminary Prospectus
including the Sale Preliminary Prospectus, the Prospectus or any amendment or supplement thereto or in any application, in reliance upon,
and in strict conformity with, written information furnished to the Company with respect to, the Underwriters by or on behalf of the Underwriters
expressly for use in, the Registration Statement, any Preliminary Prospectus including the Sale Preliminary Prospectus, the Prospectus
or any amendment or supplement thereto, or in any such application, and to reimburse the Company or any such director, officer or Controlling
Person, if any, for any and all expenses as such expenses are reasonably incurred, in connection with investigating, defending, settling,
compromising or paying any such loss, claim damage, liability, expense or action; <U>provided</U>, <U>however</U>, that the obligation
of each Underwriter to indemnify the Company (including any director, officer or Controlling Person thereof), shall be limited to the
commissions received by such Underwriter in connection with the Securities underwritten by it pursuant to this Agreement. The Company
hereby acknowledges that the only information that the Underwriters have furnished to the Company expressly for use in the Registration
Statement, the Preliminary Prospectus including the Sale Preliminary Prospectus, the Prospectus or any amendment or supplement thereto,
shall consist solely of the Underwriters&rsquo; Information. The indemnity agreement set forth in this <U>Section 5.2</U> shall be in
addition to any liabilities that the Underwriter may otherwise have.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">5.3&nbsp;<U>Notifications
and Other Indemnification Procedures</U>. Promptly after receipt by an indemnified party under this <U>Section 5</U> of notice of the
commencement of any action, such indemnified party will, if a claim in respect thereof is to be made against an indemnifying party under
this <U>Section&nbsp;5</U>, notify the indemnifying party in writing of the commencement thereof, but the failure to so notify the indemnifying
party (i)&nbsp;will not relieve it from liability under <U>Sections 5.1</U> or <U>5.2</U> above unless and to the extent it did not otherwise
learn of such action and such failure results in the forfeiture by the indemnifying party of substantial rights and defenses and (ii)&nbsp;
will not, in any event, relieve the indemnifying party from any obligations to any indemnified party other than the indemnification obligation
provided in <U>Sections&nbsp;5.1</U> or <U>5.2</U> above. In case any such action is brought against any indemnified party and such indemnified
party seeks or intends to seek indemnity from an indemnifying party, the indemnifying party will be entitled to participate in, and, to
the extent that it shall elect, jointly with all other indemnifying parties similarly notified, by written notice delivered to the indemnified
party promptly after receiving the aforesaid notice from such indemnified party, to assume the defense thereof with counsel satisfactory
to such indemnified party; <U>provided</U>, <U>however</U>, that (a)&nbsp;if the defendants in any such action include both the indemnified
party and the indemnifying party and the indemnified party shall have reasonably concluded that a conflict may arise between the positions
of the indemnifying party and the indemnified party in conducting the defense of any such action or that there may be legal defenses available
to it and/or other indemnified parties that are different from or additional to those available to the indemnifying party, or (b)&nbsp;the
indemnifying party agrees to such separate representation, then, in each case, the indemnified party or parties shall have the right to
select separate counsel to assume such legal defenses and to otherwise participate in the defense of such action on behalf of such indemnified
party or parties. Upon receipt of notice from the indemnifying party to such indemnified party of such indemnifying party&rsquo;s election
so to assume the defense of such action and approval by the indemnified party of counsel, the indemnifying party will not be liable to
such indemnified party under this <U>Section 5</U> for any legal or other expenses subsequently incurred by such indemnified party in
connection with the defense thereof unless (iii)&nbsp;the indemnified party shall have employed separate counsel in accordance with the
provision to the preceding sentence reasonably approved by the indemnifying party (or by the Underwriter in the case of <U>Section 5.2</U>),
representing the indemnified parties who are parties to such action, (iv)&nbsp;the indemnifying party shall not have employed counsel
satisfactory to the indemnified party to represent the indemnified party within a reasonable time after notice of commencement of the
action, or (v) &nbsp;the indemnifying party is not defending such action in good faith, in each of which cases the fees and expenses of
counsel shall be at the expense of the indemnifying party. An indemnifying party who is not entitled to, or elects not to, assume the
defense of a claim shall not be obligated to pay the fees and expenses of more than one counsel (as well as one local counsel for each
applicable jurisdiction) for all parties indemnified by such indemnifying party with respect to such claim, unless in the reasonable judgment
of any indemnified party a conflict of interest may exist between such indemnified party and any other of such indemnified parties with
respect to such claim.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-family: Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">5.4&nbsp;<U>Settlements</U>.
The indemnifying party under this <U>Section 5</U> shall not be liable for any settlement of any proceeding effected without its written
consent, which shall not be withheld, delayed or conditioned unreasonably, but if settled with such consent or if there is a final judgment
for the plaintiff, the indemnifying party agrees to indemnify the indemnified party against any loss, claim, damage, liability or expense
by reason of such settlement or judgment. Notwithstanding the foregoing sentence, if at any time an indemnified party shall have requested
an indemnifying party to reimburse the indemnified party for fees and expenses of counsel as contemplated by <U>Section 5.3</U> hereof,
the indemnifying party agrees that it shall be liable for any settlement of any proceeding effected without its written consent if (i)&nbsp;such
settlement is entered into more than 30 days after receipt by such indemnifying party of the aforesaid request and (ii)&nbsp;such indemnifying
party shall not have reimbursed the indemnified party in accordance with such request prior to the date of such settlement. No indemnifying
party shall, without the prior written consent of the indemnified party, effect any settlement, compromise or consent to the entry of
judgment in any pending or threatened action, suit or proceeding in respect of which any indemnified party is or could have been a party
and indemnity was or could have been sought hereunder by such indemnified party, unless such settlement, compromise or consent (x)&nbsp;includes
an unconditional written release of such indemnified party from all liability on claims that are the subject matter of such action, suit
or proceeding and (y)&nbsp;does not include a statement as to or an admission of fault, culpability or a failure to act, by or on behalf
of any indemnified party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">5.5&nbsp;<U>Contribution</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">5.5.1&nbsp;<U>Contribution
Rights</U>. In order to provide for just and equitable contribution under the Act in any case in which (i)&nbsp;any person entitled to
indemnification under this <U>Section 5</U> makes claim for indemnification pursuant hereto but it is judicially determined (by the entry
of a final judgment or decree by a court of competent jurisdiction and the expiration of time to appeal or the denial of the last right
of appeal) that such indemnification may not be enforced in such case notwithstanding the fact that this <U>Section 5</U> provides for
indemnification in such case, or (ii)&nbsp;contribution under the Act, the Exchange Act or otherwise may be required on the part of any
such person in circumstances for which indemnification is provided under this <U>Section 5</U>, then, and in each such case, each Underwriter
shall contribute to the aggregate losses, liabilities, claims, damages and expenses of the nature contemplated by said indemnity agreement
incurred by the Company and each Underwriter, as incurred, in such proportion as is represented by the percentage of the underwriting
discount appearing on the cover page of the Prospectus as compared to the offering price per Unit and the Company shall be responsible
for the balance; provided, that, no person guilty of a fraudulent misrepresentation (within the meaning of Section&nbsp; 11(f) of the
Act) with respect to any action or claim shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation
with respect to such action or claim. If the allocation provided by the immediately preceding sentence is unavailable for any reason,
the Company and the Underwriters shall contribute in such proportion as is appropriate to reflect the relative fault of the Company and
the Underwriters in connection with the actions or omissions which resulted in such loss, claim, damage, liability or action, as well
as any other relevant equitable considerations. The relative fault of the Company and the Underwriters shall be determined by reference
to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state
a material fact relates to information furnished by the Company or the Underwriters and the parties&rsquo; relative intent, knowledge,
access to information and opportunity to correct or prevent such statement or omission. Notwithstanding the provisions of this <U>Section&nbsp;5.5.1</U>,
no Underwriter shall be required to contribute any amount in excess of the underwriting commissions received by such Underwriter in connection
with the Securities underwritten by it and distributed to the public pursuant to this Agreement. For purposes of this Section, each director,
officer, agent, partner, member and employee of an Underwriter or the Company, as applicable, and each person, if any, who controls an
Underwriter or the Company, as applicable, within the meaning of Section&nbsp;15 of the Act, shall have the same rights to contribution
as such Underwriter or the Company, as applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-family: Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">5.5.2&nbsp;<U>Contribution
Procedure</U>. Within fifteen days after receipt by any party to this Agreement (or its representative) of notice of the commencement
of any action, suit or proceeding, such party will, if a claim for contribution in respect thereof is to be made against another party
(&ldquo;<B>Contributing Party</B>&rdquo;), notify the Contributing Party of the commencement thereof, but the omission to so notify the
Contributing Party will not relieve it from any liability which it may have to any other party other than for contribution hereunder.
In case any such action, suit or proceeding is brought against any party, and such party notifies a Contributing Party or its representative
of the commencement thereof within the aforesaid fifteen days, the Contributing Party will be entitled to participate therein with the
notifying party and any other Contributing Party similarly notified. Any such Contributing Party shall not be liable to any party seeking
contribution on account of any settlement of any claim, action or proceeding effected by such party seeking contribution on account of
any settlement of any claim, action or proceeding without the written consent of such Contributing Party. The contribution provisions
contained in this Section are intended to supersede, to the extent permitted by law, any right to contribution under the Act, the Exchange
Act or otherwise available. The Underwriters&rsquo; obligations to contribute pursuant to this <U>Section&nbsp;5.5</U> are several and
not joint.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">6.&nbsp;<U>Default
by an Underwriter</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">6.1&nbsp;<U>Default
Not Exceeding 10% of Firm Units</U>. If any Underwriter or Underwriters shall default in its or their obligations to purchase the Firm
Units and if the number of the Firm Units with respect to which such default relates does not exceed in the aggregate 10% of the number
of Firm Units that all Underwriters have agreed to purchase hereunder, then such Firm Units to which the default relates shall be purchased
by the non-defaulting Underwriters in proportion to their respective commitments hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">6.2&nbsp;<U>Default
Exceeding 10% of Firm Units</U>. In the event that the default addressed in <U>Section&nbsp;6.1</U> above relates to more than 10% of
the Firm Units, the Representative may, in its discretion, arrange for it or for another party or parties to purchase such Firm Units
to which such default relates on the terms contained herein. If within one Business Day after such default relating to more than 10% of
the Firm Units the Representative does not arrange for the purchase of such Firm Units, then the Company shall be entitled to a further
period of one Business Day within which to procure another party or parties satisfactory to the Representative to purchase said Firm Units
on such terms. In the event that neither the Representative nor the Company arrange for the purchase of the Firm Units to which a default
relates as provided in this <U>Section&nbsp;6</U>, this Agreement may be terminated by the Representative or the Company without liability
on the part of the Company (except as provided in <U>Sections&nbsp;3.10</U>, <U>5</U>, and <U>9.3</U> hereof) or the several Underwriters
(except as provided in <U>Section&nbsp;5</U> hereof); provided that nothing herein shall relieve a defaulting Underwriter of its liability,
if any, to the other several Underwriters and to the Company for damages occasioned by its default hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-family: Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">6.3&nbsp;<U>Postponement
of Closing Date</U>. In the event that the Firm Units to which the default relates are to be purchased by the non-defaulting Underwriters,
or are to be purchased by another party or parties as aforesaid, the Representative or the Company shall have the right to postpone the
Closing Date for a reasonable period, but not in any event exceeding five Business Days, in order to effect whatever changes may thereby
be made necessary in the Registration Statement and/or the Prospectus, as the case may be, or in any other documents and arrangements,
and the Company agrees to file promptly any amendment to, or to supplement, the Registration Statement and/or the Prospectus, as the case
may be, that in the reasonable opinion of counsel for the Underwriters may thereby be made necessary. The term &ldquo;<B>Underwriter</B>&rdquo;
as used in this Agreement shall include any party substituted under this <U>Section 6</U> with like effect as if it had originally been
a party to this Agreement with respect to such securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">7.&nbsp;<U>Additional
Covenants</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">7.1&nbsp;<U>Additional
Shares or Options</U>. The Company hereby agrees that, until the consummation of a Business Combination, it shall not issue any Class
A Ordinary Shares or any options or other securities convertible into Class A Ordinary Shares, or any preferred shares or other securities
of the Company which participate in any manner in the Trust Account or which vote as a class with the Class A Ordinary Shares on a Business
Combination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">7.2&nbsp;<U>Trust
Account Waiver Acknowledgments</U>. The Company hereby agrees that it will use its reasonable best efforts prior to commencing its due
diligence investigation of any prospective Target Business or obtaining the services of any vendor to have such Target Business and/or
vendor acknowledge in writing whether through a letter of intent, memorandum of understanding or other similar document (and subsequently
acknowledges the same in any definitive document replacing any of the foregoing), that (a)&nbsp;it has read the Prospectus and understands
that the Company has established the Trust Account, initially in an amount of $201,000,000 (without giving effect to any exercise of the
Over-allotment Option) for the benefit of the Public Shareholders and that, except for a portion of the interest earned on the amounts
held in the Trust Account, the Company may disburse monies from the Trust Account only (i)&nbsp; to the Public Shareholders in the event
they elect to redeem Class A Ordinary Shares contained in the Public Securities in connection with the consummation of a Business Combination
or amendments to the Charter Documents as described in the Prospectus, (ii)&nbsp;to the Public Shareholders if the Company fails to consummate
a Business Combination within the time period set forth in the Charter Documents and the Prospectus, or (iii)&nbsp;to the Company after
or concurrently with the consummation of a Business Combination and (b)&nbsp;for and in consideration of the Company (iv)&nbsp; agreeing
to evaluate such Target Business for purposes of consummating a Business Combination with it or (v)&nbsp; agreeing to engage the services
of the vendor, as the case may be, such Target Business or vendor agrees that it does not have any right, title, interest or claim of
any kind in or to any monies in the Trust Account (&ldquo;<B>Claim</B>&rdquo;) and waives any Claim it may have in the future as a result
of, or arising out of, any negotiations, contracts or agreements with the Company and will not seek recourse against the Trust Account
for any reason whatsoever. The Company may forego obtaining such waivers only if the Company shall have received the approval of its Chief
Executive Officer and the approving vote of at least a majority of its Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 31; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-family: Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">7.3&nbsp;<U>Insider
Letters</U>. The Company shall not take any action or omit to take any action which would cause a breach of any of the Insider Letters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">7.4&nbsp;<U>Trust
Agreement Matters.</U> The Company agrees that the Trust Agreement shall provide that the trustee is required to obtain a joint written
instruction signed by both the Company and the Representative with respect to the transfer of the funds held in the Trust Account from
the Trust Account, prior to commencing any liquidation of the assets of the Trust Account in connection with the consummation of any Business
Combination, and such provision of the Trust Agreement shall not be permitted to be amended without the prior written consent of the Representative.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">7.5&nbsp;<U>Rule
419</U>. The Company agrees that it will use its best efforts to prevent the Company from becoming subject to Rule&nbsp;419 under the
Act prior to the consummation of any Business Combination, including but not limited to using its best efforts to prevent any of the Company&rsquo;s
outstanding securities from being deemed to be a &ldquo;penny stock&rdquo; as defined in Rule&nbsp;3a-51-1 under the Exchange Act during
such period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">7.6&nbsp;<U>Emerging
Growth Company</U>. The Company shall promptly notify the Representative if the Company ceases to be an Emerging Growth Company at any
time prior to the completion of the distribution of the Securities within the meaning of the Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">7.7&nbsp;<U>Target
Net Assets</U>. The Company agrees that the Target Business that it acquires must have a fair market value equal to at least 80% of the
assets held in the Trust Account at the time of signing the definitive agreement for the Business Combination with such Target Business
(excluding taxes payable and the Deferred Underwriting Commissions). The fair market value of such business must be determined by the
Board of Directors of the Company based upon standards generally accepted by the financial community, such as actual and potential sales,
earnings, cash flow and book value. If the Board of Directors of the Company is not able to independently determine that the target business
meets such fair market value requirement, the Company will obtain an opinion from an independent investment banking firm or another independent
entity that commonly renders valuation opinions with respect to the satisfaction of such criteria. The Company is not required to obtain
an opinion as to the fair market value if the Company&rsquo;s Board of Directors independently determines that the Target Business does
have sufficient fair market value.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">8.&nbsp;<U>Representations
and Agreements to Survive Delivery</U>. Except as the context otherwise requires, all representations, warranties and agreements contained
in this Agreement shall be deemed to be representations, warranties and agreements as of the Closing Date or the Option Closing Date,
if any, and such representations, warranties and agreements of the Underwriters and the Company, including the indemnity agreements contained
in <U>Section 5</U> hereof, shall remain operative and in full force and effect regardless of any investigation made by or on behalf of
the Underwriters, the Company or any Controlling Person, and shall survive termination of this Agreement or the issuance and delivery
of the Public Securities to the Underwriters until the earlier of the expiration of any applicable statute of limitations and the 7th
anniversary of the later of the Closing Date or the Option Closing Date, if any, at which time the representations, warranties and agreements
shall terminate and be of no further force and effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">9.&nbsp;<U>Effective
Date of This Agreement and Termination Thereof</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">9.1&nbsp;<U>Effective
Date</U>. This Agreement shall become effective on the Effective Date at the time the Registration Statement is declared effective by
the Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 32; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-family: Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">9.2&nbsp;<U>Termination</U>.
The Representative shall have the right to terminate this Agreement at any time prior to the Closing Date, if (i)&nbsp;any domestic or
international event or act or occurrence has materially disrupted, or in the Representative&rsquo;s opinion will in the immediate future
materially disrupt, general securities markets in the United States; (ii)&nbsp;trading on the Nasdaq Global Market, the Nasdaq Global
Select Market, the Nasdaq Capital Market the New York Stock Exchange or the NYSE American or quoted on the OTCBB shall have been suspended,
or minimum or maximum prices for trading shall have been fixed, or maximum ranges for prices for securities shall have been fixed, or
maximum ranges for prices for securities shall have been required by FINRA or by order of the Commission or any other government authority
having jurisdiction; (iii)&nbsp;the United States shall have become involved in a new war or an increase in existing major hostilities;
(iv)&nbsp;a banking moratorium has been declared by New York State or a Federal authority; (v)&nbsp;a moratorium on foreign exchange trading
has been declared which materially adversely impacts the United States securities market; (vi)&nbsp;the Company shall have sustained a
material loss by fire, flood, accident, hurricane, earthquake, theft, sabotage or other calamity (including without limitation, a calamity
relating to a public health matter or natural disaster) or malicious act which, whether or not such loss shall have been insured, will,
in the Representative&rsquo;s sole opinion, make it inadvisable to proceed with the delivery of the Units; (vii)&nbsp;the Company is in
material breach of any of its representations, warranties or covenants hereunder; or (viii)&nbsp;the Representative shall have become
aware after the date hereof of a Material Adverse Effect on the Company, or such adverse material change in general market conditions,
including without limitation as a result of terrorist activities after the date hereof, as in the Representative&rsquo;s sole judgment
would make it impracticable to proceed with the offering, sale and/or delivery of the Units or to enforce contracts made by the Underwriters
for the sale of the Public Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">9.3&nbsp;<U>Expenses</U>.
In the event that this Agreement shall not be carried out for any reason whatsoever, within the time specified herein or any extensions
thereof pursuant to the terms herein, the obligations of the Company to pay the out of pocket expenses related to the transactions contemplated
herein shall be governed by <U>Section&nbsp;3.9</U> hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">9.4&nbsp;<U>Indemnification</U>.
Notwithstanding any contrary provision contained in this Agreement, any election hereunder or any termination of this Agreement, and whether
or not this Agreement is otherwise carried out, the provisions of <U>Section 5</U> shall not be in any way affected by such election or
termination or failure to carry out the terms of this Agreement or any part hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">10.&nbsp;<U>Miscellaneous</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">10.1&nbsp;<U>Notices</U>.
All communications hereunder, except as herein otherwise specifically provided, shall be in writing and shall be mailed, delivered by
hand or reputable overnight courier or delivered by facsimile transmission (with printed confirmation of receipt) and confirmed, or by
electronic transmission via PDF, and shall be deemed given when so transmitted, mailed, delivered or faxed or if mailed, two days after
such mailing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If to the Representative:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in">BTIG, LLC<BR>
65 E. 55th Street<BR>
New York, New York, 10022<BR>
Attn: General Counsel<BR>
Facsimile: (415) 248-2260</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in">Email:
iblegal@btig.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 33; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-family: Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">Copy (which copy shall not constitute
notice) to:</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in">DLA Piper LLP (US)<BR>
1251 Avenues of the Americas, 27th Floor<BR>
New York, New York 10020<BR>
Attn: Stephen P. Alicanti<BR>
Facsimile: (212) 884-8519</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">If to the Company:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Andretti Acquisition Corp. II</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">7615 Zionsville Road</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Indianapolis, Indiana 46268</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Attn: William M. Brown</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">Copy (which copy shall not constitute
notice) to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in">Ellenoff Grossman &amp;
Schole LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in">1345 Avenue of the Americas</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in">New York, New York 10105</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: 0in">Attn: Douglas S. Ellenoff,
Stuart Neuhauser<BR>
Facsimile: (212) 370-7889</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">10.2&nbsp;<U>Headings</U>.
The headings contained herein are for the sole purpose of convenience of reference, and shall not in any way limit or affect the meaning
or interpretation of any of the terms or provisions of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">10.3&nbsp;<U>Amendment</U>.
This Agreement may only be amended by a written instrument executed by each of the parties hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">10.4&nbsp;<U>Entire
Agreement</U>. This Agreement (together with the other agreements and documents being delivered pursuant to or in connection with this
Agreement) constitute the entire agreement of the parties hereto with respect to the subject matter hereof and thereof, and supersede
all prior agreements and understandings of the parties, oral and written, with respect to the subject matter hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">10.5&nbsp;<U>Binding
Effect</U>. This Agreement shall inure solely to the benefit of and shall be binding upon the Representative, the Underwriters, the Selected
Dealers, the Company and the Controlling Persons, directors, agents, partners, members, employees and officers referred to in <U>Section&nbsp;5</U>
hereof, and their respective successors, legal representative and assigns, and no other person shall have or be construed to have any
legal or equitable right, remedy or claim under or in respect of or by virtue of this Agreement or any provisions herein contained. The
term &ldquo;successors and assigns&rdquo; shall not include a purchaser, in its capacity as such, of securities from the Underwriters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">10.6&nbsp;<U>Waiver
of Immunity</U>. To the extent that the Company may be entitled in any jurisdiction in which judicial proceedings may at any time be commenced
hereunder, to claim for itself or its revenues or assets any immunity, including sovereign immunity, from suit, jurisdiction, attachment
in aid of execution of a judgment or prior to a judgment, execution of a judgment or any other legal process with respect to its obligations
hereunder and to the extent that in any such jurisdiction there may be attributed to the Company such an immunity (whether or not claimed),
the Company hereby irrevocably agrees not to claim and irrevocably waives such immunity to the maximum extent permitted by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 34; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-family: Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">10.7&nbsp;<U>Submission
to Jurisdiction</U>. Each of the Company and the Representative irrevocably submits to the exclusive jurisdiction of any New York State
or United States Federal court sitting in The City of New York, Borough of Manhattan, over any suit, action or proceeding arising out
of or relating to this Agreement, the Registration Statement, the Sale Preliminary Prospectus and the Prospectus or the offering of the
Securities. Each of the Company and the Representative irrevocably waives, to the fullest extent permitted by law, any objection that
it may now or hereafter have to the laying of venue of any such suit, action or proceeding brought in such a court and any claim that
any such suit, action or proceeding brought in such a court has been brought in an inconvenient forum. Any such process or summons to
be served upon the Company or the Representative may be served by transmitting a copy thereof by registered or certified mail, return
receipt requested, postage prepaid, addressed to it at the address set forth in <U>Section&nbsp;10.1</U> hereof. Such mailing shall be
deemed personal service and shall be legal and binding upon the Company or the Representative in any action, proceeding or claim. Each
of the Company and the Representative waives, to the fullest extent permitted by law, any other requirements of or objections to personal
jurisdiction with respect thereto. Notwithstanding the foregoing, any action based on this Agreement may be instituted by the Underwriters
in any competent court. The Company agrees that the Underwriters shall be entitled to recover all of their reasonable attorneys&rsquo;
fees and expenses relating to any action or proceeding and/or incurred in connection with the preparation therefor if any of them are
the prevailing party in such action or proceeding. EACH PARTY HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE
LAW, ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED
HEREBY<FONT STYLE="font-size: 10pt">.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">10.8&nbsp;<U>Governing
Law</U>. This Agreement shall be governed by and construed and enforced in accordance with the laws of the State of New York, without
giving effect to conflicts of law principles that would result in the application of the substantive laws of another jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">10.9&nbsp;<U>Execution
in Counterparts</U>. This Agreement may be executed in one or more counterparts, and by the different parties hereto in separate counterparts,
each of which shall be deemed to be an original, but all of which taken together shall constitute one and the same agreement, and shall
become effective when one or more counterparts has been signed by each of the parties hereto and delivered to each of the other parties
hereto. Delivery of a signed counterpart of this Agreement by facsimile or email/pdf transmission shall constitute valid and sufficient
delivery thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">10.10&nbsp;<U>Waiver</U>.
The failure of any of the parties hereto to at any time enforce any of the provisions of this Agreement shall not be deemed or construed
to be a waiver of any such provision, nor to in any way affect the validity of this Agreement or any provision hereof or the right of
any of the parties hereto to thereafter enforce each and every provision of this Agreement. No waiver of any breach, non-compliance or
non-fulfillment of any of the provisions of this Agreement shall be effective unless set forth in a written instrument executed by the
party or parties against whom or which enforcement of such waiver is sought; and no waiver of any such breach, non-compliance or non-fulfillment
shall be construed or deemed to be a waiver of any other or subsequent breach, non-compliance or non-fulfillment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">10.11&nbsp;<U>No
Fiduciary Relationship</U>. The Company acknowledges and agrees that (i)&nbsp;the purchase and sale of the Units pursuant to this Agreement
is an arm&rsquo;s-length commercial transaction pursuant to a contractual relationship between the Company and the Underwriters, (ii)&nbsp;in
connection therewith and with the process leading to such transaction, each Underwriter is acting solely as a principal and not the agent
or fiduciary of the Company, (iii)&nbsp;the Underwriters have not assumed an advisory or fiduciary responsibility in favor of the Company
with respect to the offering contemplated hereby or the process leading thereto (irrespective of whether the Underwriters have advised
or are currently advising the Company on other matters) or any other obligation to the Company except the obligations expressly set forth
in this Agreement, (iv)&nbsp;in no event do the parties intend that the Underwriters act or be responsible as a fiduciary to the Company,
its management, shareholders, creditors or any other person in connection with any activity that the Underwriters may undertake or have
undertaken in furtherance of this offering of the Company&rsquo;s securities, either before or after the date hereof and (v)&nbsp;the
Company has consulted its own legal and financial advisors to the extent it deemed appropriate. The Underwriters hereby expressly disclaim
any fiduciary or similar obligations to the Company, either in connection with the transactions contemplated by this Agreement or any
matters leading up to such transactions, and the Company hereby confirms its understanding and agreement to that effect. The Company agrees
that it will not claim that the Underwriters have rendered advisory services of any nature or respect, or owe a fiduciary or similar duty
to the Company, in connection with such transaction or the process leading thereto. The Company and the Underwriters agree that they are
each responsible for making their own independent judgment with respect to any such transactions, and that any opinions or views expressed
by the Underwriters to the Company regarding such transactions, including but not limited to any opinions or views with respect to the
price or market for the Company&rsquo;s securities, do not constitute advice or recommendations to the Company. The Company hereby waives
and releases, to the fullest extent permitted by law, any claims that the Company may have against the Underwriters with respect to any
breach or alleged breach of any fiduciary or similar duty to the Company in connection with the transactions contemplated by this Agreement
or any matters leading up to such transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>Remainder of page intentionally left blank</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 35; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-family: Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If the foregoing correctly
sets forth the understanding between the Underwriters and the Company, please so indicate in the space provided below for that purpose,
whereupon this letter shall constitute a binding agreement between us</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">.</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; text-indent: 0in">&nbsp;</TD>
    <TD COLSPAN="2">Very truly yours,</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; text-indent: 0in">&nbsp;</TD>
    <TD COLSPAN="2">Andretti Acquisition Corp. II</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; text-indent: 0in; width: 60%">&nbsp;</TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="text-align: justify; text-indent: 0in; width: 37%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; text-indent: 0in">&nbsp;</TD>
    <TD>By:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left; text-indent: 0in">/s/ William M. Brown</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; text-indent: 0in">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; text-indent: 0in">Name: William M. Brown</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left; text-indent: 0in">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: left; text-indent: 0in">Title: Chief Executive Officer</TD></TR>
  </TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="text-align: left">Accepted on the date first above written</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="text-align: left">BTIG, LLC,</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="text-align: left">as Representative of the several underwriters</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 4%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 36%">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">By:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">/s/ Paul Wood</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">Name: Paul Wood</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: left">Title: Managing Director</TD>
    <TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>




<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>[Signature Page to Underwriting Agreement]</I></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>


<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 36 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-family: Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-style: normal; font-weight: normal"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">SCHEDULE A<FONT STYLE="font-size: 10pt"><BR>
<BR>
</FONT>Andretti Acquisition Corp. II<FONT STYLE="font-size: 10pt"><BR>
<BR>
</FONT>20,000,000 Units</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Underwriter</B></P></TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Number of Firm Units <BR> to be Purchased</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 88%; text-align: justify; padding-bottom: 1.5pt; text-indent: 0pt; padding-left: 0pt">BTIG, LLC</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; width: 9%; text-align: right">20,000,000</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: justify; padding-bottom: 4pt; text-indent: 0pt; padding-left: 0pt">TOTAL</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">20,000,000</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 37 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-family: Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-style: normal; font-weight: normal"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>SCHEDULE B</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Investor Presentation dated June 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B></B></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>3
<FILENAME>ea021383001ex3-1_andretti2.htm
<DESCRIPTION>AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION OF THE COMPANY
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 3.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>THE COMPANIES ACT (<FONT STYLE="font-family: Times New Roman, Times, Serif; text-transform: uppercase">As
Revised</FONT>)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>OF THE CAYMAN ISLANDS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>COMPANY LIMITED BY SHARES&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AMENDED AND RESTATED</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>MEMORANDUM AND ARTICLES OF ASSOCIATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>OF&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ANDRETTI ACQUISITION CORP. II</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>(adopted
by special resolution dated 5 September 2024 and effective on 5 september 2024)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>THE
COMPANIES ACT (As Revised)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>OF THE CAYMAN ISLANDS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>COMPANY LIMITED BY SHARES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AMENDED AND RESTATED</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>MEMORANDUM OF ASSOCIATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>OF</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ANDRETTI ACQUISITION CORP. II</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>(adopted
by special resolution dated 5 september 2024 and effective on 5 september 2024)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">1</TD><TD STYLE="text-align: justify">The name of the Company is <B>Andretti Acquisition Corp. II</B></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2</TD><TD STYLE="text-align: justify">The Registered Office of the Company shall be at the offices of Maples Corporate Services Limited, PO
Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman Islands, or at such other place within the Cayman Islands as the Directors may decide.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">3</TD><TD STYLE="text-align: justify">The objects for which the Company is established are unrestricted and the Company shall have full power
and authority to carry out any object not prohibited by the laws of the Cayman Islands.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4</TD><TD STYLE="text-align: justify">The liability of each Member is limited to the amount unpaid on such Member&rsquo;s shares.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">5</TD><TD STYLE="text-align: justify">The share capital of the Company is US$55,500 divided into 500,000,000 Class A ordinary shares of a par
value of US$0.0001 each, 50,000,000 Class B ordinary shares of a par value of US$0.0001 each and 5,000,000 preference shares of a par
value of US$0.0001 each.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">6</TD><TD STYLE="text-align: justify">The Company has power to register by way of continuation as a body corporate limited by shares under the
laws of any jurisdiction outside the Cayman Islands and to be deregistered in the Cayman Islands.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">7</TD><TD STYLE="text-align: justify">Capitalised terms that are not defined in this Amended and Restated Memorandum of Association bear the
respective meanings given to them in the Amended and Restated Articles of Association of the Company.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>THE
COMPANIES ACT (As Revised)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>OF THE CAYMAN ISLANDS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>COMPANY LIMITED BY SHARES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AMENDED AND RESTATED</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ARTICLES OF ASSOCIATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>OF</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ANDRETTI ACQUISITION CORP. II</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>(adopted
by special resolution dated 5 september 2024 and effective on 5 september 2024)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">1</FONT></TD><TD STYLE="text-align: justify">Interpretation</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">1.1</TD><TD STYLE="text-align: justify">In the Articles Table A in the First Schedule to the Statute does not apply and, unless there is something
in the subject or context inconsistent therewith:</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 1.5in">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>&ldquo;Affiliate&rdquo;</B></P></TD>
    <TD STYLE="text-align: justify">in respect of a person, means any other person that, directly or indirectly, through one or more intermediaries, controls, is controlled by, or is under common control with, such person, and (a) in the case of a natural person, shall include, without limitation, such person&rsquo;s spouse, parents, children, siblings, mother-in-law and father-in-law and brothers and sisters-in-law, whether by blood, marriage or adoption or anyone residing in such person&rsquo;s home, a trust for the benefit of any of the foregoing, a company, partnership or any natural person or entity wholly or jointly owned by any of the foregoing and (b) in the case of an entity, shall include a partnership, a corporation or any natural person or entity which directly, or indirectly through one or more intermediaries, controls, is controlled by, or is under common control with, such entity.</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 1.5in"><B>&ldquo;Applicable Law&rdquo;</B></TD>
    <TD STYLE="text-align: justify">means, with respect to any person, all provisions of laws, statutes, ordinances, rules, regulations, permits, certificates, judgments, decisions, decrees or orders of any governmental authority applicable to such person.</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 1.5in"><B>&ldquo;Articles&rdquo;</B></TD>
    <TD STYLE="text-align: justify">means these amended and restated articles of association of the Company.</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 1.5in"><B>&ldquo;Audit Committee&rdquo;</B></TD>
    <TD STYLE="text-align: justify">means the audit committee of the board of directors of the Company established pursuant to the Articles, or any successor committee.</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 1.5in"><B>&ldquo;Auditor&rdquo;</B></TD>
    <TD STYLE="text-align: justify">means the person for the time being performing the duties of auditor of the Company (if any).</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 1.5in"><B>&ldquo;Business Combination&rdquo;</B></TD>
    <TD STYLE="text-align: justify">means a merger, share exchange, asset acquisition, share purchase, reorganisation or similar business combination involving the Company, with one or more businesses or entities (the &ldquo;<B>target business</B>&rdquo;), which Business Combination: (a) as long as the securities of the Company are listed on The Nasdaq Global Market, must occur with one or more target businesses that together have an aggregate fair market value of at least 80% of the assets held in the Trust Account (excluding the deferred underwriting commissions and taxes payable on the interest income earned on the Trust Account) at the time of the signing of the definitive agreement to enter into such Business Combination; and (b) must not be solely effectuated with another blank cheque company or a similar company with nominal operations.</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 1.5in"><B>&ldquo;business day&rdquo;</B></TD>
    <TD STYLE="text-align: justify">means any day other than a Saturday, a Sunday or a legal holiday or a day on which banking institutions or trust companies are authorised or obligated by law to close in New York City.</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 1.5in"><B>&ldquo;Clearing House&rdquo;</B></TD>
    <TD STYLE="text-align: justify">means a clearing house recognised by the laws of the jurisdiction in which the Shares (or depositary receipts therefor) are listed or quoted on a stock exchange or interdealer quotation system in such jurisdiction.</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 1.5in"><B>&ldquo;Class A Share&rdquo;</B></TD>
    <TD STYLE="text-align: justify">means a Class A ordinary share of a par value of US$0.0001 in the share capital of the Company.</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 1.5in"><B>&ldquo;Class B Share&rdquo;</B></TD>
    <TD STYLE="text-align: justify">means a Class B ordinary share of a par value of US$0.0001 in the share capital of the Company.</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 1.5in"><B>&ldquo;Company&rdquo;</B></TD>
    <TD STYLE="text-align: justify">means the above named company.</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 1.5in"><B>&ldquo;Company&rsquo;s Website&rdquo;</B></TD>
    <TD STYLE="text-align: justify">means the website of the Company and/or its web-address or domain name (if any).</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 1.5in"><B>&ldquo;Compensation Committee&rdquo;</B></TD>
    <TD STYLE="text-align: justify">means the compensation committee of the board of directors of the Company established pursuant to the Articles, or any successor committee.</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 1.5in"><B>&ldquo;Designated Stock Exchange&rdquo;</B></TD>
    <TD STYLE="text-align: justify">means any United States national securities exchange on which the securities of the Company are listed for trading, including The Nasdaq Global Market.</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 1.5in"><B>&ldquo;Directors&rdquo;</B></TD>
    <TD STYLE="text-align: justify">means the directors for the time being of the Company.</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 1.5in"><B>&ldquo;Dividend&rdquo;</B></TD>
    <TD STYLE="text-align: justify">means any dividend (whether interim or final) resolved to be paid on Shares pursuant to the Articles.</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 1.5in"><B>&ldquo;Electronic Communication&rdquo;</B></TD>
    <TD STYLE="text-align: justify">means a communication sent by electronic means, including electronic posting to the Company&rsquo;s Website, transmission to any number, address or internet website (including the website of the Securities and Exchange Commission) or other electronic delivery methods as otherwise decided and approved by the Directors.</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 1.5in"><B>&ldquo;Electronic Record&rdquo;</B></TD>
    <TD STYLE="text-align: justify">has the same meaning as in the Electronic Transactions Act.</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 1.5in"><B>&ldquo;Electronic <BR>
Transactions Act&rdquo;</B></TD>
    <TD STYLE="text-align: justify">means the Electronic Transactions Act (As Revised) of the Cayman Islands.</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 1.5in"><B>&ldquo;Equity-linked Securities&rdquo;</B></TD>
    <TD STYLE="text-align: justify">means any debt or equity securities that are convertible, exercisable or exchangeable for Class A Shares issued in a financing transaction in connection with a Business Combination, including but not limited to a private placement of equity or debt.</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 1.5in"><B>&ldquo;Exchange Act&rdquo;</B></TD>
    <TD STYLE="text-align: justify">means the United States Securities Exchange Act of 1934, as amended, or any similar U.S. federal statute and the rules and regulations of the Securities and Exchange Commission thereunder, all as the same shall be in effect at the time.</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 1.5in"><B>&ldquo;Founders&rdquo;</B></TD>
    <TD STYLE="text-align: justify">means all Members immediately prior to the consummation of the IPO.</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 1.5in"><B>&ldquo;Independent Director&rdquo;</B></TD>
    <TD STYLE="text-align: justify">has the same meaning as in the rules and regulations of the Designated Stock Exchange or in Rule 10A-3 under the Exchange Act, as the case may be.</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 1.5in"><B>&ldquo;IPO&rdquo;</B></TD>
    <TD STYLE="text-align: justify">means the Company&rsquo;s initial public offering of securities.</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 1.5in"><B>&ldquo;Member&rdquo;</B></TD>
    <TD STYLE="text-align: justify">has the same meaning as in the Statute.</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 1.5in"><B>&ldquo;Memorandum&rdquo;</B></TD>
    <TD STYLE="text-align: justify">means the amended and restated memorandum of association of the Company.</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 1.5in"><B>&ldquo;Officer&rdquo;</B></TD>
    <TD STYLE="text-align: justify">means a person appointed to hold an office in the Company.</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 1.5in"><B>&ldquo;Ordinary Resolution&rdquo;</B></TD>
    <TD STYLE="text-align: left">means a resolution passed by a simple majority of the Members as, being entitled to do so, vote in person or, where proxies are allowed, by proxy at a general meeting, and includes a unanimous written resolution. In computing the majority when a poll is demanded regard shall be had to the number of votes to which each Member is entitled by the Articles.</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 1.5in"><B>&ldquo;Over-Allotment Option&rdquo;</B></TD>
    <TD STYLE="text-align: justify">means the option of the Underwriters to purchase up to an additional 15% of the firm units (as described in the Articles) issued in the IPO at a price equal to US$10 per unit, less underwriting discounts and commissions.</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 1.5in"><B>&ldquo;Preference Share&rdquo;</B></TD>
    <TD STYLE="text-align: justify">means a preference share of a par value of US$0.0001 in the share capital of the Company.</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 1.5in"><B>&ldquo;Public Share&rdquo;</B></TD>
    <TD STYLE="text-align: justify">means a Class A Share issued as part of the units (as described in the Articles) issued in the IPO.</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 1.5in"><B>&ldquo;Redemption Notice&rdquo;</B></TD>
    <TD STYLE="text-align: justify">means a notice in a form approved by the Company by which a holder of Public Shares is entitled to require the Company to redeem its Public Shares, subject to any conditions contained therein. </TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 1.5in"><B>&ldquo;Register of Members&rdquo;</B></TD>
    <TD STYLE="text-align: justify">means the register of Members maintained in accordance with the Statute and includes (except where otherwise stated) any branch or duplicate register of Members.</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 1.5in"><B>&ldquo;Registered Office&rdquo;</B></TD>
    <TD STYLE="text-align: justify">means the registered office for the time being of the Company.</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 1.5in"><B>&ldquo;Representative&rdquo;</B></TD>
    <TD STYLE="text-align: justify">means a representative of the Underwriters.</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 1.5in"><B>&ldquo;Seal&rdquo;</B></TD>
    <TD STYLE="text-align: justify">means the common seal of the Company and includes every duplicate seal.</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 1.5in"><B>&ldquo;Securities and Exchange Commission&rdquo;</B></TD>
    <TD STYLE="text-align: justify">means the United States Securities and Exchange Commission.</TD></TR>
</TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 1.5in"><B>&ldquo;Share&rdquo;</B></TD>
    <TD STYLE="text-align: justify">means a Class A Share, a Class B Share or a Preference Share and includes a fraction of a share in the Company.</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 1.5in"><B>&ldquo;Special Resolution&rdquo;</B></TD>
    <TD STYLE="text-align: justify">subject to Articles 29.4 and 47.2, has the same meaning as in the Statute, and includes a unanimous written resolution.</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 1.5in"><B>&ldquo;Sponsor&rdquo;</B></TD>
    <TD STYLE="text-align: justify">means Andretti Sponsor II LLC, a Delaware limited liability company, and its successors or assigns.</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 1.5in"><B>&ldquo;Statute&rdquo;</B></TD>
    <TD STYLE="text-align: justify">means the Companies Act (As Revised) of the Cayman Islands.</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 1.5in"><B>&ldquo;Tax Filing Authorised Person&rdquo;</B></TD>
    <TD STYLE="text-align: justify">means such person as any Director shall designate from time to time, acting severally.</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 1.5in"><B>&ldquo;Treasury Share&rdquo;</B></TD>
    <TD STYLE="text-align: justify">means a Share held in the name of the Company as a treasury share in accordance with the Statute.</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 1.5in"><B>&ldquo;Trust Account&rdquo;</B></TD>
    <TD STYLE="text-align: justify">means the trust account established by the Company upon the consummation of the IPO and into which a certain amount of the net proceeds of the IPO, together with a certain amount of the proceeds of a private placement of units simultaneously with the closing date of the IPO, will be deposited. </TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: left; width: 1.5in"><B>&ldquo;Underwriter&rdquo;</B></TD>
    <TD STYLE="text-align: justify">means an underwriter of the IPO from time to time and any successor underwriter.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.2</TD><TD STYLE="text-align: justify">In the Articles:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">words importing the singular number include the plural number and vice versa;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">words importing the masculine gender include the feminine gender;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">words importing persons include corporations as well as any other legal or natural person;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">&ldquo;written&rdquo; and &ldquo;in writing&rdquo; include all modes of representing or reproducing words
in visible form, including in the form of an Electronic Record;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(e)</TD><TD STYLE="text-align: justify">&ldquo;shall&rdquo; shall be construed as imperative and &ldquo;may&rdquo; shall be construed as permissive;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(f)</TD><TD STYLE="text-align: justify">references to provisions of any law or regulation shall be construed as references to those provisions
as amended, modified, re-enacted or replaced;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(g)</TD><TD STYLE="text-align: justify">any phrase introduced by the terms &ldquo;including&rdquo;, &ldquo;include&rdquo;, &ldquo;in particular&rdquo;
or any similar expression shall be construed as illustrative and shall not limit the sense of the words preceding those terms;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(h)</TD><TD STYLE="text-align: justify">the term &ldquo;and/or&rdquo; is used to mean both &ldquo;and&rdquo; as well as &ldquo;or.&rdquo; The use of
&ldquo;and/or&rdquo; in certain contexts in no respects qualifies or modifies the use of the terms &ldquo;and&rdquo; or &ldquo;or&rdquo; in
others. The term &ldquo;or&rdquo; shall not be interpreted to be exclusive and the term &ldquo;and&rdquo; shall not be interpreted to require
the conjunctive (in each case, unless the context otherwise requires);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">headings are inserted for reference only and shall be ignored in construing the Articles;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(j)</TD><TD STYLE="text-align: justify">any requirements as to delivery under the Articles include delivery in the form of an Electronic Record;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(k)</TD><TD STYLE="text-align: justify">any requirements as to execution or signature under the Articles including the execution of the Articles
themselves can be satisfied in the form of an electronic signature as defined in the Electronic Transactions Act;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(l)</TD><TD STYLE="text-align: justify">sections 8 and 19(3) of the Electronic Transactions Act shall not apply;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(m)</TD><TD STYLE="text-align: justify">the term &ldquo;clear days&rdquo; in relation to the period of a notice means that period excluding the
day when the notice is received or deemed to be received and the day for which it is given or on which it is to take effect; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(n)</TD><TD STYLE="text-align: justify">the term &ldquo;holder&rdquo; in relation to a Share means a person whose name is entered in the Register
of Members as the holder of such Share.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">2</FONT></TD><TD STYLE="text-align: justify">Commencement of Business</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2.1</TD><TD STYLE="text-align: justify">The business of the Company may be commenced as soon after incorporation of the Company as the Directors
shall see fit.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">2.2</TD><TD STYLE="text-align: justify">The Directors may pay, out of the capital or any other monies of the Company, all expenses incurred in
or about the formation and establishment of the Company, including the expenses of registration.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">3</FONT></TD><TD STYLE="text-align: justify">Issue of Shares and other Securities</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">3.1</TD><TD STYLE="text-align: justify">Subject to the provisions, if any, in the Memorandum (and to any direction that may be given by the Company
in general meeting) and, where applicable, the rules and regulations of the Designated Stock Exchange, the Securities and Exchange Commission
and/or any other competent regulatory authority or otherwise under Applicable Law, and without prejudice to any rights attached to any
existing Shares, the Directors may allot, issue, grant options over or otherwise dispose of Shares (including fractions of a Share) with
or without preferred, deferred or other rights or restrictions, whether in regard to Dividends or other distributions, voting, return
of capital or otherwise and to such persons, at such times and on such other terms as they think proper, and may also (subject to the
Statute and the Articles) vary such rights, save that the Directors shall not allot, issue, grant options over or otherwise dispose of
Shares (including fractions of a Share) to the extent that it may affect the ability of the Company to carry out a Class B Share Conversion
set out in the Articles.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">3.2</TD><TD STYLE="text-align: justify">The Company may issue rights, options, warrants or convertible securities or securities of similar nature
conferring the right upon the holders thereof to subscribe for, purchase or receive any class of Shares or other securities in the Company
on such terms as the Directors may from time to time determine.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">3.3</TD><TD STYLE="text-align: justify">The Company may issue units of securities in the Company, which may be comprised of whole or fractional
Shares, rights, options, warrants or convertible securities or securities of similar nature conferring the right upon the holders thereof
to subscribe for, purchase or receive any class of Shares or other securities in the Company, upon such terms as the Directors may from
time to time determine. The securities comprising any such units which are issued pursuant to the IPO can only be traded separately from
one another on the 52nd day following the date of the prospectus relating to the IPO unless the Representative(s) determines that an earlier
date is acceptable, subject to the Company having filed a current report on Form 8-K with the Securities and Exchange Commission and a
press release announcing when such separate trading will begin. Prior to such date, the units can be traded, but the securities comprising
such units cannot be traded separately from one another.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">3.4</TD><TD STYLE="text-align: justify">The Company shall not issue Shares to bearer.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">4</FONT></TD><TD STYLE="text-align: justify">Register of Members</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.1</TD><TD STYLE="text-align: justify">The Company shall maintain or cause to be maintained the Register of Members in accordance with the Statute.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.2</TD><TD STYLE="text-align: justify">The Directors may determine that the Company shall maintain one or more branch registers of Members in
accordance with the Statute. The Directors may also determine which register of Members shall constitute the principal register and which
shall constitute the branch register or registers, and to vary such determination from time to time.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">5</FONT></TD><TD STYLE="text-align: justify">Closing Register of Members or Fixing Record Date</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">5.1</TD><TD STYLE="text-align: justify">For the purpose of determining Members entitled to notice of, or to vote at any meeting of Members or
any adjournment thereof, or Members entitled to receive payment of any Dividend or other distribution, or in order to make a determination
of Members for any other purpose, the Directors may, after notice has been given by advertisement in an appointed newspaper or any other
newspaper or by any other means in accordance with the rules and regulations of the Designated Stock Exchange, the Securities and Exchange
Commission and/or any other competent regulatory authority or otherwise under Applicable Law, provide that the Register of Members shall
be closed for transfers for a stated period which shall not in any case exceed forty days.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">5.2</TD><TD STYLE="text-align: justify">In lieu of, or apart from, closing the Register of Members, the Directors may fix in advance or arrears
a date as the record date for any such determination of Members entitled to notice of, or to vote at any meeting of the Members or any
adjournment thereof, or for the purpose of determining the Members entitled to receive payment of any Dividend or other distribution,
or in order to make a determination of Members for any other purpose.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">5.3</TD><TD STYLE="text-align: justify">If the Register of Members is not so closed and no record date is fixed for the determination of Members
entitled to notice of, or to vote at, a meeting of Members or Members entitled to receive payment of a Dividend or other distribution,
the date on which notice of the meeting is sent or the date on which the resolution of the Directors resolving to pay such Dividend or
other distribution is passed, as the case may be, shall be the record date for such determination of Members. When a determination of
Members entitled to vote at any meeting of Members has been made as provided in this Article, such determination shall apply to any adjournment
thereof.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">6</FONT></TD><TD STYLE="text-align: justify">Certificates for Shares</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">6.1</TD><TD STYLE="text-align: justify">A Member shall only be entitled to a share certificate if the Directors resolve that share certificates
shall be issued. Share certificates representing Shares, if any, shall be in such form as the Directors may determine. Share certificates
shall be signed by one or more Directors or other person authorised by the Directors. The Directors may authorise certificates to be issued
with the authorised signature(s) affixed by mechanical process. All certificates for Shares shall be consecutively numbered or otherwise
identified and shall specify the Shares to which they relate. All certificates surrendered to the Company for transfer shall be cancelled
and, subject to the Articles, no new certificate shall be issued until the former certificate representing a like number of relevant Shares
shall have been surrendered and cancelled.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">6.2</TD><TD STYLE="text-align: justify">The Company shall not be bound to issue more than one certificate for Shares held jointly by more than
one person and delivery of a certificate to one joint holder shall be a sufficient delivery to all of them.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">6.3</TD><TD STYLE="text-align: justify">If a share certificate is defaced, worn out, lost or destroyed, it may be renewed on such terms (if any)
as to evidence and indemnity and on the payment of such expenses reasonably incurred by the Company in investigating evidence, as the
Directors may prescribe, and (in the case of defacement or wearing out) upon delivery of the old certificate.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">6.4</TD><TD STYLE="text-align: justify">Every share certificate sent in accordance with the Articles will be sent at the risk of the Member or
other person entitled to the certificate. The Company will not be responsible for any share certificate lost or delayed in the course
of delivery.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">6.5</TD><TD STYLE="text-align: justify">Share certificates shall be issued within the relevant time limit as prescribed by the Statute, if applicable,
or as the rules and regulations of the Designated Stock Exchange, the Securities and Exchange Commission and/or any other competent regulatory
authority or otherwise under Applicable Law may from time to time determine, whichever is shorter, after the allotment or, except in the
case of a Share transfer which the Company is for the time being entitled to refuse to register and does not register, after lodgement
of a Share transfer with the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">7</FONT></TD><TD STYLE="text-align: justify">Transfer of Shares</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">7.1</TD><TD STYLE="text-align: justify">Subject to the terms of the Articles, any Member may transfer all or any of their Shares by an instrument
of transfer provided that such transfer complies with the rules and regulations of the Designated Stock Exchange, the Securities and Exchange
Commission and/or any other competent regulatory authority or otherwise under Applicable Law. If the Shares in question were issued in
conjunction with rights, options, warrants or units issued pursuant to the Articles on terms that one cannot be transferred without the
other, the Directors shall refuse to register the transfer of any such Share without evidence satisfactory to them of the like transfer
of such right, option, warrant or unit.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">7.2</TD><TD STYLE="text-align: justify">The instrument of transfer of any Share shall be in writing in the usual or common form or in a form prescribed
by the rules and regulations of the Designated Stock Exchange, the Securities and Exchange Commission and/or any other competent regulatory
authority or otherwise under Applicable Law or in any other form approved by the Directors and shall be executed by or on behalf of the
transferor (and if the Directors so require, signed by or on behalf of the transferee) and may be under hand or, if the transferor or
transferee is a Clearing House or its nominee(s), by hand or by machine imprinted signature or by such other manner of execution as the
Directors may approve from time to time. The transferor shall be deemed to remain the holder of a Share until the name of the transferee
is entered in the Register of Members.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">8</FONT></TD><TD STYLE="text-align: justify">Redemption, Repurchase and Surrender of Shares</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">8.1</TD><TD STYLE="text-align: justify">Subject to the provisions of the Statute, and, where applicable, the rules and regulations of the Designated
Stock Exchange, the Securities and Exchange Commission and/or any other competent regulatory authority or otherwise under Applicable Law,
the Company may issue Shares that are to be redeemed or are liable to be redeemed at the option of the Member or the Company. The redemption
of such Shares, except Public Shares, shall be effected in such manner and upon such other terms as the Directors or the Company, by Ordinary
Resolution, may determine before the issue of such Shares. With respect to redeeming or repurchasing the Shares:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">Members who hold Public Shares are entitled to request the redemption of such Shares in the circumstances
described in the Business Combination Article hereof;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">Class B Shares held by the Sponsor shall be surrendered by the Sponsor for no consideration to the extent
that the Over-Allotment Option is not exercised in full so that the Sponsor will own 20% of the Company&rsquo;s issued Shares after the IPO
(exclusive of any securities purchased in a private placement simultaneously with the IPO); and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">Public Shares shall be repurchased by way of tender offer in the circumstances set out in the Business
Combination Article hereof.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">8.2</TD><TD STYLE="text-align: justify">Subject to the provisions of the Statute, and, where applicable, the rules and regulations of the Designated
Stock Exchange, the Securities and Exchange Commission and/or any other competent regulatory authority or otherwise under Applicable Law,
the Company may purchase its own Shares (including any redeemable Shares) in such manner and on such other terms as the Directors may
agree with the relevant Member. For the avoidance of doubt, redemptions, repurchases and surrenders of Shares in the circumstances described
in the Article above shall not require further approval of the Members.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">8.3</TD><TD STYLE="text-align: justify">The Company may make a payment in respect of the redemption or purchase of its own Shares in any manner
permitted by the Statute, including out of capital.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">8.4</TD><TD STYLE="text-align: justify">The Directors may accept the surrender for no consideration of any fully paid Share.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">9</FONT></TD><TD STYLE="text-align: justify">Treasury Shares</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">9.1</TD><TD STYLE="text-align: justify">The Directors may, prior to the purchase, redemption or surrender of any Share, determine that such Share
shall be held as a Treasury Share.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">9.2</TD><TD STYLE="text-align: justify">The Directors may determine to cancel a Treasury Share or transfer a Treasury Share on such terms as they
think proper (including, without limitation, for nil consideration).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">10</FONT></TD><TD STYLE="text-align: justify">Variation of Rights of Shares</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">10.1</TD><TD STYLE="text-align: justify">Subject to Article 3.1, if at any time the share capital of the Company is divided into different classes
of Shares, all or any of the rights attached to any class (unless otherwise provided by the terms of issue of the Shares of that class)
may, whether or not the Company is being wound up, be varied without the consent of the holders of the issued Shares of that class where
such variation is considered by the Directors not to have a material adverse effect upon such rights; otherwise, any such variation shall
be made only with the consent in writing of the holders of not less than two-thirds of the issued Shares of that class (other than with
respect to a waiver of the provisions of the Class B Share Conversion Article hereof, which as stated therein shall only require the consent
in writing of the holders of a majority of the issued Shares of that class), or with the approval of a resolution passed by a majority
of not less than two-thirds of the votes cast at a separate meeting of the holders of the Shares of that class. For the avoidance of doubt,
the Directors reserve the right, notwithstanding that any such variation may not have a material adverse effect, to obtain consent from
the holders of Shares of the relevant class. To any such meeting all the provisions of the Articles relating to general meetings shall
apply <I>mutatis mutandis</I>, except that the necessary quorum shall be one person holding or representing by proxy at least one-third
of the issued Shares of the class and that any holder of Shares of the class present in person or by proxy may demand a poll.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">10.2</TD><TD STYLE="text-align: justify">For the purposes of a separate class meeting, the Directors may treat two or more or all the classes of
Shares as forming one class of Shares if the Directors consider that such class of Shares would be affected in the same way by the proposals
under consideration, but in any other case shall treat them as separate classes of Shares.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">10.3</TD><TD STYLE="text-align: justify">The rights conferred upon the holders of the Shares of any class issued with preferred or other rights
shall not, unless otherwise expressly provided by the terms of issue of the Shares of that class, be deemed to be varied by: (i) the creation
or issue of further Shares ranking pari passu therewith or Shares issued with preferred or other rights; (ii) where the constitutional
documents of the Company are amended or new constitutional documents of the Company are adopted, in each case, as a result of the Company
registering by way of continuation as a body corporate under the laws of any jurisdiction outside the Cayman Islands; or (iii) the conversion
of any Class B Shares pursuant to the Class B Ordinary Share Conversion Article.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">11</FONT></TD><TD STYLE="text-align: justify">Commission on Sale of Shares</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company may, in so far as the Statute
permits, pay a commission to any person in consideration of that person subscribing or agreeing to subscribe (whether absolutely or conditionally)
or procuring or agreeing to procure subscriptions (whether absolutely or conditionally) for any Shares. Such commissions may be satisfied
by the payment of cash and/or the issue of fully or partly paid-up Shares. The Company may also on any issue of Shares pay such brokerage
as may be lawful.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>


<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
                                                                                                                                               <TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">12</FONT></TD><TD STYLE="text-align: justify">Non Recognition of Trusts</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company shall not be bound by or
compelled to recognise in any way (even when notified) any equitable, contingent, future or partial interest in any Share, or (except
only as is otherwise provided by the Articles or the Statute) any other rights in respect of any Share other than an absolute right to
the entirety thereof in the holder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>


<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">
                                                                                                                                               <TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">13</FONT></TD><TD STYLE="text-align: justify">Lien on Shares</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">13.1</TD><TD STYLE="text-align: justify">The Company shall have a first and paramount lien on all Shares (whether fully paid-up or not) registered
in the name of a Member (whether solely or jointly with others) for all debts, liabilities or engagements to or with the Company (whether
presently payable or not) by such Member or their estate, either alone or jointly with any other person, whether a Member or not, but
the Directors may at any time declare any Share to be wholly or in part exempt from the provisions of this Article. The registration of
a transfer of any such Share shall operate as a waiver of the Company&rsquo;s lien thereon. The Company&rsquo;s lien on a Share shall also extend
to any amount payable in respect of that Share.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">13.2</TD><TD STYLE="text-align: justify">The Company may sell, in such manner as the Directors think fit, any Shares on which the Company has a
lien, if a sum in respect of which the lien exists is presently payable, and is not paid within 14 clear days after notice has been received
or deemed to have been received by the holder of the Shares, or to the person entitled to it in consequence of the death or bankruptcy
of the holder, demanding payment and stating that if the notice is not complied with the Shares may be sold.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">13.3</TD><TD STYLE="text-align: justify">To give effect to any such sale the Directors may authorise any person to execute an instrument of transfer
of the Shares sold to, or in accordance with the directions of, the purchaser. The purchaser or their nominee shall be registered as the
holder of the Shares comprised in any such transfer, and they shall not be bound to see to the application of the purchase money, nor
shall their title to the Shares be affected by any irregularity or invalidity in the sale or the exercise of the Company&rsquo;s power of sale
under the Articles.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">13.4</TD><TD STYLE="text-align: justify">The net proceeds of such sale after payment of costs, shall be applied in payment of such part of the
amount in respect of which the lien exists as is presently payable and any balance shall (subject to a like lien for sums not presently
payable as existed upon the Shares before the sale) be paid to the person entitled to the Shares at the date of the sale.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">14</FONT></TD><TD STYLE="text-align: justify">Call on Shares</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">14.1</TD><TD STYLE="text-align: justify">Subject to the terms of the allotment and issue of any Shares, the Directors may make calls upon the Members
in respect of any monies unpaid on their Shares (whether in respect of par value or premium), and each Member shall (subject to receiving
at least 14 clear days&rsquo; notice specifying the time or times of payment) pay to the Company at the time or times so specified the amount
called on the Shares. A call may be revoked or postponed, in whole or in part, as the Directors may determine. A call may be required
to be paid by instalments. A person upon whom a call is made shall remain liable for calls made upon them notwithstanding the subsequent
transfer of the Shares in respect of which the call was made.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">14.2</TD><TD STYLE="text-align: justify">A call shall be deemed to have been made at the time when the resolution of the Directors authorising
such call was passed.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">14.3</TD><TD STYLE="text-align: justify">The joint holders of a Share shall be jointly and severally liable to pay all calls in respect thereof.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">14.4</TD><TD STYLE="text-align: justify">If a call remains unpaid after it has become due and payable, the person from whom it is due shall pay
interest on the amount unpaid from the day it became due and payable until it is paid at such rate as the Directors may determine (and
in addition all expenses that have been incurred by the Company by reason of such non-payment), but the Directors may waive payment of
the interest or expenses wholly or in part.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">14.5</TD><TD STYLE="text-align: justify">An amount payable in respect of a Share on issue or allotment or at any fixed date, whether on account
of the par value of the Share or premium or otherwise, shall be deemed to be a call and if it is not paid all the provisions of the Articles
shall apply as if that amount had become due and payable by virtue of a call.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">14.6</TD><TD STYLE="text-align: justify">The Directors may issue Shares with different terms as to the amount and times of payment of calls, or
the interest to be paid.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">14.7</TD><TD STYLE="text-align: justify">The Directors may, if they think fit, receive an amount from any Member willing to advance all or any
part of the monies uncalled and unpaid upon any Shares held by that Member, and may (until the amount would otherwise become payable)
pay interest at such rate as may be agreed upon between the Directors and the Member paying such amount in advance.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">14.8</TD><TD STYLE="text-align: justify">No such amount paid in advance of calls shall entitle the Member paying such amount to any portion of
a Dividend or other distribution payable in respect of any period prior to the date upon which such amount would, but for such payment,
become payable.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">15</FONT></TD><TD STYLE="text-align: justify">Forfeiture of Shares</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">15.1</TD><TD STYLE="text-align: justify">If a call or instalment of a call remains unpaid after it has become due and payable the Directors may
give to the person from whom it is due not less than 14 clear days&rsquo; notice requiring payment of the amount unpaid together with any interest
which may have accrued and any expenses incurred by the Company by reason of such non-payment. The notice shall specify where payment
is to be made and shall state that if the notice is not complied with the Shares in respect of which the call was made will be liable
to be forfeited.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">15.2</TD><TD STYLE="text-align: justify">If the notice is not complied with, any Share in respect of which it was given may, before the payment
required by the notice has been made, be forfeited by a resolution of the Directors. Such forfeiture shall include all Dividends, other
distributions or other monies payable in respect of the forfeited Share and not paid before the forfeiture.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">15.3</TD><TD STYLE="text-align: justify">A forfeited Share may be sold, re-allotted or otherwise disposed of on such terms and in such manner as
the Directors think fit and at any time before a sale, re-allotment or disposition the forfeiture may be cancelled on such terms as the
Directors think fit. Where for the purposes of its disposal a forfeited Share is to be transferred to any person the Directors may authorise
some person to execute an instrument of transfer of the Share in favour of that person.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">15.4</TD><TD STYLE="text-align: justify">A person any of whose Shares have been forfeited shall cease to be a Member in respect of them and shall
surrender to the Company for cancellation the certificate for the Shares forfeited and shall remain liable to pay to the Company all monies
which at the date of forfeiture were payable by that person to the Company in respect of those Shares together with interest at such rate
as the Directors may determine, but that person&rsquo;s liability shall cease if and when the Company shall have received payment in full of
all monies due and payable by them in respect of those Shares.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">15.5</TD><TD STYLE="text-align: justify">A certificate in writing under the hand of one Director or Officer that a Share has been forfeited on
a specified date shall be conclusive evidence of the facts stated in it as against all persons claiming to be entitled to the Share. The
certificate shall (subject to the execution of an instrument of transfer) constitute a good title to the Share and the person to whom
the Share is sold or otherwise disposed of shall not be bound to see to the application of the purchase money, if any, nor shall their
title to the Share be affected by any irregularity or invalidity in the proceedings in reference to the forfeiture, sale or disposal of
the Share.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">15.6</TD><TD STYLE="text-align: justify">The provisions of the Articles as to forfeiture shall apply in the case of non payment of any sum which,
by the terms of issue of a Share, becomes payable at a fixed time, whether on account of the par value of the Share or by way of premium
as if it had been payable by virtue of a call duly made and notified.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">16</FONT></TD><TD STYLE="text-align: justify">Transmission of Shares</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">16.1</TD><TD STYLE="text-align: justify">If a Member dies, the survivor or survivors (where they were a joint holder), or their legal personal
representatives (where they were a sole holder), shall be the only persons recognised by the Company as having any title to the deceased
Member&rsquo;s Shares. The estate of a deceased Member is not thereby released from any liability in respect of any Share, for which the Member
was a joint or sole holder.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">16.2</TD><TD STYLE="text-align: justify">Any person becoming entitled to a Share in consequence of the death or bankruptcy or liquidation or dissolution
of a Member (or in any other way than by transfer) may, upon such evidence being produced as may be required by the Directors, elect,
by a notice in writing sent by that person to the Company, either to become the holder of such Share or to have some person nominated
by them registered as the holder of such Share. If they elect to have another person registered as the holder of such Share they shall
sign an instrument of transfer of that Share to that person. The Directors shall, in either case, have the same right to decline or suspend
registration as they would have had in the case of a transfer of the Share by the relevant Member before their death or bankruptcy or
liquidation or dissolution, as the case may be.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">16.3</TD><TD STYLE="text-align: justify">A person becoming entitled to a Share by reason of the death or bankruptcy or liquidation or dissolution
of a Member (or in any other case than by transfer) shall be entitled to the same Dividends, other distributions and other advantages
to which they would be entitled if they were the holder of such Share. However, they shall not, before becoming a Member in respect of
a Share, be entitled in respect of it to exercise any right conferred by membership in relation to general meetings of the Company and
the Directors may at any time give notice requiring any such person to elect either to be registered or to have some person nominated
by them registered as the holder of the Share (but the Directors shall, in either case, have the same right to decline or suspend registration
as they would have had in the case of a transfer of the Share by the relevant Member before their death or bankruptcy or liquidation or
dissolution or any other case than by transfer, as the case may be). If the notice is not complied with within 90 days of being received
or deemed to be received (as determined pursuant to the Articles), the Directors may thereafter withhold payment of all Dividends, other
distributions, bonuses or other monies payable in respect of the Share until the requirements of the notice have been complied with.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">17</FONT></TD><TD STYLE="text-align: justify">Class B Ordinary Share Conversion</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">17.1</TD><TD STYLE="text-align: justify">The rights attaching to the Class A Shares and Class B Shares shall rank <I>pari passu</I> in all respects,
and the Class A Shares and Class B Shares shall vote together as a single class on all matters (subject to the Variation of Rights of
Shares Article and the Appointment and Removal of Directors Article and the Transfer by Way of Continuation Article) with the exception
that the holder of a Class B Share shall have the conversion rights referred to in this Article.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">17.2</TD><TD STYLE="text-align: justify">Class B Shares shall automatically convert into Class A Shares on a one-for-one basis (the &ldquo;<B>Initial
Conversion Ratio</B>&rdquo;): (a) at any time and from time to time at the option of the holders thereof; or (b) in connection with the
consummation of a Business Combination.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">17.3</TD><TD STYLE="text-align: justify">Notwithstanding the Initial Conversion Ratio, in the case that additional Class A Shares or any other
Equity-linked Securities, are issued, or deemed issued, by the Company in excess of the amounts offered in the IPO and related to the
consummation of a Business Combination, all Class B Shares in issue shall automatically convert into Class A Shares in connection with
the consummation of a Business Combination at a ratio for which the Class B Shares shall convert into Class A Shares will be adjusted
(unless the holders of a majority of the Class B Shares in issue agree to waive such anti-dilution adjustment with respect to any such
issuance or deemed issuance) so that the number of Class A Shares issuable upon conversion of all Class B Shares will equal, on an as-converted
basis, in the aggregate, 20% of the sum of: (a) all Class A Shares and Class B Shares in issue upon completion of the IPO; plus (b) all
Class A Shares and Equity-linked Securities issued or deemed issued in connection with a Business Combination (excluding any Shares or
Equity-linked Securities issued, or to be issued, to any seller in a Business Combination and any private placement warrants issued to
the Sponsor or its Affiliates or to a Director or Officer upon conversion of working capital loans made to the Company); minus (c) any
redemptions of Public Shares by holders thereof in connection with a Business Combination.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">17.4</TD><TD STYLE="text-align: justify">Notwithstanding anything to the contrary contained herein, the foregoing adjustment to the Initial Conversion
Ratio may be waived as to any particular issuance or deemed issuance of additional Class&nbsp;A Shares or Equity-linked Securities by
the written consent or agreement of holders of a majority of the Class B Shares then in issue consenting or agreeing separately as a separate
class in the manner provided in the Variation of Rights of Shares Article hereof.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">17.5</TD><TD STYLE="text-align: justify">The foregoing conversion ratio shall also be adjusted to account for any subdivision (by share subdivision,
exchange, capitalisation, rights issue, reclassification, recapitalisation or otherwise) or combination (by share consolidation, exchange,
reclassification, recapitalisation or otherwise) or similar reclassification or recapitalisation of the Class A Shares in issue into a
greater or lesser number of shares occurring after the original filing of the Articles without a proportionate and corresponding subdivision,
combination or similar reclassification or recapitalisation of the Class B Shares in issue.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">17.6</TD><TD STYLE="text-align: justify">Each Class B Share shall convert into its pro rata number of Class A Shares pursuant to this Article.
The pro rata share for each holder of Class B Shares will be determined as follows: each Class B Share shall convert into such number
of Class A Shares as is equal to the product of 1 multiplied by a fraction, the numerator of which shall be the total number of Class
A Shares into which all of the Class B Shares in issue shall be converted pursuant to this Article and the denominator of which shall
be the total number of Class B Shares in issue at the time of conversion.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">17.7</TD><TD STYLE="text-align: justify">References in this Article to &ldquo;converted&rdquo;, &ldquo;conversion&rdquo; or &ldquo;exchange&rdquo; shall
mean the compulsory redemption without notice of Class B Shares of any Member and, on behalf of such Members, automatic application of
such redemption proceeds in paying for such new Class A Shares into which the Class B Shares have been converted or exchanged at a price
per Class B Share necessary to give effect to a conversion or exchange calculated on the basis that the Class A Shares to be issued as
part of the conversion or exchange will be issued at par. The Class A Shares to be issued on an exchange or conversion shall be registered
in the name of such Member or in such name as the Member may direct.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">17.8</TD><TD STYLE="text-align: justify">Notwithstanding anything to the contrary in this Article, in no event may any Class B Share convert into
Class A Shares at a ratio that is less than one-for-one.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">18</FONT></TD><TD STYLE="text-align: justify">Amendments of Memorandum and Articles of Association and Alteration of Capital</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">18.1</TD><TD STYLE="text-align: justify">The Company may by Ordinary Resolution:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">increase its share capital by such sum as the Ordinary Resolution shall prescribe and with such rights,
priorities and privileges annexed thereto, as the Company in general meeting may determine;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">consolidate and divide all or any of its share capital into Shares of larger amount than its existing
Shares;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">convert all or any of its paid-up Shares into stock, and reconvert that stock into paid-up Shares of any
denomination;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">by subdivision of its existing Shares or any of them divide the whole or any part of its share capital
into Shares of smaller amount than is fixed by the Memorandum or into Shares without par value; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(e)</TD><TD STYLE="text-align: justify">cancel any Shares that at the date of the passing of the Ordinary Resolution have not been taken or agreed
to be taken by any person and diminish the amount of its share capital by the amount of the Shares so cancelled.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">18.2</TD><TD STYLE="text-align: justify">All new Shares created in accordance with the provisions of the preceding Article shall be subject to
the same provisions of the Articles with reference to the payment of calls, liens, transfer, transmission, forfeiture and otherwise as
the Shares in the original share capital.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">18.3</TD><TD STYLE="text-align: justify">Subject to the provisions of the Statute, the provisions of the Articles as regards the matters to be
dealt with by Ordinary Resolution and Articles 29.4 and 47.2, the Company may by Special Resolution:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">change its name;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">alter or add to the Articles (subject to Articles 29.4 and 47.2);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">alter or add to the Memorandum with respect to any objects, powers or other matters specified therein;
and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">reduce its share capital or any capital redemption reserve fund.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">19</FONT></TD><TD STYLE="text-align: justify">Offices and Places of Business</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Subject to the provisions of the Statute,
the Company may by resolution of the Directors change the location of its Registered Office. The Company may, in addition to its Registered
Office, maintain such other offices or places of business as the Directors determine.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">20</FONT></TD><TD STYLE="text-align: justify">General Meetings</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">20.1</TD><TD STYLE="text-align: justify">All general meetings other than annual general meetings shall be called extraordinary general meetings.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">20.2</TD><TD STYLE="text-align: justify">The Company may, but shall not (unless required by the Statute) be obliged to, in each year hold a general
meeting as its annual general meeting, and shall specify the meeting as such in the notices calling it. Any annual general meeting shall
be held at such time and place as the Directors shall appoint. At these meetings the report of the Directors (if any) shall be presented.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">20.3</TD><TD STYLE="text-align: justify">The Directors, the chief executive officer or the chairperson of the board of Directors may call general
meetings, and, for the avoidance of doubt, the Members shall not have the ability to call general meetings.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">20.4</TD><TD STYLE="text-align: justify">Members seeking to bring business before the annual general meeting or to nominate candidates for appointment
as Directors at the annual general meeting must deliver notice to the principal executive offices of the Company not less than 120 calendar
days before the date of the Company&rsquo;s proxy statement released to Members in connection with the previous year&rsquo;s annual general
meeting or, if the Company did not hold an annual general meeting the previous year, or if the date of the current year&rsquo;s annual general
meeting has been changed by more than 30 days from the date of the previous year&rsquo;s annual general meeting, then the deadline shall
be set by the board of Directors with such deadline being a reasonable time before the Company begins to print and send its related proxy
materials.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">21</FONT></TD><TD STYLE="text-align: justify">Notice of General Meetings</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">21.1</TD><TD STYLE="text-align: justify">At least five clear days&rsquo; notice shall be given of any general meeting. Every notice shall specify the
place, the day and the hour of the meeting and the general nature of the business to be conducted at the general meeting and shall be
given in the manner hereinafter mentioned or in such other manner if any as may be prescribed by the Company, provided that a general
meeting of the Company shall, whether or not the notice specified in this Article has been given and whether or not the provisions of
the Articles regarding general meetings have been complied with, be deemed to have been duly convened if it is so agreed:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">in the case of an annual general meeting, by all of the Members entitled to attend and vote at the meeting;
and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">in the case of an extraordinary general meeting, by a majority in number of the Members having a right
to attend and vote at the meeting, together holding not less than 95% in par value of the Shares giving that right.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">21.2</TD><TD STYLE="text-align: justify">The accidental omission to give notice of a general meeting to, or the non receipt of notice of a general
meeting by, any person entitled to receive such notice shall not invalidate the proceedings of that general meeting.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">22</FONT></TD><TD STYLE="text-align: justify">Proceedings at General Meetings</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">22.1</TD><TD STYLE="text-align: justify">No business shall be transacted at any general meeting unless a quorum is present. The holders of one-third
of the Shares being individuals present in person or by proxy or if a corporation or other non-natural person by its duly authorised representative
or proxy shall be a quorum.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">22.2</TD><TD STYLE="text-align: justify">A person may participate at a general meeting by conference telephone or other communications equipment
by means of which all the persons participating in the meeting can communicate with each other. Participation by a person in a general
meeting in this manner is treated as presence in person at that meeting.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">22.3</TD><TD STYLE="text-align: justify">A resolution (including a Special Resolution) in writing (in one or more counterparts) signed by or on
behalf of all of the Members for the time being entitled to receive notice of and to attend and vote at general meetings (or, being corporations
or other non-natural persons, signed by their duly authorised representatives) shall be as valid and effective as if the resolution had
been passed at a general meeting of the Company duly convened and held.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">22.4</TD><TD STYLE="text-align: justify">If a quorum is not present within half an hour from the time appointed for the meeting to commence, the
meeting shall stand adjourned to the same day in the next week at the same time and/or place or to such other day, time and/or place as
the Directors may determine, and if at the adjourned meeting a quorum is not present within half an hour from the time appointed for the
meeting to commence, the Members present shall be a quorum.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">22.5</TD><TD STYLE="text-align: justify">The Directors may, at any time prior to the time appointed for the meeting to commence, appoint any person
to act as chairperson of a general meeting of the Company or, if the Directors do not make any such appointment, the chairperson, if any,
of the board of Directors shall preside as chairperson at such general meeting. If there is no such chairperson, or if the person shall
not be present within 15 minutes after the time appointed for the meeting to commence, or is unwilling to act, the Directors present shall
elect one of their number to be chairperson of the meeting.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">22.6</TD><TD STYLE="text-align: justify">If no Director is willing to act as chairperson or if no Director is present within 15 minutes after the
time appointed for the meeting to commence, the Members present shall choose one of their number to be chairperson of the meeting.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">22.7</TD><TD STYLE="text-align: justify">The chairperson may, with the consent of a meeting at which a quorum is present (and shall if so directed
by the meeting) adjourn the meeting from time to time and from place to place, but no business shall be transacted at any adjourned meeting
other than the business left unfinished at the meeting from which the adjournment took place.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">22.8</TD><TD STYLE="text-align: justify">When a general meeting is adjourned for 30 days or more, notice of the adjourned meeting shall be given
as in the case of an original meeting. Otherwise it shall not be necessary to give any such notice of an adjourned meeting.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">22.9</TD><TD STYLE="text-align: justify">If, prior to a Business Combination, a notice is issued in respect of a general meeting and the Directors,
in their absolute discretion, consider that it is impractical or undesirable for any reason to hold that general meeting at the place,
the day and the hour specified in the notice calling such general meeting, the Directors may postpone the general meeting to another place,
day and/or hour provided that notice of the place, the day and the hour of the rearranged general meeting is promptly given to all Members.
No business shall be transacted at any postponed meeting other than the business specified in the notice of the original meeting.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">22.10</TD><TD STYLE="text-align: justify">When a general meeting is postponed for 30 days or more, notice of the postponed meeting shall be given
as in the case of an original meeting. Otherwise it shall not be necessary to give any such notice of a postponed meeting.&nbsp;All proxy
forms submitted for the original general meeting shall remain valid for the postponed meeting.&nbsp;The Directors may postpone a general
meeting which has already been postponed.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">22.11</TD><TD STYLE="text-align: justify">A resolution put to the vote of the meeting shall be decided on a poll.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">22.12</TD><TD STYLE="text-align: justify">A poll shall be taken as the chairperson directs, and the result of the poll shall be deemed to be the
resolution of the general meeting at which the poll was demanded.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">22.13</TD><TD STYLE="text-align: justify">A poll demanded on the election of a chairperson or on a question of adjournment shall be taken forthwith.
A poll demanded on any other question shall be taken at such date, time and place as the chairperson of the general meeting directs, and
any business other than that upon which a poll has been demanded or is contingent thereon may proceed pending the taking of the poll.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">22.14</TD><TD STYLE="text-align: justify">In the case of an equality of votes the chairperson shall be entitled to a second or casting vote.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">23</FONT></TD><TD STYLE="text-align: justify">Votes of Members</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">23.1</TD><TD STYLE="text-align: justify">Subject to any rights or restrictions attached to any Shares, including as set out at Articles 29.4 and
47.2, every Member present in any such manner shall have one vote for every Share of which they are the holder.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">23.2</TD><TD STYLE="text-align: justify">In the case of joint holders the vote of the senior holder who tenders a vote, whether in person or by
proxy (or, in the case of a corporation or other non-natural person, by its duly authorised representative or proxy), shall be accepted
to the exclusion of the votes of the other joint holders, and seniority shall be determined by the order in which the names of the holders
stand in the Register of Mefmbers.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">23.3</TD><TD STYLE="text-align: justify">A Member of unsound mind, or in respect of whom an order has been made by any court, having jurisdiction
in lunacy, may vote by their committee, receiver, curator bonis, or other person on such Member&rsquo;s behalf appointed by that court, and
any such committee, receiver, curator bonis or other person may vote by proxy.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">23.4</TD><TD STYLE="text-align: justify">No person shall be entitled to vote at any general meeting unless they are registered as a Member on the
record date for such meeting nor unless all calls or other monies then payable by them in respect of Shares have been paid.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">23.5</TD><TD STYLE="text-align: justify">No objection shall be raised as to the qualification of any voter except at the general meeting or adjourned
general meeting at which the vote objected to is given or tendered and every vote not disallowed at the meeting shall be valid. Any objection
made in due time in accordance with this Article shall be referred to the chairperson whose decision shall be final and conclusive.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">23.6</TD><TD STYLE="text-align: justify">Votes may be cast either personally or by proxy (or in the case of a corporation or other non-natural
person by its duly authorised representative or proxy). A Member may appoint more than one proxy or the same proxy under one or more instruments
to attend and vote at a meeting. Where a Member appoints more than one proxy the instrument of proxy shall specify the number of Shares
in respect of which each proxy is entitled to exercise the related votes.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">23.7</TD><TD STYLE="text-align: justify">A Member holding more than one Share need not cast the votes in respect of their Shares in the same way
on any resolution and therefore may vote a Share or some or all such Shares either for or against a resolution and/or abstain from voting
a Share or some or all of the Shares and, subject to the terms of the instrument appointing the proxy, a proxy appointed under one or
more instruments may vote a Share or some or all of the Shares in respect of which they are appointed either for or against a resolution
and/or abstain from voting a Share or some or all of the Shares in respect of which they are appointed.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">24</FONT></TD><TD STYLE="text-align: justify">Proxies</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">24.1</TD><TD STYLE="text-align: justify">The instrument appointing a proxy shall be in writing and shall be executed under the hand of the appointor
or of their attorney duly authorised in writing, or, if the appointor is a corporation or other non natural person, under the hand of
its duly authorised representative. A proxy need not be a Member.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">24.2</TD><TD STYLE="text-align: justify">The Directors may, in the notice convening any meeting or adjourned meeting, or in an instrument of proxy
sent out by the Company, specify the manner by which the instrument appointing a proxy shall be deposited and the place and the time (being
not later than the time appointed for the commencement of the meeting or adjourned meeting to which the proxy relates) at which the instrument
appointing a proxy shall be deposited. In the absence of any such direction from the Directors in the notice convening any meeting or
adjourned meeting or in an instrument of proxy sent out by the Company, the instrument appointing a proxy shall be deposited physically
at the Registered Office not less than 48 hours before the time appointed for the meeting or adjourned meeting to commence at which the
person named in the instrument proposes to vote.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">24.3</TD><TD STYLE="text-align: justify">The chairperson may in any event at their discretion declare that an instrument of proxy shall be deemed
to have been duly deposited. An instrument of proxy that is not deposited in the manner permitted, or which has not been declared to have
been duly deposited by the chairperson, shall be invalid.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">24.4</TD><TD STYLE="text-align: justify">The instrument appointing a proxy may be in any usual or common form (or such other form as the Directors
may approve) and may be expressed to be for a particular meeting or any adjournment thereof or generally until revoked. An instrument
appointing a proxy shall be deemed to include the power to demand or join or concur in demanding a poll.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">24.5</TD><TD STYLE="text-align: justify">Votes given in accordance with the terms of an instrument of proxy shall be valid notwithstanding the
previous death or insanity of the principal or revocation of the proxy or of the authority under which the proxy was executed, or the
transfer of the Share in respect of which the proxy is given unless notice in writing of such death, insanity, revocation or transfer
was received by the Company at the Registered Office before the commencement of the general meeting, or adjourned meeting at which it
is sought to use the proxy.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">25</FONT></TD><TD STYLE="text-align: justify">Corporate Members</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">25.1</TD><TD STYLE="text-align: justify">Any corporation or other non-natural person which is a Member may in accordance with its constitutional
documents, or in the absence of such provision by resolution of its directors or other governing body, authorise such person as it thinks
fit to act as its representative at any meeting of the Company or of any class of Members, and the person so authorised shall be entitled
to exercise the same powers on behalf of the corporation which they represent as the corporation could exercise if it were an individual
Member.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">25.2</TD><TD STYLE="text-align: justify">If a Clearing House (or its nominee(s)), being a corporation, is a Member, it may authorise such persons
as it sees fit to act as its representative at any meeting of the Company or at any meeting of any class of Members provided that the
authorisation shall specify the number and class of Shares in respect of which each such representative is so authorised. Each person
so authorised under the provisions of this Article shall be deemed to have been duly authorised without further evidence of the facts
and be entitled to exercise the same rights and powers on behalf of the Clearing House (or its nominee(s)) as if such person was the registered
holder of such Shares held by the Clearing House (or its nominee(s)).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">26</FONT></TD><TD STYLE="text-align: justify">Shares that May Not be Voted</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Shares in the Company that are beneficially
owned by the Company shall not be voted, directly or indirectly, at any meeting and shall not be counted in determining the total number
of outstanding Shares at any given time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">27</FONT></TD><TD STYLE="text-align: justify">Directors</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">27.1</TD><TD STYLE="text-align: justify">There shall be a board of Directors consisting of not less than one person provided however that the Company
may by Ordinary Resolution increase or reduce the limits in the number of Directors.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">27.2</TD><TD STYLE="text-align: justify">The Directors shall be divided into three classes: Class I, Class II and Class III. The number of Directors
in each class shall be as nearly equal as possible. Upon the adoption of the Articles, the existing Directors shall by resolution classify
themselves as Class I, Class II or Class III Directors. The Class I Directors shall stand appointed for a term expiring at the Company&rsquo;s
first annual general meeting, the Class II Directors shall stand appointed for a term expiring at the Company&rsquo;s second annual general
meeting and the Class III Directors shall stand appointed for a term expiring at the Company&rsquo;s third annual general meeting. Commencing
at the Company&rsquo;s first annual general meeting, and at each annual general meeting thereafter, Directors appointed to succeed those
Directors whose terms expire shall be appointed for a term of office to expire at the third succeeding annual general meeting after their
appointment. Except as the Statute or other Applicable Law may otherwise require, in the interim between annual general meetings or extraordinary
general meetings called for the appointment of Directors and/or the removal of one or more Directors and the filling of any vacancy in
that connection, additional Directors and any vacancies in the board of Directors, including unfilled vacancies resulting from the removal
of Directors for cause, may be filled by the vote of a majority of the remaining Directors then in office, although less than a quorum
(as defined in the Articles), or by the sole remaining Director. All Directors shall hold office until the expiration of their respective
terms of office and until their successors shall have been appointed and qualified. A Director appointed to fill a vacancy resulting from
the death, resignation or removal of a Director shall serve for the remainder of the full term of the Director whose death, resignation
or removal shall have created such vacancy and until their successor shall have been appointed and qualified.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">28</FONT></TD><TD STYLE="text-align: justify">Powers of Directors</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">28.1</TD><TD STYLE="text-align: justify">Subject to the provisions of the Statute, the Memorandum and the Articles and to any directions given
by Special Resolution, the business of the Company shall be managed by the Directors who may exercise all the powers of the Company. No
alteration of the Memorandum or Articles and no such direction shall invalidate any prior act of the Directors which would have been valid
if that alteration had not been made or that direction had not been given. A duly convened meeting of Directors at which a quorum is present
may exercise all powers exercisable by the Directors.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">28.2</TD><TD STYLE="text-align: justify">All cheques, promissory notes, drafts, bills of exchange and other negotiable or transferable instruments
and all receipts for monies paid to the Company shall be signed, drawn, accepted, endorsed or otherwise executed as the case may be in
such manner as the Directors shall determine by resolution.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">28.3</TD><TD STYLE="text-align: justify">The Directors on behalf of the Company may pay a gratuity or pension or allowance on retirement to any
Director who has held any other salaried office or place of profit with the Company or to their surviving spouse, civil partner or dependants
and may make contributions to any fund and pay premiums for the purchase or provision of any such gratuity, pension or allowance.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">28.4</TD><TD STYLE="text-align: justify">The Directors may exercise all the powers of the Company to borrow money and to mortgage or charge its
undertaking, property and assets (present and future) and uncalled capital or any part thereof and to issue debentures, debenture stock,
mortgages, bonds and other such securities whether outright or as security for any debt, liability or obligation of the Company or of
any third party.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">29</FONT></TD><TD STYLE="text-align: justify">Appointment and Removal of Directors</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">29.1</TD><TD STYLE="text-align: justify">The Company may by Ordinary Resolution appoint any person to be a Director or may by Ordinary Resolution
remove any Director, provided that prior to the consummation of a Business Combination and for so long as there are Class B Shares in
issue, only the holders of the Class B Shares shall be entitled to vote on any such Ordinary Resolution. For the avoidance of doubt, prior
to the consummation of a Business Combination, if there are any Class B Shares in issue, holders of Class A Shares shall have no right
to vote on the appointment or removal of any Director.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">29.2</TD><TD STYLE="text-align: justify">The Directors may appoint any person to be a Director, either to fill a vacancy or as an additional Director
provided that the appointment does not cause the number of Directors to exceed any number fixed by or in accordance with the Articles
as the maximum number of Directors.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">29.3</TD><TD STYLE="text-align: justify">After the consummation of a Business Combination, the Company may by Ordinary Resolution appoint any person
to be a Director or may by Ordinary Resolution remove any Director.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">29.4</TD><TD STYLE="text-align: justify">Prior to the consummation of a Business Combination, Article 29.1 may only be amended by a Special Resolution
passed by at least 90% (or, where such amendment is proposed in respect of the consummation of a Business Combination, at least two-thirds)
of such Members as, being entitled to do so, vote in person or, where proxies are allowed, by proxy at a general meeting of which notice
specifying the intention to propose the resolution as a special resolution has been given, or by way of unanimous written resolution.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">30</FONT></TD><TD STYLE="text-align: justify">Vacation of Office of Director</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The office of a Director shall be vacated
if:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">the Director gives notice in writing to the Company that they resign the office of Director; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">the Director is absent (for the avoidance of doubt, without being represented by proxy) from three consecutive
meetings of the board of Directors without special leave of absence from the Directors, and the Directors pass a resolution that they
have by reason of such absence vacated office; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">the Director dies, becomes bankrupt or makes any arrangement or composition with their creditors generally;
or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">the Director is found to be or becomes of unsound mind; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(e)</TD><TD STYLE="text-align: justify">all of the other Directors (being not less than two in number) determine that the Director should be removed
as a Director, either by a resolution passed by all of the other Directors at a meeting of the Directors duly convened and held in accordance
with the Articles or by a resolution in writing signed by all of the other Directors.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">31</FONT></TD><TD STYLE="text-align: justify">Proceedings of Directors</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">31.1</TD><TD STYLE="text-align: justify">The quorum for the transaction of the business of the Directors may be fixed by the Directors, and unless
so fixed shall be two if there are two of more Directors, and shall be one if there is only one Director.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">31.2</TD><TD STYLE="text-align: justify">Subject to the provisions of the Articles, the Directors may regulate their proceedings as they think
fit. Questions arising at any meeting shall be decided by a majority of votes. In the case of an equality of votes, the chairperson shall
have a second or casting vote.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">31.3</TD><TD STYLE="text-align: justify">A person may participate in a meeting of the Directors or any committee of Directors by conference telephone
or other communications equipment by means of which all the persons participating in the meeting can communicate with each other at the
same time. Participation by a person in a meeting in this manner is treated as presence in person at that meeting. Unless otherwise determined
by the Directors, the meeting shall be deemed to be held at the place where the chairperson is located at the start of the meeting.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">31.4</TD><TD STYLE="text-align: justify">A resolution in writing (in one or more counterparts) signed by all the Directors or all the members of
a committee of the Directors or, in the case of a resolution in writing relating to the removal of any Director or the vacation of office
by any Director, all of the Directors other than the Director who is the subject of such resolution shall be as valid and effectual as
if it had been passed at a meeting of the Directors, or committee of Directors as the case may be, duly convened and held.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">31.5</TD><TD STYLE="text-align: justify">A Director may, or other Officer on the direction of a Director shall, call a meeting of the Directors
by at least two days&rsquo; notice in writing to every Director which notice shall set forth the general nature of the business to be considered
unless notice is waived by all the Directors either at, before or after the meeting is held. To any such notice of a meeting of the Directors
all the provisions of the Articles relating to the giving of notices by the Company to the Members shall apply <I>mutatis mutandis.</I></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">31.6</TD><TD STYLE="text-align: justify">The continuing Directors (or a sole continuing Director, as the case may be) may act notwithstanding any
vacancy in their body, but if and so long as their number is reduced below the number fixed by or pursuant to the Articles as the necessary
quorum of Directors the continuing Directors or Director may act for the purpose of increasing the number of Directors to be equal to
such fixed number, or of summoning a general meeting of the Company, but for no other purpose.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">31.7</TD><TD STYLE="text-align: justify">The Directors may elect a chairperson of their board and determine the period for which they are to hold
office; but if no such chairperson is elected, or if at any meeting the chairperson is not present within five minutes after the time
appointed for the meeting to commence, the Directors present may choose one of their number to be chairperson of the meeting.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">31.8</TD><TD STYLE="text-align: justify">All acts done by any meeting of the Directors or of a committee of the Directors shall, notwithstanding
that it is afterwards discovered that there was some defect in the appointment of any Director, and/or that they or any of them were disqualified,
and/or had vacated their office and/or were not entitled to vote, be as valid as if every such person had been duly appointed and/or not
disqualified to be a Director and/or had not vacated their office and/or had been entitled to vote, as the case may be.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">31.9</TD><TD STYLE="text-align: justify">A Director may be represented at any meetings of the board of Directors by a proxy appointed in writing
by that Director. The proxy shall count towards the quorum and the vote of the proxy shall for all purposes be deemed to be that of the
appointing Director.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">32</FONT></TD><TD STYLE="text-align: justify">Presumption of Assent</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">A Director who is present at a meeting
of the board of Directors at which action on any Company matter is taken shall be presumed to have assented to the action taken unless
their dissent shall be entered in the minutes of the meeting or unless they shall file their written dissent from such action with the
person acting as the chairperson or secretary of the meeting before the adjournment thereof or shall forward such dissent by registered
post to such person immediately after the adjournment of the meeting. Such right to dissent shall not apply to a Director who voted in
favour of such action.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">33</FONT></TD><TD STYLE="text-align: justify">Directors&rsquo; Interests</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">33.1</TD><TD STYLE="text-align: justify">A Director may hold any other office or place of profit under the Company (other than the office of Auditor)
in conjunction with their office of Director for such period and on such terms as to remuneration and otherwise as the Directors may determine.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">33.2</TD><TD STYLE="text-align: justify">A Director may act on their own or by, through or on behalf of their firm in a professional capacity for
the Company and they or their firm shall be entitled to remuneration for professional services as if they were not a Director.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">33.3</TD><TD STYLE="text-align: justify">A Director may be or become a director or other officer of or otherwise interested in any company promoted
by the Company or in which the Company may be interested as a shareholder, a contracting party or otherwise, and no such Director shall
be accountable to the Company for any remuneration or other benefits received by them as a director or officer of, or from their interest
in, such other company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">33.4</TD><TD STYLE="text-align: justify">No person shall be disqualified from the office of Director or prevented by such office from contracting
with the Company, either as vendor, purchaser or otherwise, nor shall any such contract or any contract or transaction entered into by
or on behalf of the Company in which any Director shall be in any way interested be or be liable to be avoided, nor shall any Director
so contracting or being so interested be liable to account to the Company for any profit realised by or arising in connection with any
such contract or transaction by reason of such Director holding office or of the fiduciary relationship thereby established. A Director
shall be at liberty to vote in respect of any contract or transaction in which they are interested provided that the nature of the interest
of any Director in any such contract or transaction shall be disclosed by them at or prior to its consideration and any vote thereon.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">33.5</TD><TD STYLE="text-align: justify">A general notice that a Director is a shareholder, director, officer or employee of any specified firm
or company and is to be regarded as interested in any transaction with such firm or company shall be sufficient disclosure for the purposes
of voting on a resolution in respect of a contract or transaction in which they have an interest, and after such general notice it shall
not be necessary to give special notice relating to any particular transaction.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">34</FONT></TD><TD STYLE="text-align: justify">Minutes</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Directors shall cause minutes to
be made in books kept for the purpose of recording all appointments of Officers made by the Directors, all proceedings at meetings of
the Company or the holders of any class of Shares and of the Directors, and of committees of the Directors, including the names of the
Directors present at each meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">35</FONT></TD><TD STYLE="text-align: justify">Delegation of Directors&rsquo; Powers</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">35.1</TD><TD STYLE="text-align: justify">The Directors may delegate any of their powers, authorities and discretions, including the power to sub-delegate,
to any committee consisting of one or more Directors (including, without limitation, the Audit Committee and the Compensation Committee).
Any such delegation may be made subject to any conditions the Directors may impose and either collaterally with or to the exclusion of
their own powers and any such delegation may be revoked or altered by the Directors. Subject to any such conditions, the proceedings of
a committee of Directors shall be governed by the Articles regulating the proceedings of Directors, so far as they are capable of applying.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">35.2</TD><TD STYLE="text-align: justify">The Directors may establish any committees, local boards or agencies or appoint any person to be a manager
or agent for managing the affairs of the Company and may appoint any person to be a member of such committees, local boards or agencies.
Any such appointment may be made subject to any conditions the Directors may impose, and either collaterally with or to the exclusion
of their own powers and any such appointment may be revoked or altered by the Directors. Subject to any such conditions, the proceedings
of any such committee, local board or agency shall be governed by the Articles regulating the proceedings of Directors, so far as they
are capable of applying.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">35.3</TD><TD STYLE="text-align: justify">The Directors may adopt formal written charters for committees and, if so adopted, shall review and assess
the adequacy of such formal written charters on an annual basis as may be required from time to time by the rules and regulations of the
Designated Stock Exchange, the Securities and Exchange Commission and/or any other competent regulatory authority or otherwise under Applicable
Law. Each of these committees shall be empowered to do all things necessary to exercise the rights of such committee set forth in the
Articles and shall have such powers as the Directors may delegate pursuant to the Articles and as required by the rules and regulations
of the Designated Stock Exchange, the Securities and Exchange Commission and/or any other competent regulatory authority or otherwise
under Applicable Law. Each of the Audit Committee and the Compensation Committee, if established, shall consist of such number of Directors
as the Directors shall from time to time determine (or such minimum number as may be required from time to time by the rules and regulations
of the Designated Stock Exchange, the Securities and Exchange Commission and/or any other competent regulatory authority or otherwise
under Applicable Law). For so long as any class of Shares is listed on the Designated Stock Exchange, the Audit Committee and the Compensation
Committee shall be made up of such number of Independent Directors as is required from time to time by the rules and regulations of the
Designated Stock Exchange, the Securities and Exchange Commission and/or any other competent regulatory authority or otherwise under Applicable
Law.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">35.4</TD><TD STYLE="text-align: justify">The Directors may by power of attorney or otherwise appoint any person to be the agent of the Company
on such conditions as the Directors may determine, provided that the delegation is not to the exclusion of their own powers and may be
revoked by the Directors at any time.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">35.5</TD><TD STYLE="text-align: justify">The Directors may by power of attorney or otherwise appoint any company, firm, person or body of persons,
whether nominated directly or indirectly by the Directors, to be the attorney or authorised signatory of the Company for such purpose
and with such powers, authorities and discretions (not exceeding those vested in or exercisable by the Directors under the Articles) and
for such period and subject to such conditions as they may think fit, and any such powers of attorney or other appointment may contain
such provisions for the protection and convenience of persons dealing with any such attorneys or authorised signatories as the Directors
may think fit and may also authorise any such attorney or authorised signatory to delegate all or any of the powers, authorities and discretions
vested in them.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">35.6</TD><TD STYLE="text-align: justify">The Directors may appoint such Officers as they consider necessary on such terms, at such remuneration
and to perform such duties, and subject to such provisions as to disqualification and removal as the Directors may think fit. Unless otherwise
specified in the terms of their appointment an Officer may be removed by resolution of the Directors or Members. An Officer may vacate
their office at any time if they give notice in writing to the Company that they resign their office.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">36</FONT></TD><TD STYLE="text-align: justify">No Minimum Shareholding</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Company in general meeting may fix
a minimum shareholding required to be held by a Director, but unless and until such a shareholding qualification is fixed a Director is
not required to hold Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">37</FONT></TD><TD STYLE="text-align: justify">Remuneration of Directors</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">37.1</TD><TD STYLE="text-align: justify">The remuneration to be paid to the Directors, if any, shall be such remuneration as the Directors shall
determine, provided that no cash remuneration shall be paid to any Director by the Company prior to the consummation of a Business Combination.
The Directors shall also, whether prior to or after the consummation of a Business Combination, be entitled to be paid all travelling,
hotel and other expenses properly incurred by them in connection with their attendance at meetings of Directors or committees of Directors,
or general meetings of the Company, or separate meetings of the holders of any class of Shares or debentures of the Company, or otherwise
in connection with the business of the Company or the discharge of their duties as a Director, or to receive a fixed allowance in respect
thereof as may be determined by the Directors, or a combination partly of one such method and partly the other.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">37.2</TD><TD STYLE="text-align: justify">The Directors may by resolution approve additional remuneration to any Director for any services which
in the opinion of the Directors go beyond that Director&rsquo;s ordinary routine work as a Director. Any fees paid to a Director who is also
counsel, attorney or solicitor to the Company, or otherwise serves it in a professional capacity shall be in addition to their remuneration
as a Director.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">38</FONT></TD><TD STYLE="text-align: justify">Seal</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">38.1</TD><TD STYLE="text-align: justify">The Company may, if the Directors so determine, have a Seal. The Seal shall only be used by the authority
of the Directors or of a committee of the Directors authorised by the Directors. Every instrument to which the Seal has been affixed shall
be signed by at least one person who shall be either a Director or some Officer or other person appointed by the Directors for the purpose.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">38.2</TD><TD STYLE="text-align: justify">The Company may have for use in any place or places outside the Cayman Islands a duplicate Seal or Seals
each of which shall be a facsimile of the common Seal of the Company and, if the Directors so determine, with the addition on its face
of the name of every place where it is to be used.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">38.3</TD><TD STYLE="text-align: justify">A Director or Officer, representative or attorney of the Company may without further authority of the
Directors affix the Seal over their signature alone to any document of the Company required to be authenticated by them under seal or
to be filed with the Registrar of Companies in the Cayman Islands or elsewhere wheresoever.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">39</FONT></TD><TD STYLE="text-align: justify">Dividends, Distributions and Reserve</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">39.1</TD><TD STYLE="text-align: justify">Subject to the Statute and this Article and except as otherwise provided by the rights attached to any
Shares, the Directors may resolve to pay Dividends and other distributions on Shares in issue and authorise payment of the Dividends or
other distributions out of the funds of the Company lawfully available therefor. A Dividend shall be deemed to be an interim Dividend
unless the terms of the resolution pursuant to which the Directors resolve to pay such Dividend specifically state that such Dividend
shall be a final Dividend. No Dividend or other distribution shall be paid except out of the realised or unrealised profits of the Company,
out of the share premium account or as otherwise permitted by law.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 31; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">39.2</TD><TD STYLE="text-align: justify">Except as otherwise provided by the rights attached to any Shares, all Dividends and other distributions
shall be paid according to the par value of the Shares that a Member holds. If any Share is issued on terms providing that it shall rank
for Dividend as from a particular date, that Share shall rank for Dividend accordingly.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">39.3</TD><TD STYLE="text-align: justify">The Directors may deduct from any Dividend or other distribution payable to any Member all sums of money
(if any) then payable by the Member to the Company on account of calls or otherwise.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">39.4</TD><TD STYLE="text-align: justify">The Directors may resolve that any Dividend or other distribution be paid wholly or partly by the distribution
of specific assets and in particular (but without limitation) by the distribution of shares, debentures, or securities of any other company
or in any one or more of such ways and where any difficulty arises in regard to such distribution, the Directors may settle the same as
they think expedient and in particular may issue fractional Shares and may fix the value for distribution of such specific assets or any
part thereof and may determine that cash payments shall be made to any Members upon the basis of the value so fixed in order to adjust
the rights of all Members and may vest any such specific assets in trustees in such manner as may seem expedient to the Directors.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">39.5</TD><TD STYLE="text-align: justify">Except as otherwise provided by the rights attached to any Shares, Dividends and other distributions may
be paid in any currency. The Directors may determine the basis of conversion for any currency conversions that may be required and how
any costs involved are to be met.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">39.6</TD><TD STYLE="text-align: justify">The Directors may, before resolving to pay any Dividend or other distribution, set aside such sums as
they think proper as a reserve or reserves which shall, at the discretion of the Directors, be applicable for any purpose of the Company
and pending such application may, at the discretion of the Directors, be employed in the business of the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">39.7</TD><TD STYLE="text-align: justify">Any Dividend, other distribution, interest or other monies payable in cash in respect of Shares may be
paid by wire transfer to the holder or by cheque or warrant sent through the post directed to the registered address of the holder or,
in the case of joint holders, to the registered address of the holder who is first named on the Register of Members or to such person
and to such address as such holder or joint holders may in writing direct. Every such cheque or warrant shall be made payable to the order
of the person to whom it is sent. Any one of two or more joint holders may give effectual receipts for any Dividends, other distributions,
bonuses, or other monies payable in respect of the Share held by them as joint holders.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">39.8</TD><TD STYLE="text-align: justify">No Dividend or other distribution shall bear interest against the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">39.9</TD><TD STYLE="text-align: justify">Any Dividend or other distribution which cannot be paid to a Member and/or which remains unclaimed after
six months from the date on which such Dividend or other distribution becomes payable may, in the discretion of the Directors, be paid
into a separate account in the Company&rsquo;s name, provided that the Company shall not be constituted as a trustee in respect of that account
and the Dividend or other distribution shall remain as a debt due to the Member. Any Dividend or other distribution which remains unclaimed
after a period of six years from the date on which such Dividend or other distribution becomes payable shall be forfeited and shall revert
to the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 32; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">39.10</TD><TD STYLE="text-align: justify">Other than with respect to payments or distributions from the Trust Account, no Dividends or other distributions
shall be payable on the Class A Shares unless approved by consent in writing of the holders of not less than two-thirds of the issued
Class B Shares</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">40</FONT></TD><TD STYLE="text-align: justify">Capitalisation</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">The Directors may at any time capitalise
any sum standing to the credit of any of the Company&rsquo;s reserve accounts or funds (including the share premium account and capital redemption
reserve fund) or any sum standing to the credit of the profit and loss account or otherwise available for distribution; appropriate such
sum to Members in the proportions in which such sum would have been divisible amongst such Members had the same been a distribution of
profits by way of Dividend or other distribution; and apply such sum on their behalf in paying up in full unissued Shares for allotment
and distribution credited as fully paid-up to and amongst them in the proportion aforesaid. In such event the Directors shall do all acts
and things required to give effect to such capitalisation, with full power given to the Directors to make such provisions as they think
fit in the case of Shares becoming distributable in fractions (including provisions whereby the benefit of fractional entitlements accrue
to the Company rather than to the Members concerned). The Directors may authorise any person to enter on behalf of all of the Members
interested into an agreement with the Company providing for such capitalisation and matters incidental or relating thereto and any agreement
made under such authority shall be effective and binding on all such Members and the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">41</FONT></TD><TD STYLE="text-align: justify">Books of Account</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">41.1</TD><TD STYLE="text-align: justify">The Directors shall cause proper books of account (including, where applicable, material&nbsp;underlying
documentation including contracts and invoices) to be kept with respect to all sums of money received and expended by the Company and
the matters in respect of which the receipt or expenditure takes place, all sales and purchases of goods by the Company and the assets
and liabilities of the Company. Such books of account must be retained for a minimum period of five years from the date on which they
are prepared. Proper books shall not be deemed to be kept if there are not kept such books of account as are necessary to give a true
and fair view of the state of the Company&rsquo;s affairs and to explain its transactions.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">41.2</TD><TD STYLE="text-align: justify">The Directors shall determine whether and to what extent and at what times and places and under what conditions
or regulations the accounts and books of the Company or any of them shall be open to the inspection of Members not being Directors and
no Member (not being a Director) shall have any right of inspecting any account or book or document of the Company except as conferred
by Statute or authorised by the Directors or by the Company in general meeting.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 33; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">41.3</TD><TD STYLE="text-align: justify">The Directors may cause to be prepared and to be laid before the Company in general meeting profit and
loss accounts, balance sheets, group accounts (if any) and such other reports and accounts as may be required by law.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">42</FONT></TD><TD STYLE="text-align: justify">Audit</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">42.1</TD><TD STYLE="text-align: justify">The Directors may appoint an Auditor of the Company who shall hold office on such terms as the Directors
determine.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">42.2</TD><TD STYLE="text-align: justify">Without prejudice to the freedom of the Directors to establish any other committee, if the Shares (or
depositary receipts therefor) are listed or quoted on the Designated Stock Exchange, and if required by the rules and regulations of the
Designated Stock Exchange, the Securities and Exchange Commission and/or any other competent regulatory authority or otherwise under Applicable
Law, the Directors shall establish and maintain an Audit Committee as a committee of the Directors and shall adopt a formal written Audit
Committee charter and review and assess the adequacy of the formal written charter on an annual basis. The composition and responsibilities
of the Audit Committee shall comply with the rules and regulations of the Designated Stock Exchange, the Securities and Exchange Commission
and/or any other competent regulatory authority or otherwise under Applicable Law. The Audit Committee shall meet at least once every
financial quarter, or more frequently as circumstances dictate.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">42.3</TD><TD STYLE="text-align: justify">If the Shares (or depositary receipts therefor) are listed or quoted on the Designated Stock Exchange,
the Company shall conduct an appropriate review of all related party transactions on an ongoing basis and shall utilise the Audit Committee
for the review and approval of potential conflicts of interest.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">42.4</TD><TD STYLE="text-align: justify">The remuneration of the Auditor shall be fixed by the Audit Committee (if one exists).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">42.5</TD><TD STYLE="text-align: justify">If the office of Auditor becomes vacant by resignation or death of the Auditor, or by their becoming incapable
of acting by reason of illness or other disability at a time when their services are required, the Directors shall fill the vacancy and
determine the remuneration of such Auditor.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">42.6</TD><TD STYLE="text-align: justify">Every Auditor of the Company shall have a right of access at all times to the books and accounts and vouchers
of the Company and shall be entitled to require from the Directors and Officers such information and explanation as may be necessary for
the performance of the duties of the Auditor.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">42.7</TD><TD STYLE="text-align: justify">Auditors shall, if so required by the Directors, make a report on the accounts of the Company during their
tenure of office at the next annual general meeting following their appointment in the case of a company which is registered with the
Registrar of Companies as an ordinary company, and at the next extraordinary general meeting following their appointment in the case of
a company which is registered with the Registrar of Companies as an exempted company, and at any other time during their term of office,
upon request of the Directors or any general meeting of the Members.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 34; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">42.8</TD><TD STYLE="text-align: justify">Any payment made to members of the Audit Committee (if one exists) shall require the review and approval
of the Directors, with any Director interested in such payment abstaining from such review and approval.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">42.9</TD><TD STYLE="text-align: justify">The Audit Committee shall monitor compliance with the terms of the IPO and, if any non-compliance is identified,
the Audit Committee shall be charged with the responsibility to take all action necessary to rectify such non-compliance or otherwise
cause compliance with the terms of the IPO.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">42.10</TD><TD STYLE="text-align: justify">At least one member of the Audit Committee shall be an &ldquo;audit committee financial expert&rdquo; as
determined by the rules and regulations of the Designated Stock Exchange, the Securities and Exchange Commission and/or any other competent
regulatory authority or otherwise under Applicable Law. The &ldquo;audit committee financial expert&rdquo; shall have such past employment
experience in finance or accounting, requisite professional certification in accounting, or any other comparable experience or background
which results in the individual&rsquo;s financial sophistication.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">43</FONT></TD><TD STYLE="text-align: justify">Notices</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">43.1</TD><TD STYLE="text-align: justify">Notices shall be in writing and may be given by the Company to any Member either personally or by sending
it by courier, post, telex, fax or email to such Member or to such Member&rsquo;s address as shown in the Register of Members (or where the
notice is given by email by sending it to the email address provided by such Member). Notice may also be served by Electronic Communication
in accordance with the rules and regulations of the Designated Stock Exchange, the Securities and Exchange Commission and/or any other
competent regulatory authority or by placing it on the Company&rsquo;s Website.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">43.2</TD><TD STYLE="text-align: justify">Where a notice is sent by:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">courier; service of the notice shall be deemed to be effected by delivery of the notice to a courier company,
and shall be deemed to have been received on the third day (not including Saturdays or Sundays or public holidays) following the day on
which the notice was delivered to the courier;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">post; service of the notice shall be deemed to be effected by properly addressing, pre paying and posting
a letter containing the notice, and shall be deemed to have been received on the fifth day (not including Saturdays or Sundays or public
holidays in the Cayman Islands) following the day on which the notice was posted;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">telex or fax; service of the notice shall be deemed to be effected by properly addressing and sending
such notice and shall be deemed to have been received on the same day that it was transmitted;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">email or other Electronic Communication; service of the notice shall be deemed to be effected by transmitting
the email to the email address provided by the intended recipient and shall be deemed to have been received on the same day that it was
sent, and it shall not be necessary for the receipt of the email to be acknowledged by the recipient; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(e)</TD><TD STYLE="text-align: justify">placing it on the Company&rsquo;s Website; service of the notice shall be deemed to have been effected
one hour after the notice or document was placed on the Company&rsquo;s Website.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 35; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">43.3</TD><TD STYLE="text-align: justify">A notice may be given by the Company to the person or persons which the Company has been advised are entitled
to a Share or Shares in consequence of the death or bankruptcy of a Member in the same manner as other notices which are required to be
given under the Articles and shall be addressed to them by name, or by the title of representatives of the deceased, or trustee of the
bankrupt, or by any like description at the address supplied for that purpose by the persons claiming to be so entitled, or at the option
of the Company by giving the notice in any manner in which the same might have been given if the death or bankruptcy had not occurred.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">43.4</TD><TD STYLE="text-align: justify">Notice of every general meeting shall be given in any manner authorised by the Articles to every holder
of Shares carrying an entitlement to receive such notice on the record date for such meeting except that in the case of joint holders
the notice shall be sufficient if given to the joint holder first named in the Register of Members and every person upon whom the ownership
of a Share devolves because they are a legal personal representative or a trustee in bankruptcy of a Member where the Member but for their
death or bankruptcy would be entitled to receive notice of the meeting, and no other person shall be entitled to receive notices of general
meetings.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">44</FONT></TD><TD STYLE="text-align: justify">Winding Up</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">44.1</TD><TD STYLE="text-align: justify">If the Company shall be wound up, the liquidator shall apply the assets of the Company in satisfaction
of creditors&rsquo; claims in such manner and order as such liquidator thinks fit. Subject to the rights attaching to any Shares, in a winding
up:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">if the assets available for distribution amongst the Members shall be insufficient to repay the whole
of the Company&rsquo;s issued share capital, such assets shall be distributed so that, as nearly as may be, the losses shall be borne by the
Members in proportion to the par value of the Shares held by them; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">if the assets available for distribution amongst the Members shall be more than sufficient to repay the
whole of the Company&rsquo;s issued share capital at the commencement of the winding up, the surplus shall be distributed amongst the Members
in proportion to the par value of the Shares held by them at the commencement of the winding up subject to a deduction from those Shares
in respect of which there are monies due, of all monies payable to the Company for unpaid calls or otherwise.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">44.2</TD><TD STYLE="text-align: justify">If the Company shall be wound up the liquidator may, subject to the rights attaching to any Shares and
with the approval of a Special Resolution of the Company and any other approval required by the Statute, divide amongst the Members in
kind the whole or any part of the assets of the Company (whether such assets shall consist of property of the same kind or not) and may
for that purpose value any assets and determine how the division shall be carried out as between the Members or different classes of Members.
The liquidator may, with the like approval, vest the whole or any part of such assets in trustees upon such trusts for the benefit of
the Members as the liquidator, with the like approval, shall think fit, but so that no Member shall be compelled to accept any asset upon
which there is a liability.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 36; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">45</FONT></TD><TD STYLE="text-align: justify">Indemnity and Insurance</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">45.1</TD><TD STYLE="text-align: justify">Every Director and Officer (which for the avoidance of doubt, shall not include auditors of the Company),
together with every former Director and former Officer (each an &ldquo;<B>Indemnified Person</B>&rdquo;) shall be indemnified out of the
assets of the Company against any liability, action, proceeding, claim, demand, costs, damages or expenses, including legal expenses,
whatsoever which they or any of them may incur as a result of any act or failure to act in carrying out their functions other than such
liability (if any) that they may incur by reason of their own actual fraud, wilful neglect or wilful default. No Indemnified Person shall
be liable to the Company for any loss or damage incurred by the Company as a result (whether direct or indirect) of the carrying out of
their functions unless that liability arises through the actual fraud, wilful neglect or wilful default of such Indemnified Person. No
person shall be found to have committed actual fraud, wilful neglect or wilful default under this Article unless or until a court of competent
jurisdiction shall have made a finding to that effect.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">45.2</TD><TD STYLE="text-align: justify">The Company shall advance to each Indemnified Person reasonable attorneys&rsquo; fees and other costs and expenses
incurred in connection with the defence of any action, suit, proceeding or investigation involving such Indemnified Person for which indemnity
will or could be sought. In connection with any advance of any expenses hereunder, the Indemnified Person shall execute an undertaking
to repay the advanced amount to the Company if it shall be determined by final judgment or other final adjudication that such Indemnified
Person was not entitled to indemnification pursuant to this Article. If it shall be determined by a final judgment or other final adjudication
that such Indemnified Person was not entitled to indemnification with respect to such judgment, costs or expenses, then such party shall
not be indemnified with respect to such judgment, costs or expenses and any advancement shall be returned to the Company (without interest)
by the Indemnified Person.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">45.3</TD><TD STYLE="text-align: justify">The Directors, on behalf of the Company, may purchase and maintain insurance for the benefit of any Director
or Officer against any liability which, by virtue of any rule of law, would otherwise attach to such person in respect of any negligence,
default, breach of duty or breach of trust of which such person may be guilty in relation to the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">46</FONT></TD><TD STYLE="text-align: justify">Financial Year</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Unless the Directors otherwise prescribe,
the financial year of the Company shall end on 31st December in each year and, following the year of incorporation, shall begin on 1st
January in each year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 37; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">47</FONT></TD><TD STYLE="text-align: justify">Transfer by Way of Continuation</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">47.1</TD><TD STYLE="text-align: justify">If the Company is exempted as defined in the Statute, it shall, subject to the provisions of the Statute
and with the approval of a Special Resolution passed in accordance with this Article 47, have the power to register by way of continuation
as a body corporate under the laws of any jurisdiction outside the Cayman Islands and to be deregistered in the Cayman Islands.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">47.2</TD><TD STYLE="text-align: justify">Prior to the closing of a Business Combination:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">only the Class B Shares shall carry the right to vote on any resolution of the shareholders to approve
any transfer by way of continuation pursuant to this Article (including any Special Resolution required to amend the constitutional documents
of the Company or to adopt new constitutional documents of the Company, in each case, as a result of the Company approving a transfer
by way of continuation in a jurisdiction outside the Cayman Islands); and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">this Article 47.2 may only be amended by a Special Resolution passed by at least 90% (or, where such amendment
is proposed in respect of the consummation of a Business Combination, at least two-thirds) of such Members as, being entitled to do so,
vote in person or, where proxies are allowed, by proxy at a general meeting of which notice specifying the intention to propose the resolution
as a special resolution has been given, or by way of unanimous written resolution.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">48</FONT></TD><TD STYLE="text-align: justify">Mergers and Consolidations</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">The Company shall
have the power to merge or consolidate with one or more other constituent companies (as defined in the Statute) upon such terms as the
Directors may determine and (to the extent required by the Statute) with the approval of a Special Resolution.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">49</FONT></TD><TD STYLE="text-align: justify">Business Combination</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">49.1</TD><TD STYLE="text-align: justify">Notwithstanding any other provision of the Articles, this Article shall apply during the period commencing
upon the adoption of the Articles and terminating upon the first to occur of the consummation of a Business Combination and the full distribution
of the Trust Account pursuant to this Article. In the event of a conflict between this Article and any other Articles, the provisions
of this Article shall prevail.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">49.2</TD><TD STYLE="text-align: justify">Prior to the consummation of a Business Combination, the Company shall either:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">submit such Business Combination to its Members for approval; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">provide Members with the opportunity to have their Shares repurchased by means of a tender offer for a
per-Share repurchase price payable in cash, equal to the aggregate amount then on deposit in the Trust Account, calculated as of two business
days prior to the consummation of such Business Combination, including interest earned on the Trust Account (net of taxes paid or payable,
if any), divided by the number of then issued Public Shares. Such obligation to repurchase Shares is subject to the completion of the
proposed Business Combination to which it relates.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 38; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">49.3</TD><TD STYLE="text-align: justify">If the Company initiates any tender offer in accordance with Rule 13e-4 and Regulation 14E of the Exchange
Act in connection with a proposed Business Combination, it shall file tender offer documents with the Securities and Exchange Commission
prior to completing such Business Combination which contain substantially the same financial and other information about such Business
Combination and the redemption rights as is required under Regulation 14A of the Exchange Act. If, alternatively, the Company holds a
general meeting to approve a proposed Business Combination, the Company will conduct any redemptions in conjunction with a proxy solicitation
pursuant to Regulation 14A of the Exchange Act, and not pursuant to the tender offer rules, and file proxy materials with the Securities
and Exchange Commission.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">49.4</TD><TD STYLE="text-align: justify">At a general meeting called for the purposes of approving a Business Combination pursuant to this Article,
in the event that such Business Combination is approved by Ordinary Resolution, the Company shall be authorised to consummate such Business
Combination.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">49.5</TD><TD STYLE="text-align: justify">Any Member holding Public Shares who is not the Sponsor, a Founder, Officer or Director may, at least
two business days&rsquo; prior to any vote on a Business Combination, elect to have their Public Shares redeemed for cash, in accordance
with any applicable requirements provided for in the related proxy materials (the &ldquo;<B>Business Combination Redemption</B>&rdquo;),
provided that no such Member acting together with any Affiliate of their or any other person with whom they are acting in concert or as
a partnership, limited partnership, syndicate, or other group (including, for the avoidance of doubt, a &ldquo;group&rdquo; (as defined
under Section&nbsp;13 of the Exchange Act) for the purposes of acquiring, holding, or disposing of Shares may exercise this redemption
right with respect to more than 15% of the Public Shares in the aggregate without the prior consent of the Company and provided further
that any beneficial holder of Public Shares on whose behalf a redemption right is being exercised must identify itself to the Company
in connection with any redemption election in order to validly redeem such Public Shares. If so demanded, the Company shall pay any such
redeeming Member, regardless of whether they are voting for or against such proposed Business Combination, a per-Share redemption price
payable in cash, equal to the aggregate amount then on deposit in the Trust Account calculated as of two business days prior to the consummation
of the Business Combination, including interest earned on the Trust Account (such interest shall be net of taxes payable) and not previously
released to the Company to pay its taxes, divided by the number of then issued Public Shares (such redemption price being referred to
herein as the &ldquo;<B>Redemption Price</B>&rdquo;), but only in the event that the applicable proposed Business Combination is approved
and in connection with its consummation.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">49.6</TD><TD STYLE="text-align: justify">A Member may not withdraw a Redemption Notice once submitted to the Company unless the Directors determine
(in their sole discretion) to permit the withdrawal of such redemption request (which they may do in whole or in part). The Directors
(in their sole discretion) shall determine the timing of such Business Combination Redemption of Public Shares in order to facilitate
the consummation and/or closing of a Business Combination.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 39; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">49.7</TD><TD STYLE="text-align: justify">In the event that:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">the Company does not consummate a Business Combination within 24 months from the consummation of the IPO,
or such later time as the Members may approve by Special Resolution in accordance with the Articles (the &ldquo;<B>Deadline Date</B>&rdquo;);
or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">if the Directors, acting in good faith, determine by resolution, and provide notice in writing to the
Members, that the Company is unable to consummate a Business Combination by the Deadline Date,</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">the Company shall:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">cease all operations except for the purpose of winding up;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">as promptly as reasonably possible but not more than ten business days thereafter, redeem the Public Shares,
at a per-Share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on
the funds held in the Trust Account and not previously released to the Company (net of taxes payable and less up to US$100,000 of interest
to pay dissolution expenses), divided by the number of then Public Shares in issue, which redemption will completely extinguish public
Members&rsquo; rights as Members (including the right to receive further liquidation distributions, if any); and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD STYLE="text-align: justify">as promptly as reasonably possible following such redemption, subject to the approval of the Company&rsquo;s
remaining Members and the Directors, liquidate and dissolve,</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">subject in each case
to its obligations under Cayman Islands law to provide for claims of creditors and other requirements of Applicable Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">49.8</TD><TD STYLE="text-align: justify">In the event that any amendment is made to the Articles (an &ldquo;<B>Amendment</B>&rdquo;):</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">to modify the substance or timing of the Company&rsquo;s obligation to allow redemption in connection with a
Business Combination or redeem 100% of the Public Shares if the Company does not consummate a Business Combination by the Deadline Date,
or such later time as the Members may approve by Special Resolution in accordance with the Articles; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 40; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">with respect to any other material provision relating to Members&rsquo; rights or pre-Business Combination
activity,</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">any Member holding
Public Shares who is not the Sponsor, a Founder, Officer or Director may, at least two business days&rsquo; prior to any vote on an Amendment,
elect to have their Public Shares redeemed for cash, in accordance with any applicable requirements provided for in the related proxy
materials (the &ldquo;<B>Amendment Redemption</B>&rdquo;), provided that no such Member acting together with any Affiliate of their or any
other person with whom they are acting in concert or as a partnership, limited partnership, syndicate, or other group (including, for
the avoidance of doubt, a &ldquo;group&rdquo; (as defined under Section&nbsp;13 of the Exchange Act) for the purposes of acquiring, holding,
or disposing of Shares may exercise this redemption right with respect to more than 15% of the Public Shares in the aggregate without
the prior consent of the Company and provided further that any beneficial holder of Public Shares on whose behalf a redemption right is
being exercised must identify itself to the Company in connection with any redemption election in order to validly redeem such Public
Shares. If so demanded, the Company shall pay any such redeeming Member, regardless of whether they are voting for or against such proposed
Amendment, the Redemption Price, but only in the event that the applicable proposed Amendment is approved. The Directors (in their sole
discretion) shall determine the timing of any such Amendment Redemption.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">49.9</TD><TD STYLE="text-align: justify">A holder of Public Shares shall be entitled to receive distributions from the Trust Account only in the
event of a Business Combination Redemption, an Amendment Redemption, a repurchase of Shares by means of a tender offer pursuant to this
Article, or a distribution of the Trust Account pursuant to this Article. In no other circumstance shall a holder of Public Shares have
any right or interest of any kind in the Trust Account.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">49.10</TD><TD STYLE="text-align: justify">Except in connection with the conversion of Class B Shares into Class A Shares pursuant to the Class B
Ordinary Share Conversion Article hereof where the holders of such Shares have waived any right to receive funds from the Trust Account,
after the issue of Public Shares, and prior to the consummation of a Business Combination, the Company shall not issue additional Shares
or any other securities that would entitle the holders thereof to:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">receive funds from the Trust Account; or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">vote as a class with Public Shares on a Business Combination.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">49.11</TD><TD STYLE="text-align: justify">The uninterested Independent Directors shall approve any transaction or transactions between the Company
and any of the following parties:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">any Member owning an interest in the voting power of the Company that gives such Member a significant
influence over the Company; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">any Director or Officer and any Affiliate of such Director or Officer.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 41; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">49.12</TD><TD STYLE="text-align: justify">A Director may vote in respect of a Business Combination in which such Director has a conflict of interest
with respect to the evaluation of such Business Combination. Such Director must disclose such interest or conflict to the other Directors.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">49.13</TD><TD STYLE="text-align: justify">As long as the securities of the Company are listed on The Nasdaq Global Market, the Company must complete
one or more Business Combinations having an aggregate fair market value of at least 80% of the assets held in the Trust Account (excluding
the deferred underwriting commissions and taxes payable on the income earned on the Trust Account) at the time of the Company&rsquo;s signing
a definitive agreement in connection with a Business Combination. A Business Combination must not be solely effectuated with another blank
cheque company or a similar company with nominal operations.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">49.14</TD><TD STYLE="text-align: justify">The Company may enter into a Business Combination with a target business that is Affiliated with the Sponsor,
a Founder, a Director or an Officer. In the event the Company seeks to consummate a Business Combination with a target that is Affiliated
with the Sponsor, a Founder, a Director or an Officer, the Company, or a committee of Independent Directors, will obtain an opinion from
an independent investment banking firm or another valuation or appraisal firm that regularly renders fairness opinions on the type of
target business the Company is seeking to acquire that is a member of the United States Financial Industry Regulatory Authority or an
independent accounting firm that such a Business Combination is fair to the Company from a financial point of view.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">50</FONT></TD><TD STYLE="text-align: justify">Certain Tax Filings</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Each Tax Filing Authorised Person and
any such other person, acting alone, as any Director shall designate from time to time, are authorised to file or execute and provide
U.S. Internal Revenue Service tax forms SS-4, W-8 BEN, W-8 IMY, W-9, 8832 and 2553 and such other similar tax forms as are customary to
file with any U.S. federal or state governmental authorities or foreign governmental authorities, or provide to withholding agents in
connection with the formation, activities and/or elections of the Company and such other tax forms as may be approved from time to time
by any Director or Officer. The Company further ratifies and approves any such filing made by any Tax Filing Authorised Person or such
other person prior to the date of the Articles.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">51</FONT></TD><TD STYLE="text-align: justify">Business Opportunities</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">51.1</TD><TD STYLE="text-align: justify">To the fullest extent permitted by Applicable Law, no individual serving as a Director or an Officer (&ldquo;<B>Management</B>&rdquo;)
shall have any duty, except and to the extent expressly assumed by contract, to refrain from engaging directly or indirectly in the same
or similar business activities or lines of business as the Company. To the fullest extent permitted by Applicable Law, the Company renounces
any interest or expectancy of the Company in, or in being offered an opportunity to participate in, any potential transaction or matter
which may be a corporate opportunity for Management, on the one hand, and the Company, on the other. Except to the extent expressly assumed
by contract, to the fullest extent permitted by Applicable Law, Management shall have no duty to communicate or offer any such corporate
opportunity to the Company and shall not be liable to the Company or its Members for breach of any fiduciary duty as a Member, Director
and/or Officer solely by reason of the fact that such party pursues or acquires such corporate opportunity for itself, directs such corporate
opportunity to another person, or does not communicate information regarding such corporate opportunity to the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 42; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">51.2</TD><TD STYLE="text-align: justify">Except as provided elsewhere in this Article, the Company hereby renounces any interest or expectancy
of the Company in, or in being offered an opportunity to participate in, any potential transaction or matter which may be a corporate
opportunity for both the Company and Management, about which a Director and/or Officer who is also a member of Management acquires knowledge.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">51.3</TD><TD STYLE="text-align: justify">To the extent a court might hold that the conduct of any activity related to a corporate opportunity that
is renounced in this Article to be a breach of duty to the Company or its Members, the Company hereby waives, to the fullest extent permitted
by Applicable Law, any and all claims and causes of action that the Company may have for such activities. To the fullest extent permitted
by Applicable Law, the provisions of this Article apply equally to activities conducted in the future and that have been conducted in
the past.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif">52</FONT></TD><TD STYLE="text-align: justify">Exclusive Jurisdiction and Forum</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">52.1</TD><TD STYLE="text-align: justify">Unless the Company consents in writing to the selection of an alternative forum, the courts of the Cayman
Islands shall have exclusive jurisdiction over any claim or dispute arising out of or in connection with the Memorandum, the Articles
or otherwise related in any way to each Member&rsquo;s shareholding in the Company, including but not limited to:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">any derivative action or proceeding brought on behalf of the Company;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">any action asserting a claim of breach of any fiduciary or other duty owed by any current or former Director,
Officer or other employee of the Company to the Company or the Members;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">any action asserting a claim arising pursuant to any provision of the Statute, the Memorandum or the Articles;
or</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">any action asserting a claim against the Company governed by the &ldquo;Internal Affairs Doctrine&rdquo;
(as such concept is recognised under the laws of the United States of America).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">52.2</TD><TD STYLE="text-align: justify">Each Member irrevocably submits to the exclusive jurisdiction of the courts of the Cayman Islands over
all such claims or disputes.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">52.3</TD><TD STYLE="text-align: justify">Without prejudice to any other rights or remedies that the Company may have, each Member acknowledges
that damages alone would not be an adequate remedy for any breach of the selection of the courts of the Cayman Islands as exclusive forum
and that accordingly the Company shall be entitled, without proof of special damages, to the remedies of injunction, specific performance
or other equitable relief for any threatened or actual breach of the selection of the courts of the Cayman Islands as exclusive forum.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">52.4</TD><TD STYLE="text-align: justify">This Article 52 shall not apply to any action or suits brought to enforce any liability or duty created
by the United States Securities Act of 1933, as amended, the Exchange Act, or any claim for which the federal district courts of the United
States of America are, as a matter of the laws of the United States, the sole and exclusive forum for determination of such a claim.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">41</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>4
<FILENAME>ea021383001ex4-1_andretti2.htm
<DESCRIPTION>WARRANT AGREEMENT, DATED SEPTEMBER 5, 2024, BY AND BETWEEN THE COMPANY AND CONTINENTAL STOCK TRANSFER & TRUST COMPANY, AS WARRANT AGENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 4.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>WARRANT AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>THIS WARRANT AGREEMENT</B>
(this &ldquo;<B><I>Agreement</I></B>&rdquo;), dated as of September 5, 2024, is by and between Andretti Acquisition Corp. II , a Cayman
Islands exempted company (the &ldquo;<B><I>Company</I></B>&rdquo;), and Continental Stock Transfer &amp; Trust Company, a New York corporation,
as warrant agent (in such capacity, the &ldquo;<B><I>Warrant Agent</I></B>,&rdquo; and also referred to herein as the &ldquo;<B><I>Transfer
Agent</I></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, the Company
is engaged in an initial public offering (the &ldquo;<B><I>Offering</I></B>&rdquo;) of units of the Company&rsquo;s equity securities,
each such unit comprised of one Class A ordinary share of the Company, par value $0.0001 per share (&ldquo;<B><I>Class A Shares</I></B>&rdquo;)
and one-half of one redeemable Public Warrant (as defined below) (the &ldquo;<B><I>Units</I></B>&rdquo;) and, in connection therewith,
has determined to issue and deliver up to 10,000,000 warrants (or up to 11,500,000 warrants if the Over-allotment Option (as defined below)
is exercised in full) to public investors in the Offering (the &ldquo;<B><I>Public Warrants</I></B>&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, the Company
entered into that certain Sponsor Private Placement Units Purchase Agreement with Andretti Sponsor II LLC, a Delaware limited liability
company (the &ldquo;<B><I>Sponsor</I></B>&rdquo;), pursuant to which the Sponsor agreed to purchase an aggregate of 450,000 private placement
units (including if the underwriters&rsquo; over-allotment option is exercised in full) simultaneously with the closing of the Offering
(the &ldquo;<B><I>Sponsor Private Placement Units</I></B>&rdquo;) at a purchase price of $10.00 per Private Placement Unit, and in connection
therewith, the issuance of up to 225,000 warrants (including if the Over-allotment Option is exercised in full) underlying the Private
Placement Units (the &ldquo;<B><I>Sponsor Private Placement Warrants</I></B>&rdquo;), each bearing the legend set forth in Exhibit A hereto;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, the Company
entered into that certain Underwriter Private Placement Units Purchase Agreement with BTIG, LLC (the &ldquo;<B><I>Lead Underwriter</I></B>&rdquo;),
pursuant to which the Lead Underwriter agreed to purchase an aggregate of 250,000 private placement units (or up to 310,000 private placement
units if the underwriters&rsquo; over-allotment option is exercised in full) (the &ldquo;<B><I>Lead Underwriter Private Placement Units,</I></B>&rdquo;
collectively with the Sponsor Private Placement Units, the &ldquo;<B><I>Private Placement Units</I></B>&rdquo;) simultaneously with the
closing of the Offering at a purchase price of $10.00 per Private Placement Unit, and, in connection therewith, the issuance of up to
125,000 warrants (or up to 155,000 warrants if the underwriters&rsquo; over-allotment option is exercised in full) underlying the Private
Placement Units (the &ldquo;<B><I>Lead Underwriter Private Placement Warrants</I></B>&rdquo; and, together with the Sponsor Private Placement
Warrants, the &ldquo;<B><I>Private Placement Warrants</I></B>&rdquo;), each bearing the legend set forth in Exhibit A hereto;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, the Company
was incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business
combination with one or more businesses (a &ldquo;<B><I>Business Combination</I></B>&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, in order to
finance the Company&rsquo;s transaction costs in connection with an intended initial Business Combination, the Sponsor or an affiliate
of the Sponsor or the Company&rsquo;s officers and directors (collectively, the &ldquo;<B><I>Initial Purchasers</I></B>&rdquo;) may, but
are not obligated to, loan to the Company funds as the Company may require, of which up to $1,500,000 of such loans may be convertible
into up to an additional 150,000 units at a price of $10.00 per unit (the &ldquo;<B><I>Working Capital Units</I></B>&rdquo;), which will
be identical to the Private Placement Units, and in connection with the issuance of Working Capital Units, the issuance of up to 75,000
warrants (the &ldquo;<B><I>Working Capital Warrants</I></B>&rdquo; and, together with the Public Warrants and the Private Placement Warrants,
the &ldquo;<B><I>Warrants</I></B>&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, each Warrant
entitles the holder thereof to purchase one Class A Share at a price of $11.50 per share, subject to adjustment as described herein;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, the Company
has filed with the U.S. Securities and Exchange Commission (the &ldquo;<B><I>Commission</I></B>&rdquo;) a registration statement on Form
S-1, File No. 333-280552 (the &ldquo;<B><I>Registration Statement</I></B>&rdquo;), and a prospectus (the &ldquo;<B><I>Prospectus</I></B>&rdquo;),
for the registration, under the Securities Act of 1933, as amended (the &ldquo;<B><I>Securities Act</I></B>&rdquo;), of the Units, the
Public Warrants and the Class A Shares included in the Units;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, the Company
desires the Warrant Agent to act on behalf of the Company, and the Warrant Agent is willing to so act, in connection with the issuance,
registration, transfer, exchange, redemption and exercise of the Warrants;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, the Company
desires to provide for the form and provisions of the Warrants, the terms upon which they shall be issued and exercised, and the respective
rights, limitation of rights, and immunities of the Company, the Warrant Agent, and the holders of the Warrants; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>WHEREAS</B>, all acts and
things have been done and performed which are necessary to make the Warrants, when executed on behalf of the Company and countersigned
by or on behalf of the Warrant Agent, as provided herein, the valid, binding and legal obligations of the Company, and to authorize the
execution and delivery of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>NOW, THEREFORE</B>, in
consideration of the mutual agreements herein contained, the parties hereto agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">

    <TD STYLE="width: 0.5in; font-size: 10pt">1.</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Appointment of Warrant Agent.</U> The
Company hereby appoints the Warrant Agent to act as agent for the Company for the Warrants, and the Warrant Agent hereby accepts such
appointment and agrees to perform the same in accordance with the terms and conditions set forth in this Agreement.&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">

    <TD STYLE="width: 0.5in; font-size: 10pt">2.</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Warrants</U>.&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">2.1.</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Form of Warrant.</U> Each Warrant shall
be issued in registered form only, and, if a physical certificate is issued, shall be in substantially the form of <U>Exhibit B</U> hereto,
the provisions of which are incorporated herein and shall be signed by, or bear the facsimile signature of, the Chairperson of the Company&rsquo;s
board of directors (the &ldquo;<B><I>Board</I></B>&rdquo;), President, Chief Executive Officer, Chief Financial Officer, Secretary or
other principal officer of the Company. In the event the person whose facsimile signature has been placed upon any Warrant shall have
ceased to serve in the capacity in which such person signed the Warrant before such Warrant is issued, it may be issued with the same
effect as if he or she had not ceased to be such at the date of issuance. All of the Public Warrants shall initially be represented by
one or more book-entry certificates (each, a &ldquo;<B><I>Book-Entry Warrant Certificate</I></B>&rdquo;).&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">2.2.</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Effect of Countersignature.</U> If a physical
certificate is issued, unless and until countersigned by the Warrant Agent pursuant to this Agreement, a Warrant certificate shall be
invalid and of no effect and may not be exercised by the holder thereof.&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">

    <TD STYLE="width: 0.5in; font-size: 10pt">2.3.</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Registration</U>.</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 1in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">2.3.1.</TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><U>Warrant Register.</U> The Warrant Agent shall maintain books (the &ldquo;<B><I>Warrant Register</I></B>&rdquo;) for the registration of original issuance and the registration of transfer of the Warrants. Upon the initial issuance of the Warrants, the Warrant Agent shall issue and register the Warrants in the names of the respective holders thereof in such denominations and otherwise in accordance with instructions delivered to the Warrant Agent by the Company. All of the Public Warrants shall initially be represented by one or more Book-Entry Warrant Certificates deposited with The Depository Trust Company (the &ldquo;<B><I>Depositary</I></B>&rdquo;) and registered in the name of Cede &amp; Co., a nominee of the Depositary. Ownership of beneficial interests in the Public Warrants shall be shown on, and the transfer of such ownership shall be effected through, records maintained by (i) the Depositary or its nominee for each Book-Entry Warrant Certificate, or (ii) institutions that have accounts with the Depositary (each such institution, with respect to a Warrant in its account, a &ldquo;<B><I>Participant</I></B>&rdquo;).</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">If the Depositary subsequently ceases
to make its book-entry settlement system available for the Public Warrants, the Company may instruct the Warrant Agent regarding making
other arrangements for book-entry settlement. In the event that the Public Warrants are not eligible for, or it is no longer necessary
to have the Public Warrants available in, book-entry form, the Warrant Agent shall provide written instructions to the Depositary to deliver
to the Warrant Agent for cancellation each Book-Entry Warrant Certificate, and the Company shall instruct the Warrant Agent to deliver
to the Depositary definitive certificates in physical form evidencing such Warrants (&ldquo;<B><I>Definitive Warrant Certificate</I></B>&rdquo;).
Such Definitive Warrant Certificate shall be in the form annexed hereto as <U>Exhibit B,</U> with appropriate insertions, modifications
and omissions, as provided above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left">2.3.2.</TD><TD STYLE="text-align: justify"><U>Registered Holder.</U> Prior to due presentment for registration
of transfer of any Warrant, the Company and the Warrant Agent may deem and treat the person in whose name such Warrant is registered
in the Warrant Register (the &ldquo;<B><I>Registered Holder</I></B>&rdquo;) as the absolute owner of such Warrant and of each Warrant
represented thereby (notwithstanding any notation of ownership or other writing on a Definitive Warrant Certificate made by anyone other
than the Company or the Warrant Agent), for the purpose of any exercise thereof, and for all other purposes, and neither the Company
nor the Warrant Agent shall be affected by any notice to the contrary.</TD>
</TR></TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">2.4.</TD><TD STYLE="text-align: justify"><U>Detachability of Warrants.</U> The Class A Shares and Public
Warrants comprising the Units shall begin separate trading on the 52nd day following the date of the Prospectus or, if such 52nd day
is not on a day, other than a Saturday, Sunday or federal holiday, on which banks in New York City are generally open for normal business
(a &ldquo;<B><I>Business Day</I></B>&rdquo;), then on the immediately succeeding Business Day following such date, or earlier (the &ldquo;<B><I>Detachment
Date</I></B>&rdquo;) with the consent of the Lead Underwriter, as representative of the several underwriters, but in no event shall the
Class A Shares and the Public Warrants comprising the Units be separately traded until the Company issues a press release and files with
the Commission a Current Report on Form 8-K announcing when such separate trading shall begin. The Private Placement Units shall be eligible
to be separated into their component Class A Shares and Warrants on the Detachment Date. Holders of Warrants shall contact the Transfer
Agent in order to effect such separation.</TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">2.5.</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>No Fractional Warrants Other Than as Part
of Units</U>. The Company shall not issue fractional Warrants other than as part of the Units, each of which is comprised of one Class
A Share and one-half of one Public Warrant. If, upon the detachment of Public Warrants from the Units or otherwise, a holder of Warrants
would be entitled to receive a fractional Warrant, the Company shall round down to the nearest whole number the number of Warrants to
be issued to such holder.</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">2.6.</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Private Placement Warrants and Working
Capital Warrants. </U>The Private Placement Warrants and Working Capital Warrants shall be identical to the Public Warrants, except that
until the date that is thirty (30) days after the completion by the Company of an initial Business Combination the Private Placement
Warrants and the Working Capital Warrants may not be transferred, assigned or sold by the holders thereof, other than:</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 1in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">2.6.1.</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">to the Company&rsquo;s or Lead Underwriter&rsquo;s
officers or directors, any affiliate or family member of any of the Company&rsquo;s or Lead Underwriter&rsquo;s officers or directors,
any members or partners of the Sponsor or their affiliates, any affiliates of the Sponsor, the Lead Underwriter or any employees of such
affiliates;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 1in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">2.6.2.</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">in the case of an individual, by gift to
a member of such individual&rsquo;s immediate family or to a trust, the beneficiary of which is a member of such individual&rsquo;s immediate
family, an affiliate of such individual or to a charitable organization;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 1in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">2.6.3.</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">in the case of an individual, by virtue of
the laws of descent and distribution upon death of such person;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 1in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">2.6.4.</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">in the case of an individual, pursuant to
a qualified domestic relations order;&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 1in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">2.6.5.</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">by private sales or transfers made in connection
with any forward purchase agreement or similar arrangement, in connection with an extension of the timeframe for the Company to consummate
a Business Combination or in connection with the consummation of an initial Business Combination at prices no greater than the price
at which the Warrants were originally purchased;&nbsp;&nbsp;</P></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; text-align: justify; width: 1in">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; width: 0.5in">2.6.6</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">by pro rata distributions from the Sponsor
or Lead Underwriter. to its respective members, partners or stockholders pursuant to the Sponsor&rsquo;s or Lead Underwriter&rsquo;s
limited liability company agreement or other charter documents;&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 1in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">2.6.7.</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">by virtue of the laws of the Cayman Islands or the limited liability company agreement of the Sponsor upon dissolution of the Sponsor or upon dissolution of the Lead Underwriter;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 1in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">2.6.8.</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">in the event of the Company&rsquo;s liquidation
prior to the consummation of a Business Combination;&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 1in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">2.6.9.</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">to a nominee or custodian of a person or
entity to whom a disposition or transfer would be permissible under <U>clauses 2.6.1</U> through <U>2.6.7</U> above;&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">2.6.10</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">to the Company for no value for cancellation in
    connection with the consummation of an</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">initial Business Combination; and&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left">2.6.11.</TD><TD STYLE="text-align: justify">in the event that, subsequent to the consummation of an initial
Business Combination, the Company completes a liquidation, merger, share exchange or other similar transaction which results in all of
its shareholders having the right to exchange their Class A Shares for cash, securities or other property; <U>provided, however,</U>
that, in the case of <U>clauses 2.6.1</U> through <U>2.6.7</U>, and <U>2.6.9 </U>these transferees (the &ldquo;<B><I>Permitted Transferees</I></B>&rdquo;)
enter into a written agreement with the Company agreeing to be bound by the transfer restrictions in this Agreement and the other restrictions
contained in the letter agreement, dated as of the date hereof, by and among the Company, the Sponsor, the Lead Underwriter and the Company&rsquo;s
officers and directors.</TD>
</TR></TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">2.7.</TD><TD STYLE="text-align: justify"><U>Working Capital Warrants</U>. Each of the Working Capital
Warrants shall be identical to the Private Placement Warrants.</TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">

    <TD STYLE="width: 0.5in; font-size: 10pt">3.</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Terms and Exercise of Warrants</U>.&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">3.1.</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Warrant Price.</U> Each Warrant shall
entitle the Registered Holder thereof, subject to the provisions of such Warrant and of this Agreement, including without limitation,
<U>subsection 3.3.5</U>, to purchase from the Company the number of Class A Shares stated therein, at the price of $11.50 per share,
subject to the adjustments provided in <U>Section 4</U> hereof and in the last sentence of this <U>Section 3.1</U>. The term &ldquo;Warrant
Price&rdquo; as used in this Agreement shall mean the price per share (including in cash or by payment of Warrants pursuant to a &ldquo;cashless
exercise,&rdquo; to the extent permitted hereunder) described in the prior sentence at which the Class A Shares may be purchased at the
time a Warrant is exercised. The Company in its sole discretion may lower the Warrant Price at any time prior to the Expiration Date
(as defined below) for a period of not less than twenty (20) Business Days (unless otherwise required by the Commission, any national
securities exchange on which the Warrants are listed or applicable law), provided, that the Company shall provide at least three (3)
days&rsquo; prior written notice of such reduction to Registered Holders of the Warrants and, provided further that any such reduction
shall be identical among all of the Warrants.&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">3.2.</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Duration of Warrants.</U> A Warrant may
be exercised only during the period (the &ldquo;<B><I>Exercise Period</I></B>&rdquo;) (A) commencing on the date that is thirty (30)
days after the first date on which the Company completes a Business Combination, and terminating on the earliest to occur of: (x) 5:00
p.m., New York City time on the date that is five (5) years after the date on which the Company completes its initial Business Combination,
(y) the liquidation of the Company, and (z) with respect to a redemption pursuant to <U>Section 6.1</U> hereof, 5:00 p.m., New York City
time on the Redemption Date (as defined below) as provided in <U>Section 6.2</U> hereof (the &ldquo;<B><I>Expiration Date</I></B>&rdquo;);
provided, however, that the exercise of any Warrant shall be subject to the satisfaction of any applicable conditions, as set forth in
<U>subsection 3.3.2 </U>below, with respect to an effective registration statement or a valid exemption therefrom being available. Each
outstanding Warrant not exercised on or before the Expiration Date shall become void, and all rights thereunder and all rights in respect
thereof under this Agreement shall cease at 5:00 p.m. New York City time on the Expiration Date. The Company in its sole discretion may
extend the duration of the Warrants by delaying the Expiration Date; provided, that the Company shall provide at least twenty (20) days
prior written notice of any such extension to Registered Holders of the Warrants and, provided further that any such extension shall
be identical in duration among all the Warrants.&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">

    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">3.3.</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Exercise of Warrants</U>.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 1in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">3.3.1.</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Payment.</U> Subject to the provisions
of the Warrant and this Agreement, including without limitation, <U>subsection 3.3.5</U>, a Warrant may be exercised by the Registered
Holder thereof by delivering to the Warrant Agent at its corporate trust department (i) the Definitive Warrant Certificate evidencing
the Warrants to be exercised, or, in the case of a Book-Entry Warrant Certificate, the Warrants to be exercised (the &ldquo;<B><I>Book-Entry
Warrants</I></B>&rdquo;) on the records of the Depositary to an account of the Warrant Agent at the Depositary designated for such purposes
in writing by the Warrant Agent to the Depositary from time to time, (ii) an election to purchase (&ldquo;<B><I>Election to Purchase</I></B>&rdquo;)
Class A Shares pursuant to the exercise of a Warrant, properly completed and executed by the Registered Holder on the reverse of the
Definitive Warrant Certificate or, in the case of a Book-Entry Warrant Certificate, properly delivered by the Participant in accordance
with the Depositary&rsquo;s procedures, and (iii) payment in full of the Warrant Price for each Class A Share as to which the Warrant
is exercised and any and all applicable taxes due in connection with the exercise of the Warrant, the exchange of the Warrant for the
Class A Shares and the issuance of such Class A Shares, as follows:&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 1.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">(a)</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">in lawful money of the United States, in
good bank draft or good certified check payable to the order of the Warrant Agent or by wire transfer of immediately available funds;&nbsp;</P></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 1.5in">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; width: 0.5in">(b)</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">in the event of a redemption pursuant to
<U>Section 6</U> hereof in which the Company&rsquo;s board of directors (the &ldquo;<B><I>Board</I></B>&rdquo;) has elected to require
all holders of the Warrants to exercise such Warrants on a &ldquo;cashless basis,&rdquo; by surrendering the Warrants for that number
of Class A Shares equal to the quotient obtained by dividing (x) the product of the number of Class A Shares underlying the Warrants,
multiplied by the excess of the &ldquo;Fair Market Value&rdquo;, as defined in this <U>subsection 3.3.1(b)</U>, over the Warrant Price
by (y) the Fair Market Value. Solely for purposes of this <U>subsection 3.3.1(b)</U> and <U>Section 6.3</U>, the &ldquo;Fair Market Value&rdquo;
shall mean the average reported closing price of the Class A Shares for the ten (10) trading days ending on the third trading day prior
to the date on which the notice of redemption is sent to the holders of the Warrants, pursuant to <U>Section 6</U> hereof; or&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 1.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">(c)</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">on a cashless basis as provided in <U>Section 7.4</U> hereof.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 1in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">3.3.2.</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Issuance of Class A Shares on Exercise</U>.
As soon as practicable after the exercise of any Warrant and the clearance of the funds in payment of the Warrant Price (if payment is
pursuant to <U>subsection 3.3.1(a))</U>, the Company shall issue to the Registered Holder of such Warrant a book-entry position or certificate,
as applicable, for the number of Class A Shares to which he, she or it is entitled, registered in such name or names as may be directed
by him, her or it, and if such Warrant shall not have been exercised in full, a new book-entry position or countersigned Warrant, as
applicable, for the number of Class A Shares as to which such Warrant shall not have been exercised. If fewer than all the Warrants evidenced
by a Book-Entry Warrant Certificate are exercised, a notation shall be made to the records maintained by the Depositary, its nominee
for each Book-Entry Warrant Certificate, or a Participant, as appropriate, evidencing the balance of the Warrants remaining after such
exercise. Notwithstanding the foregoing, the Company shall not be obligated to deliver any Class A Shares pursuant to the exercise of
a Warrant and shall have no obligation to settle such Warrant exercise unless a registration statement under the Securities Act with
respect to the Class A Shares underlying the Public Warrants is then effective and a prospectus relating thereto is current, subject
to the Company&rsquo;s satisfying its obligations under <U>Section 7.4 or a valid exemption from registration is available</U>. No Warrant
shall be exercisable and the Company shall not be obligated to issue Class A Shares upon exercise of a Warrant unless the Class A Shares
issuable upon such Warrant exercise have been registered, qualified or deemed to be exempt from registration or qualification under the
securities laws of the state of residence of the Registered Holder of the Warrants. In the event that the conditions in the two immediately
preceding sentences are not satisfied with respect to a Warrant, the holder of such Warrant shall not be entitled to exercise such Warrant.
In no event will the Company be required to net cash settle the Warrant exercise. The Company may require holders of Public Warrants
to settle the Warrant on a &ldquo;cashless basis&rdquo; pursuant to <U>Section 7.4</U>. If, by reason of any exercise of Warrants on
a &ldquo;cashless basis,&rdquo; the holder of any Warrant would be entitled, upon the exercise of such Warrant, to receive a fractional
interest in a Class A Share, the Company shall round down to the nearest whole number, the number of Class A Shares to be issued to such
holder.&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 1in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">3.3.3.</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Valid Issuance</U>. All Class A Shares issued
    upon the proper exercise of a Warrant in conformity with this Agreement shall be validly issued, fully paid and non-assessable.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 1in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">3.3.4.</TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><U>Date of Issuance.</U> Each person in whose name any book-entry position or certificate, as applicable, for Class A Shares is issued shall for all purposes be deemed to have become the holder of record of such Class A Shares on the date on which the Warrant, or book-entry position representing such Warrant, was surrendered and payment of the Warrant Price was made, irrespective of the date of delivery of such certificate in the case of a certificated Warrant, except that, if the date of such surrender and payment is a date when the share transfer books of the Company or book-entry system of the Warrant Agent are closed, such person shall be deemed to have become the holder of such Class A Shares at the close of business on the next succeeding date on which the share transfer books or book-entry system are open.</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 1in">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; width: 0.5in">3.3.5.</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Maximum Percentage</U>. A holder of a
Warrant may notify the Company in writing in the event it elects to be subject to the provisions contained in this <U>subsection 3.3.5</U>;
<U>however,</U> no holder of a Warrant shall be subject to this <U>subsection 3.3.5</U> unless he, she or it makes such election. If
the election is made by a holder, the Warrant Agent shall not effect the exercise of the holder&rsquo;s Warrant, and such holder shall
not have the right to exercise such Warrant, to the extent that after giving effect to such exercise, such person (together with such
person&rsquo;s affiliates) or any &ldquo;group&rdquo; of which the holder or its affiliate is a member, would beneficially own in excess
of 4.9% or 9.8% (or such other amount as a holder may specify)(the &ldquo;<B><I>Maximum Percentage</I></B>&rdquo;) of the Class A Shares
outstanding immediately after giving effect to such exercise. For purposes of the foregoing sentence, the aggregate number of Class A
Shares beneficially owned by such person and its affiliates, or any group of which such person and its affiliates is a member, shall
include the number of Class A Shares issuable upon exercise of the Warrant with respect to which the determination of such sentence is
being made, but shall exclude Class A Shares that would be issuable upon (x) exercise of the remaining, unexercised portion of the Warrant
beneficially owned by such person and its affiliates, or any group of which any such person or its affiliates is a member, and (y) exercise
or conversion of the unexercised or unconverted portion of any other securities of the Company beneficially owned by such person and
its affiliates, or any group of which such person or its affiliates is a member (including, without limitation, any convertible notes
or convertible preferred shares or warrants) subject to a limitation on conversion or exercise analogous to the limitation contained
herein. Except as set forth in the preceding sentence, for purposes of this paragraph, beneficial ownership shall be calculated in accordance
with Section 13(d) of the Securities Exchange Act of 1934, as amended (the &ldquo;<B><I>Exchange </I>Act</B>&rdquo;), and the applicable
regulations of the Commission. For purposes hereof, &ldquo;group&rdquo; has the meaning set forth in Section 13(d) of the Exchange Act
and applicable regulations of the Commission, and the percentage held by the holder shall be determined in a manner consistent with the
provisions of Section 13(d) of the Exchange Act. To the extent that a holder makes the election described in this <U>subsection 3.3.5</U>,
the Warrant Agent shall not effect the exercise of the holder&rsquo;s Warrant, and such holder shall not have the right to exercise such
Warrant unless it provides to the Warrant Agent in its Election to Purchase, a certification that, upon after giving effect to such exercise,
such person (together with such person&rsquo;s affiliates) or any &ldquo;group&rdquo; of which such holder or its affiliates is a member,
would not beneficially own in excess of the Maximum Percentage of the Class A Shares outstanding immediately after giving effect to such
exercise as determined in accordance with this <U>subsection 3.3.5</U>. For purposes of the Warrant, in determining the number of outstanding
Class A Shares, the holder may rely on the number of outstanding Class A Shares as reflected in (1) the Company&rsquo;s most recent Annual
Report on Form 10-K, Quarterly Report on Form 10-Q, Current Report on Form 8-K or other public filing with the Commission as the case
may be, (2) a more recent public announcement by the Company or (3) any other notice by the Company or the Transfer Agent setting forth
the number of Class A Shares outstanding. For any reason at any time, upon the written request of the holder of the Warrant, the Company
shall, within two (2) Business Days, confirm orally and in writing to such holder the number of Class A Shares then outstanding. In any
case, the number of outstanding Class A Shares shall be determined after giving effect to the conversion or exercise of equity securities
of the Company by the holder and its affiliates since the date as of which such number of outstanding Class A Shares was reported. By
written notice to the Company, the holder of a Warrant may from time to time increase or decrease the Maximum Percentage applicable to
such holder to any other percentage specified in such notice; <U>provided, however,</U> that any such increase shall not be effective
until the sixty-first (61st) day after such notice is delivered to the Company.&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">

    <TD STYLE="width: 0.5in; font-size: 10pt">4.</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Adjustments</U>.&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">

    <TD STYLE="width: 0.5in; font-size: 10pt">4.1.</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Share Capitalizations</U>.&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 1in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">4.1.1.</TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><U>Sub-division</U>. If after the date hereof, and subject to the provisions of <U>Section 4.6</U> below, the number of outstanding Class A Shares is increased by a share capitalization payable in Class A Shares, or by a sub-division of Class A Shares or other similar event, then, on the effective date of such share capitalization, sub-division or similar event, the number of Class A Shares issuable on exercise of each Warrant shall be increased in proportion to such increase in the outstanding Class A Shares. A rights offering made to all or substantially all holders of the Class A Shares entitling holders to purchase Class A Shares at a price less than the &ldquo;Historical Fair Market Value&rdquo; (as defined below) shall be deemed a share capitalization of a number of Class A Shares equal to the product of (i) the number of Class A Shares actually sold in such rights offering (or issuable under any other equity securities sold in such rights offering that are convertible into or exercisable for Class A Shares) and (ii) one (1) minus the quotient of (x) the price per Class A Share paid in such rights offering divided by (y) the Historical Fair Market Value. For purposes of this <U>subsection 4.1.1</U>, (i) if the rights offering is for securities convertible into or exercisable for Class A Shares, in determining the price payable for Class A Shares, there shall be taken into account any consideration received for such rights, as well as any additional amount payable upon exercise or conversion and (ii) &ldquo;<B><I>Historical Fair Market Value</I></B>&rdquo; means the volume weighted average price of the Class A Shares as reported during the ten (10) trading day period ending on the trading day prior to the first date on which the Class A Shares trade on the applicable exchange or in the applicable market, regular way, without the right to receive such rights. No Class A Shares shall be issued at less than their par value.</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">4.1.2.</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Extraordinary Dividends</U>. If the Company,
at any time while the Warrants are outstanding and unexpired, shall pay a dividend or make a distribution in cash, securities or other
assets to all or substantially all of the holders of Class A Shares on account of such Class A Shares (or other shares of the Company&rsquo;s
share capital into which the Warrants are convertible), other than (a) as described in <U>subsection 4.1.1</U> above, (b) Ordinary Cash
Dividends (as defined below), (c) to satisfy the redemption rights of the holders of Class A Shares in connection with a proposed initial
Business Combination, (d) to satisfy the redemption rights of the holders of Class A Shares in connection with a shareholder vote to
amend the Company&rsquo;s amended and restated memorandum and articles of association (as amended from time to time, the &ldquo;<B><I>Charter</I></B>&rdquo;)
(A) to modify the substance or timing of the Company&rsquo;s obligation to allow redemption in connection with the Company&rsquo;s initial
business combination or to redeem 100% of the Class A Shares included in the Units sold in the Offering (the &ldquo;<B><I>Public Shares</I></B>&rdquo;)
if the Company does not complete the Business Combination within the period set forth in the Charter or (B) with respect to any other
material provisions relating to shareholders&rsquo; rights or pre-initial Business Combination activity or (e) in connection with the
redemption of Public Shares upon the failure of the Company to complete its initial Business Combination and any subsequent distribution
of its assets upon its liquidation (any such non-excluded event being referred to herein as an &ldquo;<B><I>Extraordinary Dividend</I></B>&rdquo;),
then the Warrant Price shall be decreased, effective immediately after the effective date of such Extraordinary Dividend, by the amount
of cash and/or the fair market value (as determined by the Board, in good faith) of any securities or other assets paid on each Class
A Share in respect of such Extraordinary Dividend. For purposes of this <U>subsection 4.1.2</U>, &ldquo;<B><I>Ordinary Cash Dividends</I></B>&rdquo;
means any cash dividend or cash distribution which, when combined on a per share basis, with the per share amounts of all other cash
dividends and cash distributions paid on the Class A Shares during the 365-day period ending on the date of declaration of such dividend
or distribution (as adjusted to appropriately reflect any of the events referred to in other subsections of this <U>Section 4</U> and
excluding cash dividends or cash distributions that resulted in an adjustment to the Warrant Price or to the number of Class A Shares
issuable on exercise of each Warrant) does not exceed $0.50 (being 5% of the offering price of the Units in the Offering) but only with
respect to the amount of the aggregate cash dividends or cash distributions equal to or less than $0.50. Solely for purposes of illustration,
if the Company, at a time while the Warrants are outstanding and unexpired, pays a cash dividend of $0.35 and previously paid an aggregate
of $0.40 of cash dividends and cash distributions on the Class A Shares during the 365-day period ending on the date of declaration of
such $0.35 dividend, then the Warrant Price will be decreased, effectively immediately after the effective date of such $0.35 dividend,
by $0.25 (the absolute value of the difference between $0.75 (the aggregate amount of all cash dividends and cash distributions paid
or made in such 365-day period, including such $0.35 dividend) and $0.50 (the greater of (x) $0.50 and (y) the aggregate amount of all
cash dividends and cash distributions paid or made in such 365-day period prior to such $0.35 dividend)).&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 1in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">4.2.</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Aggregation of Shares</U>. If after the
date hereof, and subject to the provisions of <U>Section 4.6</U> hereof, the number of outstanding Class A Shares is decreased by a consolidation,
combination, reverse share sub-division or reclassification of Class A Shares or other similar event, then, on the effective date of
such consolidation, combination, reverse share sub-division, reclassification or similar event, the number of Class A Shares issuable
on exercise of each Warrant shall be decreased in proportion to such decrease in outstanding Class A Shares.&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">

    <TD STYLE="width: 0.5in; font-size: 10pt">4.3.</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Adjustments in Warrant Price</U>.&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 1in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">4.3.1.</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Whenever the number of Class A Shares purchasable
upon the exercise of the Warrants is adjusted, as provided in <U>subsection 4.1.1</U> or <U>Section 4.2</U> above, the Warrant Price
shall be adjusted (to the nearest cent) by multiplying such Warrant Price immediately prior to such adjustment by a fraction (x) the
numerator of which shall be the number of Class A Shares purchasable upon the exercise of the Warrants immediately prior to such adjustment,
and (y) the denominator of which shall be the number of Class A Shares so purchasable immediately thereafter.&nbsp;</P></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 1in">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; width: 0.5in">4.3.2.</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">If (x) the Company issues additional Class A Shares or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per Class A Share (with such issue price or effective issue price to be determined in good faith by the Board and, in the case of any such issuance to the initial shareholders (as defined in the Prospectus) or their affiliates, without taking into account any Class B Ordinary Shares (as defined below) held by such shareholders or their affiliates, as applicable, prior to such issuance (the &ldquo;<B><I>Newly Issued Price</I></B>&rdquo;)), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for funding the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Class A Shares during the 20 trading day period starting on the trading day prior to the day on which the Company consummates the Business Combination (such price, the &ldquo;<B><I>Market Value</I></B>&rdquo;) is below $9.20 per share, the Warrant Price shall be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, the $18.00 per share redemption trigger price described in <U>Section 6.1</U> below shall be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">4.4.</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Replacement of Securities upon Reorganization,
etc</U>. In case of any reclassification or reorganization of the outstanding Class A Shares (other than a change covered by <U>subsections
4.1.1</U>, <U>4.1.2</U> or <U>Section 4.2</U> hereof or that solely affects the par value of such Class A Shares), or in the case of
any merger or consolidation of the Company with or into another entity or conversion of the Company as another entity (other than a consolidation
or merger in which the Company is the continuing corporation and is not a subsidiary of another entity whose shareholders did not own
all or substantially all of the Class A Shares of the Company in substantially the same proportions immediately before such transaction
and that does not result in any reclassification or reorganization of the outstanding Class A Shares), or in the case of any sale or
conveyance to another entity of the assets or other property of the Company as an entirety or substantially as an entirety in connection
with which the Company is dissolved, the holders of the Warrants shall thereafter have the right to purchase and receive, upon the basis
and upon the terms and conditions specified in the Warrants and in lieu of the Class A Shares of the Company immediately theretofore
purchasable and receivable upon the exercise of the rights represented thereby, the kind and amount of shares or other securities or
property (including cash) receivable upon such reclassification, reorganization, merger or consolidation, or upon a dissolution following
any such sale or transfer, that the holder of the Warrants would have received if such holder had exercised his, her or its Warrant(s)
immediately prior to such event (the &ldquo;<B><I>Alternative Issuance</I></B>&rdquo;); <U>provided</U>, <U>however</U>, that (i) if
the holders of the Class A Shares were entitled to exercise a right of election as to the kind or amount of securities, cash or other
assets receivable upon such consolidation or merger, then the kind and amount of securities, cash or other assets constituting the Alternative
Issuance for which each Warrant shall become exercisable shall be deemed to be the weighted average of the kind and amount received per
share by the holders of the Class A Shares in such consolidation or merger that affirmatively make such election, and (ii) if a tender,
exchange or redemption offer shall have been made to and accepted by the holders of the Class A Shares (other than a tender, exchange
or redemption offer made by the Company in connection with redemption rights held by shareholders of the Company as provided for in the
Charter or as a result of the redemption of Class A Shares by the Company if a proposed initial Business Combination is presented to
the shareholders of the Company for approval) under circumstances in which, upon completion of such tender or exchange offer, the maker
thereof, together with members of any group (within the meaning of Rule 13d-5(b)(1) under the Exchange Act (or any successor rule)) of
which such maker is a part, and together with any affiliate or associate of such maker (within the meaning of Rule 12b-2 under the Exchange
Act (or any successor rule)) and any members of any such group of which any such affiliate or associate is a part, own beneficially (within
the meaning of Rule 13d-3 under the Exchange Act (or any successor rule)) more than 65% of the voting power of the Company&rsquo;s outstanding
equity securities (including with respect to the election of directors), the holder of a Warrant shall be entitled to receive as the
Alternative Issuance, the weighted average of the amount of cash, securities or other property to which such holder would actually have
been entitled as a shareholder if such Warrant holder had exercised the Warrant prior to the expiration of such tender or exchange offer,
accepted such offer and participated in such tender or exchange offer on a pro rata basis with all other holders of Class A Shares, subject
to adjustments (from and after the consummation of such tender or exchange offer) as nearly equivalent as possible to the adjustments
provided for in this <U>Section 4</U>; <U>provided further</U> that if less than 70% of the consideration receivable by the holders of
the Class A Shares in the applicable event is payable in the form of capital stock or shares in the successor entity that is listed for
trading on a national securities exchange or is quoted in an established over-the-counter market, or is to be so listed for trading or
quoted immediately following such event, and if the Registered Holder properly exercises the Warrant within thirty (30) days following
the public disclosure of the consummation of such applicable event by the Company pursuant to a Current Report on Form 8-K filed with
the Commission, the Warrant Price shall be reduced by an amount (in dollars) equal to the difference (but in no event less than zero)
of (i) the Warrant Price in effect prior to such reduction minus (ii) (A) the Per Share Consideration (as defined below) minus (B) the
Black-Scholes Warrant Value (as defined below). The &ldquo;<B><I>Black-Scholes Warrant Value</I></B>&rdquo; means the value of a Warrant
immediately prior to the consummation of the applicable event based on the Black-Scholes model as calculated by an accounting, appraisal,
investment banking firm or consultant of nationally recognized standing that is, in the good faith judgment of the Board, qualified to
make such calculation. &ldquo;<B><I>Per Share Consideration</I></B>&rdquo; means (i) if the consideration paid to holders of the Class
A Shares consists exclusively of cash, the amount of such cash per Class A Share, and (ii) in all other cases, the volume weighted average
price of the Class A Shares as reported during the ten (10) trading day period ending on the trading day prior to the effective date
of the applicable event. If any reclassification or reorganization also results in a change in Class A Shares covered by <U>subsection
4.1.1,</U> then such adjustment shall be made pursuant to <U>subsection 4.1.1</U> or <U>Sections 4.2</U>, <U>4.3</U> and this <U>Section
4.4</U>. The provisions of this <U>Section 4.4</U> shall similarly apply to successive reclassifications, reorganizations, mergers or
consolidations, sales or other transfers. In no event will the Warrant Price be reduced to less than the par value per share issuable
upon exercise of the Warrant.&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; width: 0.5in">4.5.</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Notices of Changes in Warrant</U>. Upon
every adjustment of the Warrant Price or the number of Class A Shares issuable upon exercise of a Warrant, the Company shall give written
notice thereof to the Warrant Agent, which notice shall state the Warrant Price resulting from such adjustment and the increase or decrease,
if any, in the number of Class A Shares purchasable at such price upon the exercise of a Warrant, setting forth in reasonable detail
the method of calculation and the facts upon which such calculation is based. Upon the occurrence of any event specified in <U>Sections
4.1</U>, <U>4.2</U>, <U>4.3</U> or <U>4.4</U>, the Company shall give written notice of the occurrence of such event to each holder of
a Warrant, at the last address set forth for such holder in the Warrant Register, of the record date or the effective date of the event.
Failure to give such notice, or any defect therein, shall not affect the legality or validity of such event.&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">4.6.</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>No Fractional Shares</U>. Notwithstanding
any provision contained in this Agreement to the contrary, the Company shall not issue fractional Class A Shares upon the exercise of
Warrants. If, by reason of any adjustment made pursuant to this <U>Section 4,</U> the holder of any Warrant would be entitled, upon the
exercise of such Warrant, to receive a fractional interest in a share, the Company shall, upon such exercise, round down to the nearest
whole number the number of Class A Shares to be issued to such holder.&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">4.7.</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Form of Warrant</U>. The form of Warrant
need not be changed because of any adjustment pursuant to this <U>Section 4,</U> and Warrants issued after such adjustment may state
the same Warrant Price and the same number of Class A Shares as is stated in the Warrants initially issued pursuant to this Agreement;
<U>provided, however, </U>that the Company may at any time in its sole discretion make any change in the form of Warrant that the Company
may deem appropriate and that does not affect the substance thereof, and any Warrant thereafter issued or countersigned, whether in exchange
or substitution for an outstanding Warrant or otherwise, may be in the form as so changed.&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">4.8.</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Other Events.</U> In case any event shall
occur affecting the Company as to which none of the provisions of the preceding subsections of this <U>Section 4</U> are strictly applicable,
but which would require an adjustment to the terms of the Warrants in order to (i) avoid an adverse impact on the Warrants and (ii) effectuate
the intent and purpose of this <U>Section 4</U>, then, in each such case, the Company shall appoint a firm of independent public accountants,
investment banking or other appraisal firm of recognized national standing, which shall give its opinion as to whether or not any adjustment
to the rights represented by the Warrants is necessary to effectuate the intent and purpose of this <U>Section 4</U> and, if they determine
that an adjustment is necessary, the terms of such adjustment. The Company shall adjust the terms of the Warrants in a manner that is
consistent with any adjustment recommended in such opinion. For the avoidance of doubt, all adjustments made pursuant to this <U>Section
4.8</U> shall be made equally to all outstanding Warrants.&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 8pt; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 8pt; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.9.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>No
    Adjustment.</U> For the avoidance of doubt, no adjustment shall be made to the terms of the Warrants solely as a result of an adjustment
    to the conversion ratio of the Company&rsquo;s Class B ordinary shares (the &ldquo;<B><I>Class B Ordinary Shares</I></B>&rdquo;)
    into Class A Shares or the conversion of the Class B Ordinary Shares into Class A Shares, in each case, pursuant to the Charter.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><U>Transfer
    and Exchange of Warrants</U>.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">5.1.</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Registration of Transfer.</U> The Warrant
Agent shall register the transfer, from time to time, of any outstanding Warrant upon the Warrant Register, upon surrender of such Warrant
for transfer, in the case of a certificated Warrant, properly endorsed with signatures properly guaranteed and accompanied by appropriate
instructions for transfer. Upon any such transfer, a new Warrant representing an equal aggregate number of Warrants shall be issued and
the old Warrant shall be cancelled by the Warrant Agent. In the case of certificated Warrants, the Warrants so cancelled shall be delivered
by the Warrant Agent to the Company from time to time upon request.&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">5.2.</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Procedure for Surrender of Warrants.</U>
Warrants may be surrendered to the Warrant Agent, together with a written request for exchange or transfer, and thereupon the Warrant
Agent shall issue in exchange therefor one or more new Warrants as requested by the Registered Holder of the Warrants so surrendered,
representing an equal aggregate number of Warrants; <U>provided, however,</U> that except as otherwise provided herein or in any Book-Entry
Warrant Certificate or Definitive Warrant Certificate, each Book-Entry Warrant Certificate and Definitive Warrant Certificate may be
transferred only in whole and only to the Depositary, to another nominee of the Depositary, to a successor depository, or to a nominee
of a successor depository; <U>provided further, however,</U> that in the event that a Warrant surrendered for transfer bears a restrictive
legend (as in the case of the Private Placement Warrants and the Working Capital Warrants), the Warrant Agent shall not cancel such Warrant
and issue new Warrants in exchange thereof until the Warrant Agent has received an opinion of counsel for the Company stating that such
transfer may be made and indicating whether the new Warrants must also bear a restrictive legend.&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">5.3.</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Fractional Warrants</U>. The Warrant Agent
shall not be required to effect any registration of transfer or exchange which shall result in the issuance of a warrant certificate
or book-entry position for a fraction of a warrant, except as part of the Units.&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">5.4.</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Service Charges</U>. No service charge
shall be made for any exchange or registration of transfer of Warrants.&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">5.5.</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Warrant Execution and Countersignature</U>.
The Warrant Agent is hereby authorized to countersign and to deliver, in accordance with the terms of this Agreement, the Warrants required
to be issued pursuant to the provisions of this <U>Section 5,</U> and the Company, whenever required by the Warrant Agent, shall supply
the Warrant Agent with Warrants duly executed on behalf of the Company for such purpose.&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">5.6.</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Transfer of Warrants</U>. Prior to the
Detachment Date, the Public Warrants may be transferred or exchanged only together with the Unit in which such Warrant is included, and
only for the purpose of effecting, or in conjunction with, a transfer or exchange of such Unit. Furthermore, each transfer of a Unit
on the register relating to such Units shall operate also to transfer the Warrants included in such Unit. Notwithstanding the foregoing,
the provisions of this <U>Section 5.6</U> shall have no effect on any transfer of Warrants on and after the Detachment Date.&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">

    <TD STYLE="width: 0.5in; font-size: 10pt">6.</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Redemption</U>.&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">6.1.</TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><U>Redemption of Warrants for Cash</U>. All, but not less than all, of the outstanding Warrants may be redeemed (in whole and not in part), at the option of the Company, at any time during the Exercise Period, at the office of the Warrant Agent, upon notice to the Registered Holders of the Warrants, as described in <U>Section 6.2</U> below, at a Redemption Price (as defined below) of $0.01 per Warrant; <U>provided</U> that (a) the Reference Value equals or exceeds $18.00 per share (subject to adjustment in compliance with <U>Section 4</U> hereof) and (b) there is an effective registration statement covering the Class A Shares issuable upon exercise of the Warrants, and a current prospectus relating thereto, available throughout the Measurement Period and the 30-day Redemption Period (each as defined in <U>Section 6.2</U> below).</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">6.2.</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Date Fixed for, and Notice of, Redemption;
Redemption Price; Reference Value</U>. In the event that the Company elects to redeem the Warrants pursuant to <U>Section 6.1</U>, the
Company shall fix a date for the redemption (the &ldquo;<B><I>Redemption Date</I></B>&rdquo;). Notice of redemption shall be mailed by
first class mail, postage prepaid, by the Company not less than thirty (30) days prior to the Redemption Date (such period, the &ldquo;<B><I>Redemption
Period</I></B>&rdquo;) to the Registered Holders of the Warrants to be redeemed at their last addresses as they shall appear on the registration
books. Any notice mailed in the manner herein provided shall be conclusively presumed to have been duly given whether or not the Registered
Holder received such notice. As used in this Agreement, (a) &ldquo;<B><I>Redemption Price</I></B>&rdquo; shall mean the price per Warrant
at which any Warrants are redeemed pursuant to <U>Sections 6.1</U> and (b) &ldquo;<B><I>Reference Value</I></B>&rdquo; shall mean the
last reported sales price of the Class A Shares for any twenty (20) trading days within the thirty (30) trading-day period commencing
at least 30 days after the completion of the initial Business Combination and ending on the third trading day prior to the date on which
notice of the redemption is given (the &ldquo;<B><I>Measurement Period</I></B>&rdquo;).&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">6.3.</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Exercise After Notice of Redemption</U>.
The Warrants may be exercised, for cash (or on a &ldquo;cashless basis&rdquo; in accordance with <U>Section 3</U> of this Agreement)
at any time after notice of redemption shall have been given by the Company pursuant to <U>Section 6.2</U> hereof and prior to the Redemption
Date. In the event the Company determines to require all holders of Warrants to exercise their Warrants on a &ldquo;cashless basis&rdquo;
pursuant to <U>subsection 3.3.1(b)</U>, the notice of redemption will contain the information necessary to calculate the number of Class
A Shares to be received upon exercise of the Warrants, including the &ldquo;Fair Market Value&rdquo; (as such term is defined in subsection
3.3.1(b) hereof) in such case. On and after the Redemption Date, the record holder of the Warrants shall have no further rights except
to receive, upon surrender of the Warrants, the Redemption Price.&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">

    <TD STYLE="width: 0.5in; font-size: 10pt">7.</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Other Provisions Relating to Rights of
Holders of Warrants</U>.&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">7.1.</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>No Rights as Shareholder</U>. A Warrant
does not entitle the Registered Holder thereof to any of the rights of a shareholder of the Company, including, without limitation, the
right to receive dividends, or other distributions, exercise any preemptive rights to vote or to consent or to receive notice as shareholders
in respect of the meetings of shareholders or the election of directors of the Company or any other matter.&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">7.2.</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Lost, Stolen, Mutilated, or Destroyed
Warrants</U>. If any Warrant is lost, stolen, mutilated, or destroyed, the Company and the Warrant Agent may on such terms as to indemnity
or otherwise as they may in their discretion impose (which shall, in the case of a mutilated Warrant, include the surrender thereof),
issue a new Warrant of like denomination, tenor, and date as the Warrant so lost, stolen, mutilated, or destroyed. Any such new Warrant
shall constitute a substitute contractual obligation of the Company, whether or not the allegedly lost, stolen, mutilated, or destroyed
Warrant shall be at any time enforceable by anyone.&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">7.3.</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Reservation of Class A Shares</U>. The
Company shall at all times reserve and keep available a number of its authorized but unissued Class A Shares that shall be sufficient
to permit the exercise in full of all outstanding Warrants issued pursuant to this Agreement.&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">

    <TD STYLE="width: 0.5in; font-size: 10pt">7.4.</TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><U>Registration of Class A Shares; Cashless Exercise at Company&rsquo;s Option</U>.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 1in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">7.4.1.</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Registration of the Class A Shares</U>.
The Company agrees that as soon as practicable, but in no event later than twenty (20) Business Days after the closing of its initial
Business Combination, it shall use its commercially reasonable efforts to file with the Commission a post-effective amendment to the
Registration Statement, or a new registration statement registering, under the Securities Act, the issuance of the Class A Shares issuable
upon exercise of the Warrants. The Company shall use its commercially reasonable efforts to cause the same to become effective and to
maintain the effectiveness of such post-effective amendment or registration statement, and a current prospectus relating thereto, until
the expiration or redemption of the Warrants in accordance with the provisions of this Agreement. If any such post-effective or registration
statement has not been declared effective by the sixtieth (60th) Business Day following the closing of the initial Business Combination,
holders of the Warrants shall have the right, during the period beginning on the sixty-first (61st) Business Day after the closing of
the initial Business Combination and ending upon such post-effective amendment or registration statement being declared effective by
the Commission, and during any other period when the Company shall fail to have maintained an effective registration statement covering
the Class A Shares issuable upon exercise of the Warrants, to exercise such Warrants on a &ldquo;cashless basis,&rdquo; by exchanging
the Warrants (in accordance with Section 3(a)(9) of the Securities Act (or any successor rule) or another exemption) for that number
of Class A Shares equal to the quotient obtained by dividing (x) the product of the number of Class A Shares underlying the Warrants,
multiplied by the excess of the &ldquo;Fair Market Value&rdquo; (as defined below) over the Warrant Price by (y) the Fair Market Value.
Solely for purposes of this <U>subsection 7.4.1</U>, &ldquo;Fair Market Value&rdquo; shall mean the average reported closing price of
the Class A Shares as reported during the ten (10) trading day period ending on the third (3<SUP>rd)</SUP> trading day prior to the date
that notice of exercise is received by the Warrant Agent from the holder of such Warrants or its securities broker or intermediary. The
date that notice of &ldquo;cashless exercise&rdquo; is received by the Warrant Agent shall be conclusively determined by the Warrant
Agent. In connection with the &ldquo;cashless exercise&rdquo; of a Public Warrant, the Company shall, upon request, provide the Warrant
Agent with an opinion of counsel for the Company (which shall be an outside law firm with securities law experience) stating that (i)
the exercise of the Warrants on a &ldquo;cashless basis&rdquo; in accordance with this <U>subsection 7.4.1</U> is not required to be
registered under the Securities Act and (ii) the Class A Shares issued upon such exercise shall be freely tradable under United States
federal securities laws by anyone who is not an affiliate (as such term is defined in Rule 144 under the Securities Act (or any successor
rule)) of the Company and, accordingly, shall not be required to bear a restrictive legend. Except as provided in <U>subsection 7.4.2</U>,
for the avoidance of any doubt, unless and until all of the Warrants have been exercised or have expired, the Company shall continue
to be obligated to comply with its registration obligations under the first three sentences of this <U>subsection 7.4.1.</U>&nbsp;</P></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 1in">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; width: 0.5in">7.4.2.</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Cashless Exercise at Company&rsquo;s Option</U>.
If the Class A Shares are at the time of any exercise of a Warrant not listed on a national securities exchange such that they satisfy
the definition of &ldquo;covered securities&rdquo; under Section 18(b)(1) of the Securities Act (or any successor rule), the Company
may, at its option, require holders of Warrants who exercise their Warrants to exercise such Public Warrants on a &ldquo;cashless basis&rdquo;
in accordance with Section 3(a)(9) of the Securities Act (or any successor rule) as described in <U>subsection 7.4.1</U> and (i) in the
event the Company so elects, the Company shall not be required to file or maintain in effect a registration statement for the registration,
under the Securities Act, of the Class A Shares issuable upon exercise of the Warrants, notwithstanding anything in this Agreement to
the contrary or (ii) if the Company does not so file or maintain such registration statement, the Company agrees to use its commercially
reasonable efforts to register or qualify for sale the Class A Shares issuable upon exercise of the Public Warrants under the applicable
blue sky laws of the state of residence of the exercising Public Warrant holder to the extent an exemption is not available.&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">

    <TD STYLE="width: 0.5in; font-size: 10pt">8.</TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><U>Concerning the Warrant Agent and Other Matters</U>.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">8.1.</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Payment of Taxes</U>. The Company shall
from time to time promptly pay all taxes and charges that may be imposed upon the Company or the Warrant Agent in respect of the issuance
or delivery of Class A Shares upon the exercise of the Warrants, but the Company shall not be obligated to pay any transfer taxes in
respect of the Warrants or such Class A Shares.&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">

    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">8.2.</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Resignation, Consolidation, or Merger
of Warrant Agent</U>.&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 1in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">8.2.1.</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Appointment of Successor Warrant Agent.
</U>The Warrant Agent, or any successor to it hereafter appointed, may resign its duties and be discharged from all further duties and
liabilities hereunder after giving sixty (60) days&rsquo; notice in writing to the Company. If the office of the Warrant Agent becomes
vacant by resignation or incapacity to act or otherwise, the Company shall appoint in writing a successor Warrant Agent in place of the
Warrant Agent. If the Company shall fail to make such appointment within a period of thirty (30) days after it has been notified in writing
of such resignation or incapacity by the Warrant Agent or by the holder of a Warrant (who shall, with such notice, submit his, her or
its Warrant for inspection by the Company), then the holder of any Warrant may apply to the Supreme Court of the State of New York for
the County of New York for the appointment of a successor Warrant Agent at the Company&rsquo;s cost. Any successor Warrant Agent, whether
appointed by the Company or by such court, shall be a corporation or other entity organized and existing under the laws of the State
of New York, in good standing and having its principal office in the Borough of Manhattan, City and State of New York, and authorized
under such laws to exercise corporate trust powers and subject to supervision or examination by federal or state authority. After appointment,
any successor Warrant Agent shall be vested with all the authority, powers, rights, immunities, duties, and obligations of its predecessor
Warrant Agent with like effect as if originally named as Warrant Agent hereunder, without any further act or deed; but if for any reason
it becomes necessary or appropriate, the predecessor Warrant Agent shall execute and deliver, at the expense of the Company, an instrument
transferring to such successor Warrant Agent all the authority, powers, and rights of such predecessor Warrant Agent hereunder; and upon
request of any successor Warrant Agent the Company shall make, execute, acknowledge, and deliver any and all instruments in writing for
more fully and effectually vesting in and confirming to such successor Warrant Agent all such authority, powers, rights, immunities,
duties, and obligations.&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 1in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">8.2.2.</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Notice of Successor Warrant Agent.</U>
In the event a successor Warrant Agent shall be appointed, the Company shall give notice thereof to the predecessor Warrant Agent and
the Transfer Agent for the Class A Shares not later than the effective date of any such appointment.&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 1in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">8.2.3.</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Merger or Consolidation of Warrant Agent.
</U>Any entity into which the Warrant Agent may be merged or with which it may be consolidated or any entity resulting from any merger
or consolidation to which the Warrant Agent shall be a party shall be the successor Warrant Agent under this Agreement without any further
act.&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">

    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">8.3.</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Fees and Expenses of Warrant Agent</U>.&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 1in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">8.3.1.</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Remuneration.</U> The Company agrees to
pay the Warrant Agent reasonable remuneration for its services as such Warrant Agent hereunder and shall, pursuant to its obligations
under this Agreement, reimburse the Warrant Agent upon demand for all expenditures that the Warrant Agent may reasonably incur in the
execution of its duties hereunder.&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left">8.3.2.</TD><TD STYLE="text-align: justify"><U>Further Assurances.</U> The Company agrees to perform,
execute, acknowledge, and deliver or cause to be performed, executed, acknowledged, and delivered all such further and other acts, instruments,
and assurances as may reasonably be required by the Warrant Agent for the carrying out or performing of the provisions of this Agreement.</TD>
</TR></TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">8.4.</TD><TD STYLE="text-align: justify"><U>Liability of Warrant Agent</U>.</TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 1in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">8.4.1.</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Reliance on Company Statement.</U> Whenever
in the performance of its duties under this Agreement, the Warrant Agent shall deem it necessary or desirable that any fact or matter
be proved or established by the Company prior to taking or suffering any action hereunder, such fact or matter (unless other evidence
in respect thereof be herein specifically prescribed) may be deemed to be conclusively proved and established by a statement signed by
the Chief Executive Officer, Chief Financial Officer, President, Executive Vice President, Vice President, Secretary or Chairman of the
Board of the Company and delivered to the Warrant Agent. The Warrant Agent may rely upon such statement for any action taken or suffered
in good faith by it pursuant to the provisions of this Agreement.&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 1in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">8.4.2.</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Indemnity.</U> The Warrant Agent shall
be liable hereunder only for its own gross negligence, willful misconduct, fraud or bad faith. The Company agrees to indemnify the Warrant
Agent and save it harmless against any and all liabilities, including judgments, out of pocket costs and reasonable outside counsel fees,
for anything done or omitted by the Warrant Agent in the execution of this Agreement, except as a result of the Warrant Agent&rsquo;s
gross negligence, willful misconduct, fraud or bad faith.&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in; text-align: left">8.4.3.</TD><TD STYLE="text-align: justify"><U>Exclusions.</U> The Warrant Agent shall have no responsibility
with respect to the validity of this Agreement or with respect to the validity or execution of any Warrant (except its countersignature
thereof). The Warrant Agent shall not be responsible for any breach by the Company of any covenant or condition contained in this Agreement
or in any Warrant. The Warrant Agent shall not be responsible to make any adjustments required under the provisions of <U>Section 4</U>
hereof or responsible for the manner, method, or amount of any such adjustment or the ascertaining of the existence of facts that would
require any such adjustment; nor shall it by any act hereunder be deemed to make any representation or warranty as to the authorization
or reservation of any Class A Shares to be issued pursuant to this Agreement or any Warrant or as to whether any Class A Shares shall,
when issued, be valid and fully paid and non-assessable.</TD>
</TR></TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in; text-align: left">8.5.</TD><TD STYLE="text-align: justify"><U>Acceptance of Agency.</U> The Warrant Agent hereby accepts
the agency established by this Agreement and agrees to perform the same upon the terms and conditions herein set forth and among other
things, shall account promptly to the Company with respect to Warrants exercised and concurrently account for, and pay to the Company,
all monies received by the Warrant Agent for the purchase of Class A Shares through the exercise of the Warrants.</TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">

    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">8.6.</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Waiver.</U> The Warrant Agent has no right
of set-off or any other right, title, interest or claim of any kind (&ldquo;<B><I>Claim</I></B>&rdquo;) in, or to any distribution of,
the Trust Account (as defined in that certain Investment Management Trust Agreement, dated as of the date hereof, by and between the
Company and the Warrant Agent as trustee thereunder) and hereby agrees not to seek re0.5incourse, reimbursement, payment or satisfaction
for any Claim against the Trust Account for any reason whatsoever. The Warrant Agent hereby irrevocably waives any and all Claims against
the Trust Account, including any monies therein or any distribution therefrom, and any and all rights to seek access to the Trust Account.</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">

    <TD STYLE="width: 0.5in; font-size: 10pt">9.</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Miscellaneous Provisions</U>.&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">9.1.</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Successors.</U> All the covenants and
provisions of this Agreement by or for the benefit of the Company or the Warrant Agent shall bind and inure to the benefit of their respective
successors and assigns.&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">9.2.</TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><U>Notices.</U> Any notice, statement or demand authorized by this Agreement to be given or made by the Warrant Agent or by the holder of any Warrant to or on the Company shall be sufficiently given when so delivered if by hand or overnight delivery or if sent by certified mail or private courier service within five (5) days after deposit of such notice, postage prepaid, addressed (until another address is filed in writing by the Company with the Warrant Agent), as follows:</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Andretti Acquisition Corp. II</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">7615 Zionsville Road</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: 0.5in">Indianapolis, Indiana 46268</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Attention: William M. Brown, Chief Executive Officer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any notice, statement or demand authorized by
this Agreement to be given or made by the holder of any Warrant or by the Company to or on the Warrant Agent shall be sufficiently given
when so delivered if by hand or overnight delivery or if sent by certified mail or private courier service within five (5) days after
deposit of such notice, postage prepaid, addressed (until another address is filed in writing by the Warrant Agent with the Company),
as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Continental Stock Transfer &amp; Trust Company<BR>
1 State Street, 30th Floor<BR>
New York, NY 10004<BR>
Attention: Compliance Department</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">in each case, with copies to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">DLA Piper LLP (US)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">1251 Avenue of the Americas ,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">27th Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">New York, New York 10020</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Attn: Stephen Alicanti, Esq.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Telephone: (212) 335-4783</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">BTIG, LLC<BR>
65 E 55th Street</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">New York, NY 10022</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Facsimile: (415) 248-2260</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">Ellenoff Grossman &amp; Schole LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">1345 Avenue of the Americas, 11th Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">New York, New York 10105<BR>
Attn: Stuart Neuhauser. Esq.<BR>
Email: sneuhauser@egsllp.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">9.3.</TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><U>Applicable Law and Exclusive Forum.</U> The validity, interpretation, and performance of this Agreement and of the Warrants shall be governed in all respects by the laws of the State of New York, without giving effect to conflicts of law principles that would result in the application of the substantive laws of another jurisdiction. The Company hereby agrees that any action, proceeding or claim against it arising out of or relating in any way to this Agreement shall be brought and enforced in the courts of the State of New York or the United States District Court for the Southern District of New York, and irrevocably submits to such jurisdiction, which jurisdiction shall be the exclusive forum for any such action, proceeding or claim. The Company hereby waives any objection to such exclusive jurisdiction and that such courts represent an inconvenient forum. Notwithstanding the foregoing, the provisions of this paragraph will not apply to suits brought to enforce any liability or duty created by the Exchange Act or any other claim for which the federal district courts of the United States of America are the sole and exclusive forum. Any person or entity purchasing or otherwise acquiring any interest in the Warrants shall be deemed to have notice of and to have consented to the forum provisions in this <U>Section 9.3</U>. If any action, the subject matter of which is within the scope the forum provisions above, is filed in a court other than a court located within the State of New York or the United States District Court for the Southern District of New York (a &ldquo;<B><I>foreign action</I></B>&rdquo;) in the name of any warrant holder, such warrant holder shall be deemed to have consented to: (x) the personal jurisdiction of the state and federal courts located within the State of New York or the United States District Court for the Southern District of New York in connection with any action brought in any such court to enforce the forum provisions (an &ldquo;<B><I>enforcement action</I></B>&rdquo;), and (y) having service of process made upon such warrant holder in any such enforcement action by service upon such warrant holder&rsquo;s counsel in the foreign action as agent for such warrant holder.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">9.4.</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Persons Having Rights under this Agreement.
</U>Nothing in this Agreement shall be construed to confer upon, or give to, any person, corporation or other entity other than the parties
hereto and the Registered Holders of the Warrants any right, remedy, or claim under or by reason of this Agreement or of any covenant,
condition, stipulation, promise, or agreement hereof. All covenants, conditions, stipulations, promises, and agreements contained in
this Agreement shall be for the sole and exclusive benefit of the parties hereto and their successors and assigns and of the Registered
Holders of the Warrants.&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">9.5.</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Examination of the Warrant Agreement.
</U>A copy of this Agreement shall be available at all reasonable times at the office of the Warrant Agent in the Borough of Manhattan,
City and State of New York, for inspection by the Registered Holder of any Warrant. The Warrant Agent may require any such holder to
submit such holder&rsquo;s Warrant for inspection by the Warrant Agent.&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">9.6.</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Counterparts.</U> This Agreement may be
executed in any number of original or facsimile counterparts and each of such counterparts shall for all purposes be deemed to be an
original, and all such counterparts shall together constitute but one and the same instrument.&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">9.7.</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Effect of Headings.</U> The section headings
    herein are for convenience only and are not part of this Agreement and shall not affect the interpretation thereof.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">9.8.</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>Amendments.</U> This Agreement may be
amended by the parties hereto without the consent of any Registered Holder (i) for the purpose of (x) curing any ambiguity or to correct
any defective provision contained herein, including to conform the provisions hereof to the description of the terms of the Warrants
and this Agreement set forth in the Prospectus, (y) adjusting the definition of &ldquo;Ordinary Cash Dividend&rdquo; as contemplated
by and in accordance with the second sentence of <U>subsection 4.1.2</U> or (z) adding or changing any other provisions with respect
to matters or questions arising under this Agreement as the parties may deem necessary or desirable and that the parties deem shall not
adversely affect the interest of the Registered Holders, and (ii) to provide for the delivery of an Alternative Issuance pursuant to
<U>Section 4.4</U>. All other modifications or amendments, including any modification or amendment to increase the Warrant Price or shorten
the Exercise Period shall require the vote or written consent of the Registered Holders of 50% of the number of the then outstanding
Public Warrants and, solely with respect to any amendment to the terms of the Private Placement Warrants or Working Capital Warrants
or any provision of this Agreement with respect to the Private Placement Warrants, or Working Capital Warrants (including, for the avoidance
of doubt, the forfeiture or cancellation of any Private Placement Warrants or Working Capital Warrants), 50% of the number of then outstanding
Private Placement Warrants (including the vote or written consent of the Lead Underwriter) and Working Capital Warrants. Notwithstanding
the foregoing, the Company may lower the Warrant Price or extend the duration of the Exercise Period pursuant to <U>Sections 3.1</U>
and <U>3.2,</U> respectively, without the consent of the Registered Holders.&nbsp;</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="width: 0.5in; font-size: 10pt">9.9.</TD>
    <TD STYLE="font-size: 10pt; text-align: justify"><U>Severability.</U> This Agreement shall be deemed severable, and the invalidity or unenforceability of any term or provision hereof shall not affect the validity or enforceability of this Agreement or of any other term or provision hereof. Furthermore, in lieu of any such invalid or unenforceable term or provision, the parties hereto intend that there shall be added as a part of this Agreement a provision as similar in terms to such invalid or unenforceable provision as may be possible and be valid and enforceable.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>Signature Page Follows</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">IN WITNESS WHEREOF, the parties hereto have caused
this Agreement to be duly executed as of the date first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-size: 10pt"><B>ANDRETTI ACQUISITION CORP. II </B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; font-size: 10pt">/s/ William M. Brown</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 5%; font-size: 10pt">Name: </TD>
    <TD STYLE="width: 31%; font-size: 10pt">William M. Brown</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">Title: </TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Chief Executive Officer</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-size: 10pt"><B>CONTINENTAL STOCK TRANSFER &amp; TRUST COMPANY</B>, as Warrant Agent</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; font-size: 10pt">/s/ Henry Farrell</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">Name: </TD>
    <TD STYLE="font-size: 10pt">Henry Farrell</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">Title: </TD>
    <TD STYLE="font-size: 10pt">Vice President </TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PRIVATE PLACEMENT WARRANTS LEGEND</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">THE SECURITIES REPRESENTED BY THIS CERTIFICATE
HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS, AND MAY NOT BE OFFERED, SOLD, TRANSFERRED
OR OTHERWISE DISPOSED OF UNLESS REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND ANY APPLICABLE STATE SECURITIES LAWS OR AN
EXEMPTION FROM REGISTRATION IS AVAILABLE. IN ADDITION, SUBJECT TO ANY ADDITIONAL LIMITATIONS ON TRANSFER DESCRIBED IN THE AGREEMENTS BY
AND AMONG ANDRETTI ACQUISITION CORP. II (THE &ldquo;COMPANY&rdquo;), ANDRETTI SPONSOR II LLC AND THE OTHER SIGNATORIES THERETO, THE SECURITIES
REPRESENTED BY THIS CERTIFICATE MAY NOT BE SOLD OR TRANSFERRED PRIOR TO THE DATE THAT IS THIRTY (30) DAYS AFTER THE DATE UPON WHICH THE
COMPANY COMPLETES ITS INITIAL BUSINESS COMBINATION (AS DEFINED IN SECTION 3 OF THE WARRANT AGREEMENT REFERRED TO HEREIN) EXCEPT TO A PERMITTED
TRANSFEREE WHO AGREES IN WRITING WITH THE COMPANY TO BE SUBJECT TO SUCH TRANSFER PROVISIONS.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">SECURITIES EVIDENCED BY THIS CERTIFICATE AND ORDINARY
SHARES OF THE COMPANY ISSUED UPON EXERCISE OF SUCH SECURITIES SHALL BE ENTITLED TO REGISTRATION RIGHTS UNDER A REGISTRATION RIGHTS AGREEMENT
TO BE EXECUTED BY THE COMPANY.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXHIBIT B</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[Form of Warrant Certificate]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[FACE]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Number</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Warrants</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>THIS WARRANT SHALL BE VOID IF NOT EXERCISED
PRIOR TO<BR>
THE EXPIRATION OF THE EXERCISE PERIOD PROVIDED FOR IN THE<BR>
WARRANT AGREEMENT DESCRIBED BELOW<BR>
ANDRETTI ACQUISITION CORP. II </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>Incorporated Under the Laws of the Cayman Islands</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>CUSIP G26745 110</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Warrant Certificate</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>This Warrant Certificate certifies that </B>,
or registered assigns, is the registered holder of warrants evidenced hereby (the <B>&ldquo;Warrants&rdquo;</B> and each, a <B>&ldquo;Warrant&rdquo;</B>)
to purchase Class A Ordinary Shares, $0.0001 par value per share (the <B>&ldquo;Ordinary Shares&rdquo;</B>), of Andretti Acquisition Corp.
II, a Cayman Islands exempted company (the <B>&ldquo;Company&rdquo;</B>). Each whole Warrant entitles the holder, upon exercise during
the period set forth in the Warrant Agreement referred to below, to receive from the Company that number of fully paid and non-assessable
Ordinary Shares as set forth below, at the exercise price (the <B>&ldquo;Warrant Price&rdquo;</B>) as determined pursuant to the Warrant
Agreement, payable in lawful money (or through &ldquo;cashless exercise&rdquo; as provided for in the Warrant Agreement) of the United
States of America upon surrender of this Warrant Certificate and payment of the Warrant Price at the office or agency of the Warrant Agent
referred to below, subject to the conditions set forth herein and in the Warrant Agreement. Defined terms used in this Warrant Certificate
but not defined herein shall have the meanings given to them in the Warrant Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Each whole Warrant is initially exercisable for
one fully paid and non-assessable Ordinary Share. No fractional shares will be issued upon exercise of any Warrant. If, upon the exercise
of Warrants, a holder would be entitled to receive a fractional interest in an Ordinary Share, the Company will, upon exercise, round
down to the nearest whole number the number of Ordinary Shares to be issued to the Warrant holder. The number of Ordinary Shares issuable
upon exercise of the Warrants is subject to adjustment upon the occurrence of certain events set forth in the Warrant Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The initial Warrant Price per Ordinary Share for
any Warrant is equal to $11.50 per share. The Warrant Price is subject to adjustment upon the occurrence of certain events set forth in
the Warrant Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Subject to the conditions set forth in the Warrant
Agreement, the Warrants may be exercised only during the Exercise Period and to the extent not exercised by the end of such Exercise Period,
such Warrants shall become void. The Warrants may be redeemed, subject to certain conditions, as set forth in the Warrant Agreement. <FONT STYLE="background-color: white">In
addition, and notwithstanding anything else in this Warrant Certificate or the Warrant Agreement, to the extent that the holder of a Warrant
has delivered a notice contemplated by <U>subsection 3.5.5</U> of the Warrant Agreement, neither the Company nor the Warrant Agent shall
issue to Holder, and Holder may not acquire, any right it might have to acquire, a number of Ordinary Shares upon exercise of any Warrant
to the extent that, upon such exercise, the number of Ordinary Shares then beneficially owned by Holder would exceed the Maximum Percentage
of Ordinary Shares outstanding immediately after giving effect to such exercise as determined in accordance with <U>subsection 3.3.5.</U>
of the Warrant Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Reference is hereby made to the further provisions
of this Warrant Certificate set forth on the reverse hereof and such further provisions shall for all purposes have the same effect as
though fully set forth at this place.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This Warrant Certificate shall not be valid unless
countersigned by the Warrant Agent, as such term is used in the Warrant Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This Warrant Certificate shall be governed by
and construed in accordance with the internal laws of the State of New York.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-size: 10pt">ANDRETTI ACQUISITION CORP. II</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 4%">&nbsp;</TD>
    <TD STYLE="width: 5%; font-size: 10pt">Name:</TD>
    <TD STYLE="width: 31%">&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">Title:</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-size: 10pt">CONTINENTAL STOCK TRANSFER &amp; TRUST COMPANY as Warrant Agent</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">Name:</TD>
    <TD>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">Title:</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[Form of Warrant Certificate]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[Reverse]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Warrants evidenced by this Warrant Certificate
are part of a duly authorized issue of Warrants entitling the holder on exercise to receive Ordinary Shares and are issued or to be issued
pursuant to a Warrant Agreement dated as of September 5,2024 (the <B>&ldquo;Warrant Agreement&rdquo;</B>), duly executed and delivered
by the Company to Continental Stock Transfer &amp; Trust Company, a New York corporation, as warrant agent (the <B>&ldquo;Warrant Agent&rdquo;</B>),
which Warrant Agreement is hereby incorporated by reference in and made a part of this instrument and is hereby referred to for a description
of the rights, limitation of rights, obligations, duties and immunities thereunder of the Warrant Agent, the Company and the holders (the
words <B>&ldquo;holders&rdquo;</B> or <B>&ldquo;holder&rdquo;</B> meaning the Registered Holders or Registered Holder, respectively) of
the Warrants. A copy of the Warrant Agreement may be obtained by the holder hereof upon written request to the Company. Defined terms
used in this Warrant Certificate but not defined herein shall have the meanings given to them in the Warrant Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Warrants may be exercised at any time during the
Exercise Period set forth in the Warrant Agreement. The holder of Warrants evidenced by this Warrant Certificate may exercise them by
surrendering this Warrant Certificate, with the form of election to purchase set forth hereon properly completed and executed, together
with payment of the Warrant Price as specified in the Warrant Agreement (or through &ldquo;cashless exercise&rdquo; as provided for in
the Warrant Agreement) at the principal corporate trust office of the Warrant Agent. In the event that upon any exercise of Warrants evidenced
hereby the number of Warrants exercised shall be less than the total number of Warrants evidenced hereby, there shall be issued to the
holder hereof or his, her or its assignee, a new Warrant Certificate evidencing the number of Warrants not exercised.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Notwithstanding anything else in this Warrant
Certificate or the Warrant Agreement, no Warrant may be exercised unless at the time of exercise (i) a registration statement covering
the Ordinary Shares to be issued upon exercise is effective under the Securities Act of 1933, as amended, and (ii) a prospectus thereunder
relating to the Ordinary Shares is current, except through &ldquo;cashless exercise&rdquo; as provided for in the Warrant Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Warrant Agreement provides that upon the occurrence
of certain events the number of Ordinary Shares issuable upon the exercise of the Warrants set forth on the face hereof may, subject to
certain conditions, be adjusted. If, upon exercise of a Warrant, the holder thereof would be entitled to receive a fractional interest
in an Ordinary Share, the Company shall, upon exercise, round down to the nearest whole number of Ordinary Shares to be issued to the
holder of the Warrant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Warrant Certificates, when surrendered at the
principal corporate trust office of the Warrant Agent by the Registered Holder thereof in person or by legal representative or attorney
duly authorized in writing, may be exchanged, in the manner and subject to the limitations provided in the Warrant Agreement, but without
payment of any service charge, for another Warrant Certificate or Warrant Certificates of like tenor evidencing in the aggregate a like
number of Warrants.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Upon due presentation for registration of transfer
of this Warrant Certificate at the office of the Warrant Agent, a new Warrant Certificate or Warrant Certificates of like tenor and evidencing
in the aggregate a like number of Warrants shall be issued to the transferee(s) in exchange for this Warrant Certificate, subject to the
limitations provided in the Warrant Agreement, without charge except for any tax or other governmental charge imposed in connection therewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company and the Warrant Agent may deem and
treat the Registered Holder(s) hereof as the absolute owner(s) of this Warrant Certificate (notwithstanding any notation of ownership
or other writing hereon made by anyone), for the purpose of any exercise hereof, of any distribution to the holder(s) hereof, and for
all other purposes, and neither the Company nor the Warrant Agent shall be affected by any notice to the contrary. Neither the Warrants
nor this Warrant Certificate entitles any holder hereof to any rights of a shareholder of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Election to Purchase</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(To Be Executed Upon Exercise of Warrant)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The undersigned hereby irrevocably elects to exercise
the right, represented by this Warrant Certificate, to receive Ordinary Shares and herewith tenders payment for such Ordinary Shares to
the order of Andretti Acquisition Corp. II (the <B>&ldquo;Company&rdquo;</B>) in the amount of $_____ in accordance with the terms hereof.
The undersigned requests that a certificate for such Ordinary Shares be registered in the name of , whose address is , and that such Ordinary
Shares be delivered to , whose address is . If said number of Ordinary Shares is less than all of the Ordinary Shares purchasable hereunder,
the undersigned requests that a new Warrant Certificate representing the remaining balance of such Ordinary Shares be registered in the
name of , ______ whose address is _______and that such Warrant Certificate be delivered to ______ , whose address is ________.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="background-color: white">In the event
that the Warrant has been called for redemption by the Company pursuant to <U>Section 6.1</U> of the Warrant Agreement and the Company
has required &ldquo;cashless&rdquo; exercise pursuant to <U>Section 6.3</U> and <U>Section 3.3.1(b)</U> of the Warrant Agreement, the
number of Ordinary Shares that this Warrant is exercisable for shall be determined in accordance with <U>Section 6.3</U> and <U>Section
3.3.1(b)</U> of the Warrant Agreement.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the event that the Warrant is to be exercised
on a &ldquo;cashless&rdquo; basis pursuant to <U>Section 7.4</U> of the Warrant Agreement, the number of Ordinary Shares that this Warrant
is exercisable for shall be determined in accordance with <U>Section 7.4</U> of the Warrant Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the event that the Warrant may be exercised,
to the extent allowed by the Warrant Agreement, through cashless exercise (i) the number of Ordinary Shares that this Warrant is exercisable
for would be determined in accordance with the relevant section of the Warrant Agreement which allows for such cashless exercise and (ii)
the holder hereof shall complete the following: The undersigned hereby irrevocably elects to exercise the right, represented by this Warrant
Certificate, through the cashless exercise provisions of the Warrant Agreement, to receive Ordinary Shares. If said number of Ordinary
Shares is less than all of the Ordinary Shares purchasable hereunder (after giving effect to the cashless exercise), the undersigned requests
that a new Warrant Certificate representing the remaining balance of such Ordinary Shares be registered in the name of , whose address
is and that such Warrant Certificate be delivered to , whose address is.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">To be included in any Election to Purchase of
a holder who has provided the notice set forth in <U>subsection 3.3.5</U> of the Warrant Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; background-color: white">By
signing this Election to Purchase, the undersigned hereby certifies that upon after giving effect to such exercise, the undersigned (together
with such person&rsquo;s affiliates) or any &ldquo;group&rdquo; of which holder or its affiliates is a member, would not beneficially
own in excess of the Maximum Percentage of the Ordinary Shares outstanding immediately after giving effect to such exercise as determined
in accordance with <U>subsection 3.3.5.</U> of the Warrant Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[Signature Page Follows]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%; font-size: 10pt">Date: </TD>
    <TD STYLE="width: 40%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">(Signature)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">(Address)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">(Tax Identification Number)</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 40%; font-size: 10pt">Signature Guaranteed:</TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1.5pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">THE SIGNATURE(S) SHOULD BE GUARANTEED BY AN ELIGIBLE
GUARANTOR INSTITUTION (BANKS, STOCKBROKERS, SAVINGS AND LOAN ASSOCIATIONS AND CREDIT UNIONS WITH MEMBERSHIP IN AN APPROVED SIGNATURE GUARANTEE
MEDALLION PROGRAM, PURSUANT TO SEC RULE 17Ad-15 UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED (OR ANY SUCCESSOR RULE)).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>5
<FILENAME>ea021383001ex10-1_andretti2.htm
<DESCRIPTION>INVESTMENT MANAGEMENT TRUST AGREEMENT, SEPTEMBER 5, 2024, BY AND BETWEEN THE COMPANY AND CONTINENTAL STOCK TRANSFER & TRUST COMPANY, AS TRUSTEE
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><B>Exhibit 10.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>INVESTMENT MANAGEMENT TRUST AGREEMENT </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This Investment Management Trust Agreement (this
&ldquo;<B><U>Agreement</U></B>&rdquo;) is made effective as of September 5, 2024 by and between Andretti Acquisition Corp. II, a Cayman
Islands exempted company (the &ldquo;<B><U>Company</U></B>&rdquo;), and Continental Stock Transfer &amp; Trust Company, a New York corporation
(the &ldquo;<B><U>Trustee</U></B>&rdquo;).</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">WHEREAS, the Company&rsquo;s registration statement
on Form S-1, (File No. 333-280552) (the &ldquo;<B><U>Registration Statement</U></B>&rdquo;) and prospectus (the &ldquo;<B><U>Prospectus</U></B>&rdquo;)
for the initial public offering of the Company&rsquo;s units (the &ldquo;<B><U>Units</U></B>&rdquo;), each of which consists of one of
the Company&rsquo;s Class A ordinary shares, par value $0.0001 per share (the &ldquo;<B><U>Ordinary Shares</U></B>&rdquo;), and one-half
of one redeemable warrant, each whole warrant entitling the holder thereof to purchase one Ordinary Share (such initial public offering
hereinafter referred to as the &ldquo;<B><U>Offering</U></B>&rdquo;), has been declared effective as of the date hereof by the U.S. Securities
and Exchange Commission;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">WHEREAS, the Company has entered into an Underwriting
Agreement (the &ldquo;<B><U>Underwriting Agreement</U></B>&rdquo;) with BTIG, LLC, as representative (the &ldquo;<B><U>Representative</U></B>&rdquo;)
of the underwriters (the &ldquo;<B><U>Underwriters</U></B>&rdquo;) named therein;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">WHEREAS, as described in the Registration Statement,
$201,000,000 of the gross proceeds of the Offering and sale of the Private Placement Units (as defined in the Underwriting Agreement)
(or $231,150,000 if the Underwriters&rsquo; over-allotment option is exercised in full) will be delivered to the Trustee to be deposited
and held in a segregated trust account located at all times in the United States (the &ldquo;<B><U>Trust Account</U></B>&rdquo;) for the
benefit of the Company and the holders of the Ordinary Shares included in the Units issued in the Offering as hereinafter provided (the
amount to be delivered to the Trustee (and any interest subsequently earned thereon) is referred to herein as the &ldquo;<B><U>Property</U></B>,&rdquo;
the shareholders for whose benefit the Trustee shall hold the Property will be referred to as the &ldquo;<B><U>Public Shareholders</U></B>,&rdquo;
and the Public Shareholders and the Company will be referred to together as the &ldquo;<B><U>Beneficiaries</U></B>&rdquo;);</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">WHEREAS, pursuant to the Underwriting Agreement,
a portion of the Property equal to $8,500,000, or $9,775,000 if the Underwriters&rsquo; over-allotment option is exercised in full, is
attributable to deferred underwriting discounts and commissions that will be payable by the Company to the Representative upon the consummation
of the Business Combination (as defined below) (such discounts and commissions, the &ldquo;<B><U>Deferred Discount</U></B>&rdquo;); and</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">WHEREAS, the Company and the Trustee desire to
enter into this Agreement to set forth the terms and conditions pursuant to which the Trustee shall hold the Property.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">NOW THEREFORE, IT IS AGREED:</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt; text-indent: 0.5in">1. <B><U>Agreements and Covenants of Trustee</U></B>.
The Trustee hereby agrees and covenants to:</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(a) Hold the Property in trust for the Beneficiaries
in accordance with the terms of this Agreement in the Trust Account established by the Trustee in the United States at J.P. Morgan Chase
Bank, N.A. (or at another U.S. chartered commercial bank with consolidated assets of $100 billion or more) and at a brokerage institution
selected by the Trustee that is reasonably satisfactory to the Company;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(b) Manage, supervise and administer the Trust
Account subject to the terms and conditions set forth herein;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(c) Promptly upon receipt
of written instruction of the Company, (i) invest and reinvest the Property, initially solely in United States government securities
within the meaning of Section 2(a)(16) of the Investment Company Act of 1940, as amended, having a maturity of 185 days or less, or in
money market funds meeting the conditions of paragraphs (d)(1), (d)(2), (d)(3) and (d)(4) of Rule 2a-7 promulgated under the Investment
Company Act of 1940, as amended (or any successor rule), which invest only in direct U.S. government treasury obligations, (ii) hold
the Property as uninvested cash or (iii) hold the Property in an interest or non-interest bearing demand deposit account at a U.S. chartered
commercial bank with consolidated assets of $100 billion or more selected by the Trustee that is reasonably satisfactory to the Company;
it being understood that the Trust Account will earn no interest while account funds are uninvested awaiting the Company&rsquo;s instructions
hereunder and while invested or uninvested, the Trustee may earn bank credits or other consideration during such periods;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(d) Collect and receive, when due, all interest
or other income arising from the Property, which shall become part of the &ldquo;<B><U>Property</U></B>,&rdquo; as such term is used herein;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(e) Promptly notify the Company and the Representative
of all communications received by the Trustee with respect to any Property requiring action by the Company;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(f) Supply any necessary information or documents
as may be requested by the Company (or its authorized agents) in connection with the Company&rsquo;s preparation of the tax returns relating
to assets held in the Trust Account or in connection with the preparation of the Company&rsquo;s financial statements or completion of
the audit of the Company&rsquo;s financial statements by the Company&rsquo;s auditors;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(g) Participate in any plan or proceeding for
protecting or enforcing any right or interest arising from the Property if, as and when instructed by the Company to do so;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(h) Render to the Company monthly written statements
of the activities of, and amounts in, the Trust Account reflecting all receipts and disbursements of the Trust Account;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(i) Commence liquidation of the Trust Account
only after and promptly after (x) receipt of, and only in accordance with, the terms of a letter from the Company (&ldquo;<B><U>Termination
Letter</U></B>&rdquo;) in a form substantially similar to that attached hereto as either <U>Exhibit A</U> or <U>Exhibit B</U>, as applicable,
signed on behalf of the Company by its Chief Executive Officer, President, Chief Financial Officer, Secretary or Chairperson of the board
of directors of the Company (the &ldquo;<B><U>Board</U></B>&rdquo;) or other authorized officer of the Company, and, in the case of Exhibit
A, acknowledged and agreed to by the Representative, and complete the liquidation of the Trust Account and distribute the Property in
the Trust Account, including interest earned on the funds held in the Trust Account (which interest shall be net of taxes payable and,
in the case of&nbsp;<U>Exhibit B</U>, less up to $100,000 of interest to pay liquidation and dissolution expenses), only as directed in
the Termination Letter and the other documents referred to therein, or (y) upon the date which is the later of (1) 24 months after the
closing of the Offering (or such earlier date as the Company&rsquo;s board of directors may approve); and (2) such later date as may be
approved by the Company&rsquo;s shareholders in accordance with the Company&rsquo;s amended and restated memorandum and articles of association,
as may be amended from time to time (the &ldquo;<B><U>Memorandum and Articles</U></B>&rdquo;) (such period, the &ldquo;<B>Completion Window</B>&rdquo;),
if a Termination Letter has not been received by the Trustee prior to such date, in which case the Trust Account shall be liquidated in
accordance with the procedures set forth in the Termination Letter attached as&nbsp;<U>Exhibit B</U>&nbsp;and the Property in the Trust
Account, including interest earned on the funds held in the Trust Account (which interest shall be net of taxes payable and up to $100,000
of interest to pay dissolution expenses), shall be distributed to the Public Shareholders of record as of such date;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(j) Upon written request from the Company, which
may be given from time to time in a form substantially similar to that attached hereto as <U>Exhibit C</U> (a &ldquo;<B><U>Tax Payment
Withdrawal Instruction</U></B>&rdquo;), withdraw from the Trust Account and distribute to the Company the amount of interest earned on
the Property requested by the Company to cover any tax obligation owed by the Company, which amount shall be delivered directly to the
Company by electronic funds transfer or other method of prompt payment, and the Company shall forward such payment to the relevant taxing
authority, so long as there is no reduction in the aggregate principal amount initially deposited in the Trust Account; <I>provided</I>,
<I>however</I>, that to the extent there is not sufficient cash in the Trust Account to pay such tax obligation, the Trustee shall liquidate
such assets held in the Trust Account as shall be designated by the Company in writing to make such distribution (it being acknowledged
and agreed that any such amount in excess of interest income earned on the Property shall not be payable from the Trust Account). The
written request of the Company referenced above shall constitute presumptive evidence that the Company is entitled to said funds, and
the Trustee shall have no responsibility to look beyond said request;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt; text-indent: 1in">(k) Upon written request from the Company, which
may be given from time to time in a form substantially similar to that attached hereto as <U>Exhibit D</U> (a &ldquo;<B><U>Shareholder
Redemption Withdrawal Instruction</U></B>&rdquo;), the Trustee shall distribute on behalf of the Company the amount requested by the Company
to be used to redeem Ordinary Shares from Public Shareholders properly submitted in connection with a shareholder vote to approve an amendment
to the Memorandum and Articles not for the purposes of approving, or in conjunction with the consummation of, a Business Combination (as
defined below) (A) to modify the substance or timing of the Company&rsquo;s obligation to allow redemption in connection with a Business
Combination or to redeem one hundred per cent (100%) of the Public Shares if the Company has not consummated a Business Combination within
the Completion Window or (B) with respect to any other material provisions relating to the rights of holders of Ordinary Shares or pre-initial
Business Combination activity. The written request of the Company referenced above shall constitute presumptive evidence that the Company
is entitled to distribute said funds, and the Trustee shall have no responsibility to look beyond said request; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(l) Not make any withdrawals or distributions
from the Trust Account other than pursuant to <U>Sections 1(i)</U>, <U>1(j),</U> or <U>1(k) </U>above.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">2. <B><U>Agreements and Covenants of the Company</U></B>.
The Company hereby agrees and covenants to:</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(a) Give all instructions to the Trustee hereunder
in writing, signed by the Company&rsquo;s Chairperson of the Board, President, Chief Executive Officer, Chief Financial Officer, Secretary
or other authorized officer of the Company. In addition, except with respect to its duties under <U>Sections 1(i),&nbsp;1(j) and 1(k)
</U>hereof, the Trustee shall be entitled to rely on, and shall be protected in relying on, any verbal or telephonic advice or instruction
which it, in good faith and with reasonable care, believes to be given by any one of the persons authorized above to give written instructions,
<I>provided </I>that the Company shall promptly confirm such instructions in writing;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(b) Subject to <U>Section 4</U> hereof, hold the
Trustee harmless and indemnify the Trustee from and against any and all expenses, including reasonable counsel fees and disbursements,
or losses suffered by the Trustee in connection with any action taken by it hereunder and in connection with any action, suit or other
proceeding brought against the Trustee involving any claim, or in connection with any claim or demand, which in any way arises out of
or relates to this Agreement, the services of the Trustee hereunder, or the Property or any interest earned on the Property, except for
expenses and losses resulting from the Trustee&rsquo;s gross negligence, fraud or willful misconduct. Promptly after the receipt by the
Trustee of notice of demand or claim or the commencement of any action, suit or proceeding, pursuant to which the Trustee intends to seek
indemnification under this <U>Section 2(b)</U>, it shall notify the Company in writing of such claim (hereinafter referred to as the &ldquo;<B><U>Indemnified
Claim</U></B>&rdquo;). The Trustee shall have the right to conduct and manage the defense against such Indemnified Claim; <I>provided
</I>that the Trustee shall obtain the consent of the Company with respect to the selection of counsel, which consent shall not be unreasonably
withheld. The Trustee may not agree to settle any Indemnified Claim without the prior written consent of the Company, which such consent
shall not be unreasonably withheld, conditioned, or delayed; provided, further that the Company may conduct and manage the defense against
any Indemnified Claim if the Trustee does not promptly take reasonable steps to mount such a defense. The Company may participate in such
action with its own counsel;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(c) Pay the Trustee the fees set forth on <U>Schedule
A</U> hereto, including an initial acceptance fee, annual administration fee and transaction processing fee which fees shall be subject
to modification by the parties from time to time. It is expressly understood that the Property shall not be used to pay such fees unless
and until it is distributed to the Company pursuant to <U>Sections 1(i)</U> through <U>1(k)</U> hereof. The Company shall pay the Trustee
the initial acceptance fee and the first annual administration fee at the consummation of the Offering. The Company shall not be responsible
for any other fees or charges of the Trustee except as set forth in this <U>Section 2(c)</U>, <U>Schedule A</U> and as may be provided
in <U>Section 2(b)</U> hereof;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(d) In connection with any vote of the Company&rsquo;s
shareholders regarding a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination
involving the Company and one or more businesses or entities (the &ldquo;<B><U>Business Combination</U></B>&rdquo;), provide to the Trustee
an affidavit or certificate of the inspector of elections for the general meeting verifying the vote of such shareholders regarding such
Business Combination;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(e) Provide the Representative with a copy of
any Termination Letter(s) and/or any other correspondence that is sent to the Trustee with respect to any proposed withdrawal from the
Trust Account promptly after it issues the same;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(f) Unless otherwise agreed between the Company
and the Representative, ensure that any Instruction Letter (as defined in <U>Exhibit A</U>) delivered in connection with a Termination
Letter in the form of <U>Exhibit A</U> expressly provides that the Deferred Discount is paid directly to the account or accounts directed
by the Representative on behalf of the Underwriters prior to any transfer of funds held in the Trust Account to the Company or any other
person;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(g) Instruct the Trustee to make only those distributions
that are permitted under this Agreement, and refrain from instructing the Trustee to make any distributions that are not permitted under
this Agreement; and</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(h) Within four (4) business days after the Underwriters
exercise the over-allotment option (or any unexercised portion thereof) or such over-allotment option expires, provide the Trustee with
a notice in writing of the total amount of the Deferred Discount, which shall in no event be less than $8,500,000.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">3. <B><U>Limitations of Liability</U></B>. The
Trustee shall have no responsibility or liability to:</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(a) Imply obligations, perform duties, inquire
or otherwise be subject to the provisions of any agreement or document other than this Agreement and that which is expressly set forth
herein;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(b) Take any action with respect to the Property,
other than as directed in <U>Section 1</U> hereof, and the Trustee shall have no liability to any third party except for liability arising
out of the Trustee&rsquo;s gross negligence, fraud or willful misconduct;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(c) Institute any proceeding for the collection
of any principal and income arising from, or institute, appear in or defend any proceeding of any kind with respect to, any of the Property
unless and until it shall have received instructions from the Company given as provided herein to do so and the Company shall have advanced
or guaranteed to it funds sufficient to pay any expenses incident thereto; &nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(d) Refund any depreciation in principal of any
Property;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(e) Assume that the authority of any person designated
by the Company to give instructions hereunder shall not be continuing unless provided otherwise in such designation, or unless the Company
shall have delivered a written revocation of such authority to the Trustee;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 1in">(f) The other parties hereto or to anyone else
for any action taken or omitted by it, or any action suffered by it to be taken or omitted, in good faith and in the Trustee&rsquo;s best
judgment, except for the Trustee&rsquo;s gross negligence, fraud or willful misconduct. The Trustee may rely conclusively and shall be
protected in acting upon any order, notice, demand, certificate, opinion or advice of counsel (including counsel chosen by the Trustee,
which counsel may be the Company&rsquo;s counsel), statement, instrument, report or other paper or document (not only as to its due execution
and the validity and effectiveness of its provisions, but also as to the truth and acceptability of any information therein contained)
which the Trustee believes, in good faith and with reasonable care, to be genuine and to be signed or presented by the proper person or
persons. The Trustee shall not be bound by any notice or demand, or any waiver, modification, termination or rescission of this Agreement
or any of the terms hereof, unless evidenced by a written instrument delivered to the Trustee, signed by the proper party or parties and,
if the duties or rights of the Trustee are affected, unless it shall give its prior written consent thereto;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(g) Verify the accuracy of the information contained
in the Registration Statement;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(h) Provide any assurance that any Business Combination
entered into by the Company or any other action taken by the Company is as contemplated by the Registration Statement;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(i) File information returns with respect to the
Trust Account with any local, state or federal taxing authority or provide periodic written statements to the Company documenting the
taxes payable by the Company, if any, relating to any interest income earned on the Property;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(j) Prepare, execute and file tax reports, income
or other tax returns and pay any taxes with respect to any income generated by, and activities relating to, the Trust Account, regardless
of whether such tax is payable by the Trust Account or the Company, including, but not limited to, tax obligations, except pursuant to
<U>Section 1(j)</U> hereof; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(k) Verify calculations, qualify or otherwise
approve the Company&rsquo;s written requests for distributions pursuant to <U>Sections 1(i)</U>, <U>1(j) and1(k) </U>hereof.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">4. <B><U>Trust Account Waiver</U></B>. The Trustee
has no right of set-off or any right, title, interest or claim of any kind (&ldquo;<B><U>Claim</U></B>&rdquo;) to, or to any monies in,
the Trust Account, and hereby irrevocably waives any Claim to, or to any monies in, the Trust Account that it may have now or in the future.
In the event the Trustee has any Claim against the Company under this Agreement, including, without limitation, under <U>Section 2(b)</U>
or <U>Section 2(c)</U> hereof, the Trustee shall pursue such Claim solely against the Company and its assets outside the Trust Account
and not against the Property or any monies in the Trust Account.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">5. <B><U>Termination</U></B>. This Agreement shall
terminate as follows:</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(a) If the Trustee gives written notice to the
Company that it desires to resign under this Agreement, the Company shall use its reasonable efforts to locate a successor trustee, pending
which the Trustee shall continue to act in accordance with this Agreement. At such time that the Company notifies the Trustee that a successor
trustee has been appointed and has agreed to become subject to the terms of this Agreement, the Trustee shall transfer the management
of the Trust Account to the successor trustee, including but not limited to the transfer of copies of the reports and statements relating
to the Trust Account, whereupon this Agreement shall terminate; <I>provided</I>, <I>however</I>, that in the event that the Company does
not locate a successor trustee within ninety (90) days of receipt of the resignation notice from the Trustee, the Trustee may submit an
application to have the Property deposited with any court in the State of New York or with the United States District Court for the Southern
District of New York and upon such deposit, the Trustee shall be immune from any liability whatsoever;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(b) At such time that the Trustee has completed
the liquidation of the Trust Account and its obligations in accordance with the provisions of <U>Section 1(i)</U> hereof and distributed
the Property in accordance with the provisions of the Termination Letter, this Agreement shall terminate except with respect to <U>Section
2(b)</U>; or</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(c) If the Offering is not consummated within
ten (10) business days of the date of this Agreement,</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">any funds received by the Trustee from the Company or Sponsor for purposes
of funding the Trust Account shall be promptly returned to the Company or Sponsor, as applicable.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">6. <B><U>Miscellaneous</U></B>.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(a) The Company and the Trustee each acknowledge
that the Trustee will follow the security procedures set forth below with respect to funds transferred from the Trust Account. The Company
and the Trustee will each restrict access to confidential information relating to such security procedures to authorized persons. Each
party must notify the other party immediately if it has reason to believe unauthorized persons may have obtained access to such confidential
information, or of any change in its authorized personnel. In executing funds transfers, the Trustee shall rely upon all information supplied
to it by the Company, including, account names, account numbers and all other identifying information relating to a Beneficiary, Beneficiary&rsquo;s
bank or intermediary bank. Except for any liability arising out of the Trustee&rsquo;s gross negligence, fraud or willful misconduct,
the Trustee shall not be liable for any loss, liability or expense resulting from any error in the information or transmission of the
funds.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(b) This Agreement shall be governed by and construed
and enforced in accordance with the laws of the State of New York, without giving effect to conflicts of law principles that would result
in the application of the substantive laws of another jurisdiction. This Agreement may be executed in several original or facsimile counterparts,
each one of which shall constitute an original, and together shall constitute but one instrument.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(c) This Agreement contains the entire agreement
and understanding of the parties hereto with respect to the subject matter hereof. Except for <U>Sections 1(i)</U>, <U>1(j), 1(k), and
1(l) </U> hereof (which sections may not be modified, amended or deleted unless such modification, amendment or deletion is approved by
the affirmative vote of two-thirds of the then outstanding Ordinary Shares and Class B ordinary shares, par value $0.0001 per share, of
the Company, which are represented in person or by proxy and are voted at a general meeting of the Company, voting together as a single
class; <I>provided </I>that no such amendment will affect any Public Shareholder who has properly elected to redeem his, her or its Ordinary
Shares in connection with a shareholder vote to approve an amendment to this Agreement (A) to modify the substance or timing of the Company&rsquo;s
obligation to allow redemption in connection with a Business Combination or to redeem one hundred per cent (100%) of the Public Shares
if the Company has not consummated a Business Combination within the Completion Window or (B) with respect to any other material provisions
relating to the rights of holders of Ordinary Shares or pre-initial Business Combination activity) this Agreement or any provision hereof
may only be changed, amended or modified (other than to correct a typographical error) by a writing signed by each of the parties hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(d) The parties hereto consent to the jurisdiction
and venue of any state or federal court located in the City of New York, State of New York, for purposes of resolving any disputes hereunder.
AS TO ANY CLAIM, CROSS-CLAIM OR COUNTERCLAIM IN ANY WAY RELATING TO THIS AGREEMENT, EACH PARTY WAIVES THE RIGHT TO TRIAL BY JURY.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(e) Any notice, consent or request to be given
in connection with any of the terms or provisions of this Agreement shall be in writing and shall be sent by express mail or similar private
courier service, by certified mail (return receipt requested), by hand delivery or by facsimile or email transmission:</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-indent: 0.5in">if to the Trustee, to:</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Continental Stock Transfer &amp; Trust Company</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">1 State Street, 30th Floor</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">New York, New York 10004</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Attn: Francis Wolf and Celeste Gonzalez</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Email: fwolf@continentalstock.com</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Email: cgonzalez@continentalstock.com</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">if to the Company, to:</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Andretti Acquisition Corp. II</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">7615 Zionsville Road<BR>
Indianapolis, Indiana 46268<BR>
Telephone: (317) 872-2700</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Attn: William M. Brown</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Email: matt.brown@andrettiacquisition.com</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">in each case, with copies to:</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ellenoff Grossman&nbsp;&amp; Schole LLP<BR>
1345 Avenue of the Americas<BR>
New&nbsp;York, NY&nbsp;10105<BR>
(212)&nbsp;370-1300</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Attn: Stuart Neuhauser, Esq.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">and</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">BTIG, LLC</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">65 E. 55th Street</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">New York, New York, 10022</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Attn: General Counsel</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Facsimile: (415) 248-2260</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Email: iblegal@btig.com</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(f) Each of the Company and the Trustee hereby
represents that it has the full right and power and has been duly authorized to enter into this Agreement and to perform its respective
obligations as contemplated hereunder. The Trustee acknowledges and agrees that it shall not make any claims or proceed against the Trust
Account, including by way of set-off, and shall not be entitled to any funds in the Trust Account under any circumstance.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(g) This Agreement is
the joint product of the Trustee and the Company and each provision hereof has been subject to the mutual consultation, negotiation
and agreement of such parties and shall not be construed for or against any party hereto.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(h) Each of the Company and the Trustee hereby
acknowledges and agrees that the Representative, on behalf of the Underwriters, is a third-party beneficiary of this Agreement.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">(i) Except as specified herein, no party to this
Agreement may assign its rights or delegate its obligations hereunder to any other person or entity without the prior written consent
of the other.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">[<I>Signature Page Follows</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>



<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>IN WITNESS WHEREOF</B>, the parties have duly
executed this Investment Management Trust Agreement as of the date first written above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="3" STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>Continental Stock Transfer &amp; Trust Company, as Trustee</B></FONT></TD></TR>
  <TR>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 35%">&nbsp;</TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: top">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">/s/ Francis Wolf</P></TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">Francis Wolf</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">Vice President</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>Andretti Acquisition Corp. II</B></FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: top">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">/s/ William M. Brown</P></TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">William M. Brown</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">Chief Executive Officer </FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: small-caps 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Signature
Page to</P>

<P STYLE="font: small-caps 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Investment
Management Trust Agreement</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SCHEDULE A </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">Fee Item</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: bottom; font-weight: bold; text-align: center">Time and method of payment</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Amount</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 43%; text-align: left">Initial set-up fee</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 44%; text-align: left">Initial closing of Offering by wire transfer.</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 9%; text-align: right">3,500.00</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; text-align: left">Trustee administration fee</TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left">Payable annually. First year fee payable at initial closing of Offering by wire transfer; thereafter, payable by wire transfer or check.</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">10,000.00</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Transaction processing fee for disbursements to Company under <U>Sections 1(i)</U>, <U>1(j)</U> and <U>1(k)</U></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left"><FONT STYLE="font-size: 10pt">Billed to Company following disbursement made to Company under <U>Section 1</U>.</FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">$</TD><TD STYLE="text-align: right">250.00</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Paying Agent services as required pursuant to <U>Sections 1(i) and 1(k)</U></FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top; text-align: left"><FONT STYLE="font-size: 10pt">Billed to Company upon delivery of service pursuant to <U>Sections 1(i) and 1(k)</U>.</FONT></TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">Prevailing rates</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Schedule A</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Exhibit A </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>[Letterhead of Company] </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>[Insert date] </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Continental Stock Transfer &amp; Trust Company</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">1 State Street, 30th Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">New York, New York 10004</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Attn: Francis Wolf and Celeste Gonzalez</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify"><FONT STYLE="font-size: 10pt">Re:
Trust Account&mdash;Termination Letter</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dear Mr. Wolf and Ms. Gonzalez:</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to <U>Section 1(i)</U> of the Investment
Management Trust Agreement between Andretti Acquisition Corp. II (the &ldquo;<B><U>Company</U></B>&rdquo;) and Continental Stock Transfer
&amp; Trust Company (the &ldquo;<B><U>Trustee</U></B>&rdquo;), dated as of September 5, 2024 (the &ldquo;<B><U>Trust Agreement</U></B>&rdquo;),
this is to advise you that the Company has entered into an agreement with [&bull;] (the &ldquo;<B><U>Target Business</U></B>&rdquo;) to
consummate a business combination with Target Business (the &ldquo;<B><U>Business Combination</U></B>&rdquo;) on or about [insert date].
The Company shall notify you at least seventy-two (72) hours in advance of the actual date of the consummation of the Business Combination
(the &ldquo;<B><U>Consummation Date</U></B>&rdquo;). Capitalized terms used but not defined herein shall have the meanings set forth in
the Trust Agreement.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In accordance with the terms of the Trust Agreement,
we hereby authorize you to commence to liquidate all of the assets of the Trust Account and to transfer the proceeds into the trust operating
account in the United States at J.P. Morgan Chase Bank, N.A. to the effect that, on the Consummation Date, all of the funds held in the
Trust Account will be immediately available for transfer to the account or accounts that the Company shall direct on the Consummation
Date (including as directed to it by the Representative on behalf of the Underwriters with respect to the Deferred Discount). It is acknowledged
and agreed that while the funds are on deposit in the trust operating account at J.P. Morgan Chase Bank, N.A. awaiting distribution, the
Company will not earn any interest or dividends.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On the Consummation Date (i) counsel for the Company
shall deliver to you written notification that the Business Combination has been consummated, or will be consummated concurrently with
your transfer of funds to the accounts as directed by the Company (the &ldquo;<B><U>Notification</U></B>&rdquo;), (ii) the Company shall
deliver to you (a) a certificate of the Chief Executive Officer or Chief Financial Officer of the Company, which verifies that the Business
Combination has been approved by a vote of the Company&rsquo;s shareholders, if a vote is held and (b) a joint written instruction signed
by the Company and the Representative with respect to the transfer of the funds held in the Trust Account, including payment of amounts
owed to Public Shareholders who have properly exercised their redemption rights and payment of the Deferred Discount directly to the account
or accounts directed by the Representative from the Trust Account (the &ldquo;<B><U>Instruction Letter</U></B>&rdquo;). You are hereby
directed and authorized to transfer the funds held in the Trust Account immediately upon your receipt of the Notification and the Instruction
Letter, in accordance with the terms of the Instruction Letter. In the event that certain deposits held in the Trust Account may not be
liquidated by the Consummation Date without penalty, you will notify the Company in writing of the same and the Company shall direct you
as to whether such funds should remain in the Trust Account and be distributed after the Consummation Date to the Company. Upon the distribution
of all the funds, net of any payments necessary for reasonable unreimbursed expenses related to liquidating the Trust Account, your obligations
under the Trust Agreement shall be terminated.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In the event that the Business Combination is
not consummated on the Consummation Date described in the notice thereof and we have not notified you on or before the original Consummation
Date of a new Consummation Date, then upon receipt by the Trustee of written instructions from the Company, the funds held in the Trust
Account shall be reinvested as provided in <U>Section 1(c)</U> of the Trust Agreement on the business day immediately following the Consummation
Date as set forth in such written instructions as soon thereafter as possible.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>




<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Very truly yours,</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 35%">&nbsp;</TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Andretti Acquisition Corp. II</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    </TR>
  <TR>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD>&nbsp;</TD>
    </TR>
  <TR>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    </TR>
  <TR>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Agreed and acknowledged by:</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 5%">&nbsp;</TD>
    <TD STYLE="width: 35%">&nbsp;</TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">BTIG, LLC</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>Exhibit B </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>[Letterhead of Company] </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>[Insert date] </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Continental Stock Transfer &amp; Trust Company</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">1 State Street, 30th Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">New York, New York 10004</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Attn: Francis Wolf and Celeste Gonzalez</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0in; text-indent: 0in; text-align: justify"><FONT STYLE="font-size: 10pt">Re:
Trust Account&mdash;Termination Letter</FONT></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dear Mr. Wolf and Ms. Gonzalez:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to <U>Section 1(i)</U> of the Investment
Management Trust Agreement between Andretti Acquisition Corp. II (the &ldquo;<B><U>Company</U></B>&rdquo;) and Continental Stock Transfer
&amp; Trust Company (the &ldquo;<B><U>Trustee</U></B>&rdquo;), dated as of September 5, 2024 (the &ldquo;<B><U>Trust Agreement</U></B>&rdquo;),
this is to advise you that [the Company has been unable to effect a business combination with a Target Business within the time frame
specified in the Company&rsquo;s amended and restated memorandum and articles of association, as may be amended from time to time (the
&ldquo;<B><U>Memorandum and Articles</U></B>&rdquo;)] OR [the Company&rsquo;s board of directors has determined to terminate the period
in which the Company must consummate a Business Combination on ____, 20___ pursuant to the Company&rsquo;s amended and restated memorandum
and articles of association, as may be amended from time to time (the &ldquo;<B><U>Memorandum and Articles</U></B>&rdquo;)] as described
in the Company&rsquo;s Prospectus relating to the Offering. Capitalized terms used but not defined herein shall have the meanings set
forth in the Trust Agreement.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In accordance with the terms of the Trust Agreement,
we hereby authorize you to liquidate all of the assets in the Trust Account and to transfer the total proceeds into the trust operating
account in the United States at J.P. Morgan Chase Bank, N.A. to await distribution to the Public Shareholders. The Company has selected
[&bull;], 20[ ]<SUP>1</SUP> as the effective date for the purpose of determining when the Public Shareholders will be entitled to receive
their share of the liquidation proceeds. You agree to be the Paying Agent of record and, in your separate capacity as Paying Agent, agree
to distribute said funds directly to the Company&rsquo;s Public Shareholders in accordance with the terms of the Trust Agreement and the
Amended and Restated Memorandum and Articles of Association. Upon the distribution of all the funds, net of any payments necessary for
reasonable unreimbursed expenses related to liquidating the Trust Account, your obligations under the Trust Agreement shall be terminated,
except to the extent otherwise provided in <U>Section 1(j)</U> of the Trust Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Very truly yours,</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 35%">&nbsp;</TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Andretti Acquisition Corp. II</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD>&nbsp;</TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    </TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 5%"><FONT STYLE="font-size: 10pt">cc:</FONT></TD>
    <TD STYLE="font-size: 10pt; width: 95%"><FONT STYLE="font-size: 10pt">BTIG, LLC</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font-size: 10pt; margin-top: 0in; margin-bottom: 0in; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt"><SUP>1</SUP></FONT></TD><TD STYLE="text-align: justify">24 months after the closing date of the Offering, such earlier
date as the Company&rsquo;s board of directors may approve, or such later date as the Company's shareholders may approve.</TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>







<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Exhibit C </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>[Letterhead of Company] </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>[Insert date] </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Continental Stock Transfer &amp; Trust Company</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">1 State Street, 30th Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">New York, New York 10004</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Attn: Francis Wolf and Celeste Gonzalez</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; font-size: 10pt; width: 0.5in"><FONT STYLE="font-size: 10pt">Re:</FONT></TD>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">Trust Account&mdash;Tax Payment Withdrawal Instruction </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dear Mr. Wolf and Ms. Gonzalez:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to <U>Section 1(j)</U> of the Investment
Management Trust Agreement between Andretti Acquisition Corp. II (the &ldquo;<B><U>Company</U></B>&rdquo;) and Continental Stock Transfer
&amp; Trust Company (the &ldquo;<B><U>Trustee</U></B>&rdquo;), dated as of September 5, 2024 (the &ldquo;<B><U>Trust Agreement</U></B>&rdquo;),
the Company hereby requests that you deliver to the Company $[&bull;] of the interest income earned on the Property as of the date hereof.
Capitalized terms used but not defined herein shall have the meanings set forth in the Trust Agreement.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Company needs such funds to pay for the tax
obligations as set forth on the attached tax return or tax statement. In accordance with the terms of the Trust Agreement, you are hereby
directed and authorized to transfer (via wire transfer) such funds promptly upon your receipt of this letter to the Company&rsquo;s operating
account at:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>[WIRE INSTRUCTION INFORMATION] </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Very truly yours,</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 35%">&nbsp;</TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Andretti Acquisition Corp. II</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD>&nbsp;</TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    </TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 5%"><FONT STYLE="font-size: 10pt">cc:</FONT></TD>
    <TD STYLE="font-size: 10pt; width: 95%"><FONT STYLE="font-size: 10pt">BTIG, LLC</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>






<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Exhibit D </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>[Letterhead of Company] </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>[Insert date] </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Continental Stock Transfer &amp; Trust Company</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">1 State Street, 30th Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">New York, New York 10004</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Attn: Francis Wolf and Celeste Gonzalez</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; font-size: 10pt; width: 0.5in"><FONT STYLE="font-size: 10pt">Re:</FONT></TD>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">Trust Account&mdash;Shareholder Redemption Withdrawal Instruction </FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dear Mr. Wolf and Ms. Gonzalez:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in">Pursuant to <U>Section 1(k)</U> of the Investment
Management Trust Agreement between Andretti Acquisition Corp. II (the &ldquo;<B><U>Company</U></B>&rdquo;) and Continental Stock Transfer
&amp; Trust Company (the &ldquo;<B><U>Trustee</U></B>&rdquo;), dated as of September 5, 2024 (the &ldquo;<B><U>Trust Agreement</U></B>&rdquo;),
the Company hereby requests that you deliver to the redeeming Public Shareholders of the Company $[&bull;] of the principal and interest
income earned on the Property as of the date hereof to a segregated account held by you on behalf of the Beneficiaries for distribution
to the Public Shareholders who have requested redemption of their Ordinary Shares. Capitalized terms used but not defined herein shall
have the meanings set forth in the Trust Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company needs such funds to pay its Public Shareholders who have
properly elected to have their Ordinary Shares redeemed by the Company in connection with a shareholder vote to approve an amendment to
the Company&rsquo;s amended and restated memorandum and articles of association, as may be amended from time to time (the &ldquo;<B><U>Memorandum
and Articles</U></B>&rdquo;) not for the purposes of approving, or in conjunction with the consummation of, a Business Combination (A)
to modify the substance or timing of the Company&rsquo;s obligation to allow redemption in connection with a Business Combination or to
redeem one hundred per cent (100%) of the Public Shares if the Company has not consummated a Business Combination within the Completion
Window or (B) with respect to any other material provisions relating to the rights of holders of Ordinary Shares or pre-initial Business
Combination activity. As such, you are hereby directed and authorized to transfer (via wire transfer) such funds promptly upon your receipt
of this letter to the redeeming Public Shareholders in accordance with your customary procedures.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Very truly yours,</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 35%">&nbsp;</TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Andretti Acquisition Corp. II</FONT></TD>
    <TD>&nbsp;</TD></TR>
<TR>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD>&nbsp;</TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    </TR>
<TR>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    </TR>
</TABLE>
<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt; width: 5%"><FONT STYLE="font-size: 10pt">cc:</FONT></TD>
    <TD STYLE="font-size: 10pt; width: 95%"><FONT STYLE="font-size: 10pt">BTIG, LLC</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>6
<FILENAME>ea021383001ex10-2_andretti2.htm
<DESCRIPTION>REGISTRATION RIGHTS AGREEMENT, DATED SEPTEMBER 5, 2024, BY AND AMONG THE COMPANY AND CERTAIN SECURITY HOLDERS
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 10.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>REGISTRATION
RIGHTS AGREEMENT </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">THIS
REGISTRATION RIGHTS AGREEMENT (this &ldquo;<B><U>Agreement</U></B>&rdquo;), dated as of September 5, 2024 is made and entered into by
and among Andretti Acquisition Corp. II, a Cayman Islands exempted company (the &ldquo;<B><U>Company</U></B>&rdquo;), Andretti Sponsor
II LLC, a Delaware limited liability company (the &ldquo;<B><U>Sponsor</U></B>&rdquo;), BTIG, LLC (the &ldquo;<B><U>Representative</U></B>&rdquo;)
and the undersigned parties listed under Holder on the signature pages hereto (each such party, and any person or entity who hereafter
becomes a party to this Agreement pursuant to <U>Section&nbsp;5.2</U> of this Agreement, a &ldquo;<B><U>Holder</U></B>&rdquo; and collectively
the &ldquo;<B><U>Holders</U></B>&rdquo;).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>RECITALS
</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
the Company intends to consummate an initial public offering of the Company&rsquo;s units (the &ldquo;<B><U>IPO</U></B>&rdquo;), each unit
consisting of Class A Ordinary Share, par value $0.0001 per share (the &ldquo;<B>Ordinary Shares</B>&rdquo;), of the Company, and one-half
of one redeemable warrant (a &ldquo;<B><U>Warrant</U></B>&rdquo;) to be governed by the Warrant Agreement to be entered into between
the Company and Continental stock Transfer &amp; Trust Company, as warrant agent (the &ldquo;<B><U>Warrant Agreement</U></B>&rdquo;).
Each whole Warrant entitles the holder to purchase one Class A Ordinary Share at an exercise price of $11.50 per Ordinary Share;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
the Sponsor owns an aggregate of 5,750,000 of the Company&rsquo;s Class&nbsp;B ordinary shares, par value $0.0001 per share (the &ldquo;<B><U>Founder
Shares</U></B>&rdquo;) up to 750,000 of which will be surrendered to the Company for no consideration depending on the extent to which
the underwriters of the IPO exercise their over-allotment option;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
the Founder Shares are convertible into Ordinary Shares, on the terms and conditions provided in the Company&rsquo;s amended and restated
memorandum and articles of association, as may be further amended from time to time;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS,
</B>on the date hereof, the Company and the Sponsor have entered into certain Sponsor Private Placement Units Purchase Agreement with
the Company (the &ldquo;<B><U>Sponsor Private Placement Units Purchase Agreement</U></B>&rdquo;), pursuant to which the Sponsor agreed
to purchase an aggregate of 450,000 units (the <U>&ldquo;<B>Sponsor Private Placement Units</B></U>&rdquo;), each Private Placement Unit
consisting of one Ordinary Share (the &ldquo;<B><U>Sponsor Private Placement Shares</U></B>&rdquo;) and one-half of one redeemable Warrant
(the &ldquo;<B><U>Sponsor Private Placement Warrants</U></B>&rdquo;) (including to the extent that the over-allotment option in connection
with the IPO is exercised) in a private placement transaction occurring simultaneously with the closing of the IPO. Each whole Sponsor
Private Placement Warrant entitles the holder thereof to purchase one Ordinary Share (a &ldquo;<B><U>Sponsor Warrant Share</U></B>&rdquo;)
at an exercise price of $11.50 per Ordinary Share;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS,
</B>on the date hereof, the Company and the Representative have entered into certain Representative Private Placement Units Purchase
Agreement with the Company (the &ldquo;<B><U>Representative Private Placement Units Purchase Agreement</U></B>&rdquo; and together with
the Sponsor Private Placement Units Purchase Agreement, the &ldquo;<B><U>Private Placement Units Purchase Agreement</U></B>&rdquo;),
pursuant to which the Representative or its designees agreed to purchase an aggregate of 250,000 units (the &ldquo;<B><U>Representative
Private Placement Units</U></B>&rdquo; and together with the Sponsor Private Placement Units, &ldquo;the <B><U>Private Placement Units</U></B>&rdquo;),
each Representative Private Placement Unit consisting of one Ordinary Share (the &ldquo;<B><U>Representative Private Placement Shares</U></B>&rdquo;
and together with the Sponsor Private Placement Shares, the &ldquo;<B><U>Private Placement Shares</U></B>&rdquo;) and one-half of one
redeemable Warrant (the &ldquo;<B><U>Representative Private Placement Warrants</U></B>&rdquo; and together with the Sponsor Private Placement
Warrants, the &ldquo;<B><U>Private Placement Warrants</U></B>&rdquo;) (or up to 310,000 if the over-allotment option in connection with
the IPO is exercised) in a private placement transaction occurring simultaneously with the closing of the IPO. Each whole Representative
Private Placement Warrant entitles the holder thereof to purchase one Ordinary Share (a &ldquo;<B><U>Representative Warrant Share</U></B>&rdquo;
and collectively, the &ldquo;<B><U>Representative Warrant Shares</U></B>&rdquo; and together with the Sponsor Warrant Shares, the &ldquo;<B><U>Warrant
Shares</U></B>&rdquo;) at an exercise price of $11.50 per Ordinary Share;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-indent: 0.5in; text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
in order to finance the Company&rsquo;s transaction costs in connection with its search for and consummation of an initial Business Combination
(as defined below), the Sponsor, its affiliates or any of the Company&rsquo;s officers and directors may loan to the Company funds as
the Company may require, of which up to $1,500,000 of such loans may be convertible into additional units (the &ldquo;<B><U>Working Capital
Units</U></B>&rdquo;) at a price of $10.00 per Working Capital Unit at the option of the lender. Each Working Capital Unit consists of
one Ordinary Share (the &ldquo;<B><U>Working Capital Shares</U></B>&rdquo;) and one-half of one redeemable Warrant (the &ldquo;<B><U>Working
Capital Warrants</U></B>&rdquo;), with each whole Working Capital Warrant entitling the holder thereof to purchase one Ordinary Share
(a &ldquo;<B><U>Working Capital Warrant Share</U></B>&rdquo;) at an exercise price of $11.50 per Ordinary Share;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>WHEREAS</B>,
the Company and the Holders desire to enter into this Agreement, pursuant to which the Company shall grant the Holders certain registration
rights with respect to certain securities of the Company, as set forth in this Agreement.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>NOW,
THEREFORE</B>, in consideration of the representations, covenants and agreements contained herein, and certain other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound, hereby
agree as follows:</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
1 </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>DEFINITIONS
</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>1.1
<U>Definitions</U></B>. The terms defined in this <U>Article 1</U> shall, for all purposes of this Agreement, have the respective meanings
set forth below:</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><U>Agreement</U></B>&rdquo;
shall have the meaning given in the Preamble.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><U>Block
Trade</U></B>&rdquo; shall have the meaning given to it in <U>subsection 2.3.1</U> of this Agreement.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><U>Board</U></B>&rdquo;
shall mean the board of directors of the Company.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><U>Business
Combination</U></B>&rdquo; shall mean any merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or
other similar business combination with one or more businesses or entities, involving the Company.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><U>Commission</U></B>&rdquo;
shall mean the U.S. Securities and Exchange Commission.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><U>Company</U></B>&rdquo;
shall have the meaning given in the Preamble.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><U>Demanding
Holder</U></B>&rdquo; shall mean any Holder or group of Holders, that together elects to dispose of Registrable Securities having an
aggregate value of at least $25&nbsp;million, at the time of the Underwritten Demand, under a Registration Statement pursuant to an Underwritten
Offering.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><U>Effectiveness
Period</U></B>&rdquo; shall have the meaning given in <U>subsection 3.1.1</U> of this Agreement.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><U>Exchange
Act</U></B>&rdquo; shall mean the Securities Exchange Act of 1934, as it may be amended from time to time.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><U>Financial
Counterparty</U></B>&rdquo; shall have the meaning given in <U>subsection 2.3.1</U> of this Agreement.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><U>Founder
Shares</U></B>&rdquo; shall have the meaning given in the Recitals hereto and shall be deemed to include the Ordinary Shares issuable
upon conversion thereof.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><U>Holder
Indemnified Persons</U></B>&rdquo; shall have the meaning given in <U>subsection 4.1.1</U> of this Agreement.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><U>Founder
Shares Lock-up Period</U></B>&rdquo; shall mean the earlier of (i)&nbsp;six months following the consummation of the Company&rsquo;s
initial Business Combination; or (ii)&nbsp;subsequent to the consummation of the Company&rsquo;s initial Business Combination, the date
on which the Company consummates a transaction which results in all of its shareholders having the right to exchange their shares for
cash, securities, or other property.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><U>Holders</U></B>&rdquo;
shall have the meaning given in the Preamble.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><U>Insider
Letter</U></B>&rdquo; shall mean that certain letter agreement, dated as of the date hereof, by and among the Company, the Sponsor and
each of the Company&rsquo;s officers and directors.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;<U>IPO</U>&rdquo;
</B>shall have the meaning given in the Recitals hereto.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><U>Maximum
Number of Securities</U></B>&rdquo; shall have the meaning given in <U>subsection 2.1.4</U> of this Agreement.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><U>Misstatement</U></B>&rdquo;
shall mean, in the case of a Registration Statement, an untrue statement of a material fact or an omission to state a material fact required
to be stated therein, or necessary to make the statements therein not misleading, and in the case of a Prospectus, an untrue statement
of a material fact or an omission to state a material fact necessary in order to make the statements therein, in the light of the circumstances
under which they were made, not misleading.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><U>Ordinary
Shares</U></B>&rdquo; shall have the meaning given in the Recitals hereto.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><U>Other
Coordinated Offering</U></B>&rdquo; shall have the meaning given to it in <U>subsection 2.3.1</U> of this Agreement.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><U>Piggyback
Registration</U></B>&rdquo; shall have the meaning given in <U>subsection 2.2.1</U> of this Agreement.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><U>Permitted
Transferees</U></B>&rdquo; shall mean any person or entity to whom a Holder of Registrable Securities is permitted to transfer such
Registrable Securities prior to the expiration of the Founder Shares Lock-up Period, Private Placement Lock-up Period or any other
lock-up period, as the case may be, under the Insider Letter, the Private Placement Units Purchase Agreement, this Agreement and any
other applicable agreement between such Holder and the Company, and to any transferee thereafter.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><U>Private
Placement Lock-up Period</U></B>&rdquo; shall mean the period ending 30 days after the completion of the Company&rsquo;s initial
Business Combination.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><U>Private
Placement Shares</U></B>&rdquo; shall have the meaning given in the Recitals hereto.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><U>Private
Placement Units</U></B>&rdquo; shall have the meaning given in the Recitals hereto.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><U>Private
Placement Units Purchase Agreement</U></B>&rdquo; shall have the meaning given in the Recitals hereto.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><U>Private
Placement Warrants</U></B>&rdquo; shall have the meaning given in the Recitals hereto.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><U>Pro
Rata</U></B>&rdquo; shall have the meaning given in <U>subsection 2.1.4</U> of this Agreement.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><U>Prospectus</U></B>&rdquo;
shall mean the prospectus included in any Registration Statement, as supplemented by any and all prospectus supplements and as amended
by any and all post-effective amendments and including all material incorporated by reference in such prospectus.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><U>Registrable
Security</U></B>&rdquo; shall mean (a)&nbsp;the Founder Shares and the Ordinary Shares issued or issuable upon the conversion of any
Founder Shares, (b)&nbsp;the Private Placement Units, Private Placement Shares, Private Placement Warrants and Warrant Shares, (c)&nbsp;any
outstanding Ordinary Shares or any other equity security (including the Ordinary Shares issued or issuable upon the exercise of any other
equity security) of the Company held by a Holder as of the date of this Agreement or acquired prior to or in connection with the Business
Combination, which, for the avoidance of doubt, shall include any Ordinary Shares received by a Holder on or after the date hereof as
a distribution from the Sponsor in connection with its liquidation and dissolution, (d)&nbsp;any Working Capital Units, Working Capital
Shares, Working Capital Warrants and Working Capital Warrant Shares, and (e)&nbsp;any other equity security of the Company issued or
issuable with respect to any such Ordinary Share by way of a share capitalization or share split or in connection with a combination
of shares, recapitalization, merger, consolidation or reorganization;<U>&nbsp;provided</U>,<U>&nbsp;however</U>, that, as to any particular
Registrable Security, such securities shall cease to be Registrable Securities when: (A)&nbsp;a Registration Statement with respect to
the sale of such securities shall have become effective under the Securities Act and such securities shall have been sold, transferred,
disposed of or exchanged in accordance with such Registration Statement; (B)&nbsp;such securities shall have been otherwise transferred,
new certificates for such securities not bearing a legend restricting further transfer shall have been delivered by the Company and subsequent
public distribution of such securities shall not require registration under the Securities Act; (C)&nbsp;such securities shall have ceased
to be outstanding; (D)&nbsp;such securities may be sold without registration pursuant to Rule&nbsp;144 promulgated under the Securities
Act (or any successor rule&nbsp;promulgated thereafter by the Commission) (but with no volume or other restrictions or limitations);
or (E)&nbsp;such securities have been sold to, or through, a broker, dealer or underwriter in a public distribution or other public securities
transaction.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><U>Registration</U></B>&rdquo;
shall mean a registration effected by preparing and filing a registration statement or similar document in compliance with the requirements
of the Securities Act, and the applicable rules and regulations promulgated thereunder, and any such registration statement having become
effective by the Commission.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><U>Registration
Expenses</U></B>&rdquo; shall mean the out-of-pocket expenses of a Registration, including, without limitation, the following:</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
all registration and filing fees (including fees with respect to filings required to be made with the Financial Industry Regulatory Authority)
and any securities exchange on which the Ordinary Shares are then listed;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
fees and expenses of compliance with securities or blue sky laws (including reasonable fees and disbursements of counsel for the Underwriters
in connection with blue sky qualifications of Registrable Securities);</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
printing, messenger, telephone and delivery expenses;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)
reasonable fees and disbursements of counsel for the Company;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(e)
reasonable fees and disbursements of all independent registered public accountants of the Company incurred specifically in connection
with such Registration or Underwritten Offering;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(f)
the fees and expenses incurred in connection with the listing of any Registrable Securities on each securities exchange or automated
quotation system on which similar securities issued by the Company are then listed;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(g)
the fees and expenses incurred by the Company in connection with any road show for any Underwritten Offerings; and</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(h)
reasonable fees and expenses of one (1)&nbsp;legal counsel selected jointly by the Demanding Holders initiating an Underwritten Demand,
the Requesting Holders participating in an Underwritten Offering and the Holders participating in a Piggyback Registration, as applicable.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><U>Registration
Statement</U></B>&rdquo; shall mean any registration statement under the Securities Act that covers the Registrable Securities pursuant
to the provisions of this Agreement, including the Prospectus included in such registration statement, amendments (including post-effective
amendments) and supplements to such registration statement and all exhibits to and all material incorporated by reference in such registration
statement.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><U>Representative</U></B>&rdquo;
shall have the meaning given in the Preamble.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><U>Representative
Private Placement Units Purchase Agreement</U></B>&rdquo; shall have the meaning given in the Recitals hereto.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><U>Representative
Private Placement Units</U></B>&rdquo; shall have the meaning given in the Recitals hereto.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><U>Representative
Private Placement Shares</U></B>&rdquo; shall have the meaning given in the Recitals hereto.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><U>Representative
Private Placement Warrants</U></B>&rdquo; shall have the meaning given in the Recitals hereto.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><U>Requesting
Holder</U></B>&rdquo; shall have the meaning given in <U>subsection 2.1.3</U> of this Agreement.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><U>Securities
Act</U></B>&rdquo; shall mean the Securities Act of 1933, as amended from time to time.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><U>Shelf
Registration</U></B>&rdquo; shall have the meaning given in <U>subsection 2.1.1</U> of this Agreement.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><U>Sponsor</U></B>&rdquo;
shall have the meaning given in the Preamble.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><U>Sponsor
Private Placement Units Purchase Agreement</U></B>&rdquo; shall have the meaning given in the Recitals hereto.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><U>Sponsor
Private Placement Units</U></B><U>&rdquo;</U> shall have the meaning given in the Recitals hereto.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><U>Sponsor
Private Placement Shares</U></B>&rdquo; shall have the meaning given in the Recitals hereto.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><U>Sponsor
Private Placement Warrants</U></B>&rdquo; shall have the meaning given in the Recitals hereto.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><U>Suspension
Event</U></B>&rdquo; shall have the meaning given in <U>Section&nbsp;3.4</U> of this Agreement.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><U>Underwriter</U></B>&rdquo;
shall mean a securities dealer who purchases any Registrable Securities as principal in an Underwritten Offering and not as part of such
dealer&rsquo;s market-making activities.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><U>Underwritten
Demand</U></B>&rdquo; shall have the meaning given in <U>subsection 2.1.3</U> of this Agreement.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><U>Underwritten
Offering</U></B>&rdquo; shall mean a Registration in which securities of the Company are sold to an Underwriter in a firm commitment
underwriting for distribution to the public.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;<U>Warrant</U>&rdquo;
</B>shall have the meaning given in the Recitals hereto.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;<U>Warrant
Share</U>&rdquo; </B>shall have the meaning given in the Recitals hereto.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&ldquo;<U>Warrant
Agreement</U>&rdquo; </B>shall have the meaning given in the Recitals hereto.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><U>Working
Capital Shares</U></B>&rdquo; shall have the meaning given in the Recitals hereto.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><U>Working
Capital Units</U></B>&rdquo; shall have the meaning given in the Recitals hereto.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><U>Working
Capital Warrants</U></B>&rdquo; shall have the meaning given in the Recitals hereto.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<B><U>Working
Capital Warrant Shares</U></B>&rdquo; shall have the meaning given in the Recitals hereto.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
2 </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>REGISTRATIONS
</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.1
<U>Registration</U></B>.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.1
<U>Shelf Registration</U>. The Company agrees that, within fifteen (15)&nbsp;business days after the consummation of the Business Combination,
the Company will use commercially reasonable efforts to file with the Commission (at the Company&rsquo;s sole cost and expense) a Registration
Statement registering the resale or other disposition of the Registrable Securities (a &ldquo;<B><U>Shelf Registration</U></B>&rdquo;).</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.2
<U>Effective Registration</U>. The Company shall use commercially reasonable efforts to cause such Registration Statement to become effective
by the Commission as soon as reasonably practicable after the initial filing of the Registration Statement. Subject to the limitations
contained in this Agreement, the Company shall effect any Shelf Registration on such appropriate registration form of the Commission
(a)&nbsp;as shall be selected by the Company and (b)&nbsp;as shall permit the resale or other disposition of the Registrable Securities
by the Holders. If at any time a Registration Statement filed with the Commission pursuant to <U>Section&nbsp;2.1.1</U> is effective
and a Holder provides written notice to the Company that it intends to effect an offering of all or part of the Registrable Securities
included on such Registration Statement, the Company will use commercially reasonable efforts to amend or supplement such Registration
Statement as may be necessary in order to enable such offering to take place in accordance with the terms of this Agreement.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.3
<U>Underwritten Offering</U>. Subject to the provisions of <U>subsection 2.1.4</U> and <U>Sections 2.4</U> and <U>3.4</U> hereof, any
Demanding Holder may make a written demand for an Underwritten Offering pursuant to a Registration Statement filed with the Commission
in accordance with <U>Section&nbsp;2.1.1</U> (an &ldquo;<B><U>Underwritten Demand</U></B>&rdquo;). The Company shall, within ten (10)&nbsp;days
of the Company&rsquo;s receipt of the Underwritten Demand, notify, in writing, all other Holders of such demand, and each Holder who
thereafter requests to include all or a portion of such Holder&rsquo;s Registrable Securities in such Underwritten Offering pursuant
to such Underwritten Demand (each such Holder that requests to include all or a portion of such Holder&rsquo;s Registrable Securities
in such Underwritten Offering, a &ldquo;<B><U>Requesting Holder</U></B>&rdquo;) shall so notify the Company, in writing, within two (2)&nbsp;days
(one (1)&nbsp;day if such offering is an overnight or bought Underwritten Offering) after the receipt by the Holder of the notice from
the Company. Upon receipt by the Company of any such written notification from a Requesting Holder(s), such Requesting Holder(s) shall
be entitled to have their Registrable Securities included in such Underwritten Offering pursuant to such Underwritten Demand. All such
Holders proposing to distribute their Registrable Securities through such Underwritten Offering under this <U>subsection 2.1.3</U> shall
enter into an underwriting agreement in customary form with the Underwriter(s) selected for such Underwritten Offering by the Demanding
Holders initiating such Underwritten Offering. Notwithstanding the foregoing, the Company is not obligated to effect more than an aggregate
of three (3)&nbsp;Underwritten Offerings pursuant to this <U>subsection 2.1.3</U> and is not obligated to effect an Underwritten Offering
pursuant to this <U>subsection 2.1.3</U> within ninety (90)&nbsp;days after the closing of an Underwritten Offering.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.1.4
<U>Reduction of Underwritten Offering</U>. If the managing Underwriter or Underwriters in an Underwritten Offering pursuant to an Underwritten
Demand, in good faith, advises the Company, the Demanding Holders, the Requesting Holders and other persons or entities holding Ordinary
Shares or other equity securities of the Company that the Company is obligated to include pursuant to separate written contractual arrangements
with such persons or entities (if any) in writing that the dollar amount or number of Registrable Securities or other equity securities
of the Company requested to be included in such Underwritten Offering exceeds the maximum dollar amount or maximum number of equity securities
of the Company that can be sold in the Underwritten Offering without adversely affecting the proposed offering price, the timing, the
distribution method or the probability of success of such offering (such maximum dollar amount or maximum number of such securities,
as applicable, the &ldquo;<B><U>Maximum Number of Securities</U></B>&rdquo;), then the Company shall include in such Underwritten Offering,
as follows: (a)&nbsp;first, the Registrable Securities of the Demanding Holders (pro rata based on the respective number of Registrable
Securities that each Demanding Holder has requested be included in such Underwritten Offering and the aggregate number of Registrable
Securities that the Demanding Holders have requested be included in such Underwritten Offering (such proportion is referred to herein
as &ldquo;<B><U>Pro Rata</U></B>&rdquo;)) that can be sold without exceeding the Maximum Number of Securities; (b)&nbsp;second, to the
extent that the Maximum Number of Securities has not been reached under the foregoing <U>clause (a)</U>, the Registrable Securities of
the Requesting Holders, Pro Rata, which can be sold without exceeding the Maximum Number of Securities; (c)&nbsp;third, to the extent
that the Maximum Number of Securities has not been reached under the foregoing <U>clauses (a)</U>&nbsp;and <U>(b)</U>, Ordinary Shares
or other equity securities of the Company that the Company desires to sell and that can be sold without exceeding the Maximum Number
of Securities; and (d)&nbsp;fourth, to the extent that the Maximum Number of Securities has not been reached under the foregoing <U>clauses
(a)</U>, <U>(b)</U> and <U>(c)</U>, Ordinary Shares or other equity securities of the Company held by other persons or entities that
the Company is obligated to include pursuant to separate written contractual arrangements with such persons or entities and that can
be sold without exceeding the Maximum Number of Securities.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.2
<U>Piggyback Registration</U></B>.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2.1
<U>Piggyback Rights</U>. Subject to the provisions of <U>subsection 2.2.2</U> and <U>Sections 2.4</U> and <U>3.4</U> hereof, if, at any
time on or after the date the Company consummates a Business Combination, the Company proposes to consummate an Underwritten Offering
for its own account or for the account of shareholders of the Company, then the Company shall give written notice of such proposed action
to all of the Holders as soon as practicable, which notice shall (a)&nbsp;describe the amount and type of securities to be included,
the intended method(s) of distribution and the name of the proposed managing Underwriter or Underwriters, if any, and (b)&nbsp;offer
to all of the Holders the opportunity to include of such number of Registrable Securities as such Holders may request in writing within
two (2)&nbsp;days (unless such offering is an overnight or bought Underwritten Offering, then one (1)&nbsp;day), in each case after receipt
of such written notice (such Registration a &ldquo;<B><U>Piggyback Registration</U></B>&rdquo;). The Company shall, in good faith, cause
such Registrable Securities to be included in such Piggyback Registration and shall use its reasonable best efforts to cause the managing
Underwriter or Underwriters of a proposed Underwritten Offering to permit the Registrable Securities requested by the Holders pursuant
to this <U>subsection 2.2.1</U> to be included in a Piggyback Registration on the same terms and conditions as any similar securities
of the Company included in such Piggyback Registration and to permit the resale or other disposition of such Registrable Securities in
accordance with the intended method(s) of distribution thereof. All such Holders proposing to include Registrable Securities in an Underwritten
Offering under this <U>subsection 2.2.1</U> shall enter into an underwriting agreement in customary form with the Underwriter(s) selected
for such Underwritten Offering by the Company.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2.2
<U>Reduction of Piggyback Registration</U>. If the managing Underwriter or Underwriters in an Underwritten Offering that is to be a Piggyback
Registration, in good faith, advises the Company and the Holders of Registrable Securities participating in the Piggyback Registration
in writing that the dollar amount or number of shares or equity securities of the Company that the Company desires to sell, taken together
with (a)&nbsp;the shares or equity securities of the Company, if any, as to which the Underwritten Offering has been demanded pursuant
to separate written contractual arrangements with persons or entities other than the Holders of Registrable Securities hereunder, (b)&nbsp;the
Registrable Securities as to which a Piggyback Registration has been requested pursuant to this <U>Section&nbsp;2.2</U> and (c)&nbsp;the
shares or equity securities of the Company, if any, as to which inclusion in the Underwritten Offering has been requested pursuant to
separate written contractual piggyback registration rights of other shareholders of the Company, exceeds the Maximum Number of Securities,
then:</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)
If the Underwritten Offering is undertaken for the Company&rsquo;s account, the Company shall include in any such Underwritten Offering
(A)&nbsp;first, the Ordinary Shares or other equity securities of the Company that the Company desires to sell, which can be sold without
exceeding the Maximum Number of Securities; (B)&nbsp;second, to the extent that the Maximum Number of Securities has not been reached
under the foregoing <U>clause (A)</U>, the Registrable Securities of Holders requesting a Piggyback Registration pursuant to <U>subsection
2.2.1</U>, Pro Rata, which can be sold without exceeding the Maximum Number of Securities; and (C)&nbsp;third, to the extent that the
Maximum Number of Securities has not been reached under the foregoing <U>clauses (A)</U>&nbsp;and <U>(B)</U>, Ordinary Shares or other
equity securities of the Company, if any, as to which inclusion in the Underwritten Offering has been requested pursuant to written contractual
piggyback registration rights of other shareholders of the Company, which can be sold without exceeding the Maximum Number of Securities;
or</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 1.5in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)
If the Underwritten Offering is pursuant to a request by persons or entities other than the Holders of Registrable Securities, then the
Company shall include in any such Underwritten Offering (A)&nbsp;first, Ordinary Shares or other equity securities of the Company, if
any, of such requesting persons or entities, other than the Holders, which can be sold without exceeding the Maximum Number of Securities;
(B)&nbsp;second, to the extent that the Maximum Number of Securities has not been reached under the foregoing <U>clause (A)</U>, the
Registrable Securities of Holders requesting a Piggyback Registration pursuant to <U>subsection 2.2.1</U>, Pro Rata, which can be sold
without exceeding the Maximum Number of Securities; (C)&nbsp;third, to the extent that the Maximum Number of Securities has not been
reached under the foregoing <U>clauses (A)</U>&nbsp;and <U>(B)</U>, Ordinary Shares or other equity securities of the Company that the
Company desires to sell, which can be sold without exceeding the Maximum Number of Securities; and (D)&nbsp;fourth, to the extent that
the Maximum Number of Securities has not been reached under the foregoing <U>clauses (A)</U>, <U>(B)</U> and <U>(C)</U>, Ordinary Shares
or other equity securities of the Company for the account of other persons or entities that the Company is obligated to register pursuant
to separate written contractual arrangements with such persons or entities, which can be sold without exceeding the Maximum Number of
Securities.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2.3
<U>Piggyback Registration Withdrawal</U>. Any Holder shall have the right to withdraw from a Piggyback Registration for any or no reason
whatsoever upon written notification to the Company and the Underwriter or Underwriters (if any) of his, her or its intention to withdraw
from such Piggyback Registration prior to the commencement of the Underwritten Offering. Notwithstanding anything to the contrary in
this Agreement, the Company shall be responsible for the Registration Expenses incurred in connection with the Piggyback Registration
prior to its withdrawal under this <U>subsection 2.2.3</U>.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.2.4
<U>Unlimited Piggyback Registration Rights</U>. For purposes of clarity, any Registration or Underwritten Offering effected pursuant
to this <U>Section&nbsp;2.2</U> shall not be counted as an Underwritten Offering pursuant to an Underwritten Demand effected under <U>Section&nbsp;2.1
</U>hereof.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.3
<U>Block Trades Other Coordinated Offerings</U></B>.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3.1
Notwithstanding any other provision of this <U>Article 2</U>, but subject to <U>Sections 2.4</U> and <U>3.4</U>, at any time and from
time to time when an effective Registration Statement is on file with the Commission, if a Demanding Holder wishes to engage in (a)&nbsp;an
underwritten registered offering not involving a &ldquo;roadshow,&rdquo; an offer commonly known as a &ldquo;block trade&rdquo; (a &ldquo;<B><U>Block
Trade</U></B>&rdquo;) or (b)&nbsp;an &ldquo;at the market&rdquo; or similar registered offering through a broker, sales agent or distribution
agent, whether as agent or principal, (an &ldquo;<B><U>Other Coordinated Offering</U></B>&rdquo;), in each case, with a total offering
price reasonably expected to exceed, in the aggregate, $25&nbsp;million, then if such Demanding Holder requires any assistance from the
Company pursuant to this <U>Section&nbsp;2.3</U>, such Holder shall notify the Company promptly of the Block Trade or Other Coordinated
Offering at least five (5)&nbsp;business days prior to the day such offering is to commence and the Company shall use its commercially
reasonable efforts to facilitate such Block Trade or Other Coordinated Offering; provided that the Demanding Holders representing a majority
of the Registrable Securities wishing to engage in the Block Trade or Other Coordinated Offering shall use commercially reasonable efforts
to work with the Company and any Underwriters or brokers, sales agents or placement agents (each, a &ldquo;<B><U>Financial Counterparty</U></B>&rdquo;)
prior to making such request in order to facilitate preparation of the registration statement, prospectus and other offering documentation
related to the Block Trade or Other Coordinated Offering.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3.2
Prior to the filing of the applicable &ldquo;red herring&rdquo; prospectus or prospectus supplement used in connection with a Block Trade
or Other Coordinated Offering, a majority-in interest of the Demanding Holders initiating such Block Trade or Other Coordinated Offering
shall have the right to withdraw from such Block Trade or Other Coordinated Offering for any or no reason whatsoever upon written notification
to the Company, the Underwriter or Underwriters (if any) and Financial Counterparty (if any) of their intention to withdraw from such
Block Trade or Other Coordinated Offering. Notwithstanding anything to the contrary in this Agreement, the Company shall be responsible
for the Registration Expenses incurred in connection with a Block Trade or Other Coordinated Offering prior to its withdrawal under this
<U>subsection 2.3.2</U>.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3.3
Notwithstanding anything to the contrary in this Agreement, <U>Section&nbsp;2.2</U> shall not apply to a Block Trade or Other Coordinated
Offering initiated by a Demanding Holder pursuant to <U>Section&nbsp;2.3</U> of this Agreement.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3.4
The Demanding Holder in a Block Trade or Other Coordinated Offering shall have the right to select the Underwriters and Financial Counterparty
(if any) for such Block Trade or Other Coordinated Offering (in each case, which shall consist of one or more reputable nationally recognized
investment banks).</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.3.5
A Demanding Holder in the aggregate may demand no more than four (4)&nbsp;Block Trades or Other Coordinated Offerings pursuant to this
<U>Section&nbsp;2.3</U> in any twelve (12)&nbsp;month period. For the avoidance of doubt, any Block Trade or Other Coordinated Offering
effected pursuant to this <U>Section&nbsp;2.3</U> shall not be counted as a demand for an Underwritten Offering pursuant to <U>subsection
2.1.3</U> hereof.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>2.4
<U>Restrictions on Registration Rights</U></B>. If (a)&nbsp;the Holders have requested an Underwritten Offering pursuant to an Underwritten
Demand and the Company and the Holders are unable to obtain the commitment of underwriters to firmly underwrite the offer; or (b)&nbsp;the
Holders have requested an Underwritten Offering pursuant to an Underwritten Demand and in the good faith judgment of the Board such Underwritten
Offering would be seriously detrimental to the Company and the Board concludes as a result that it is essential to defer the undertaking
of such Underwritten Offering at such time, then in each case the Company shall furnish to such Holders a certificate signed by the Chairman
of the Board stating that in the good faith judgment of the Board it would be seriously detrimental to the Company to undertake such
Underwritten Offering in the near future and that it is therefore essential to defer the undertaking of such Underwritten Offering. In
such event, the Company shall have the right to defer such offering for a period of not more than thirty (30)&nbsp;days; provided, however,
that the Company shall not defer its obligation in this manner more than once in any twelve (12)-month period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
3 </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>COMPANY
PROCEDURES </U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.1
<U>General Procedures.</U></B> The Company shall use its reasonable best efforts to effect such Registration or Underwritten Offering
to permit the resale or other disposition of such Registrable Securities in accordance with the intended plan of distribution thereof,
and pursuant thereto the Company shall, as expeditiously as possible and to the extent applicable:</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.1
prepare and file with the Commission after the consummation of the Business Combination a Registration Statement with respect to such
Registrable Securities and use commercially reasonable efforts to cause such Registration Statement to become effective in accordance
with <U>Section&nbsp;2.1</U> hereof and remain effective, including filing a replacement Registration Statement, if necessary, until
all Registrable Securities covered by such Registration Statement have been sold or are no longer outstanding (such period, the &ldquo;<B><U>Effectiveness
Period</U></B>&rdquo;);</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.2
prepare and file with the Commission such amendments and post-effective amendments to the Registration Statement, and such supplements
to the Prospectus, as may be reasonably requested by the Holders or any Underwriter or as may be required by the rules, regulations or
instructions applicable to the registration form used by the Company or by the Securities Act or rules and regulations thereunder to
keep the Registration Statement effective until all Registrable Securities covered by such Registration Statement are sold in accordance
with the intended plan of distribution set forth in such Registration Statement or supplement to the Prospectus or are no longer outstanding;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.3
prior to filing a Registration Statement or Prospectus, or any amendment or supplement thereto, furnish without charge to the Underwriters
or Financial Counterparty, if any, and the Holders of Registrable Securities included in such Registration or Underwritten Offering or
Block Trade, and such Holders&rsquo; legal counsel, copies of such Registration Statement as proposed to be filed, each amendment and
supplement to such Registration Statement (in each case including all exhibits thereto and documents incorporated by reference therein),
the Prospectus (including each preliminary Prospectus) and such other documents as the Underwriters and the Holders of Registrable Securities
included in such Registration or Underwritten Offering or the legal counsel for any such Holders may reasonably request in order to facilitate
the disposition of the Registrable Securities owned by such Holders; provided, that the Company will not have any obligation to provide
any document pursuant to this clause that is available on the Commission&rsquo;s EDGAR system;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.4
prior to any Underwritten Offering of Registrable Securities, use commercially reasonable efforts to (a)&nbsp;register or qualify the
Registrable Securities covered by the Registration Statement under such securities or &ldquo;<B><U>blue sky</U></B>&rdquo; laws of such
jurisdictions in the United States as the Holders of Registrable Securities included in such Registration Statement (in light of their
intended plan of distribution) may request and (b)&nbsp;take such action necessary to cause such Registrable Securities covered by the
Registration Statement to be registered with or approved by such other governmental authorities as may be necessary by virtue of the
business and operations of the Company and do any and all other acts and things that may be necessary or advisable to enable the Holders
of Registrable Securities included in such Registration Statement to consummate the disposition of such Registrable Securities in such
jurisdictions; provided, however, that the Company shall not be required to qualify generally to do business in any jurisdiction where
it would not otherwise be required to qualify or take any action to which it would be subject to general service of process or taxation
in any such jurisdiction where it is not then otherwise so subject;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.5
cause all such Registrable Securities to be listed on each securities exchange or automated quotation system on which similar securities
issued by the Company are then listed;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.6
provide a transfer agent or warrant agent, as applicable, and registrar for all such Registrable Securities no later than the effective
date of such Registration Statement or Underwritten Offering;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.7
advise each seller of such Registrable Securities, promptly after it shall receive notice or obtain knowledge thereof, of the issuance
of any stop order by the Commission suspending the effectiveness of such Registration Statement or the initiation or threatening of any
proceeding for such purpose and promptly use its reasonable best efforts to prevent the issuance of any stop order or to obtain its withdrawal
if such stop order should be issued;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.8
during the Effectiveness Period, furnish a conformed copy of each filing of any Registration Statement or Prospectus or any amendment
or supplement to such Registration Statement or Prospectus or any document that is to be incorporated by reference into such Registration
Statement or Prospectus, promptly after such filing of such documents with the Commission to each seller of such Registrable Securities
or its counsel; provided, that the Company will not have any obligation to provide any document pursuant to this clause that is available
on the Commission&rsquo;s EDGAR system;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.9
notify the Holders at any time when a Prospectus relating to such Registration Statement is required to be delivered under the Securities
Act;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.10
subject to the provisions of this Agreement, notify the Holders of the happening of any event as a result of which a Misstatement exists,
and then to correct such Misstatement as set forth in <U>Section&nbsp;3.4</U> hereof;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.11
in the event of an Underwritten Offering, a Block Trade, an Other Coordinated Offering, or sale by a Financial Counterparty pursuant
to such Registration, permit a representative of the Holders, the Underwriters or other Financial Counterparty facilitating such Underwritten
Offering, Block Trade, Other Coordinated Offering or other sale pursuant to such Registration, if any, and any attorney or accountant
retained by such Holders or Underwriter to participate, at each such person&rsquo;s own expense, in the preparation of the Registration
Statement or the Prospectus, and cause the Company&rsquo;s officers, directors and employees to supply all information reasonably requested
by any such representative, Underwriter, Financial Counterparty, attorney or accountant in connection with the Registration; provided,
however, that such representatives or Underwriters or Financial Counterparty enter into confidentiality agreements, in form and substance
reasonably satisfactory to the Company, prior to the release or disclosure of any such information;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.12
obtain a comfort letter from the Company&rsquo;s independent registered public accountants in the event of an Underwritten Offering,
a Block Trade, an Other Coordinated Offering, or sale by a Financial Counterparty pursuant to such Registration (subject to such Financial
Counterparty providing such certification or representation reasonably requested by the Company&rsquo;s independent registered public
accountants and the Company&rsquo;s counsel), in customary form and covering such matters of the type customarily covered by comfort
letters as the managing Underwriter may reasonably request, and reasonably satisfactory to a majority-in-interest of the participating
Holders;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.13
in the event of an Underwritten Offering, a Block Trade, an Other Coordinated Offering, or sale by a Financial Counterparty pursuant
to such Registration, on the date the Registrable Securities are delivered for sale pursuant to such Registration, obtain an opinion,
dated such date, of counsel representing the Company for the purposes of such Registration, addressed to the participating Holders or
the Financial Counterparty, if any, and the Underwriters, if any, covering such legal matters with respect to the Registration in respect
of which such opinion is being given as the participating Holders, Financial Counterparty or Underwriter may reasonably request and as
are customarily included in such opinions and negative assurance letters, and reasonably satisfactory to such participating Holders,
Financial Counterparty or Underwriter;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.14
in the event of an Underwritten Offering or a Block Trade, or an Other Coordinated Offering or sale by a Financial Counterparty pursuant
to such Registration to which the Company has consented, to the extent reasonably requested by such Financial Counterparty in order to
engage in such offering, allow the Underwriters or Financial Counterparty to conduct customary &ldquo;underwriter&rsquo;s due diligence&rdquo;
with respect to the Company;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.15
in the event of any Underwritten Offering, a Block Trade, an Other Coordinated Offering or sale by a Financial Counterparty pursuant
to such Registration, enter into and perform its obligations under an underwriting agreement or other purchase or sales agreement, in
usual and customary form, with the managing Underwriter or the Financial Counterparty of such offering or sale;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.16
make available to its security holders, as soon as reasonably practicable, an earnings statement covering the period of at least twelve
(12)&nbsp;months beginning with the first (1st) day of the Company&rsquo;s first full calendar quarter after the effective date of the
Registration Statement which satisfies the provisions of Section&nbsp;11(a) of the Securities Act and Rule 158 thereunder (or any successor
rule promulgated thereafter by the Commission);</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.17
use its reasonable efforts to make available senior executives of the Company to participate in customary &ldquo;<B><U>road show</U></B>&rdquo;
presentations that may be reasonably requested by the Underwriter in any Underwritten Offering; and</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1.18
otherwise, in good faith, cooperate reasonably with, and take such customary actions as may reasonably be requested by the Holders, in
connection with such Registration.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the foregoing, the Company shall not be required to provide any documents or information to an Underwriter or Financial Counterparty
if such Underwriter of Financial Counterparty has not then been named with respect to the applicable Underwritten Offering or other offering
involving a registration as an Underwriter or Financial Counterparty, as applicable.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.2
<U>Registration Expenses</U></B>. The Registration Expenses in respect of all Registrations shall be borne by the Company. It is acknowledged
by the Holders that the Holders shall bear all incremental selling expenses relating to the sale of Registrable Securities, such as Underwriters&rsquo;
commissions and discounts, brokerage fees, Underwriter marketing costs and, other than as set forth in the definition of &ldquo;<B>Registration
Expenses</B>,&rdquo; all reasonable fees and expenses of any legal counsel representing the Holders.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.3
<U>Requirements for Participation in Underwritten Offerings</U></B>. No person or entity may participate in any Underwritten Offering
for equity securities of the Company pursuant to a Registration initiated by the Company hereunder unless such person or entity (a)&nbsp;agrees
to sell such person&rsquo;s or entity&rsquo;s securities on the basis provided in any underwriting arrangements approved by the Company
and (b)&nbsp;completes and executes all customary questionnaires, powers of attorney, indemnities, lock-up agreements, underwriting agreements
and other customary documents as may be reasonably required under the terms of such underwriting arrangements.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.4
<U>Suspension of Sales</U></B>. Notwithstanding anything to the contrary in this Agreement, the Company shall be entitled to (A)&nbsp;delay
or postpone the (i)&nbsp;initial effectiveness of any Registration Statement or (ii)&nbsp;launch of any Underwritten Offering, in each
case, filed or requested pursuant to this Agreement, and (B)&nbsp;from time to time to require the Holders not to sell under any Registration
Statement or Prospectus or to suspend the effectiveness thereof, if the negotiation or consummation of a transaction by the Company or
its subsidiaries is pending or an event has occurred, which negotiation, consummation or event, the Board reasonably believes, upon the
advice of legal counsel, would require additional disclosure by the Company in the applicable Registration Statement or Prospectus of
material information that the Company has a bona fide business purpose for keeping confidential and the non-disclosure of which in the
Registration Statement or Prospectus would be expected, in the reasonable determination of the Board, upon the advice of legal counsel,
to cause the Registration Statement or Prospectus to fail to comply with applicable disclosure requirements (each such circumstance,
a &ldquo;<B><U>Suspension Event</U></B>&rdquo;); provided, however, that the Company may not delay or suspend a Registration Statement,
Prospectus or Underwritten Offering on more than two occasions, for more than sixty (60)&nbsp;consecutive calendar days, or more than
ninety (90)&nbsp;total calendar days, in each case during any twelve (12)-month period. Upon receipt of any written notice from the Company
of a Suspension Event while a Registration Statement filed pursuant to this Agreement is effective or if as a result of a Suspension
Event a Misstatement exists, each Holder agrees that (i)&nbsp;it will immediately discontinue offers and sales of Registered Securities
under each Registration Statement filed pursuant to this Agreement until the Holder receives copies of a supplemental or amended Prospectus
(which the Company agrees to promptly prepare) that corrects the relevant misstatements or omissions and receives notice that any post-effective
amendment has become effective or unless otherwise notified by the Company that it may resume such offers and sales and (ii)&nbsp;it
will maintain the confidentiality of information included in such written notice delivered by the Company unless otherwise required by
law or subpoena. If so directed by the Company, the Holders will deliver to the Company or, in Holders&rsquo; sole discretion destroy,
all copies of each Prospectus covering Registrable Securities in Holders&rsquo; possession; provided, however, that this obligation to
deliver or destroy shall not apply (A)&nbsp;to the extent the Holders are required to retain a copy of such Prospectus (x)&nbsp;to comply
with applicable legal, regulatory, self-regulatory or professional requirements or (y)&nbsp;in accordance with a bona fide pre-existing
document retention policy or (B)&nbsp;to copies stored electronically on archival servers as a result of automatic data back-up.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.5
<U>Reporting Obligations</U></B>. As long as any Holder shall own Registrable Securities, the Company, at all times while it shall be
a reporting company under the Exchange Act, covenants to file timely (or obtain extensions in respect thereof and file within the applicable
grace period) all reports required to be filed by the Company after the date hereof pursuant to Section&nbsp;13(a) or 15(d) of the Exchange
Act. The Company further covenants that it shall take such further action as any Holder may reasonably request, all to the extent required
from time to time to enable such Holder to resell or otherwise dispose of Registrable Securities held by such Holder without registration
under the Securities Act within the limitation of the exemptions provided by Rule 144 promulgated under the Securities Act (or any successor
rule promulgated thereafter by the Commission), including providing any legal opinions. Upon the request of any Holder, the Company shall
deliver to such Holder a written certification of a duly authorized officer as to whether it has complied with such requirements.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>3.6
<U>Limitation on Registration Rights</U></B>. Notwithstanding anything herein to the contrary, (i) the Representative may not exercise
its rights under Sections 2.1 and 2.2 hereunder after five (5) and seven (7) years, respectively, from the effective date of the Company&rsquo;s
registration statement on Form S-1, and (ii) the Representative may not exercise its rights under Section 2.1 more than one time.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
4 </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>INDEMNIFICATION
AND CONTRIBUTION </U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>4.1
<U>Indemnification</U></B>.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1.1
The Company agrees to indemnify, to the extent permitted by law, each Holder of Registrable Securities, its officers, directors, employees,
advisors, agents, representatives, members and each person who controls such Holder (within the meaning of the Securities Act) (collectively,
the &ldquo;<B><U>Holder Indemnified Persons</U></B>&rdquo;) against all losses, claims, damages, liabilities and expenses (including
reasonable attorneys&rsquo; fees and inclusive of all reasonable attorneys&rsquo; fees arising out of the enforcement of each such persons&rsquo;
rights under this <U>Section&nbsp;4.1</U>) resulting from any Misstatement, except insofar as the same are caused by or contained or
included in any information furnished in writing to the Company by or on behalf of such Holder Indemnified Person specifically for use
therein.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1.2
In connection with any Registration Statement in which a Holder of Registrable Securities is participating, such Holder shall furnish
to the Company in writing such information and affidavits as the Company reasonably requests for use in connection with any such Registration
Statement or Prospectus and, to the extent permitted by law, shall, severally and not jointly, indemnify the Company, its officers, directors,
employees, advisors, agents, representatives and each person who controls the Company (within the meaning of the Securities Act) against
any losses, claims, damages, liabilities and expenses (including reasonable attorneys&rsquo; fees and inclusive of all reasonable attorneys&rsquo;
fees arising out of the enforcement of each such persons&rsquo; rights under this <U>Section&nbsp;4.1</U>) resulting from any Misstatement,
but only to the extent that the same are made in reliance on and in conformity with information relating to the Holder so furnished in
writing to the Company by or on behalf of such Holder specifically for use therein. In no event shall the liability of any selling Holder
hereunder be greater in amount than the net proceeds received by such Holder from the sale of Registrable Securities pursuant to such
Registration Statement giving rise to such indemnification obligation.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1.3
Any person entitled to indemnification herein shall (a)&nbsp;give prompt written notice to the indemnifying party of any claim with respect
to which it seeks indemnification (provided that the failure to give prompt notice shall not impair any person&rsquo;s right to indemnification
hereunder to the extent such failure has not materially prejudiced the indemnifying party) and (b)&nbsp;unless in such indemnified party&rsquo;s
reasonable judgment a conflict of interest between such indemnified and indemnifying parties may exist with respect to such claim or
there may be reasonable defenses available to the indemnified party that are different from or additional to those available to the indemnifying
party, permit such indemnifying party to assume the defense of such claim with counsel reasonably satisfactory to the indemnified party.
If such defense is assumed, the indemnifying party shall not be subject to any liability for any settlement made by the indemnified party
without its consent (but such consent shall not be unreasonably withheld). An indemnifying party who is not entitled to, or elects not
to, assume the defense of a claim shall not be obligated to pay the fees and expenses of more than one counsel for all parties indemnified
by such indemnifying party with respect to such claim, unless in the reasonable judgment of any indemnified party a conflict of interest
may exist between such indemnified party and any other of such indemnified parties with respect to such claim. No indemnifying party
shall, without the consent of the indemnified party, consent to the entry of any judgment or enter into any settlement which cannot be
settled in all respects by the payment of money (and such money is so paid by the indemnifying party pursuant to the terms of such settlement)
or which settlement does not include as an unconditional term thereof the giving by the claimant or plaintiff to such indemnified party
of a release from all liability in respect to such claim or litigation.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1.4
The indemnification provided for under this Agreement shall remain in full force and effect regardless of any investigation made by or
on behalf of the indemnified party or any officer, director, employee, advisor, agent, representative, member or controlling person of
such indemnified party and shall survive the transfer of securities.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1.5
If the indemnification provided under this <U>Section&nbsp;4.1</U> is held by a court of competent jurisdiction to be unavailable to
an indemnified party in respect of any losses, claims, damages, liabilities and expenses referred to herein, then the indemnifying party,
in lieu of indemnifying the indemnified party, shall to the extent permitted by law contribute to the amount paid or payable by the indemnified
party as a result of such losses, claims, damages, liabilities and expenses in such proportion as is appropriate to reflect the relative
fault of the indemnifying party and the indemnified party, as well as any other relevant equitable considerations. The relative fault
of the indemnifying party and indemnified party shall be determined by a court of law by reference to, among other things, whether the
Misstatement relates to information supplied by such indemnifying party or such indemnified party and the indemnifying party&rsquo;s
and indemnified party&rsquo;s relative intent, knowledge, access to information and opportunity to correct or prevent such action; provided,
however, that the liability of any Holder under this <U>subsection 4.1.5</U> shall be limited to the amount of the net proceeds received
by such Holder in such offering giving rise to such liability. The amount paid or payable by a party as a result of the losses or other
liabilities referred to above shall be deemed to include, subject to the limitations set forth in <U>subsections 4.1.1</U>, <U>4.1.2
</U>and <U>4.1.3</U> above, any legal or other fees, charges or expenses reasonably incurred by such party in connection with any investigation
or proceeding. The parties hereto agree that it would not be just and equitable if contribution pursuant to this <U>subsection 4.1.5
</U>were determined by pro rata allocation or by any other method of allocation, which does not take account of the equitable considerations
referred to in this <U>subsection 4.1.5</U>. No person guilty of fraudulent misrepresentation (within the meaning of Section&nbsp;11(f)
of the Securities Act) shall be entitled to contribution pursuant to this <U>subsection 4.1.5</U> from any person who was not guilty
of such fraudulent misrepresentation.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>ARTICLE
5 </B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><U>MISCELLANEOUS
</U></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.1
<U>Notices</U></B>. Any notice or communication under this Agreement must be in writing and given by (a)&nbsp;deposit in the United States
mail, addressed to the party to be notified, postage prepaid and registered or certified with return receipt requested, (b)&nbsp;delivery
in person or by courier service or sent by overnight mail via a reputable overnight carrier, in each case providing evidence of delivery
or (c)&nbsp;transmission by facsimile or email. Each notice or communication that is mailed, delivered or transmitted in the manner described
above shall be deemed sufficiently given, served, sent, and received, in the case of mailed notices, on the third (3rd) business day
following the date on which it is mailed, in the case of notices delivered by courier service, hand delivery or overnight mail, at such
time as it is delivered to the addressee (with the delivery receipt or the affidavit of messenger) or at such time as delivery is refused
by the addressee upon presentation, and in the case of notices delivered by facsimile or email, at such time as it is successfully transmitted
to the addressee. Any notice or communication under this Agreement must be addressed, if to the Company, to: 7615 Zionsville Road, Indianapolis,
Indiana 46268, and, if to any other Holder, to the address of such Holder as it appears in the applicable register for the Registrable
Securities or such other address as may be designated in writing by such Holder (including on the signature pages hereto). Any party
may change its address for notice at any time and from time to time by written notice to the other parties hereto, and such change of
address shall become effective thirty (30)&nbsp;days after delivery of such notice as provided in this <U>Section&nbsp;5.1</U>.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.2
<U>Assignment; No Third Party Beneficiaries</U></B>.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2.1
This Agreement and the rights, duties and obligations of the Company hereunder may not be assigned or delegated by the Company in whole
or in part.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2.2.
Prior to the expiration of the Founder Shares Lock-up Period or the Private Placement Lock-up Period, as the case may be, no Holder may
assign or delegate such Holder&rsquo;s rights, duties or obligations under this Agreement, in whole or in part, except in connection
with a transfer of Registrable Securities by such Holder to a Permitted Transferee but only if such Permitted Transferee agrees to become
bound by the transfer restrictions set forth in this Agreement. After the expiration of the Founder Shares Lock-up Period or the Private
Placement Lock-up Period, as the case may be, the Holder may assign or delegate such Holder&rsquo;s rights, duties or obligations under
this Agreement, in while or in part, to any transferee.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2.3
This Agreement and the provisions hereof shall be binding upon and shall inure to the benefit of each of the parties and its successors
and the permitted assigns of the Holders, which shall include Permitted Transferees.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2.4
This Agreement shall not confer any rights or benefits on any persons that are not parties hereto, other than as expressly set forth
in this Agreement and this <U>Section&nbsp;5.2</U>.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.2.5
No assignment by any party hereto of such party&rsquo;s rights, duties and obligations hereunder shall be binding upon or obligate the
Company unless and until the Company shall have received (a)&nbsp;written notice of such assignment as provided in <U>Section&nbsp;5.1
</U>hereof and (b)&nbsp;the written agreement of the assignee, in a form reasonably satisfactory to the Company, to be bound by the terms
and provisions of this Agreement (which may be accomplished by an addendum or certificate of joinder to this Agreement). Any transfer
or assignment made other than as provided in this <U>Section&nbsp;5.2</U> shall be null and void.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.3
<U>Counterparts</U></B>. This Agreement may be executed in multiple counterparts (including facsimile or PDF counterparts), each of which
shall be deemed an original, and all of which together shall constitute the same instrument, but only one of which need be produced.</FONT></P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.4
<U>Governing Law; Venue</U></B>. NOTWITHSTANDING THE PLACE WHERE THIS AGREEMENT MAY BE EXECUTED BY ANY OF THE PARTIES HERETO, THE PARTIES
EXPRESSLY AGREE THAT THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED UNDER THE LAWS OF THE STATE OF NEW YORK AS APPLIED TO AGREEMENTS
AMONG NEW YORK RESIDENTS ENTERED INTO AND TO BE PERFORMED ENTIRELY WITHIN NEW YORK, WITHOUT REGARD TO THE CONFLICT OF LAW PROVISIONS
OF SUCH JURISDICTION.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.5
<U>Amendments and Modifications</U></B>. Upon the written consent of the Company and the Holders of at least a majority in interest of
the Registrable Securities at the time in question (which majority must include the Representative if such amendment or modification
is material and adverse to the Representative), compliance with any of the provisions, covenants and conditions set forth in this Agreement
may be waived, or any of such provisions, covenants or conditions may be amended or modified;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">provided,
however, that notwithstanding the foregoing, any amendment hereto or waiver hereof that adversely affects any Holder, solely in his,
her or its capacity as a holder of the shares of the Company, in a manner that is materially different from the other Holders (in such
capacity) shall require the consent of each such Holder so affected. No course of dealing between any Holder or the Company and any other
party hereto or any failure or delay on the part of a Holder or the Company in exercising any rights or remedies under this Agreement
shall operate as a waiver of any rights or remedies of any Holder or the Company. No single or partial exercise of any rights or remedies
under this Agreement by a party shall operate as a waiver or preclude the exercise of any other rights or remedies hereunder or thereunder
by such party.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.6
<U>Other Registration Rights</U></B>. The Company represents and warrants that no person, other than (a)&nbsp;a Holder of Registrable
Securities, (b)&nbsp;the holders of the Company&rsquo;s warrants pursuant to that certain Warrant Agreement dated as of September 5,
2024, each by and between the Company and Continental Stock Transfer&nbsp;&amp; Trust Company and (c)&nbsp;holders of Private Placement
Units, Private Placement Shares and Private Placement Warrants pursuant to that certain Private Placement Units Purchase Agreement dated
as of September 5, 2024, has any right to require the Company to register any securities of the Company for sale or to include such securities
of the Company in any Registration filed by the Company for the sale of securities for its own account or for the account of any other
person. Further, the Company represents and warrants that this Agreement supersedes any other registration rights agreement or agreement
with similar terms and conditions and in the event of a conflict between any such agreement or agreements and this Agreement, the terms
of this Agreement shall prevail.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>5.7
<U>Term</U></B>. This Agreement shall terminate upon the earlier of (a)&nbsp;the tenth (10th) anniversary of the date of this Agreement
and (b)&nbsp;the date as of which the Holders cease to hold any Registrable Securities. The provisions of <U>Article 4</U> shall survive
any termination.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">[<I>Signature
Page Follows</I>]</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>IN
WITNESS WHEREOF</B>, the undersigned have caused this Agreement to be executed as of the date first written above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>COMPANY:</B></FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ANDRETTI
    ACQUISITION CORP. II,</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    Cayman Islands exempted company</FONT></P></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 35%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
William M. Brown</FONT></P>
</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">William M. Brown</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>HOLDERS:</B></FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ANDRETTI
    SPONSOR II LLC,</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    Delaware limited liability company</FONT></P></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
William M. Brown </FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp;&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT>William M. Brown</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Managing Member</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BTIG, LLC</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
Paul Wood</FONT></P>
</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Paul Wood</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Managing Director, Co-Head
    of SPAC Investment Banking</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: small-caps 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">S<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ignature
Page to</FONT></P>

<P STYLE="font: small-caps 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">R<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">egistration
Rights Agreement&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>7
<FILENAME>ea021383001ex10-3_andretti2.htm
<DESCRIPTION>SPONSOR PRIVATE PLACEMENT UNITS PURCHASE AGREEMENT, DATED SEPTEMBER 5, 2024, BY AND BETWEEN THE COMPANY AND THE SPONSOR
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0in; text-align: right"><B>Exhibit 10.3</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PRIVATE PLACEMENT UNITS PURCHASE AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">THIS PRIVATE PLACEMENT UNITS PURCHASE AGREEMENT, dated as of September
5, 2024 (as it may from time to time be amended, this &ldquo;<B><I>Agreement</I></B>&rdquo;), is entered into by and between Andretti
Acquisition Corp. II, a Cayman Islands exempted company (the &ldquo;<B><I>Company</I></B>&rdquo;), and Andretti Sponsor II LLC, a Delaware
limited liability company (the &ldquo;<B><I>Purchaser</I></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, the Company intends
to consummate an initial public offering of the Company&rsquo;s units (the &ldquo;<B><I>Public Offering</I></B>&rdquo;), each unit consisting
of one Class A Ordinary Share, par value $0.0001 per share, of the Company (an &ldquo;<B><I>Ordinary Share</I></B>&rdquo;), and one-half
of one redeemable warrant (a &ldquo;<B><I>Warrant</I></B>&rdquo;) to purchase Ordinary Share (a &ldquo;<B><I>Warrant Share</I></B>&rdquo;)
to be governed by the Warrant Agreement to be entered into between the Company and Continental Stock Transfer &amp; Trust Company, as
warrant agent (the &ldquo;<B><I>Warrant Agreement</I></B>&rdquo;). Each whole Warrant entitles the holder to purchase one Ordinary Share
at an exercise price of $11.50 per Ordinary Share. The Purchaser has agreed to purchase an aggregate of 450,000 private placement units
(including if the over-allotment option in connection with the Public Offering is exercised in full) (the &ldquo;<B><I>Private Placement
Units</I></B>&rdquo;), each Private Placement Unit comprised of one Ordinary Share (the &ldquo;<B><I>Private Placement Shares</I></B>&rdquo;)
and one-half of one redeemable Warrant (the &ldquo;<B><I>Private Placement Warrants</I></B>&rdquo;) to purchase one Ordinary Shares (the
&ldquo;<B><I>Private Placement Warrant Shares</I></B>&rdquo;), as provided in the registration statement in connection with the Public
Offering, for a purchase price of $4,500,000, or $10.00 per unit.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NOW THEREFORE, in consideration
of the mutual promises contained in this Agreement and other good and valuable consideration, the receipt and sufficiency of which are
hereby acknowledged, the parties to this Agreement hereby, intending legally to be bound, agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><U>AGREEMENT</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 1. Authorization,
Purchase and Sale; Terms of the Private Placement Units.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">A. <U>Authorization of the Private
Placement Units</U>. The Company has duly authorized the issuance and sale of the Private Placement Units to the Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">B. <U>Purchase and Sale of
the Private Placement Units</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i) On the date
of the consummation of the Public Offering or on such earlier time and date as may be mutually agreed by the Purchaser and the Company
(the &ldquo;<B><I>Closing Date</I></B>&rdquo;), the Company shall issue and sell to the Purchaser, and the Purchaser shall purchase from
the Company, an aggregate of 450,000 Private Placement Units at a price of $10.00 per unit for an aggregate purchase price of $4,500,000
(the &ldquo;<B><I>Purchase Price</I></B>&rdquo;), which shall be paid by wire transfer of immediately available funds to the Company at
least one business day prior to the Closing Date in accordance with the Company&rsquo;s wiring instructions. On the Closing Date, upon
the payment by the Purchaser of the Purchase Price, the Company, at its option, shall deliver a certificate evidencing the Private Placement
Units purchased by the Purchaser on such date duly registered in the Purchaser&rsquo;s name to the Purchaser, or effect such delivery
in book-entry form.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">C. <U>Terms of the Private
Placement Units and Private Placement Warrants</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i) Each Private
Placement Unit shall have the terms set forth herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ii) Each Private
Placement Warrant shall have the terms set forth in the Warrant Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(iii) At the time
of the closing of the Public Offering, the Company and the Purchaser shall enter into a registration rights agreement (the &ldquo;<B><I>Registration
Rights Agreement</I></B>&rdquo;) pursuant to which the Company will grant certain registration rights to the Purchaser relating to the
Private Placement Units, the Private Placement Shares, the Private Placement Warrants and the Private Placement Warrant Shares (together,
the &ldquo;<B><I>Securities</I></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 2. Representations
and Warranties of the Company.</B> As a material inducement to the Purchaser to enter into this Agreement and purchase the Private Placement
Units, the Company hereby represents and warrants to the Purchaser (which representations and warranties shall survive the Closing Date)
that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A. <U>Incorporation and Corporate
Power</U>. The Company is an exempted company duly incorporated, validly existing and in good standing under the laws of the Cayman Islands
and is qualified to do business in every jurisdiction in which the failure to so qualify would reasonably be expected to have a material
adverse effect on the financial condition, operating results or assets of the Company. The Company possesses all requisite corporate power
and authority necessary to carry out the transactions contemplated by this Agreement and the Warrant Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">B. <U>Authorization; No Breach</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i) The execution,
delivery and performance of this Agreement and the Private Placement Units have been duly authorized by the Company as of the Closing
Date. This Agreement constitutes the valid and binding obligation of the Company, enforceable in accordance with its terms, subject to
bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium and other laws of general applicability relating to or affecting
creditors&rsquo; rights and to general equitable principles (whether considered in a proceeding in equity or law). Upon issuance in accordance
with, and payment pursuant to, the terms of the Warrant Agreement and this Agreement, the Private Placement Units, the Private Placement
Shares and Private Placement Warrants comprising such units, and Private Placement Warrant Shares will constitute valid and binding obligations
of the Company, enforceable in accordance with their terms as of the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ii) The execution
and delivery by the Company of this Agreement and the Private Placement Units, the issuance and sale of the Private Placement Units,
the issuance of the Private Placement Shares and Private Placement Warrant comprising the Private Placement Units, the issuance of the
Private Placement Warrant Shares and the fulfillment of, and compliance with, the respective terms hereof and thereof by the Company,
do not and will not as of the Closing Date (a) conflict with or result in a breach of the terms, conditions or provisions of, (b) constitute
a default under, (c) result in the creation of any lien, security interest, charge or encumbrance upon the Company&rsquo;s equity or
assets under, (d) result in a violation of, or (e) require any authorization, consent, approval, exemption or other action by or notice
or declaration to, or filing with, any court or administrative or governmental body or agency pursuant to the Amended and Restated Memorandum
and Articles of Association of the Company in effect on the date hereof or as may be amended at or prior to completion of the contemplated
Public Offering, or any material law, statute, rule or regulation to which the Company is subject, or any agreement, order, judgment
or decree to which the Company is subject, except for any filings required after the date hereof under federal or state securities laws.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">C. <U>Title to Securities</U>.
Upon issuance in accordance with, and payment pursuant to, the terms hereof, the Warrant Agreement and the Amended and Restated Memorandum
and Articles of Association of the Company, as the case may be, each of the Securities will be duly and validly issued, fully paid and
non-assessable. On the date of issuance of the Private Placement Units, the Private Placement Shares, the Private Placement Warrants
and the Warrant Shares shall have been reserved for issuance. Upon issuance in accordance with the terms hereof and the Warrant Agreement,
the Purchaser will have or receive good title to the Private Placement Units, the Private Placement Shares, the Private Placement Warrants
and the Warrant Shares, free and clear of all liens, claims and encumbrances of any kind other than (i) transfer restrictions hereunder
and pursuant to the insider letter to be entered into on or prior to the closing of the Public Offering and (ii) transfer restrictions
under federal and state securities laws .&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">D. <U>Governmental Consents</U>.
No permit, consent, approval or authorization of, or declaration to or filing with, any governmental authority is required in connection
with the execution, delivery and performance by the Company of this Agreement or the consummation by the Company of any other transactions
contemplated hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">E. <U>Regulation D Qualification</U>.
Neither the Company nor, to its knowledge, any of its affiliates, members, officers, directors or beneficial shareholders of 20% or more
of its outstanding securities, has experienced a disqualifying event as enumerated pursuant to Rule 506(d) of Regulation D under the Securities
Act of 1933, as amended (the &ldquo;<B><I>Securities Act</I></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 3. Representations
and Warranties of the Purchaser.</B> As a material inducement to the Company to enter into this Agreement and issue and sell the Private
Placement Units to the Purchaser, the Purchaser hereby represents and warrants to the Company (which representations and warranties shall
survive each Closing Date) that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">A. <U>Organization and Requisite
Authority</U>. The Purchaser possesses all requisite power and authority necessary to carry out the transactions contemplated by this
Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">B. <U>Authorization; No Breach</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i) This Agreement
constitutes a valid and binding obligation of the Purchaser, enforceable in accordance with its terms, subject to bankruptcy, insolvency,
fraudulent conveyance, reorganization, moratorium and other laws of general applicability relating to or affecting creditors&rsquo; rights
and to general equitable principles (whether considered in a proceeding in equity or law).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ii) The execution
and delivery by the Purchaser of this Agreement and the fulfillment of and compliance with the terms hereof by the Purchaser does not
and shall not as of each Closing Date conflict with or result in a breach by the Purchaser of the terms, conditions or provisions of any
agreement, instrument, order, judgment or decree to which the Purchaser is subject.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">C. <U>Investment Representations</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(i) The Purchaser
is acquiring the Securities, for the Purchaser&rsquo;s own account, for investment purposes only and not with a view towards, or for resale
in connection with, any public sale or distribution thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(ii) The Purchaser
is an &ldquo;accredited investor&rdquo; as such term is defined in Rule 501(a)(3) of Regulation D, and the Purchaser has not experienced
a disqualifying event as enumerated pursuant to Rule 506(d) of Regulation D under the Securities Act.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(iii) The Purchaser
understands that the Securities are being offered and will be sold to it in reliance on specific exemptions from the registration requirements
of the United States federal and state securities laws and that the Company is relying upon the truth and accuracy of, and the Purchaser&rsquo;s
compliance with, the representations and warranties of the Purchaser set forth herein in order to determine the availability of such exemptions
and the eligibility of the Purchaser to acquire such Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(iv) The Purchaser
did not decide to enter into this Agreement as a result of any general solicitation or general advertising within the meaning of Rule
502(c) under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(v) The Purchaser
has been furnished with all materials relating to the business, finances and operations of the Company and materials relating to the offer
and sale of the Securities which have been requested by the Purchaser. The Purchaser has been afforded the opportunity to ask questions
of the executive officers and directors of the Company. The Purchaser understands that its investment in the Securities involves a high
degree of risk and it has sought such accounting, legal and tax advice as it has considered necessary to make an informed investment decision
with respect to the acquisition of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(vi) The Purchaser
understands that no United States federal or state agency or any other government or governmental agency has passed on or made any recommendation
or endorsement of the Securities or the fairness or suitability of the investment in the Securities by the Purchaser nor have such authorities
passed upon or endorsed the merits of the offering of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(vii) The Purchaser
understands that: (a) the Securities have not been and are not being registered under the Securities Act or any state securities laws,
and may not be offered for sale, sold, assigned or transferred unless (1) subsequently registered thereunder or (2) sold in reliance on
an exemption therefrom; and (b) except as specifically set forth in the Registration Rights Agreement, neither the Company nor any other
person is under any obligation to register the Securities under the Securities Act or any state securities laws or to comply with the
terms and conditions of any exemption thereunder. While the Purchaser understands that Rule 144 under the Securities Act is not available
for the resale of securities initially issued by shell companies (other than business combination related shell companies) or issuers
that have been at any time previously a shell company, the Purchaser understands that Rule 144 includes an exception to this prohibition
if the following conditions are met: (i) the issuer of the securities that was formerly a shell company has ceased to be a shell company;
(ii) the issuer of the securities is subject to the reporting requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934,
as amended (the &ldquo;<B><I>Exchange Act</I></B>&rdquo;); (iii) the issuer of the securities has filed all Exchange Act reports and material
required to be filed, as applicable, during the preceding 12 months (or such shorter period that the issuer was required to file such
reports and materials), other than Form 8-K reports; and (iv) at least one year has elapsed from the time that the issuer filed current
Form 10 type information with the SEC reflecting its status as an entity that is not a shell company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0.5in">(viii) The Purchaser
has such knowledge and experience in financial and business matters, knows of the high degree of risk associated with investments in the
securities of companies in the development stage such as the Company, is capable of evaluating the merits and risks of an investment in
the Securities and is able to bear the economic risk of an investment in the Securities in the amount contemplated hereunder for an indefinite
period of time. The Purchaser has adequate means of providing for its current financial needs and contingencies and will have no current
or anticipated future needs for liquidity which would be jeopardized by the investment in the Securities. The Purchaser can afford a complete
loss of its investment in the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 4. Conditions
of the Purchaser&rsquo;s Obligations.</B> The obligation of the Purchaser to purchase and pay for the Private Placement Units is subject
to the fulfillment, on or before each Closing Date, of each of the following conditions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A. <U>Representations and
Warranties</U>. The representations and warranties of the Company contained in <U>Section 2</U> shall be true and correct at and as of
such Closing Date as though then made.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">B. <U>Performance</U>. The
Company shall have performed and complied with all agreements, obligations and conditions contained in this Agreement that are required
to be performed or complied with by it on or before such Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">C. <U>No Injunction</U>.
No litigation, statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated
or endorsed by or in any court or governmental authority of competent jurisdiction or any self-regulatory organization having authority
over the matters contemplated hereby, which prohibits the consummation of any of the transactions contemplated by this Agreement or the
Warrant Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">D. <U>Warrant Agreement</U>. The Company
shall have entered into the Warrant Agreement on terms satisfactory to the Purchaser.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 5. Conditions
of the Company&rsquo;s Obligations.</B> The obligations of the Company to the Purchaser under this Agreement are subject to the fulfillment,
on or before each Closing Date, of each of the following conditions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A. <U>Representations and
Warranties</U>. The representations and warranties of the Purchaser contained in <U>Section 3</U> shall be true and correct at and as
of such Closing Date as though then made.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">B. <U>Performance</U>. The
Purchaser shall have performed and complied with all agreements, obligations and conditions contained in this Agreement that are required
to be performed or complied with by the Purchaser on or before such Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">C. <U>Corporate Consents</U>.
The Company shall have obtained the consent of its Board of Directors authorizing the execution, delivery and performance of this Agreement
and the Warrant Agreement and the issuance and sale of the Private Placement Units hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">D. <U>No Injunction</U>.
No litigation, statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated
or endorsed by or in any court or governmental authority of competent jurisdiction or any self-regulatory organization having authority
over the matters contemplated hereby, which prohibits the consummation of any of the transactions contemplated by this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">E. <U>Warrant Agreement</U>.
The Company shall have entered into the Warrant Agreement on terms satisfactory to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 6. Termination.</B>
This Agreement may be terminated at any time after December 31, 2024 upon the election by either the Company or the Purchaser upon written
notice to the other party if the closing of the Public Offering does not occur prior to such date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 7. Survival of
Representations and Warranties.</B> All of the representations and warranties contained herein shall survive each Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 8. Definitions.</B>
Terms used but not otherwise defined in this Agreement shall have the meaning assigned to such terms in the registration statement on
Form S-1 the Company has filed with the U.S. Securities and Exchange Commission, under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Section 9. Miscellaneous.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">A. <U>Successors and Assigns</U>.
Except as otherwise expressly provided herein, all covenants and agreements contained in this Agreement by or on behalf of any of the
parties hereto shall bind and inure to the benefit of the respective successors of the parties hereto whether so expressed or not. Notwithstanding
the foregoing or anything to the contrary herein, the parties may not assign this Agreement, other than assignments by the Purchaser to
affiliates thereof (including, without limitation one or more of its members).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">B. <U>Severability</U>. Whenever
possible, each provision of this Agreement shall be interpreted in such manner as to be effective and valid under applicable law, but
if any provision of this Agreement is held to be prohibited by or invalid under applicable law, such provision shall be ineffective only
to the extent of such prohibition or invalidity, without invalidating the remainder of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">C. <U>Counterparts</U>. This
Agreement may be executed simultaneously in two or more counterparts, none of which need contain the signatures of more than one party,
but all such counterparts taken together shall constitute one and the same agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">D. <U>Descriptive Headings;
Interpretation</U>. The descriptive headings of this Agreement are inserted for convenience only and do not constitute a substantive part
of this Agreement. The use of the word &ldquo;including&rdquo; in this Agreement shall be by way of example rather than by limitation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">E. <U>Governing Law</U>.
This Agreement shall be deemed to be a contract made under the laws of the State of New York and for all purposes shall be construed in
accordance with the internal laws of the State of New York.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">F. <U>Amendments</U>. This
Agreement may not be amended, modified or waived as to any particular provision, except by a written instrument executed by all parties
hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[Signature Page Follows]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>IN WITNESS WHEREOF</B>, the parties hereto have
executed this Agreement to be effective as of the date first set forth above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-size: 10pt"><B>COMPANY</B>:</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-size: 10pt"><B>ANDRETTI ACQUISITION CORP. II</B></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; font-size: 10pt">/s/ William M. Brown</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 3%">&nbsp;</TD>
    <TD STYLE="width: 5%; font-size: 10pt">Name:</TD>
    <TD STYLE="width: 32%; font-size: 10pt">William M. Brown</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">Title:</TD>
    <TD STYLE="font-size: 10pt">Chief Executive Officer</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-size: 10pt"><B>PURCHASER</B>:</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3" STYLE="font-size: 10pt"><B>ANDRETTI SPONSOR II LLC</B>, <BR>
a Delaware limited liability company</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="3">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">By:</TD>
    <TD COLSPAN="2" STYLE="border-bottom: black 1.5pt solid; font-size: 10pt">/s/ William M. Brown</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font-size: 10pt">Name:</TD>
    <TD STYLE="font-size: 10pt">William M. Brown</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">Title:</TD>
    <TD STYLE="font-size: 10pt">Managing Member</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[Signature Page to Private Placement Units Purchase
Agreement]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>8
<FILENAME>ea021383001ex10-4_andretti2.htm
<DESCRIPTION>BTIG PRIVATE PLACEMENT UNITS PURCHASE AGREEMENT, DATED SEPTEMBER 5, 2024, BY AND BETWEEN THE COMPANY AND THE SPONSOR
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><B>Exhibit 10.4</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PRIVATE PLACEMENT UNITS PURCHASE AGREEMENT </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This PRIVATE PLACEMENT UNITS
PURCHASE AGREEMENT (this &ldquo;<B>Agreement</B>&rdquo;) is made as of the 5<SUP>th</SUP> day of September, 2024, by and between Andretti
Acquisition Corp. II, a Cayman Islands exempted company (the &ldquo;<B>Company</B>&rdquo;) and BTIG, LLC (&ldquo; <B>BTIG</B>&rdquo; or
the &ldquo;<B>Subscriber</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, the Company intends
to consummate an initial public offering (the &ldquo;<B>IPO</B>&rdquo;) of the Company&rsquo;s units (the &ldquo;<B>Units</B>&rdquo;),
each Unit consisting of one Class A ordinary share, par value $0.0001 per share (the &ldquo;<B>Class A Ordinary Shares</B>&rdquo;), of
the Company, and one-half of one redeemable warrant (a &ldquo;<B>Public Warrant</B>&rdquo;) to be governed by the Warrant Agreement to
be entered into between the Company and Continental stock Transfer &amp; Trust Company, as warrant agent (the &ldquo;<B>Warrant Agreement</B>&rdquo;).
Each whole Warrant entitles the holder thereof to purchase one Class A Ordinary Share at an exercise price of $11.50 per Class A Ordinary
Share;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, the Company desires
to sell to the Subscriber on a private placement basis (the &ldquo;<B>Offering</B>&rdquo;) an aggregate of 250,000 private placement units
(or up to 310,000 private placement units if the underwriters&rsquo; over-allotment option is exercised in full) (each, a &ldquo;<B>Placement
Unit</B>&rdquo; and, collectively, the &ldquo;<B>Placement Units</B>&rdquo;) of the Company for a purchase price of $10.00 per Placement
Unit. Each Placement Unit is comprised of one Class A Ordinary Share (a &ldquo;<B>Placement Share</B>&rdquo;) and one-half of one Warrant
(a &ldquo;<B>Placement Warrant</B>&rdquo; and together with the Public Warrants, the &ldquo;<B>Warrants</B>&rdquo;) to be governed by
the Warrant Agreement. Each whole Placement Warrant is exercisable to purchase one Class A Ordinary Share (a &ldquo;<B>Warrant Share</B>&rdquo;)
at an exercise price of $11.50. The Placement Units, the Placement Shares and Placement Warrants comprising part of the Placement Units,
and the Warrant Shares underlying the Placement Warrants collectively, are hereinafter referred to as the &ldquo;<B>Securities</B>.&rdquo;
As provided in the registration statement in connection with the IPO of the Company&rsquo;s Units, as amended at the time it becomes effective
(the &ldquo;<B>Registration Statement</B>&rdquo;), the Warrants are exercisable during the period commencing 30 days following the consummation
of the Company&rsquo;s initial business combination (the &ldquo;<B>Business Combination</B>&rdquo;) and will expire on the fifth anniversary
of the consummation of the Business Combination (provided that so long as the Private Warrants are held by the Subscriber or its designees,
the Subscriber or its designees will not be permitted to exercise such Warrants after the five year anniversary of the commencement of
sales in the IPO in accordance with FINRA Rule 5110(g)(8)); and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, the Subscriber wishes
to purchase an aggregate of 250,000 Placement Units (or up to 310,000 Placement Units if the underwriters&rsquo; over-allotment option
is exercised in full), and the Company wishes to accept such subscription from the Subscriber.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NOW, THEREFORE, in consideration
of the premises and the mutual covenants hereinafter set forth and other good and valuable consideration, the receipt and sufficiency
of which are hereby acknowledged, the Company and the Subscriber hereby agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">1. <I>Agreement to Subscribe</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">1.1. <U>Purchase and Issuance of the Placement
Units</U>. Upon the terms and subject to the conditions of this Agreement, on the date of the consummation of the IPO or on such earlier
time and date as may be mutually agreed by the Subscriber and the Company (the &ldquo;<B>Closing Date</B>&rdquo;), the Subscriber hereby
agrees to purchase from the Company, and the Company hereby agrees to sell to the Subscriber 250,000 Placement Units (or up to 310,000
Placement Units if the underwriters&rsquo; over-allotment option is exercised in full) at a price per unit of $10.00 for an aggregate
purchase price of $2,500,000 (or up to $3,100,000 if the underwriters&rsquo; over-allotment option is exercised in full) (the &ldquo;<B>Purchase
Price</B>&rdquo;). On the Closing Date, the Company shall, at its option, deliver to the Subscriber the certificates representing the
Placement Units purchased or effect such delivery in book-entry form.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">1.2. <U>Purchase Price</U>. The Purchase Price
shall be paid by wire transfer of immediately available funds, or by such other method as may be reasonably acceptable to the Company,
to the trust account (the <B>&ldquo;Trust Account&rdquo;</B>) at a financial institution to be chosen by the Company, maintained by Continental
Stock Transfer &amp; Trust Company, acting as trustee (&ldquo;<B>Continental</B>&rdquo;), on or prior to the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">1.3. <U>Closings</U>. The Closing shall take place
at the offices of Ellenoff Grossman &amp; Schole LLP, 1345 Avenue of the Americas, 11th Floor, New York, New York 10105, or such other
place as may be agreed upon by the parties hereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">1.4 <U>Termination</U>. This Agreement and each
of the obligations of the undersigned shall be null and void and without effect if a Closing does not occur prior to December 31, 2024.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">2. <I>Representations and Warranties of the Subscriber</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As a material inducement to the Company to enter
into this Agreement and issue and sell the Placement Units to the Subscriber, the Subscriber represents and warrants to the Company that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">2.1. <U>No Government Recommendation or Approval</U>.
The Subscriber understands that no federal or state agency has passed upon or made any recommendation or endorsement of the Company, the
merits of the Offering of the Securities or the suitability of the investment in the Securities by the Subscriber.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">2.2. <U>Accredited Investor</U>. The Subscriber
represents that it is an &ldquo;accredited investor&rdquo; as such term is defined in Rule 501(a) of Regulation D under the Securities
Act of 1933, as amended (the &ldquo;<B>Securities Act</B>&rdquo;), and acknowledges that the sale contemplated hereby is being made in
reliance, among other things, on a private placement exemption to &ldquo;accredited investors&rdquo; under the Securities Act and similar
exemptions under state law. The Subscriber has not experienced a disqualifying event as enumerated pursuant to Rule 506(d) of Regulation
D under the Securities Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">2.3. <U>Intent</U>. The Subscriber is purchasing
the Securities solely for investment purposes, for the Subscriber&rsquo;s own account (and/or for the account or benefit of its members
or affiliates, as permitted, pursuant to the terms hereof), and not with a view towards, or for resale in connection with, any public
sale or distribution thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">2.4. <U>Restrictions on Transfer</U>. The Subscriber
acknowledges and understands the Placement Units are being offered in a transaction not involving a public offering in the United States
within the meaning of the Securities Act. The Securities have not been registered under the Securities Act and, if in the future the Subscriber
decides to offer, resell, pledge or otherwise transfer the Securities, such Securities may be offered, resold, pledged or otherwise transferred
only (A) pursuant to an effective registration statement filed under the Securities Act, (B) pursuant to an exemption from registration
under Rule 144 promulgated under the Securities Act, if available, or (C) pursuant to any other available exemption from the registration
requirements of the Securities Act, and in each case in accordance with any applicable securities laws of any state or any other jurisdiction.
Notwithstanding the foregoing, the Subscriber acknowledges and understands the Securities are subject to transfer restrictions as described
in Section 7 hereof. The Subscriber agrees that if any transfer of its Securities or any interest therein is proposed to be made, as a
condition precedent to any such transfer, the Subscriber may be required to deliver to the Company an opinion of counsel satisfactory
to the Company with respect to such transfer. Absent registration or another available exemption from registration, the Subscriber agrees
it will not resell the Securities (unless otherwise permitted pursuant to the terms hereof). The Subscriber further acknowledges that
because the Company is a shell company, Rule 144 may not be available to the Subscriber for the resale of the Securities until the following
conditions are met: (i) the issuer of the securities that was formerly a shell company has ceased to be a shell company; (ii) the issuer
of the securities is subject to the reporting requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended (the
&ldquo;<B>Exchange Act</B>&rdquo;); (iii) the issuer of the securities has filed all Exchange Act reports and material required to be
filed, as applicable, during the preceding 12 months (or such shorter period that the issuer was required to file such reports and materials),
other than Form 8-K reports; and (iv) at least one year has elapsed from the time that the issuer filed current Form 10 type information
with the SEC reflecting its status as an entity that is not a shell company, despite technical compliance with the requirements of Rule
144 and the release or waiver of any contractual transfer restrictions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">2.5. <U>Sophisticated Investor</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i) The Subscriber is sophisticated
in financial matters and is able to evaluate the risks and benefits of the investment in the Securities. The Subscriber has adequate means
of providing for its current financial needs and contingencies and will have no current or anticipated future needs for liquidity which
would be jeopardized by the investment in the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ii) The Subscriber has been
furnished with all materials relating to the business, finances and operations of the Company and materials relating to the offer and
sale of the Securities which have been requested by the Subscriber. The Subscriber has been afforded the opportunity to ask questions
of the executive officers and directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(iii) The Subscriber is aware
that an investment in the Securities is highly speculative and subject to substantial risks because, among other things, (a) the Securities
are subject to transfer restrictions and have not been registered under the Securities Act and therefore cannot be sold unless subsequently
registered under the Securities Act or an exemption from such registration is available, (b) except as specifically set forth in the Registration
Rights Agreement (as defined below) pursuant to which the Company will grant certain registration rights to the Subscriber relating to
the Securities, neither the Company nor any other person is under any obligation to register the Securities under the Securities Act or
any state securities laws or to comply with the terms and conditions of any exemption thereunder and (c) the Subscriber has waived its
redemption rights with respect to the Securities as set forth in Section 5 hereof, and the Securities held by the Subscriber are not entitled
to, and have no right, interest or claim to any monies held in the Trust Account, and accordingly the Subscriber may suffer a loss of
a portion or all of its investment in the Securities. The Subscriber is able to bear the economic risk of its investment in the Securities
for an indefinite period of time. The Subscriber has sought such accounting, legal and tax advice as it has considered necessary to make
an informed investment decision with respect to the acquisition of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-family: Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">2.6. <U>Organization and Authority</U>. The Subscriber
is duly organized, validly existing and in good standing under the laws of its state of incorporation or formation and it possesses all
requisite power and authority necessary to carry out the transactions contemplated by this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">2.7. <U>Authority</U>. This Agreement has been
validly authorized, executed and delivered by the Subscriber and is a valid and binding agreement of the Subscriber enforceable against
the Subscriber in accordance with its terms, subject to the general principles of equity and to bankruptcy or other laws affecting the
enforcement of creditors&rsquo; rights generally.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">2.8. <U>No Conflicts</U>. The execution, delivery
and performance of this Agreement and the consummation by the Subscriber of the transactions contemplated hereby do not violate, conflict
with or constitute a default under (i) the Subscriber&rsquo;s organizational documents, (ii) any agreement or instrument to which the
Subscriber is a party or (iii) any law, statute, rule or regulation to which the Subscriber is subject, or any agreement, order, judgment
or decree to which the Subscriber is subject.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">2.9. <U>No Legal Advice from Company</U>. The
Subscriber acknowledges it has had the opportunity to review this Agreement and the transactions contemplated by this Agreement with the
Subscriber&rsquo;s own legal counsel and investment and tax advisors. Except for any statements or representations of the Company made
in this Agreement and the other agreements entered into between the parties hereto, the Subscriber is relying solely on such counsel and
advisors and not on any statements or representations of the Company or any of its representatives or agents for legal, tax or investment
advice with respect to this investment, the transactions contemplated by this Agreement or the securities laws of any jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">2.10. <U>Reliance on Representations and Warranties</U>.
The Subscriber understands the Placement Units are being offered and sold to the Subscriber in reliance on exemptions from the registration
requirements under the Securities Act, and analogous provisions in the laws and regulations of various states, and that the Company is
relying upon the truth and accuracy of the representations, warranties, agreements, acknowledgments and understandings of the Subscriber
set forth in this Agreement in order to determine the applicability of such provisions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">2.11. <U>No General Solicitation</U>. The Subscriber
is not subscribing for the Placement Units as a result of or subsequent to any general solicitation or general advertising, including
but not limited to any advertisement, article, notice or other communication published in any newspaper, magazine, or similar media or
broadcast over television or radio, or presented at any seminar or meeting or in a registration statement with respect to the IPO filed
with the Securities and Exchange Commission (&ldquo;<B>SEC</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">2.12. <U>Legend</U>. The Subscriber acknowledges
and agrees the certificates evidencing each of the Securities shall bear a restrictive legend (the &ldquo;<B>Legend</B>&rdquo;), in form
and substance substantially as set forth in Section 4 hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">3. <I>Representations, Warranties and Covenants
of the Company</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company represents and warrants to, and agrees
with, the Subscriber that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">3.1. <U>Valid Issuance</U>. The Company is authorized
to issue 500,000,000 Class A Ordinary Shares, 50,000,000 Class B ordinary shares, par value $0.0001 per share (&ldquo;<B>Class B Ordinary
Shares</B>&rdquo;) and 5,000,000 preference shares, par value $0.0001 per share (&ldquo;<B>Preference Shares</B>&rdquo;). As of the date
hereof, the Company has issued and outstanding 5,750,000 Class B Ordinary Shares (of which up to 750,000 shares are subject to forfeiture
as described in the Registration Statement) and no Preference Shares. All of the issued Class B Ordinary Shares of the Company have been
duly authorized, validly issued, and are fully paid and non-assessable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">3.2 <U>Title to Securities</U>. Upon issuance
in accordance with, and payment pursuant to, the terms hereof and the Warrant Agreement and the Amended and Restated Memorandum and Articles
of Association of the Company (as applicable), as the case may be, each of the Securities will be duly and validly issued, fully paid
and non-assessable. On the date of issuance of the Securities shall have been reserved for issuance. Upon issuance in accordance with,
and payment pursuant to, the terms hereof and the Warrant Agreement, as the case may be, the Subscriber will have or receive good title
to the Securities, free and clear of all liens, claims and encumbrances of any kind, other than (i) transfer restrictions hereunder, (ii)
transfer restrictions under federal and state securities laws and (iii) liens, claims or encumbrances imposed due to the actions of the
Subscriber.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">3.3. <U>Organization and Qualification</U>. The
Company is an exempted company duly incorporated, validly existing and in good standing under the laws of the Cayman Islands and has the
requisite corporate power to own its properties and assets and to carry on its business as now being conducted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-family: Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">3.4. <U>Authorization; Enforcement</U>. (i) The
Company has the requisite corporate power and authority to enter into and perform its obligations under this Agreement and to issue the
Securities in accordance with the terms hereof, (ii) the execution, delivery and performance of this Agreement by the Company and the
consummation by it of the transactions contemplated hereby have been duly authorized by all necessary corporate action, and no further
consent or authorization of the Company or its Board of Directors or shareholders is required, and (iii) this Agreement constitutes valid
and binding obligations of the Company enforceable against the Company in accordance with its terms, except as such enforceability may
be limited by applicable bankruptcy, insolvency, fraudulent conveyance, moratorium, reorganization, or similar laws relating to, or affecting
generally the enforcement of, creditors&rsquo; rights and remedies or by equitable principles of general application and except as enforcement
of rights to indemnity and contribution may be limited by federal and state securities laws or principles of public policy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">3.5. <U>No Conflicts</U>. The execution, delivery
and performance of this Agreement and the consummation by the Company of the transactions contemplated hereby do not (i) result in a violation
of the Company&rsquo;s amended and restated memorandum and articles of association, (ii) conflict with, or constitute a default under
any agreement or instrument to which the Company is a party or (iii) any law statute, rule or regulation to which the Company is subject
or any agreement, order, judgment or decree to which the Company is subject. Other than any SEC or state securities filings which may
be required to be made by the Company subsequent to the Closing, and any registration statement which may be filed pursuant thereto, the
Company is not required under federal, state or local law, rule or regulation to obtain any consent, authorization or order of, or make
any filing or registration with, any court or governmental agency or self-regulatory entity in order for it to perform any of its obligations
under this Agreement or issue the Securities in accordance with the terms hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">4. <I>Legends</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">4.1. <U>Legend</U>. The Company will issue the
Placement Units, Placement Shares, and Placement Warrants, and when issued, the Warrant Shares, purchased by the Subscriber in the name
of the Subscriber. The Securities will bear the following Legend and appropriate &ldquo;stop transfer&rdquo; instructions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&ldquo;THE SECURITIES REPRESENTED BY
THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS, AND MAY NOT BE OFFERED,
SOLD, TRANSFERRED OR OTHERWISE DISPOSED OF UNLESS REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND ANY APPLICABLE STATE SECURITIES
LAWS OR AN EXEMPTION FROM REGISTRATION IS AVAILABLE. IN ADDITION, SUBJECT TO ANY ADDITIONAL LIMITATIONS ON TRANSFER DESCRIBED IN THE AGREEMENTS
BY AND AMONG ANDRETTI ACQUISITION CORP. II (THE &ldquo;COMPANY&rdquo;), ANDRETTI SPONSOR II LLC AND THE OTHER SIGNATORIES THERETO, THE
SECURITIES REPRESENTED BY THIS CERTIFICATE MAY NOT BE SOLD OR TRANSFERRED PRIOR TO THE DATE THAT IS THIRTY (30) DAYS AFTER THE DATE UPON
WHICH THE COMPANY COMPLETES ITS INITIAL BUSINESS COMBINATION (AS DEFINED IN SECTION 3 OF THE WARRANT AGREEMENT REFERRED TO HEREIN) EXCEPT
TO A PERMITTED TRANSFEREE WHO AGREES IN WRITING WITH THE COMPANY TO BE SUBJECT TO SUCH TRANSFER PROVISIONS.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">SECURITIES EVIDENCED BY THIS CERTIFICATE
AND ORDINARY SHARES OF THE COMPANY ISSUED UPON EXERCISE OF SUCH SECURITIES SHALL BE ENTITLED TO REGISTRATION RIGHTS UNDER A REGISTRATION
RIGHTS AGREEMENT TO BE EXECUTED BY THE COMPANY.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">4.2. <U>Subscriber&rsquo;s Compliance</U>. Nothing
in this Section 4 shall affect in any way the Subscriber&rsquo;s obligation and agreement to comply with all applicable securities laws
upon resale of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">4.3. <U>Company&rsquo;s Refusal to Register Transfer
of the Securities</U>. The Company shall refuse to register any transfer of the Securities, if in the sole judgment of the Company such
purported transfer would not be made (i) pursuant to an effective registration statement filed under the Securities Act, or pursuant to
an available exemption from the registration requirements of the Securities Act and (ii) in compliance herewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">4.4 <U>Registration Rights</U>. The Subscriber
will be entitled to certain registration rights which will be governed by a registration rights agreement (&ldquo;<B>Registration Rights
Agreement</B>&rdquo;) to be entered into between, among others, the Subscriber and the Company, on or prior to the effective date of the
Registration Statement. Pursuant to the Registration Rights Agreement, the Subscriber may not exercise its demand and &ldquo;piggyback&rdquo;
registration rights after five (5) and seven (7) years from the commencement of sales in the IPO and may not exercise its demand rights
on more than one occasion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-family: Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">5. <I>Waiver of Liquidation Distributions.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the Securities purchased pursuant
to this Agreement, the Subscriber hereby waives any and all right, title, interest or claim of any kind in or to any distributions of
the amounts in the Trust Account with respect to the Securities, whether (i) in connection with the exercise of redemption rights if the
Company consummates the Business Combination, (ii) in connection with any tender offer conducted by the Company prior to a Business Combination,
(iii) upon the Company&rsquo;s redemption of Class A Ordinary Shares included in the Units sold in the Company&rsquo;s IPO upon the Company&rsquo;s
failure to complete the Business Combination within the period provided for in the Company's amended and restated memorandum and articles
of association or (iv) in connection with a shareholder vote to approve an amendment to the Company&rsquo;s amended and restated memorandum
and articles of association not for the purposes of approving, or in conjunction with the consummation of, a Business Combination (A)
to modify the substance or timing of the Company&rsquo;s obligation to allow redemption in connection with a Business Combination or to
redeem 100% of the Class A Ordinary Shares included in the Units sold in the Company&rsquo;s IPO if the Company has not consummated a
Business Combination within the period provided for in the Company's amended and restated memorandum and articles of association or (B)
with respect to any other material provisions relating to the right of holders of Class A Ordinary Shares or pre-Business Combination
activity. In the event that the Subscriber purchases Class A Ordinary Shares as part of the Units in the IPO or in the aftermarket, any
additional Class A Ordinary Shares so purchased shall be eligible to receive the redemption value of such Class A Ordinary Shares upon
the same terms offered to all other purchasers of Class A Ordinary Shares included as part of the Units in the IPO. Nothing herein shall
preclude the Subscriber from making any claim or seeking recourse against the Company&rsquo;s funds held outside of the Trust Account
or seeking to enforce the terms of the Underwriting Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">6. <I>Terms of Placement Warrants</I>. Each Placement
Warrant shall have the terms set forth in the Warrant Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">7. <I>Lock-Up Period</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">7.1. The Subscriber agrees that they shall not
Transfer any Securities until 30 days following the consummation of the Business Combination; provided, however, that Transfers of Securities
are permitted (a) to the Company&rsquo;s or the Subscriber&rsquo;s officers or directors, any affiliates or family members of any of the
Company&rsquo;s or the Subscriber&rsquo;s officers or directors, any members of the Company&rsquo;s sponsor, or any affiliates of the
Company&rsquo;s sponsor, (b) in the case of an individual, by gift to a member of the individual&rsquo;s immediate family or to a trust,
the beneficiary of which is a member of the individual&rsquo;s immediate family or an affiliate of such person, or to a charitable organization;
(c) in the case of an individual, by virtue of laws of descent and distribution upon death of the individual; (d) in the case of an individual,
pursuant to a qualified domestic relations order; (e) by virtue of the laws of the State of New York or the Subscriber&rsquo;s partnership
agreement in the event of the Subscriber&rsquo;s liquidation; (f) in the event of the Company&rsquo;s liquidation prior to the consummation
of a Business Combination; provided, however, that in the case of clauses (a) through (f) these permitted transferees must enter into
a written agreement agreeing to be bound by these transfer restrictions and by the same agreements entered into by the Company&rsquo;s
sponsor and the Subscriber with respect to such securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">7.2. For purposes of Section 7.1, the term &ldquo;<B>Transfer</B>&rdquo;
shall mean the (a) sale of, offer to sell, contract or agreement to sell, hypothecate, pledge, grant of any option to purchase or otherwise
dispose of or agreement to dispose of, directly or indirectly, or establishment or increase of a put equivalent position or liquidation
with respect to or decrease of a call equivalent position within the meaning of Section 16 of the Securities Exchange Act of 1934, as
amended, and the rules and regulations of the SEC promulgated thereunder with respect to, any of the Securities, (b) entry into any swap
or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of any of the Securities,
whether any such transaction is to be settled by delivery of such Securities, in cash or otherwise, or (c) public announcement of any
intention to effect any transaction specified in clause (a) or (b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">7.3 In addition to the restrictions on transfer
described in Section 7.1, the Subscriber acknowledges and agrees that the Placement Units and their component parts and the related registration
rights will be deemed compensation by the Financial Industry Regulatory Authority (&ldquo;<B>FINRA</B>&rdquo;) and will therefore, pursuant
to Rule 5110(e) of the FINRA Manual, be subject to lock-up for a period of 180 days immediately following the commencement of sales in
the IPO, subject to FINRA Rule 5110(e)(2). Additionally, the Placement Units and their component parts and the related registration rights
may not be sold, transferred, assigned, pledged or hypothecated during the foregoing 180 day period except to any underwriter or selected
dealer participating in the IPO and the officers or partners, registered persons or affiliates of the Subscriber and any such participating
underwriter or selected dealer. Additionally, the Placement Units and their component parts and the related registration rights will not
be the subject of any hedging, short sale, derivative, put or call transaction that would result in the economic disposition of such securities
by any person for a period of 180 days immediately following the commencement of sales in the IPO.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-family: Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">8. <I>Terms of the Placement Units</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Placement Units shall be substantially identical
to the Units offered in the IPO except that the Placement Units (including the Placement Shares and Placement Warrants comprising such
units and the Warrant Shares) (i) will be subject to the transfer restrictions described in Section 7 hereof; (ii) will be entitled to
registration rights and (iii) with respect to the Placement Warrants, may not be exercisable more than five years from the commencement
of sales in the IPO in accordance with FINRA Rule 5110(g)(8).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">9. <I>Conditions of the Subscriber&rsquo;s Obligations
</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The obligation of the Subscriber to purchase and
pay for the Private Placement Units is subject to the fulfillment, on or before the Closing Date, of each of the following conditions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">9.1. <U>Representations and Warranties</U>. The
representations and warranties of the Company contained in Section 3 hereof shall be true and correct at and as of the Closing Date as
though then made.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">9.2. <U>Performance</U>. The Company shall have
performed and complied with all agreements, obligations and conditions contained in this Agreement that are required to be performed or
complied with by it on or before the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">9.3. <U>No Injunction</U>. No litigation, statute,
rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated or endorsed by or in any
court or governmental authority of competent jurisdiction or any self-regulatory organization having authority over the matters contemplated
hereby, which prohibits the consummation of any of the transactions contemplated by this Agreement or the Warrant Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">9.4. <U>Warrant Agreement</U>. The Company shall
have entered into the Warrant Agreement with a warrant agent on terms satisfactory to the Subscriber.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">10. <I>Conditions of the Company&rsquo;s Obligations</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">10.1. <U>Representations and Warranties</U>. The
representations and warranties of the Subscriber contained in Section 2 hereof shall be true and correct at and as of the Closing Date
as though then made.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">10.2. <U>Performance</U>. The Subscriber shall
have performed and complied with all agreements, obligations and conditions contained in this Agreement that are required to be performed
or complied with by the Subscriber on or before the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">10.3. <U>No Injunction</U>. No litigation, statute,
rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated or endorsed by or in any
court or governmental authority of competent jurisdiction or any self-regulatory organization having authority over the matters contemplated
hereby, which prohibits the consummation of any of the transactions contemplated by this Agreement or the Warrant Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">10.4. <U>Warrant Agreement</U>. The Company shall
have entered into the Warrant Agreement with a warrant agent on terms satisfactory to the Subscriber.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">11. <I>Governing Law; Jurisdiction</I>; <I>Waiver
of Jury Trial</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This Agreement shall be governed by and construed
in accordance with the laws of the State of New York for agreements made and to be wholly performed within such state. The parties hereto
hereby waive any right to a jury trial in connection with any litigation pursuant to this Agreement and the transactions contemplated
hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">12. <I>Assignment; Entire Agreement; Amendment</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">12.1. <U>Assignment</U>. Neither this Agreement
nor any rights hereunder may be assigned by any party to any other person other than by the Subscriber to a person agreeing to be bound
by the terms hereof, including the transfer restrictions contained in Section 7 hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">12.2. <U>Entire Agreement</U>. This Agreement
sets forth the entire agreement and understanding between the parties as to the subject matter thereof and merges and supersedes all prior
discussions, agreements and understandings of any and every nature among them.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">12.3. <U>Amendment</U>. Except as expressly provided
in this Agreement, neither this Agreement nor any term hereof may be amended, waived, discharged or terminated other than by a written
instrument signed by all of the parties hereto. Any amendment to the terms of the Placement Warrants (including, for the avoidance of
doubt, the forfeiture or cancellation thereof) shall require the prior written consent of BTIG. Each of the parties hereto shall receive
notice of any proposed amendment to the terms of the Placement Warrants at least two business days prior to the effective date of such
amendment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">12.4. <U>Binding upon Successors</U>. This Agreement
shall be binding upon and inure to the benefit of the parties hereto and to their respective heirs, legal representatives, successors
and permitted assigns.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I></I></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-family: Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>13. <I>Notices</I></I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">13.1 <U>Notices</U>. Unless otherwise provided
herein, any notice or other communication to a party hereunder shall be sufficiently given if in writing and personally delivered or sent
by facsimile or other electronic transmission with copy sent in another manner herein provided or sent by courier (which for all purposes
of this Agreement shall include Federal Express or other recognized overnight courier) or mailed to said party by certified mail, return
receipt requested, at its address provided for herein or such other address as either may designate for itself in such notice to the other.
Communications shall be deemed to have been received when delivered personally, on the scheduled arrival date when sent by next day or
2nd-day courier service, or if sent by facsimile upon receipt of confirmation of transmittal or, if sent by mail, then three days after
deposit in the mail. If given by electronic transmission, such notice shall be deemed to be delivered (a) if by electronic mail, when
directed to an electronic mail address at which the recipient has consented to receive notice; (b) if by a posting on an electronic network
together with separate notice to the recipient of such specific posting, upon the later of (1) such posting and (2) the giving of such
separate notice; and (c) if by any other form of electronic transmission, when directed to the recipient.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">14. <I>Counterparts</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This Agreement may be executed in one or more
counterparts, all of which when taken together shall be considered one and the same agreement and shall become effective when counterparts
have been signed by each party and delivered to the other party, it being understood that both parties need not sign the same counterpart.
In the event that any signature is delivered by facsimile transmission or by e-mail delivery of a &ldquo;pdf&rdquo; format data file,
such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with
the same force and effect as if such facsimile or &ldquo;.pdf&rdquo; signature page were an original thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">15. <I>Survival; Severability</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">15.1. <U>Survival</U>. The representations, warranties,
covenants and agreements of the parties hereto shall survive the Closing Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">15.2. <U>Severability</U>. In the event that any
provision of this Agreement becomes or is declared by a court of competent jurisdiction to be illegal, unenforceable or void, this Agreement
shall continue in full force and effect without said provision; provided that no such severability shall be effective if it materially
changes the economic benefit of this Agreement to any party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">16. <I>Headings.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The titles and subtitles used in this Agreement
are used for convenience only and are not to be considered in construing or interpreting this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[remainder of page intentionally left blank]</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-family: Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; font-style: normal; font-weight: normal"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-indent: 0.5in; font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">IN WITNESS WHEREOF, the parties hereto have executed this Agreement
to be effective as of the date first set forth above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><B>COMPANY:</B></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><B>ANDRETTI ACQUISITION CORP. II</B></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 3%">By:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 37%">/s/ William M. Brown</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Name: William M. Brown</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Title: Chief Executive Officer</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><B>SUBSCRIBER:</B></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><B>BTIG, LLC</B></TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>By:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">/s/ Paul Wood</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Name: Paul Wood</TD>
    </TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>Title: Managing Director, Co-Head of SPAC Investment Banking</TD>
    </TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>[Signature Page &ndash; Unit Purchase Agreement]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.5
<SEQUENCE>9
<FILENAME>ea021383001ex10-5_andretti2.htm
<DESCRIPTION>LETTER AGREEMENT, DATED SEPTEMBER 5, 2024, BY AND AMONG THE COMPANY, ITS OFFICERS, DIRECTORS, AND THE SPONSOR
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Exhibit 10.5</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">September 5, 2024</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Andretti Acquisition Corp. II</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">7615 Zionsville Road</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indianapolis, Indiana 46268</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Re: <U>Initial Public Offering</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">This letter (this &ldquo;<B><U>Letter Agreement</U></B>&rdquo;)
is being delivered to you in accordance with the Underwriting Agreement (the &ldquo;<B><U>Underwriting Agreement</U></B>&rdquo;) entered
into by and among Andretti Acquisition Corp. II, a Cayman Islands exempted company (the &ldquo;<B><U>Company</U></B>&rdquo;) and BTIG,
LLC, as representative (the &ldquo;<B><U>Representative</U></B>&rdquo;) of the underwriters (the &ldquo;<B><U>Underwriters</U></B>&rdquo;),
relating to an underwritten initial public offering (the &ldquo;<B><U>Public Offering</U></B>&rdquo;), of up to 23,000,000 of the Company&rsquo;s
units (including up to 3,000,000 units which may be purchased to cover over-allotments, if any) (the &ldquo;<B><U>Units</U></B>&rdquo;),
each comprised of one Class A ordinary share, par value $0.0001 per share, of the Company (the &ldquo;<B><U>Class A Ordinary Shares</U></B>&rdquo;)
and one-half of one redeemable warrant (each whole warrant, a &ldquo;<B><U>Warrant</U></B>&rdquo;). Each Warrant entitles the holder thereof
to purchase one Class A Ordinary Share at a price of $11.50 per share, subject to adjustment. The Units shall be sold in the Public Offering
pursuant to the registration statement on Form S-1 (File No. 333-280552) and prospectus (the &ldquo;<B><U>Prospectus</U></B>&rdquo;) filed
by the Company with the U.S. Securities and Exchange Commission (the &ldquo;<B><U>Commission</U></B>&rdquo;) and the Company shall apply
to have the Units listed on the Nasdaq Global Market. Certain capitalized terms used herein are defined in paragraph 11 hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">In order to induce the Company and the Underwriters
to enter into the Underwriting Agreement and to proceed with the Public Offering and for other good and valuable consideration, the receipt
and sufficiency of which are hereby acknowledged, Andretti Sponsor II LLC, a Delaware limited liability company (the &ldquo;<B><U>Sponsor</U></B>&rdquo;)
and each of the undersigned individuals, each of whom is, or will be, a member of the Company&rsquo;s board of directors and/or management
team (each an &ldquo;<B><U>Insider</U></B>&rdquo; and, collectively, the &ldquo;<B><U>Insiders</U></B>&rdquo;), hereby agree with the
Company as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">1. The Sponsor and each Insider agree that if
the Company seeks shareholder approval of a proposed Business Combination, then in connection with such proposed Business Combination,
it, he or she shall (i) vote all Founder Shares and any shares acquired by it, him or her in the Public Offering or the secondary public
market in favor of such proposed Business Combination, except that it, he or she shall not vote any Class A Ordinary Shares that it, he
or she purchased after the Company publicly announces its intention to engage in such proposed Business Combination for or against such
proposed Business Combination and (ii) not redeem any Class A Ordinary Shares owned by it, him or her in connection with such shareholder
approval. If the Company seeks to consummate a proposed Business Combination by engaging in a tender offer, the Sponsor and each Insider
agrees that it, he or she will not sell or tender any Ordinary Shares owned by it, him or her in connection herewith.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">2. The Sponsor and each Insider agree that
in the event that the Company fails to consummate a Business Combination by the date that is 24 months after the closing of the
Public Offering, or such earlier date as Company&rsquo;s board of directors may approve, or such later date as the Company&rsquo;s
shareholders may approve, in each case in accordance with the Company&rsquo;s amended and restated memorandum and articles of
association, as may be amended from time to time (the &ldquo;<B><U>Completion Window</U></B>&rdquo; and the &ldquo;<B><U>Memorandum
and Articles,</U></B>&rdquo; respectively), the Sponsor and each Insider shall take all reasonable steps to cause the Company to (i)
cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten (10)
business days thereafter, subject to lawfully available funds therefor, redeem 100% of the Class A Ordinary Shares sold as part of
the Units in the Public Offering (the &ldquo;<B><U>Offering Shares</U></B>&rdquo;), at a per-share price, payable in cash, equal to
the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account (which
interest shall be net of taxes payable and less up to $100,000 of interest to pay dissolution expenses), divided by the number of
Offering Shares then in issue, which redemption will completely extinguish the Public Shareholders&rsquo; rights as shareholders
(including the right to receive further liquidation distributions, if any), subject to applicable law and (iii) as promptly as
reasonably possible following such redemption, subject to the approval of the Company&rsquo;s remaining shareholders and the
Company&rsquo;s board of directors, dissolve and liquidate, subject in each case to the Company&rsquo;s obligations under Cayman
Islands law to provide for claims of creditors and other requirements of applicable law. The Sponsor and the Insiders agree to not
propose any amendment to the Memorandum and Articles not for the purposes of approving, or in conjunction with the consummation of,
a Business Combination (A) to modify the substance or timing of the Company&rsquo;s obligation to allow redemption in connection
with a Business Combination or to redeem one hundred per cent (100%) of the Offering Shares if the Company has not consummated a
Business Combination within the Completion Window or (B) with respect to any other material provisions relating to the rights of
holders of Class A Ordinary Shares or pre-initial Business Combination activity, unless the Company provides its Public Shareholders
with the opportunity to redeem their Offering Shares upon effectiveness of any such amendment at a per share price, payable in cash,
equal to the aggregate amount then on deposit in the Trust Account including interest earned on the Trust Account and not previously
released to the Company to pay its taxes, divided by the number of Offering Shares then in issue, subject to applicable law. The
Sponsor and each Insider acknowledges that it, he or she will not be entitled to rights to liquidating distributions from the Trust
Account with respect to any Founder Shares held by it, him or her if the Company fails to complete a Business Combination within the
Completion Window; although it, he or she will be entitled to liquidating distributions from the Trust Account with respect to any
Offering Shares it, he or she holds if the Company fails to complete a Business Combination within the prescribed time frame. The
Sponsor and each Insider hereby further acknowledge that it, he or she will not be entitled to (a) redemption rights with respect to
any Founder Shares and Offering Shares held by it, him or her, in connection with the consummation of a Business Combination, or (b)
redemption rights with respect to Founder Shares and Offering Shares held by it, him or her in connection with a shareholder vote to
amend the Memorandum and Articles in the manner described above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">3. To the fullest extent permitted by applicable
law and the Memorandum and Articles, the Company hereby agrees to defend, indemnify, hold harmless and exonerate (including the advancement
of expenses to the fullest extent permitted by applicable law) the Sponsor and its members (present and former), managers and affiliates
and their respective present and former officers and directors (each, a &ldquo;<B><U>Sponsor Indemnitee</U></B>&rdquo;) from any and all
costs, fees, expenses, judgments, liabilities, fines, penalties, reasonable attorneys&rsquo; fees and amounts paid in settlement (including
all interest, assessments and other charges paid or payable in connection with or in respect of such costs, fees, expenses, judgments,
liabilities, fines, penalties and amounts paid in settlement) actually, and reasonably, incurred by a Sponsor Indemnitee or on a Sponsor
Indemnitee&rsquo;s behalf in connection with any threatened, pending or completed action, suit, arbitration, mediation, alternate dispute
resolution mechanism, investigation, inquiry, hearing or any other actual, threatened or completed proceeding instituted by the Company
or any third party, whether civil, criminal, administrative or investigative in nature, in respect of any investment opportunities sourced
by a Sponsor Indemnitee for the Company or any liability arising with respect to a Sponsor Indemnitee&rsquo;s activities in connection
with the affairs of the Company (in each case to the extent that such indemnification, hold harmless and exoneration obligations with
respect to such matters are not expressly covered by a separate written agreement between the Company and the applicable Sponsor Indemnitee);
<I>provided</I>, that in no event shall a Sponsor Indemnitee be entitled to be indemnified or held harmless hereunder in respect of any
costs, fees, expenses, judgments, liabilities, fines, penalties and amounts paid in settlement (if any) that a Sponsor Indemnitee may
incur by reason of such person&rsquo;s own actual fraud or intentional misconduct; <I>provided</I>, <I>further</I>, that, for the avoidance
of doubt, under no circumstance shall a Sponsor Indemnitee have a claim to any monies or assets held in the Trust Account, and the Company
shall not be permitted to procure monies or assets held in the Trust Account for the satisfaction of its obligations to any Sponsor Indemnitee
in respect of the indemnification provided hereunder. The Sponsor Indemnitees shall be third party beneficiaries of this paragraph.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><FONT STYLE="font-size: 10pt">4.
During the period commencing on the effective date of the Underwriting Agreement and ending 180 days after such date, the undersigned
shall not, without the prior written consent of the Representative, (i) sell, offer to sell, contract or agree to sell, hypothecate,
pledge, grant any option to purchase or otherwise dispose of or agree to dispose of, directly or indirectly, or establish or increase
a put equivalent position or liquidate or decrease a call equivalent position within the meaning of Section 16 of the Securities Exchange
Act of 1934, as amended, and the rules and regulations of the Commission promulgated thereunder, any Units, Class A Ordinary Shares,
the Company&rsquo;s Class B ordinary shares, par value $0.0001 per share (the &ldquo;<B><U>Class B Ordinary Shares</U></B>&rdquo; and,
together with the Class A Ordinary Shares, the &ldquo;<B><U>Ordinary Shares</U></B>&rdquo;), Warrants or any securities convertible into,
or </FONT>exercisable, or exchangeable for, Class A Ordinary Shares owned by him, her or it; <I>provided</I>, <I>however</I>, that the
foregoing shall not apply to transfers to the Sponsor by the Insiders, (ii) enter into any swap or other arrangement that transfers to
another, in whole or in part, any of the economic consequences of ownership of any Units, Class A Ordinary Shares, Founder Shares, Warrants
or any securities convertible into, or exercisable, or exchangeable for, Class A Ordinary Shares owned by him, her or it, whether any
such transaction is to be settled by delivery of such securities, in cash or otherwise or (iii) publicly announce any intention to effect
any transaction specified in clause (i) or (ii). If the undersigned is an officer or director of the Company, the undersigned further
agrees that the forgoing restrictions shall be equally applicable to any issuer-directed Units that the undersigned may purchase in the
Public Offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">5. In the event of the liquidation of the Trust
Account, the Sponsor (which for purposes of clarification shall not extend to any officer, member or manager of the Sponsor) agrees to
indemnify and hold harmless the Company against any and all loss, liability, claim, damage and expense whatsoever (including, but not
limited to, any and all legal or other expenses reasonably incurred in investigating, preparing or defending against any litigation, whether
pending or threatened, or any claim whatsoever) to which the Company may become subject as a result of any claim by (i) any third party
(other than the Company&rsquo;s independent public accountants) for services rendered or products sold to the Company or (ii) a prospective
target business with which the Company has entered into a letter of intent, confidentiality or other similar agreement or business combination
agreement (a &ldquo;<B><U>Target</U></B>&rdquo;); <I>provided</I>, <I>however</I>, that such indemnification of the Company by the Sponsor
shall apply only to the extent necessary to ensure that such claims by a third party for services rendered (other than the Company&rsquo;s
independent public accountants) or products sold to the Company or a Target do not reduce the amount of funds in the Trust Account to
below (A) $10.05 per share of the Offering Shares or (B) such lesser amount per share of the Offering Shares held in the Trust Account
as of the date of the liquidation of the Trust Account due to reductions in the value of the trust assets, in each case including interest
earned on the funds held in the Trust Account and net of taxes payable, except as to any claims by a third party or Target that executed
an agreement waiving claims against and all rights to seek access to the Trust Account whether or not such agreement is enforceable. In
the event that any such executed waiver is deemed to be unenforceable against such third party, the Sponsor shall not be responsible for
any liability as a result of any such third-party claims. Notwithstanding any of the foregoing, such indemnification of the Company by
the Sponsor shall not apply as to any claims under the Company&rsquo;s obligation to indemnify the Underwriters against certain liabilities,
including liabilities under the Securities Act of 1933, as amended (the &ldquo;<B><U>Securities Act</U></B>&rdquo;). The Sponsor shall
have the right to defend against any such claim with counsel of its choice reasonably satisfactory to the Company if, within fifteen (15)
days following written receipt of notice of the claim to the Sponsor, the Sponsor notifies the Company in writing that it shall undertake
such defense.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">6. To the extent that the Underwriters do not
exercise their over-allotment option to purchase an additional 3,000,000 Units (as described in the Prospectus), the Sponsor agrees, upon
the expiration or waiver of such option, to forfeit and surrender for no consideration for cancellation, a number of Founder Shares equal
to the product of 750,000 multiplied by a fraction, (i) the numerator of which is 3,000,000 minus the number of Units purchased by the
Underwriters upon the exercise of their over-allotment option, and (ii) the denominator of which is 3,000,000. The forfeiture and surrender
will be adjusted to the extent that the over-allotment option is not exercised in full by the Underwriters so that the Founder Shares
will represent 20% of the Company&rsquo;s issued and outstanding Ordinary Shares after the Public Offering. The Sponsor further agrees
that to the extent that the size of the Public Offering is increased or decreased and the Sponsor has either purchased or sold Ordinary
Shares or an adjustment to the number of Founder Shares has been effected by way of a share dividend or share capitalization, or a surrender
for no consideration or share contribution back to capital, or otherwise, in each case in connection with such increase or decrease in
the size of the Public Offering, then (A) the references to 3,000,000 in the numerator and denominator of the formula in the first sentence
of this paragraph 6 shall be changed to a number equal to 15% of the number of Class A Ordinary Shares included in the Units issued in
the Public Offering and (B) the reference to 750,000 in the formula set forth in the first sentence of this paragraph 6 shall be adjusted
to such number of Founder Shares that the Sponsor would have to collectively return to the Company in order for all holders of Founder
Shares to hold an aggregate of 20% of the Company&rsquo;s issued and outstanding Ordinary Shares after the Public Offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><FONT STYLE="font-size: 10pt">7. The Sponsor and
each Insider hereby agrees and acknowledges that: (i) each of the Underwriters and the Company would be irreparably injured in the event
of a breach by the Sponsor of its obligations (as applicable) under paragraphs 1, 2, 4, 5, 6, 8(a) and 8(b) or by each Insider of its
obligations under paragraphs 1, 2, 4, 8(a) and 8(b), (ii) monetary damages may not be an adequate remedy for such breach and (iii) the
non-breaching party shall be entitled to injunctive relief, in addition to any other remedy that such party may have in law or in equity,
in the event of such breach. </FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">8. <U>Transfer Restrictions</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">(a) Subject to the exceptions set forth herein,
the Sponsor and each Insider agree not to Transfer any Founder Shares or the Class A Ordinary Shares issuable upon conversion of the Founder
Shares held by it, him or her until the earlier of (i) one year after the completion of a Business Combination or earlier if, subsequent
to a Business Combination, the closing price of the Class A Ordinary Shares equals or exceeds $12.00 per share (as adjusted for share
sub-divisions, share consolidations, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within
any 30-trading day period commencing at least 150 days after the Business Combination and (ii) subsequent to a Business Combination, the
date on which the Company consummates a subsequent liquidation, merger, share exchange or other similar transaction which results in all
of the Company&rsquo;s shareholders having the right to exchange their Class A Ordinary Shares for cash, securities or other property
(the &ldquo;<B><U>Lock-up</U></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">(b) Subject to the exceptions set forth herein,
the Sponsor and each Insider agree not to Transfer any Private Placement Units (including the Private Placement Warrants, the Private
Placement Shares and the Class A Ordinary Shares issuable upon exercise of the Private Placement Warrants) held by it, he or she until
thirty (30) days after the completion of a Business Combination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">(c) Notwithstanding the provisions set forth in
paragraphs 8(a) and 8(b), transfers of the Founder Shares (including the Class A Ordinary Shares issued or issuable upon the conversion
of the Founder Shares) and Private Placement Units (including the Private Placement Warrants, the Private Placement Shares and the Class
A Ordinary Shares issuable upon exercise of the Private Placement Warrants) that are held by the Sponsor, any Insider or any of their
permitted transferees, as applicable (that have complied with any applicable requirements of this paragraph 8(c)), are permitted (i) to
the Company&rsquo;s or the Representative&rsquo;s officers, directors, advisors or consultants, any affiliate or family member of any
of the Company&rsquo;s or the Representative&rsquo;s officers, directors, advisors or consultants, any members or partners of the Sponsor
or their affiliates and funds and accounts advised by such members or partners, any affiliates of the Sponsor, or any employees of such
affiliates, (ii) in the case of an individual, as a gift to such person&rsquo;s immediate family or to a trust, the beneficiary of which
is a member of such person&rsquo;s immediate family, an affiliate of such person or to a charitable organization; (iii) in the case of
an individual, by virtue of laws of descent and distribution upon death of such person; (iv) in the case of an individual, pursuant to
a qualified domestic relations order; (v) by private sales or transfers made in connection with any forward purchase agreement or similar
arrangement, in connection with an extension of the Completion Window or in connection with the consummation of a Business Combination
at prices no greater than the price at which the shares or warrants were originally purchased; (vi) pro rata distributions from the Sponsor
or the Representative to its respective members, partners or shareholders pursuant to the Sponsor&rsquo;s or the Representative&rsquo;s
limited liability company agreement or other charter documents; (vii) by virtue of the laws of the Cayman Islands or the Sponsor&rsquo;s
limited liability company agreement upon dissolution of the Sponsor or upon dissolution of the Representative, (viii) in the event of
the Company&rsquo;s liquidation prior to consummation of a Business Combination; (ix) in the event that, subsequent to the consummation
of a Business Combination, the Company completes a liquidation, merger, share exchange or other similar transaction which results in all
of its shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property or (x) to a nominee
or custodian of a person or entity to whom a transfer would be permissible under clauses (i) through (vii); <I>provided</I>, <I>however</I>,
that, in the case of clauses (i) through (vii), these permitted transferees must enter into a written agreement agreeing to be bound by
these transfer restrictions herein and the other restrictions contained in this Agreement (including provisions relating to voting, the
Trust Account and liquidating distributions).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">9. Each Insider&rsquo;s biographical information
furnished to the Company and the Representative that is included in the Prospectus is true and accurate in all respects and does not omit
any material information with respect to such Insider&rsquo;s background and contains all of the information required to be disclosed
pursuant to Item 401 of Regulation S-K, promulgated under the Securities Act. Each Insider&rsquo;s questionnaire furnished to the Company
and the Representative including any such information that is included in the Prospectus is true and accurate in all respects. Each Insider
represents and warrants that: (i) such Insider is not subject to or a respondent in any legal action for, any injunction, cease-and-desist
order or order or stipulation to desist or refrain from any act or practice relating to the offering of securities in any jurisdiction;
(ii) such Insider has never been convicted of, or pleaded guilty to, any crime (A) involving fraud, (B) relating to any financial transaction
or handling of funds of another person or (C) pertaining to any dealings in any securities and such Insider is not currently a defendant
in any such criminal proceeding; and (iii) none of the Sponsor or any such Insider has ever been suspended or expelled from membership
in any securities or commodities exchange or association or had a securities or commodities license or registration denied, suspended
or revoked.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><FONT STYLE="font-size: 10pt">10. The Sponsor
and each Insider has full right and power, without violating any agreement to which it, he or she is bound (including, without limitation,
any non-competition or non-solicitation agreement with any employer or former employer), to enter into this Letter Agreement and, as applicable,
to serve as an officer of the Company or as a director on the board of directors of the Company and each Insider hereby consents to being
named in the Prospectus as an officer and/or director of the Company, as applicable. </FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">11. As used herein, (i) &ldquo;<B><U>Business Combination</U></B>&rdquo;
shall mean a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination,
involving the Company and one or more businesses or entities; (ii) &ldquo;<B><U>Founder Shares</U></B>&rdquo; shall mean the Class B Ordinary
Shares held by the Sponsor prior to the consummation of the Public Offering; (iii) &ldquo;<B><U>Private Placement Shares</U></B>&rdquo;
shall mean the 700,000 Class A Ordinary Shares (or up to 760,000 Class A Ordinary Shares if the underwriters' over-allotment option is
exercised in full) comprising part of the Private Placement Units; (v) &ldquo;<B><U>Private Placement Warrants</U></B>&rdquo; shall mean
the 350,000 warrants (or up to 380,000 warrants if the underwriters&rsquo; over-allotment option is exercised in full) comprising part
of the Private Placement Units; (iv) &ldquo;<B><U>Private Placement Units</U></B>&rdquo; shall mean the an aggregate of 700,000 private
placement units (or up to 760,000 private placement units if the underwriters&rsquo; over-allotment option is exercised in full) that
the Representative and Sponsor have agreed to purchase for an aggregate purchase price of $7,000,000 (or up to $7,600,000 if the underwriters&rsquo;
over-allotment option is exercised in full), or $10.00 per unit, in a private placement that shall occur simultaneously with the consummation
of the Public Offering; (v) &ldquo;<B><U>Public Shareholders</U></B>&rdquo; shall mean the holders of Offering Shares other than the Sponsor
and the Insiders; (vi) &ldquo;<B><U>Trust Account</U></B>&rdquo; shall mean the trust fund into which a portion of the net proceeds of
the Public Offering and the sale of the Private Placement Units shall be deposited; and (vii) &ldquo;<B><U>Transfer</U></B>&rdquo; shall
mean the (a) sale of, offer to sell, contract or agreement to sell, hypothecate, pledge, grant of any option to purchase or otherwise
dispose of or agreement to dispose of, directly or indirectly, or establishment or increase of a put equivalent position or liquidation
with respect to or decrease of a call equivalent position within the meaning of Section 16 of the Exchange Act, and the rules and regulations
of the Commission promulgated thereunder with any respect to, any security, (b) entry into any swap or other arrangement that transfers
to another, in whole or in part, any of the economic consequences of ownership of any security, whether any such transaction is to be
settled by delivery of such securities, in cash or otherwise, or (c) public announcement of any intention to effect any transaction specified
in clause (a) or (b).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">12. This Letter Agreement constitutes the entire
agreement and understanding of the parties hereto in respect of the subject matter hereof and supersedes all prior understandings, agreements
or representations by or among the parties hereto, written or oral, to the extent they relate in any way to the subject matter hereof
or the transactions contemplated hereby. This Letter Agreement may not be changed, amended, modified or waived (other than to correct
a typographical error) as to any particular provision, except by a written instrument executed by all parties hereto. Each of the parties
hereto hereby acknowledges and agrees that each Representative is a third-party beneficiary of this Letter Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">13. No party hereto may assign either this Letter
Agreement or any of its rights, interests or obligations hereunder without the prior written consent of the other parties. Any purported
assignment in violation of this paragraph 13 shall be void and ineffectual and shall not operate to transfer or assign any interest or
title to the purported assignee. This Letter Agreement shall be binding on the Sponsor, each Insider and each of their respective successors,
heirs and assigns and permitted transferees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">14. This Letter Agreement shall be governed by
and construed and enforced in accordance with the laws of the State of New York, without giving effect to conflicts of law principles
that would result in the application of the substantive laws of another jurisdiction. The parties hereto (i) all agree that any action,
proceeding, claim or dispute arising out of, or relating in any way to, this Letter Agreement shall be brought and enforced in the courts
of the State of New York located in the City and County of New York, Borough of Manhattan, and irrevocably submit to such jurisdiction
and venue, which jurisdiction and venue shall be exclusive and (ii) waive any objection to such exclusive jurisdiction and venue or that
such courts represent an inconvenient forum.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">15. Any notice, consent or request to be given
in connection with any of the terms or provisions of this Letter Agreement shall be in writing and shall be sent by express mail or similar
private courier service, by certified mail (return receipt requested), by hand delivery or facsimile transmission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"><FONT STYLE="font-size: 10pt">16. This Letter
Agreement shall terminate on the earlier of (i) the expiration of the Lock-up or (ii) the liquidation of the Company; <I>provided</I>,
<I>however</I>, that this Letter Agreement shall earlier terminate in the event that the Public Offering is not consummated and closed
by December 31, 2024; <I>provided</I>, <I>further</I>, that paragraph 5 of this Letter Agreement shall survive such liquidation. </FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>



<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Sincerely,</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>ANDRETTI SPONSOR II LLC</B></FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 35%">&nbsp;</TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: top">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">/s/ William M. Brown</P></TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">William M. Brown</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">Managing Member</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>[SIGNATURE PAGE TO LETTER AGREEMENT]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>




<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD COLSPAN="2" STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>INSIDERS:</B></FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD COLSPAN="2" STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; width: 5%">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: top; width: 35%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">/s/ William J. Sandbrook</P></TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">William J. Sandbrook</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: top">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">/s/ William M. Brown</P></TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="vertical-align: top; font-size: 10pt"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-size: 10pt">William M. Brown</FONT></P>
                                                     <P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P></TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: top">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">/s/ Michael M. Andretti</P></TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">Michael M. Andretti</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: top">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">/s/ Zakary C. Brown</P></TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">Zakary C. Brown</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: top">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">/s/ James W. Keyes</P></TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">James W. Keyes</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">/s/ Cassandra S. Lee</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">Cassandra S. Lee</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: top">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">/s/ Gerald D. Putnam</P></TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">Gerald D. Putnam</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: top">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">/s/ John J. Romanelli</P></TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">John J. Romanelli</FONT></TD>
    <TD>&nbsp;</TD></TR>
</TABLE>

<P STYLE="margin: 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>[SIGNATURE PAGE TO LETTER AGREEMENT] </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Acknowledged and Agreed:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>ANDRETTI ACQUISITION CORP. II</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="vertical-align: top; font-size: 10pt; width: 5%"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: top; width: 35%">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">/s/ William M. Brown</P></TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">William M. Brown</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">Chief Executive Officer</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>[SIGNATURE PAGE TO LETTER AGREEMENT] </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">8</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.6
<SEQUENCE>10
<FILENAME>ea021383001ex10-6_andretti2.htm
<DESCRIPTION>ADMINISTRATIVE SUPPORT AGREEMENT, DATED SEPTEMBER 5, 2024, BY AND BETWEEN THE COMPANY AND ANDRETTI SPONSOR II LLC
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 10.6</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ANDRETTI ACQUISITION CORP. II</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">7615 Zionsville Road</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Indianapolis, Indiana 46268</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">September 5, 2024</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Andretti Sponsor II LLC</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">7615 Zionsville Road</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indianapolis, Indiana 46268</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left"><FONT STYLE="font-size: 10pt">Re:</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Administrative Services Agreement</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-indent: 0in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Ladies and Gentlemen:</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.5in">This letter agreement by and between Andretti
Acquisition Corp. II (the &ldquo;<B><I>Company</I></B>&rdquo;) and Andretti Sponsor II LLC (the &ldquo;<B><I>Services Provider</I></B>&rdquo;),
our sponsor, Andretti Sponsor II LLC (&ldquo;<B><I>Sponsor</I></B>&rdquo;), dated as of the date hereof, will confirm our agreement that,
commencing on the date the securities of the Company are first listed on the Nasdaq Global Market (the &ldquo;<B><I>Listing Date</I></B>&rdquo;),
pursuant to a Registration Statement on Form S-1 and prospectus filed with the U.S. Securities and Exchange Commission (the &ldquo;<B><I>Registration
Statement</I></B>&rdquo;) and continuing until the earlier of the consummation by the Company of an initial business combination and the
Company&rsquo;s liquidation (in each case as described in the Registration Statement) (such earlier date hereinafter referred to as the
&ldquo;<B><I>Termination Date</I></B>&rdquo;):</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i) The Services Provider shall make available
(or cause other persons to make available) to the Company, at 7615 Zionsville Road, Indianapolis, Indiana 46268 (or any successor location
of the Services Provider), certain office space, utilities and secretarial and administrative support as may be reasonably required by
the Company. As reimbursement therefor, the Company shall pay the Services Provider (and the Services Provider will receive on behalf
of itself or, to the extent it causes another person to make support available to the Company, as nominee on behalf of such other person)
the sum of $2,500 per month beginning on the Listing Date and continuing monthly thereafter until the Termination Date.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(ii) The Services Provider hereby irrevocably
waives any and all right, title, interest, causes of action and claims of any kind as a result of, or arising out of, this letter agreement
(each, a &ldquo;<B><I>Claim</I></B>&rdquo;) in or to, and any and all right to seek payment of any amounts due to it out of, the trust
account established for the benefit of the public shareholders of the Company and into which substantially all of the proceeds of the
Company&rsquo;s initial public offering will be deposited (the &ldquo;<B><I>Trust Account</I></B>&rdquo;), and hereby irrevocably waives
any Claim it may have in the future, which Claim would reduce, encumber or otherwise adversely affect the Trust Account or any monies
or other assets in the Trust Account, and further agrees not to seek recourse, reimbursement, payment or satisfaction of any Claim against
the Trust Account or any monies or other assets in the Trust Account for any reason whatsoever.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This letter agreement constitutes the entire agreement
and understanding of the parties hereto in respect of its subject matter and supersedes all prior understandings, agreements or representations
by or among the parties hereto, written or oral, to the extent they relate in any way to the subject matter hereof or the transactions
contemplated hereby.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This letter agreement may not be amended, modified
or waived as to any particular provision, except by a written instrument executed by the parties hereto.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 24.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">No party hereto may assign either this letter
agreement or any of its rights, interests or obligations hereunder without the prior written approval of the other party; provided, however,
that the Services Provider may assign this letter agreement, in whole or in part, to Sponsor or any other person that directly, or indirectly
through one or more intermediaries, controls, or is controlled by, or is under common control with, Sponsor without the prior written
approval of the Company. Any purported assignment in violation of this paragraph shall be void and ineffectual and shall not operate to
transfer or assign any interest or title to the purported assignee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This letter agreement constitutes the entire relationship
of the parties hereto, and any litigation between the parties (whether grounded in contract, tort, statute, law or equity) shall be governed
by, construed in accordance with and interpreted pursuant to the laws of the State of New York, without giving effect to its choice of
laws principles.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">[<I>Signature Page Follows</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: normal 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">Very truly yours,</FONT></TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>ANDRETTI ACQUISITION CORP. II</B></FONT></TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 35%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt; width: 60%">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: top">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">/s/ William M. Brown</P></TD>
    <TD STYLE="vertical-align: top">
</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">William M. Brown</FONT></TD>
    <TD STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">Chief Executive Officer</FONT></TD>
    <TD STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt">AGREED TO AND ACCEPTED BY:</FONT></TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR>
    <TD COLSPAN="2">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-size: 10pt"><B>Andretti Sponsor II LLC</B></FONT></TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 35%">&nbsp;</TD>
    <TD STYLE="vertical-align: top; font-size: 10pt; width: 60%">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; vertical-align: top">
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">/s/ William M. Brown</P></TD>
    <TD STYLE="vertical-align: top">
</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">William M. Brown </FONT></TD>
    <TD STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="vertical-align: top; font-size: 10pt"><FONT STYLE="font-size: 10pt">Managing Member</FONT></TD>
    <TD STYLE="vertical-align: top; font-size: 10pt">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: small-caps 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>[Signature Page to&nbsp;Administrative Services
Agreement]</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I></I></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>&nbsp;</I></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.7
<SEQUENCE>11
<FILENAME>ea021383001ex10-7_andretti2.htm
<DESCRIPTION>FORM OF INDEMNITY AGREEMENT
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 10.7</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM&nbsp;OF INDEMNITY AGREEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>THIS INDEMNITY AGREEMENT</B> (this &ldquo;<B><I>Agreement</I></B>&rdquo;)
is made as of September 5, 2024, by and between Andretti Acquisition Corp. II, a Cayman Islands exempted company (the &ldquo;<B><I>Company</I></B>&rdquo;),
and the undersigned (&ldquo;<B><I>Indemnitee</I></B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>RECITALS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>WHEREAS,</B> highly competent persons have become more reluctant
to serve publicly-held companies as directors, officers or in other capacities unless they are provided with adequate protection through
insurance or adequate indemnification against inordinate risks of claims and actions against them arising out of their service to and
activities on behalf of such companies;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>WHEREAS</B>, the Board of Directors of the Company (the &ldquo;<B><I>Board</I></B>&rdquo;)
has determined that, in order to attract and retain qualified individuals, the Company will attempt to maintain on an ongoing basis, at
its sole expense, liability insurance to protect persons serving the Company and its Subsidiaries (as defined below) from certain liabilities;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>WHEREAS</B>, while the Amended and Restated Memorandum and Articles
of Association of the Company provide for the indemnification of the officers and directors of the Company,&nbsp;Indemnitee may also be
entitled to indemnification pursuant to applicable Cayman Islands law, and the Amended and Restated Memorandum and Articles of Association
(as may be amended from time to time, the &ldquo;<B><I>Amended and Restated Memorandum and Articles of Association</I></B>&rdquo;) provide
that the indemnification provisions set forth therein are not exclusive, and thereby contemplate that contracts may be entered into between
the Company and members of the board of directors, officers and other persons with respect to indemnification, hold harmless, exoneration,
advancement and reimbursement rights;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>WHEREAS</B>, the uncertainties relating to such insurance and to
indemnification have increased the difficulty of attracting and retaining such persons;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>WHEREAS</B>, the Board has determined that the increased difficulty
in attracting and retaining such persons is detrimental to the best interests of the Company&rsquo;s shareholders and that the Company
should act to assure such persons that there will be increased certainty of such protection in the future;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>WHEREAS</B>, it is reasonable, prudent and necessary for the Company
contractually to obligate itself to indemnify, hold harmless, exonerate and to advance expenses on behalf of, such persons to the fullest
extent permitted by applicable law and the Amended and Restated Memorandum and Articles of Association of the Company so that they will
serve or continue to serve the Company free from undue concern that they will not be so protected against liabilities;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>WHEREAS</B>, this Agreement is a supplement to and in furtherance
of the Amended and Restated Memorandum and Articles of Association of the Company and any resolutions adopted pursuant thereto, and shall
not be deemed a substitute therefor, nor to diminish or abrogate any rights of Indemnitee thereunder; and</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>WHEREAS</B>,&nbsp;Indemnitee may not be willing to serve as an officer
or director without adequate protection, and the Company desires Indemnitee to serve in such capacity, and Indemnitee is willing to serve,
continue to serve and to take on additional service for or on behalf of the Company on the condition that he or she be so indemnified.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>NOW, THEREFORE</B>, in consideration of the premises and the covenants
contained herein, the Company and Indemnitee do hereby covenant and agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TERMS AND CONDITIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>1. SERVICES TO THE COMPANY.</B> In consideration of the Company&rsquo;s
covenants and obligations hereunder,&nbsp;Indemnitee will serve or continue to serve as an officer, director, advisor, key employee or
any other capacity of the Company, as applicable, for so long as Indemnitee is duly elected or appointed or retained or until Indemnitee
tenders his or her resignation or until Indemnitee is removed. The foregoing notwithstanding, this Agreement shall continue in full force
and effect after Indemnitee has ceased to serve as a director, officer, advisor, key employee or in any other capacity of the Company,
as provided in Section&nbsp;17. This Agreement, however, shall not impose any obligation on Indemnitee or the Company to continue Indemnitee&rsquo;s
service to the Company beyond any period otherwise required by law or by other agreements or commitments of the parties, if any.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>2. DEFINITIONS. </B>As used in this Agreement:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(a)&nbsp;References to &ldquo;<B><I>agent</I></B>&rdquo; shall mean
any person who is or was a director, officer or employee of the Company or a Subsidiary of the Company or other person authorized by the
Company to act for the Company, to include such person serving in such capacity as a director, officer, employee, fiduciary or other official
of another company, corporation, partnership, limited liability company, joint venture, trust or other enterprise at the request of, for
the convenience of, or to represent the interests of the Company or a Subsidiary of the Company.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(b)&nbsp;The terms &ldquo;<B><I>Beneficial Owner</I></B>&rdquo; and
&ldquo;<B><I>Beneficial Ownership</I></B>&rdquo; shall have the meanings set forth in Rule&nbsp;13d-3 promulgated under the Exchange Act
(as defined below) as in effect on the date hereof.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(c)&nbsp;&ldquo;<B><I>Cayman Court</I></B>&rdquo; shall mean the courts
of the Cayman Islands.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(d)&nbsp;A &ldquo;<B><I>Change in Control</I></B>&rdquo; shall be deemed
to occur upon the earliest to occur after the date of this Agreement of any of the following events:</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(i)&nbsp;<U>Acquisition of Shares by Third Party</U>. Other than an
affiliate of Andretti Sponsor II LLC, a Delaware limited liability company (the &ldquo;<B><I>Sponsor</I></B>&rdquo;), any Person (as defined
below) is or becomes the Beneficial Owner, directly or indirectly, of securities of the Company representing fifteen percent (15%) or
more of the combined voting power of the Company&rsquo;s then outstanding securities entitled to vote generally in the election of directors,
unless (1)&nbsp;the change in the relative Beneficial Ownership of the Company&rsquo;s securities by any Person results solely from a
reduction in the aggregate number of outstanding shares of securities entitled to vote generally in the election of directors, or (2)&nbsp;such
acquisition was approved in advance by the Continuing Directors (as defined below) and such acquisition would not constitute a Change
in Control under part (iii)&nbsp;of this definition;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(ii)&nbsp;<U>Change in Board of Directors</U>. Individuals who, as
of the date hereof, constitute the Board, and any new director whose election by the Board or nomination for election by the Company&rsquo;s
shareholders was approved by a vote of at least two thirds of the directors then still in office who were directors on the date hereof
or whose election for nomination for election was previously so approved (collectively, the &ldquo;<B><I>Continuing Directors</I></B>&rdquo;),
cease for any reason to constitute at least a majority of the members of the Board;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(iii)&nbsp;<U>Corporate Transactions</U>. The effective date of a merger,
share exchange, asset acquisition, share purchase, reorganization or similar business combination, involving the Company and one or more
businesses (a &ldquo;<B><I>Business Combination</I></B>&rdquo;), in each case, unless, following such Business Combination: (1)&nbsp;all
or substantially all of the individuals and entities who were the Beneficial Owners of securities entitled to vote generally in the election
of directors immediately prior to such Business Combination beneficially own, directly or indirectly, more than 50% of the combined voting
power of the then outstanding securities of the Company entitled to vote generally in the election of directors resulting from such Business
Combination (including, without limitation, a company which as a result of such transaction owns the Company or all or substantially all
of the Company&rsquo;s assets either directly or through one or more Subsidiaries) in substantially the same proportions as their ownership
immediately prior to such Business Combination, of the securities entitled to vote generally in the election of directors; (2)&nbsp;other
than an affiliate of the Sponsor, no Person (excluding any company resulting from such Business Combination) is the Beneficial Owner,
directly or indirectly, of 15% or more of the combined voting power of the then outstanding securities entitled to vote generally in the
election of directors of the surviving company except to the extent that such ownership existed prior to the Business Combination; and
(3)&nbsp;at least a majority of the Board of Directors of the company resulting from such Business Combination were Continuing Directors
at the time of the execution of the initial agreement, or of the action of the Board of Directors, providing for such Business Combination;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(iv)&nbsp;<U>Liquidation</U>. The approval by the shareholders of the
Company of a complete liquidation of the Company or an agreement or series of agreements for the sale or disposition by the Company of
all or substantially all of the Company&rsquo;s assets, other than factoring the Company&rsquo;s current receivables or escrows due (or,
if such approval is not required, the decision by the Board to proceed with such a liquidation, sale, or disposition in one transaction
or a series of related transactions); or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(v)&nbsp;<U>Other Events</U>. There occurs any other event of a nature
that would be required to be reported in response to Item 6(e)&nbsp;of Schedule 14A of Regulation 14A (or any successor rule) (or a response
to any similar item on any similar schedule or form) promulgated under the Exchange Act (as defined below), whether or not the Company
is then subject to such reporting requirement.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(e)&nbsp;&ldquo;<B><I>Companies Law</I></B>&rdquo; shall mean the Companies
Act (Revised) of the Cayman Islands, as amended from time to time.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(f)&nbsp;&ldquo;<B><I>Corporate Status</I></B>&rdquo; describes the
status of a person who is or was a director, officer, trustee, general partner, manager, managing member, fiduciary, employee or agent
of the Company or of any other Enterprise (as defined below) which such person is or was serving at the request of the Company.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(g)&nbsp;&ldquo;<B><I>Disinterested Director</I></B>&rdquo; shall mean
a director of the Company who is not and was not a party to the Proceeding (as defined below) in respect of which indemnification is sought
by Indemnitee.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(h)&nbsp;&ldquo;<B><I>Enterprise</I></B>&rdquo; shall mean the Company
and any other company, corporation, constituent company or corporation (including any constituent of a constituent) absorbed in a consolidation
or merger to which the Company (or any of its wholly owned Subsidiaries) is a party, limited liability company, partnership, joint venture,
trust, employee benefit plan or other enterprise of which Indemnitee is or was serving at the request of the Company as a director, officer,
trustee, general partner, managing member, fiduciary, employee or agent.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(i)&nbsp;&ldquo;<B><I>Exchange Act</I></B>&rdquo; shall mean the United
States Securities Exchange Act of 1934, as amended.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(j)&nbsp;&ldquo;<B><I>Expenses</I></B>&rdquo; shall include all direct
and indirect costs, fees and expenses of any type or nature whatsoever, including, without limitation, all reasonable attorneys&rsquo;
fees and costs, retainers, court costs, transcript costs, fees of experts, witness fees, travel expenses, fees of private investigators
and professional advisors, duplicating costs, printing and binding costs, telephone charges, postage, delivery service fees, fax transmission
charges, secretarial services and all other disbursements, obligations or expenses in connection with prosecuting, defending, preparing
to prosecute or defend, investigating, being or preparing to be a witness in, settlement or appeal of, or otherwise participating in,
a Proceeding (as defined below), including reasonable compensation for time spent by the Indemnitee for which he or she is not otherwise
compensated by the Company or any third party. Expenses also shall include Expenses incurred in connection with any appeal resulting from
any Proceeding (as defined below), including without limitation the principal, premium, security for, and other costs relating to any
cost bond, supersedes bond, or other appeal bond or its equivalent. Expenses, however, shall not include amounts paid in settlement by
Indemnitee or the amount of judgments or fines against Indemnitee.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(k)&nbsp;References to &ldquo;<B><I>fines</I></B>&rdquo; shall include
any excise tax assessed on Indemnitee with respect to any employee benefit plan.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(l)&nbsp;References to &ldquo;<B>serving at the request of the Company</B>&rdquo;
shall include any service as a director, officer, employee, agent or fiduciary of the Company or a Subsidiary of the Company which imposes
duties on, or involves services by, such director, officer, employee, agent or fiduciary with respect to an employee benefit plan, its
participants or beneficiaries; and if Indemnitee acted in good faith and in a manner Indemnitee reasonably believed to be in the best
interests of the participants and beneficiaries of an employee benefit plan,&nbsp;Indemnitee shall be deemed to have acted in a manner
&ldquo;<B>not opposed to the best interests of the Company</B>&rdquo; as referred to in this Agreement.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(m)&nbsp;&ldquo;<B><I>Independent Counsel</I></B>&rdquo; shall mean
a law firm or a member of a law firm with significant experience in matters of corporation law and that neither presently is, nor in the
past five years has been, retained to represent: (i)&nbsp;the Company or Indemnitee in any matter material to either such party (other
than with respect to matters concerning Indemnitee under this Agreement, or of other indemnitees under similar indemnification agreements);
or (ii)&nbsp;any other party to the Proceeding (as defined below) giving rise to a claim for indemnification hereunder. Notwithstanding
the foregoing, the term &ldquo;Independent Counsel&rdquo; shall not include any person who, under the applicable standards of professional
conduct then prevailing, would have a conflict of interest in representing either the Company or Indemnitee in an action to determine
Indemnitee&rsquo;s rights under this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(n)&nbsp;The term &ldquo;<B><I>Person</I></B>&rdquo; shall have the
meaning as set forth in Sections 13(d)&nbsp;and 14(d)&nbsp;of the Exchange Act as in effect on the date hereof; provided, however, that
&ldquo;Person&rdquo; shall exclude: (i)&nbsp;the Company; (ii)&nbsp;any Subsidiaries of the Company; (iii)&nbsp;any employment benefit
plan of the Company or of a Subsidiary (as defined below) of the Company or of any corporation owned, directly or indirectly, by the shareholders
of the Company in substantially the same proportions as their ownership of shares of the Company; and (iv)&nbsp;any trustee or other fiduciary
holding securities under an employee benefit plan of the Company or of a Subsidiary (as defined below) of the Company or of a corporation
owned directly or indirectly by the shareholders of the Company in substantially the same proportions as their ownership of shares of
the Company.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(o)&nbsp;The term &ldquo;<B><I>Proceeding</I></B>&rdquo; shall include
any threatened, pending or completed action, suit, arbitration, mediation, alternate dispute resolution mechanism, investigation, inquiry,
administrative hearing or any other actual, threatened or completed proceeding, whether brought in the right of the Company or otherwise
and whether of a civil (including intentional or unintentional tort claims), criminal, administrative or investigative or related nature,
in which Indemnitee was, is, will or might be involved as a party or otherwise by reason of the fact that Indemnitee is or was a director
or officer of the Company, by reason of any action (or failure to act) taken by him or her or of any action (or failure to act) on his
or her part while acting as a director or officer of the Company, or by reason of the fact that he or she is or was serving at the request
of the Company as a director, officer, trustee, general partner, managing member, fiduciary, employee or agent of any other Enterprise,
in each case whether or not serving in such capacity at the time any liability or expense is incurred for which indemnification, reimbursement,
or advancement of expenses can be provided under this Agreement.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(p)&nbsp;The term &ldquo;<B><I>Subsidiary,</I></B>&rdquo; with respect
to any Person, shall mean any corporation, limited liability company, partnership, joint venture, trust or other entity of which a majority
of the voting power of the voting equity securities or equity interest is owned, directly or indirectly, by that Person.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>3. INDEMNITY IN THIRD-PARTY PROCEEDINGS.</B> To the fullest extent
permitted by applicable law and the Amended and Restated Memorandum and Articles of Association of the Company, the Company shall indemnify,
hold harmless and exonerate Indemnitee in accordance with the provisions of this Section&nbsp;3 if Indemnitee was, is, or is threatened
to be made, a party to or a participant (as a witness, deponent or otherwise) in any Proceeding, other than a Proceeding by or in the
right of the Company to procure a judgment in its favor by reason of Indemnitee&rsquo;s Corporate Status. Pursuant to this Section&nbsp;3,&nbsp;Indemnitee
shall be indemnified, held harmless and exonerated against all Expenses, judgments, liabilities, fines, penalties and amounts paid in
settlement (including all interest, assessments and other charges paid or payable in connection with or in respect of such Expenses, judgments,
fines, penalties and amounts paid in settlement) actually, and reasonably incurred by Indemnitee or on his or her behalf in connection
with such Proceeding or any claim, issue or matter therein, if Indemnitee acted in good faith and in a manner he or she reasonably believed
to be in or not opposed to the best interests of the Company and, in the case of a criminal Proceeding, had no reasonable cause to believe
that his or her conduct was unlawful.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>4. INDEMNITY IN PROCEEDINGS BY OR IN THE RIGHT OF THE COMPANY. </B>To
the fullest extent permitted by applicable law and the Amended and Restated Memorandum and Articles of Association of the Company, the
Company shall indemnify, hold harmless and exonerate Indemnitee in accordance with the provisions of this Section&nbsp;4 if Indemnitee
was, is, or is threatened to be made, a party to or a participant (as a witness, deponent or otherwise) in any Proceeding by or in the
right of the Company to procure a judgment in its favor by reason of Indemnitee&rsquo;s Corporate Status. Pursuant to this Section&nbsp;4,&nbsp;Indemnitee
shall be indemnified, held harmless and exonerated against all Expenses actually and reasonably incurred by him or her on his or her behalf
in connection with such Proceeding or any claim, issue or matter therein, if Indemnitee acted in good faith and in a manner he or she
reasonably believed to be in or not opposed to the best interests of the Company. No indemnification, hold harmless or exoneration for
Expenses shall be made under this Section&nbsp;4 in respect of any claim, issue or matter as to which Indemnitee shall have been finally
adjudged by a court to be liable to the Company, unless and only to the extent that any court in which the Proceeding was brought or the
Cayman Court shall determine upon application that, despite the adjudication of liability but in view of all the circumstances of the
case,&nbsp;Indemnitee is fairly and reasonably entitled to indemnification, to be held harmless or to exoneration.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>5. INDEMNIFICATION FOR EXPENSES OF A PARTY WHO IS WHOLLY OR PARTLY
SUCCESSFUL.</B> Notwithstanding any other provisions of this Agreement except for Section&nbsp;27, to the extent that Indemnitee was or
is, by reason of Indemnitee&rsquo;s Corporate Status, a party to (or a participant in) and is successful, on the merits or otherwise,
in any Proceeding or in defense of any claim, issue or matter therein, in whole or in part, the Company shall, to the fullest extent permitted
by applicable law and the Amended and Restated Memorandum and Articles of Association of the Company, indemnify, hold harmless and exonerate
Indemnitee against all Expenses actually and reasonably incurred by him or her in connection therewith. If Indemnitee is not wholly successful
in such Proceeding but is successful, on the merits or otherwise, as to one or more but less than all claims, issues or matters in such
Proceeding, the Company shall, to the fullest extent permitted by applicable law and the Amended and Restated Memorandum and Articles
of Association of the Company, indemnify, hold harmless and exonerate Indemnitee against all Expenses actually and reasonably incurred
by him or her or on his or her behalf in connection with each successfully resolved claim, issue or matter. If Indemnitee is not wholly
successful in such Proceeding, the Company also shall, to the fullest extent permitted by applicable law and the Amended and Restated
Memorandum and Articles of Association of the Company, indemnify, hold harmless and exonerate Indemnitee against all Expenses reasonably
incurred in connection with a claim, issue or matter related to any claim, issue, or matter on which Indemnitee was successful. For purposes
of this Section&nbsp;and without limitation, the termination of any claim, issue or matter in such a Proceeding by dismissal, with or
without prejudice, shall be deemed to be a successful result as to such claim, issue or matter.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>6. INDEMNIFICATION FOR EXPENSES OF A WITNESS</B>. Notwithstanding
any other provision of this Agreement except for Section&nbsp;27, to the extent that Indemnitee is, by reason of his or her Corporate
Status, a witness or deponent in any Proceeding to which Indemnitee was or is not a party or threatened to be made a party, he or she
shall, to the fullest extent permitted by applicable law and the Amended and Restated Memorandum and Articles of Association of the Company,
be indemnified, held harmless and exonerated against all Expenses actually and reasonably incurred by him or her or on his or her behalf
in connection therewith.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>7. ADDITIONAL INDEMNIFICATION, HOLD HARMLESS AND EXONERATION RIGHTS</B>.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(a)&nbsp;Notwithstanding any limitation in Sections 3, 4, or 5, except
for Section&nbsp;27, the Company shall, to the fullest extent permitted by applicable law and the Amended and Restated Memorandum and
Articles of Association of the Company, indemnify, hold harmless and exonerate Indemnitee if Indemnitee is a party to or threatened to
be made a party to any Proceeding (including a Proceeding by or in the right of the Company to procure a judgment in its favor) against
all Expenses, judgments, fines, penalties and amounts paid in settlement (including all interest, assessments and other charges paid or
payable in connection with or in respect of such Expenses, judgments, fines, penalties and amounts paid in settlement) actually and reasonably
incurred by Indemnitee in connection with the Proceeding. No indemnification, hold harmless or exoneration rights shall be available under
this Section&nbsp;7(a)&nbsp;on account of Indemnitee&rsquo;s conduct which constitutes a breach of Indemnitee&rsquo;s duty of loyalty
to the Company or its shareholders or is an act or omission not in good faith or which involves intentional misconduct or a knowing violation
of the law.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(b)&nbsp;Notwithstanding any limitation in Sections 3, 4, 5 or 7(a),
except for Section&nbsp;27, the Company shall, to the fullest extent permitted by applicable law and the Amended and Restated Memorandum
and Articles of Association of the Company, indemnify, hold harmless and exonerate Indemnitee if Indemnitee is a party to or threatened
to be made a party to any Proceeding (including a Proceeding by or in the right of the Company to procure a judgment in its favor) against
all Expenses, judgments, fines, penalties and amounts paid in settlement (including all interest, assessments and other charges paid or
payable in connection with or in respect of such Expenses, judgments, fines, penalties and amounts paid in settlement) actually and reasonably
incurred by Indemnitee in connection with the Proceeding.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>8. CONTRIBUTION IN THE EVENT OF JOINT LIABILITY.</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(a)&nbsp;To the fullest extent permissible under applicable law, if
the indemnification, hold harmless and/or exoneration rights provided for in this Agreement are unavailable to Indemnitee in whole or
in part for any reason whatsoever, the Company, in lieu of indemnifying, holding harmless or exonerating Indemnitee, shall pay, in the
first instance, the entire amount incurred by Indemnitee, whether for judgments, liabilities, fines, penalties, amounts paid or to be
paid in settlement and/or for Expenses, in connection with any Proceeding without requiring Indemnitee to contribute to such payment,
and the Company hereby waives and relinquishes any right of contribution it may have at any time against Indemnitee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(b)&nbsp;The Company shall not enter into any settlement of any Proceeding
in which the Company is jointly liable with Indemnitee (or would be if joined in such Proceeding) unless such settlement provides for
a full and final release of all claims asserted against Indemnitee.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(c)&nbsp;The Company hereby agrees to fully indemnify, hold harmless
and exonerate Indemnitee from any claims for contribution which may be brought by officers, directors or employees of the Company other
than Indemnitee who may be jointly liable with Indemnitee.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>9. EXCLUSIONS. </B>Notwithstanding any provision in this Agreement,
the Company shall not be obligated under this Agreement to make any indemnification, advance expenses, hold harmless or exoneration payment
in connection with any claim made against Indemnitee:</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(a)&nbsp;for which payment has actually been received by or on behalf
of Indemnitee under any insurance policy or other indemnity or advancement provision and which payment has not subsequently been returned,
except with respect to any excess beyond the amount actually received under any insurance policy, contract, agreement, other indemnity
or advancement provision or otherwise;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(b)&nbsp;for an accounting of profits made from the purchase and sale
(or sale and purchase) by Indemnitee of securities of the Company within the meaning of Section&nbsp;16(b)&nbsp;of the Exchange Act (or
any successor rule) or similar provisions of state statutory law or common law; or</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(c)&nbsp;except as otherwise provided in Sections 14(f)-(g)&nbsp;hereof,
prior to a Change in Control, in connection with any Proceeding (or any part of any Proceeding) initiated by Indemnitee, including any
Proceeding (or any part of any Proceeding) initiated by Indemnitee against the Company or its directors, officers, employees or other
indemnitees, unless (i)&nbsp;the Board authorized the Proceeding (or any part of any Proceeding) prior to its initiation or (ii)&nbsp;the
Company provides the indemnification, hold harmless or exoneration payment, in its sole discretion, pursuant to the powers vested in the
Company under applicable law.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>10. ADVANCES OF EXPENSES; DEFENSE OF CLAIM.</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(a)&nbsp;Notwithstanding any provision of this Agreement to the contrary
except for Section&nbsp;27, and to the fullest extent not prohibited by applicable law, the Company shall pay the Expenses incurred by
Indemnitee (or reasonably expected by Indemnitee to be incurred by Indemnitee within three months) in connection with any Proceeding within
ten (10)&nbsp;days after the receipt by the Company of a statement or statements requesting such advances from time to time, prior to
the final disposition of any Proceeding. Advances shall, to the fullest extent permitted by applicable law and the Amended and Restated
Memorandum and Articles of Association of the Company, be unsecured and interest free. Advances shall, to the fullest extent permitted
by applicable law and the Amended and Restated Memorandum and Articles of Association of the Company, be made without regard to Indemnitee&rsquo;s
ability to repay the Expenses and without regard to Indemnitee&rsquo;s ultimate entitlement to be indemnified, held harmless or exonerated
under the other provisions of this Agreement. Advances shall include any and all reasonable Expenses incurred pursuing a Proceeding to
enforce this right of advancement, including Expenses incurred preparing and forwarding statements to the Company to support the advances
claimed. To the fullest extent required by applicable law, such payments of Expenses in advance of the final disposition of the Proceeding
shall be made only upon the Company&rsquo;s receipt of an undertaking, by or on behalf of Indemnitee, to repay the advanced amounts to
the extent that it is ultimately determined that Indemnitee is not entitled to be indemnified by the Company under the provisions of this
Agreement, the Amended and Restated Memorandum and Articles of Association, applicable law or otherwise. This Section&nbsp;10(a)&nbsp;shall
not apply to any claim made by Indemnitee for which an indemnification, hold harmless or exoneration payment is excluded pursuant to Section&nbsp;9.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(b)&nbsp;The Company will be entitled to participate in the Proceeding
at its own expense.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(c)&nbsp;The Company shall not settle any action, claim or Proceeding
(in whole or in part) which would impose any Expense, judgment, fine, penalty or limitation on Indemnitee without Indemnitee&rsquo;s prior
written consent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>11. PROCEDURE FOR NOTIFICATION AND APPLICATION FOR INDEMNIFICATION.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(a)&nbsp;Indemnitee agrees to notify promptly the Company in writing
upon being served with any summons, citation, subpoena, complaint, indictment, information or other document relating to any Proceeding,
claim, issue or matter therein which may be subject to indemnification, hold harmless or exoneration rights, or advancement of Expenses
covered hereunder. The failure of Indemnitee to so notify the Company shall not relieve the Company of any obligation which it may have
to Indemnitee under this Agreement, or otherwise.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(b)&nbsp;Indemnitee may deliver to the Company a written application
to indemnify, hold harmless or exonerate Indemnitee in accordance with this Agreement. Such application(s)&nbsp;may be delivered from
time to time and at such time(s)&nbsp;as Indemnitee deems appropriate in his or her sole discretion. Following such a written application
for indemnification by Indemnitee,&nbsp;Indemnitee&rsquo;s entitlement to indemnification shall be determined according to Section&nbsp;12(a)&nbsp;of
this Agreement.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>12. PROCEDURE UPON APPLICATION FOR INDEMNIFICATION.</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(a)&nbsp;A determination, if required by applicable law, with respect
to Indemnitee&rsquo;s entitlement to indemnification shall be made in the specific case by one of the following methods, which shall be
at the election of Indemnitee: (i)&nbsp;by a majority vote of the Disinterested Directors, even though less than a quorum of the Board,
(ii)&nbsp;by a committee of such directors designated by majority vote of such directors, (iii)&nbsp;if there are no Disinterested Directors
or if such directors so direct, by Independent Counsel in a written opinion to the Board, a copy of which shall be delivered to Indemnitee,
or (iv)&nbsp;by vote of the shareholders. The Company promptly will advise Indemnitee in writing with respect to any determination that
Indemnitee is or is not entitled to indemnification, including a description of any reason or basis for which indemnification has been
denied. If it is so determined that Indemnitee is entitled to indemnification, payment to Indemnitee shall be made within ten (10)&nbsp;days
after such determination. Indemnitee shall reasonably cooperate with the person, persons or entity making such determination with respect
to Indemnitee&rsquo;s entitlement to indemnification, including providing to such person, persons or entity upon reasonable advance request
any documentation or information which is not privileged or otherwise protected from disclosure and which is reasonably available to Indemnitee
and reasonably necessary to such determination. Any costs or Expenses (including reasonable attorneys&rsquo; fees and disbursements) incurred
by Indemnitee in so cooperating with the person, persons or entity making such determination shall be borne by the Company (irrespective
of the determination as to Indemnitee&rsquo;s entitlement to indemnification) and the Company hereby agrees to indemnify and to hold Indemnitee
harmless therefrom.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(b)&nbsp;In the event the determination of entitlement to indemnification
is to be made by Independent Counsel pursuant to Section&nbsp;12(a)&nbsp;hereof, the Independent Counsel shall be selected as provided
in this Section&nbsp;12(b). The Independent Counsel shall be selected by Indemnitee (unless Indemnitee shall request that such selection
be made by the Board), and Indemnitee shall give written notice to the Company advising it of the identity of the Independent Counsel
so selected and certifying that the Independent Counsel so selected meets the requirements of &ldquo;Independent Counsel&rdquo; as defined
in Section&nbsp;2 of this Agreement. If the Independent Counsel is selected by the Board, the Company shall give written notice to Indemnitee
advising him or her of the identity of the Independent Counsel so selected and certifying that the Independent Counsel so selected meets
the requirements of &ldquo;Independent Counsel&rdquo; as defined in Section&nbsp;2 of this Agreement. In either event,&nbsp;Indemnitee
or the Company, as the case may be, may, within ten (10)&nbsp;days after such written notice of selection shall have been received, deliver
to the Company or to Indemnitee, as the case may be, a written objection to such selection; provided, however, that such objection may
be asserted only on the ground that the Independent Counsel so selected does not meet the requirements of &ldquo;Independent Counsel&rdquo;
as defined in Section&nbsp;2 of this Agreement, and the objection shall set forth with particularity the factual basis of such assertion.
Absent a proper and timely objection, the person so selected shall act as Independent Counsel. If such written objection is so made and
substantiated, the Independent Counsel so selected may not serve as Independent Counsel unless and until such objection is withdrawn or
a court of competent jurisdiction has determined that such objection is without merit. If, within twenty (20) days after submission by
Indemnitee of a written request for indemnification pursuant to Section&nbsp;11(b)&nbsp;hereof, no Independent Counsel shall have been
selected and not objected to, either the Company or Indemnitee may petition the Cayman Court for resolution of any objection which shall
have been made by the Company or Indemnitee to the other&rsquo;s selection of Independent Counsel and/or for the appointment as Independent
Counsel of a person selected by the Cayman Court, and the person with respect to whom all objections are so resolved or the person so
appointed shall act as Independent Counsel under Section&nbsp;(a)&nbsp;hereof. Upon the due commencement of any judicial proceeding or
arbitration pursuant to Section&nbsp;14(a)&nbsp;of this Agreement,&nbsp;Independent Counsel shall be discharged and relieved of any further
responsibility in such capacity (subject to the applicable standards of professional conduct then prevailing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(c)&nbsp;The Company agrees to pay the reasonable fees and expenses
of Independent Counsel and to fully indemnify and hold harmless such Independent Counsel against any and all Expenses, claims, liabilities
and damages arising out of or relating to this Agreement or its engagement pursuant hereto.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>13. PRESUMPTIONS AND EFFECT OF CERTAIN PROCEEDINGS.</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(a)&nbsp;In making a determination with respect to entitlement to indemnification
hereunder, the person, persons or entity making such determination shall presume that Indemnitee is entitled to indemnification under
this Agreement if Indemnitee has submitted a request for indemnification in accordance with Section&nbsp;11(b)&nbsp;of this Agreement,
and the Company shall have the burden of proof to overcome that presumption in connection with the making by any person, persons or entity
of any determination contrary to that presumption. Neither the failure of the Company (including by the Disinterested Directors or Independent
Counsel) to have made a determination prior to the commencement of any action pursuant to this Agreement that indemnification is proper
in the circumstances because Indemnitee has met the applicable standard of conduct, nor an actual determination by the Company (including
by the Disinterested Directors or Independent Counsel) that Indemnitee has not met such applicable standard of conduct, shall be a defense
to the action or create a presumption that Indemnitee has not met the applicable standard of conduct.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(b)&nbsp;If the person, persons or entity empowered or selected under
Section&nbsp;12 of this Agreement to determine whether Indemnitee is entitled to indemnification shall not have made a determination within
thirty (30) days after receipt by the Company of the request therefor, the requisite determination of entitlement to indemnification shall,
to the fullest extent permitted by applicable law and the Amended and Restated Memorandum and Articles of Association of the Company,
be deemed to have been made and Indemnitee 12 shall be entitled to such indemnification, absent (i)&nbsp;a misstatement by Indemnitee
of a material fact, or an omission of a material fact necessary to make Indemnitee&rsquo;s statement not materially misleading, in connection
with the request for indemnification, or (ii)&nbsp;a final judicial determination that any or all such indemnification is expressly prohibited
under applicable law or the Amended and Restated Memorandum and Articles of Association of the Company; provided, however, that such 30-day
period may be extended for a reasonable time, not to exceed an additional fifteen (15) days, if the person, persons or entity making the
determination with respect to entitlement to indemnification in good faith requires such additional time for the obtaining or evaluating
of documentation and/or information relating thereto.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(c)&nbsp;The termination of any Proceeding or of any claim, issue or
matter therein, by judgment, order, settlement or conviction, or upon a plea of nolo contendere or its equivalent, shall not (except as
otherwise expressly provided in this Agreement) of itself adversely affect the right of Indemnitee to indemnification or create a presumption
that Indemnitee did not act in good faith and in a manner which he or she reasonably believed to be in or not opposed to the best interests
of the Company or, with respect to any criminal Proceeding, that Indemnitee had reasonable cause to believe that his or her conduct was
unlawful.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(d)&nbsp;For purposes of any determination of good faith,&nbsp;Indemnitee
shall be deemed to have acted in good faith if Indemnitee&rsquo;s action is based on the records or books of account of the Enterprise,
including financial statements, or on information supplied to Indemnitee by the directors, manager, or officers of the Enterprise in the
course of their duties, or on the advice of legal counsel for the Enterprise, its Board, any committee of the Board or any director, trustee,
general partner, manager or managing member, or on information or records given or reports made to the Enterprise, its Board, any committee
of the Board or any director, trustee, general partner, manager or managing member, by an independent certified public accountant or by
an appraiser or other expert selected by the Enterprise, its Board, any committee of the Board or any director, trustee, general partner,
manager or managing member. The provisions of this Section&nbsp;13(d)&nbsp;shall not be deemed to be exclusive or to limit in any way
the other circumstances in which Indemnitee may be deemed or found to have met the applicable standard of conduct set forth in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(e)&nbsp;The knowledge and/or actions, or failure to act, of any other
director, officer, trustee, partner, manager, managing member, fiduciary, agent or employee of the Enterprise shall not be imputed to
Indemnitee for purposes of determining the right to indemnification under this Agreement.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>14. REMEDIES OF INDEMNITEE.</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(a)&nbsp;In the event that (i)&nbsp;a determination is made pursuant
to Section&nbsp;12 of this Agreement that Indemnitee is not entitled to indemnification under this Agreement, (ii)&nbsp;advancement of
Expenses, to the fullest extent permitted by applicable law and the Amended and Restated Memorandum and Articles of Association of the
Company, is not timely made pursuant to Section&nbsp;10 of this Agreement, (iii)&nbsp;no determination of entitlement to indemnification
shall have been made pursuant to Section&nbsp;12(a)&nbsp;of this Agreement within thirty (30) days after receipt by the Company of the
request for indemnification, (iv)&nbsp;payment of indemnification is not made pursuant to Section&nbsp;5, 6, 7 or the last sentence of
Section&nbsp;12(a)&nbsp;of this Agreement within ten (10)&nbsp;days after receipt by the Company of a written request therefor, (v)&nbsp;a
contribution payment is not made in a timely manner pursuant to Section&nbsp;8 of this Agreement, (vi)&nbsp;payment of indemnification
pursuant to Section&nbsp;3 or 4 of this Agreement is not made within ten (10)&nbsp;days after a determination has been made that Indemnitee
is entitled to indemnification, or (vii)&nbsp;payment to Indemnitee pursuant to any hold harmless or exoneration rights under this Agreement
or otherwise is not made in accordance with this Agreement,&nbsp;Indemnitee shall be entitled to an adjudication by the Cayman Court to
such indemnification, hold harmless, exoneration, contribution or advancement rights. Alternatively,&nbsp;Indemnitee, at his or her option,
may seek an award in arbitration to be conducted by a single arbitrator pursuant to the Commercial Arbitration Rules&nbsp;of the American
Arbitration Association. Except as set forth herein, the provisions of Cayman Islands law (without regard to its conflict of laws rules)
shall apply to any such arbitration. The Company shall not oppose Indemnitee&rsquo;s right to seek any such adjudication or award in arbitration.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(b)&nbsp;In the event that a determination shall have been made pursuant
to Section&nbsp;12(a)&nbsp;of this Agreement that Indemnitee is not entitled to indemnification, any judicial proceeding or arbitration
commenced pursuant to this Section&nbsp;14 shall be conducted in all respects as a de novo trial, or arbitration, on the merits and Indemnitee
shall not be prejudiced by reason of that adverse determination.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(c)&nbsp;In any judicial proceeding or arbitration commenced pursuant
to this Section&nbsp;14,&nbsp;Indemnitee shall be presumed to be entitled to be indemnified, held harmless, exonerated to receive advancement
of Expenses under this Agreement and the Company shall have the burden of proving Indemnitee is not entitled to be indemnified, held harmless,
exonerated and to receive advancement of Expenses, as the case may be, and the Company may not refer to or introduce into evidence any
determination pursuant to Section&nbsp;12(a)&nbsp;of this Agreement adverse to Indemnitee for any purpose. If Indemnitee commences a judicial
proceeding or arbitration pursuant to this Section&nbsp;14,&nbsp;Indemnitee shall not be required to reimburse the Company for any advances
pursuant to Section&nbsp;10 until a final determination is made with respect to Indemnitee&rsquo;s entitlement to indemnification (as
to which all rights of appeal have been exhausted or lapsed).</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(d)&nbsp;If a determination shall have been made pursuant to Section&nbsp;12(a)&nbsp;of
this Agreement that Indemnitee is entitled to indemnification, the Company shall be bound by such determination in any judicial proceeding
or arbitration commenced pursuant to this Section&nbsp;14, absent (i)&nbsp;a misstatement by Indemnitee of a material fact, or an omission
of a material fact necessary to make Indemnitee&rsquo;s statement not materially misleading, in connection with the request for indemnification,
or (ii)&nbsp;a prohibition of such indemnification under applicable law.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(e)&nbsp;The Company shall be precluded from asserting in any judicial
proceeding or arbitration commenced pursuant to this Section&nbsp;14 that the procedures and presumptions of this Agreement are not valid,
binding and enforceable and shall stipulate in any such court or before any such arbitrator that the Company is bound by all the provisions
of this Agreement.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(f)&nbsp;The Company shall indemnify and hold harmless Indemnitee to
the fullest extent permitted by applicable law and the Amended and Restated Memorandum and Articles of Association of the Company against
all Expenses and, if requested by Indemnitee, shall (within ten (10)&nbsp;days after the Company&rsquo;s receipt of such written request)
pay to Indemnitee, to the fullest extent permitted by applicable law and the Amended and Restated Memorandum and Articles of Association
of the Company, such Expenses which are incurred by Indemnitee in connection with any judicial proceeding or arbitration brought by Indemnitee:
(i)&nbsp;to enforce his or her rights under, or to recover damages for breach of, this Agreement or any other indemnification, hold harmless,
exoneration, advancement or contribution agreement or provision of the Amended and Restated Memorandum and Articles of Association now
or hereafter in effect; or (ii)&nbsp;for recovery or advances under any insurance policy maintained by any person for the benefit of Indemnitee,
regardless of the outcome and whether Indemnitee ultimately is determined to be entitled to such indemnification, hold harmless or exoneration
right, advancement, contribution or insurance recovery, as the case may be (unless such judicial proceeding or arbitration was not brought
by Indemnitee in good faith).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(g)&nbsp;Interest shall be paid by the Company to Indemnitee at the
legal rate under New York law for amounts which the Company indemnifies, holds harmless or exonerates, or advances, or is obliged to indemnify,
hold harmless or exonerate or advance for the period commencing with the date on which Indemnitee requests indemnification, to be held
harmless, exonerated, contribution, reimbursement or advancement of any Expenses and ending with the date on which such payment is made
to Indemnitee by the Company.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>15. SECURITY</B>. Notwithstanding anything herein to the contrary,
except for Section&nbsp;27, to the extent requested by Indemnitee and approved by the Board, the Company may at any time and from time
to time provide security to Indemnitee for the Company&rsquo;s obligations hereunder through an irrevocable bank line of credit, funded
trust or other collateral. Any such security, once provided to Indemnitee, may not be revoked or released without the prior written consent
of Indemnitee.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>16. NON-EXCLUSIVITY; SURVIVAL OF RIGHTS; INSURANCE; SUBROGATION.</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(a)&nbsp;The rights of Indemnitee as provided by this Agreement shall
not be deemed exclusive of any other rights to which Indemnitee may at any time be entitled under applicable law, the Amended and Restated
Memorandum and Articles of Association, any agreement, a vote of shareholders or a resolution of directors, or otherwise. No amendment,
alteration or repeal of this Agreement or of any provision hereof shall limit or restrict any right of Indemnitee under this Agreement
in respect of any Proceeding (regardless of when such Proceeding is first threatened, commenced or completed) or claim, issue or matter
therein arising out of, or related to, any action taken or omitted by such Indemnitee in his or her Corporate Status prior to such amendment,
alteration or repeal. To the extent that a change in applicable law, whether by statute or judicial decision, permits greater indemnification,
hold harmless or exoneration rights or advancement of Expenses than would be afforded currently under the Amended and Restated Memorandum
and Articles of Association or this Agreement, it is the intent of the parties hereto that Indemnitee shall enjoy by this Agreement the
greater benefits so afforded by such change. No right or remedy herein conferred is intended to be exclusive of any other right or remedy,
and every other right and remedy shall be cumulative and in addition to every other right and remedy given hereunder or now or hereafter
existing at law or in equity or otherwise. The assertion or employment of any right or remedy hereunder, or otherwise, shall not prevent
the concurrent assertion or employment of any other right or remedy.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(b)&nbsp;The Companies Law and the Amended and Restated Memorandum
and Articles of Association permit the Company to purchase and maintain insurance or furnish similar protection or make other arrangements
including, but not limited to, providing a trust fund, letter of credit, or surety bond (&ldquo;<B><I>Indemnification Arrangements</I></B>&rdquo;)
on behalf of Indemnitee against any liability asserted against him or her or incurred by or on behalf of him or her or in such capacity
as a director, officer, employee or agent of the Company, or arising out of his or her status as such, whether or not the Company would
have the power to indemnify him or her against such liability under the provisions of this Agreement or under the Companies Law, as it
may then be in effect. The purchase, establishment, and maintenance of any such Indemnification Arrangement shall not in any way limit
or affect the rights and obligations of the Company or of Indemnitee under this Agreement except as expressly provided herein, and the
execution and delivery of this Agreement by the Company and Indemnitee shall not in any way limit or affect the rights and obligations
of the Company or the other party or parties thereto under any such Indemnification Arrangement.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(c)&nbsp;To the extent that the Company maintains an insurance policy
or policies providing liability insurance for directors, officers, trustees, partners, managers, managing members, fiduciaries, employees,
or agents of the Company or of any other Enterprise which such person serves at the request of the Company,&nbsp;Indemnitee shall be covered
by such policy or policies in accordance with its or their terms to the maximum extent of the coverage available for any such director,
officer, trustee, partner, managers, managing member, fiduciary, employee or agent under such policy or policies. If, at the time the
Company receives notice from any source of a Proceeding as to which Indemnitee is a party or a participant (as a witness, deponent or
otherwise), the Company has director and officer liability insurance in effect, the Company shall give prompt notice of such Proceeding
to the insurers in accordance with the procedures set forth in the respective policies. The Company shall thereafter take all necessary
or desirable action to cause such insurers to pay, on behalf of Indemnitee, all amounts payable as a result of such Proceeding in accordance
with the terms of such policies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(d)&nbsp;In the event of any payment under this Agreement, the Company,
to the fullest extent permitted by applicable law and the Amended and Restated Memorandum and Articles of Association of the Company,
shall be subrogated to the extent of such payment to all of the rights of recovery of Indemnitee, including with respect to any insurance.
The Indemnitee shall execute all papers required and take all action necessary to secure such 16 rights, including execution of such documents
as are necessary to enable the Company to bring suit to enforce such rights. No such payment by the Company shall be deemed to relieve
any insurer of its obligations.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(e)&nbsp;The Company&rsquo;s obligation to indemnify, hold harmless,
exonerate or advance Expenses hereunder to Indemnitee who is or was serving at the request of the Company as a director, officer, trustee,
partner, manager, managing member, fiduciary, employee or agent of any other Enterprise shall be reduced by any amount Indemnitee has
actually received as indemnification, hold harmless or exoneration payments or advancement of expenses from such Enterprise. Notwithstanding
any other provision of this Agreement to the contrary except for Section&nbsp;27, (i)&nbsp;Indemnitee shall have no obligation to reduce,
offset, allocate, pursue or apportion any indemnification, hold harmless, exoneration, advancement, contribution or insurance coverage
among multiple parties possessing such duties to Indemnitee prior to the Company&rsquo;s satisfaction and performance of all its obligations
under this Agreement, and (ii)&nbsp;the Company shall perform fully its obligations under this Agreement without regard to whether Indemnitee
holds, may pursue or has pursued any indemnification, advancement, hold harmless, exoneration, contribution or insurance coverage rights
against any person or entity other than the Company.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(f)&nbsp;Notwithstanding anything contained herein, the Company is
the primary indemnitor, and any indemnification or advancement obligation of the Sponsor or its affiliates is secondary.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>17. DURATION OF AGREEMENT</B>. All agreements and obligations of
the Company contained herein shall continue during the period Indemnitee serves as a director or officer of the Company or as a director,
officer, trustee, partner, manager, managing member, fiduciary, employee or agent of any other corporation, partnership, joint venture,
trust, employee benefit plan or other Enterprise which Indemnitee serves at the request of the Company and shall continue thereafter so
long as Indemnitee shall be subject to any possible Proceeding (including any rights of appeal thereto and any Proceeding commenced by
Indemnitee pursuant to Section&nbsp;14 of this Agreement) by reason of his or her Corporate Status, whether or not he or she is acting
in any such capacity at the time any liability or expense is incurred for which indemnification or advancement can be provided under this
Agreement.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>18. SEVERABILITY. </B>If any provision or provisions of this Agreement
shall be held to be invalid, illegal or unenforceable for any reason whatsoever: (a)&nbsp;the validity, legality and enforceability of
the remaining provisions of this Agreement (including, without limitation, each portion of any Section, paragraph or sentence of this
Agreement containing any such provision held to be invalid, illegal or unenforceable, that is not itself invalid, illegal or unenforceable)
shall not in any way be affected or impaired thereby and shall remain enforceable to the fullest extent permitted by applicable law and
the Amended and Restated Memorandum and Articles of Association of the Company; (b)&nbsp;such provision or provisions shall be deemed
reformed to the extent necessary to conform to applicable law and to give the maximum effect to the intent of the parties hereto; and
(c)&nbsp;to the fullest extent possible, the provisions of this Agreement (including, without limitation, each portion of any Section,
paragraph or sentence of this Agreement containing any such provision held to be invalid, illegal or unenforceable, that is not itself
invalid, illegal or unenforceable) shall be construed so as to give effect to the intent manifested thereby.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>19. ENFORCEMENT AND BINDING EFFECT.</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(a)&nbsp;The Company expressly confirms and agrees that it has entered
into this Agreement and assumed the obligations imposed on it hereby in order to induce Indemnitee to serve as a director, officer or
key employee of the Company, and the Company acknowledges that Indemnitee is relying upon this Agreement in serving as a director, officer
or key employee of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(b)&nbsp;Without limiting any of the rights of Indemnitee under the
Amended and Restated Memorandum and Articles of Association of the Company as they may be amended from time to time, this Agreement constitutes
the entire agreement between the parties hereto with respect to the subject matter hereof and supersedes all prior agreements and understandings,
oral, written and implied, between the parties hereto with respect to the subject matter hereof.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(c)&nbsp;The indemnification, hold harmless, exoneration and advancement
of expenses rights provided by or granted pursuant to this Agreement shall be binding upon and be enforceable by the parties hereto and
their respective successors and assigns (including any direct or indirect successor by purchase, merger, consolidation or otherwise to
all or substantially all of the business and/or assets of the Company), shall continue as to an Indemnitee who has ceased to be a director,
officer, employee or agent of the Company or a director, officer, trustee, general partner, manager, managing member, fiduciary, employee
or agent of any other Enterprise at the Company&rsquo;s request, and shall inure to the benefit of Indemnitee and his or her spouse, assigns,
heirs, devisees, executors and administrators and other legal representatives.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(d)&nbsp;The Company shall require and cause any successor (whether
direct or indirect by purchase, merger, consolidation or otherwise) to all, substantially all or a substantial part, of the business and/or
assets of the Company, by written agreement in form and substance satisfactory to Indemnitee, expressly to assume and agree to perform
this Agreement in the same manner and to the same extent that the Company would be required to perform if no such succession had taken
place.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(e)&nbsp;The Company and Indemnitee agree herein that a monetary remedy
for breach of this Agreement, at some later date, may be inadequate, impracticable and difficult of proof, and further agree that such
breach may cause Indemnitee irreparable harm. Accordingly, the parties hereto agree that Indemnitee may, to the fullest extent permitted
by applicable law and the Amended and Restated Memorandum and Articles of Association of the Company, enforce this Agreement by seeking,
among other things, injunctive relief and/or specific performance hereof, without any necessity of showing actual damage or irreparable
harm and that by seeking injunctive relief and/or specific performance,&nbsp;Indemnitee shall not be precluded from seeking or obtaining
any other relief to which he or she may be entitled. The Company and Indemnitee further agree that Indemnitee shall, to the fullest extent
permitted by applicable law and the Amended and Restated Memorandum and Articles of Association of the Company, be entitled to such specific
performance and injunctive relief, including temporary restraining orders, preliminary injunctions and permanent injunctions, without
the necessity of posting bonds or other undertaking in connection therewith. The Company acknowledges that in the absence of a waiver,
a bond or undertaking may be required of Indemnitee by a court of competent jurisdiction, Company hereby waives any such requirement of
such a bond or undertaking to the fullest extent permitted by applicable law and the Amended and Restated Memorandum and Articles of Association
of the Company.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>20. MODIFICATION AND WAIVER.</B> No supplement, modification or
amendment of this Agreement shall be binding unless executed in writing by the Company and Indemnitee. No waiver of any of the provisions
of this Agreement shall be deemed or shall constitute a waiver of any other provisions of this Agreement nor shall any waiver constitute
a continuing waiver.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>21. NOTICES. </B>All notices, requests, demands and other communications
under this Agreement shall be in writing and shall be deemed to have been duly given (i)&nbsp;if delivered by hand and receipted for by
the party to whom said notice or other communication shall have been directed, or (ii)&nbsp;mailed by certified or registered mail with
postage prepaid, on the third (3rd) business day after the date on which it is so mailed:</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(a)&nbsp;If to Indemnitee, at the address indicated on the signature
page&nbsp;of this Agreement, or such other address as Indemnitee shall provide in writing to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(b)&nbsp;If to the Company, to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Andretti Acquisition Corp. II</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">7615 Zionsville Road</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Indianapolis, Indiana 46268</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Attn: William M. Brown</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">With a copy, which shall not constitute notice, to</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ellenoff Grossman&nbsp;&amp; Schole LLP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">1345 Avenue of the Americas, 11<FONT STYLE="font-size: 10pt"><SUP>th
</SUP></FONT>Floor</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">New York, New York 10105</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Attn: Stuart Neuhauser,&nbsp;Esq.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">or to any other address as may have been furnished to Indemnitee in
writing by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>22. APPLICABLE LAW AND CONSENT TO JURISDICTION.</B> This Agreement
and the legal relations among the parties shall be governed by, and construed and enforced in accordance with, the laws of the State of
New York, without regard to its conflict of laws rules. Except with respect to any arbitration commenced by Indemnitee pursuant to Section&nbsp;14(a)&nbsp;of
this Agreement, to the fullest extent permitted by applicable law and the Amended and Restated Memorandum and Articles of Association
of the Company, the Company and Indemnitee hereby irrevocably and unconditionally: (a)&nbsp;agree that any action or proceeding arising
out of or in connection with this Agreement shall be brought only in the Cayman Court and not in any other state or federal court in the
United States of America or any court in any other country; (b)&nbsp;consent to submit to the exclusive jurisdiction of the Cayman Court
for purposes of any action or proceeding arising out of or in connection with this Agreement; (c)&nbsp;waive any objection to the laying
of venue of any such action or proceeding in the Cayman Court; and (d)&nbsp;waive, and agree not to plead or to make, any claim that any
such action or proceeding brought in the Cayman Court has been brought in an improper or inconvenient forum, or is subject (in whole or
in part) to a jury trial. To the fullest extent permitted by applicable law and the Amended and Restated Memorandum and Articles of Association
of the Company, the parties hereby agree that the mailing of process and other papers in connection with any such action or proceeding
in the manner provided by Section&nbsp;21 or in such other manner as may be permitted by applicable law and the Amended and Restated Memorandum
and Articles of Association of the Company, shall be valid and sufficient service thereof.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>23. IDENTICAL COUNTERPARTS.</B> This Agreement may be executed in
one or more counterparts, each of which shall for all purposes be deemed to be an original but all of which together shall constitute
one and the same Agreement. Only one such counterpart signed by the party against whom enforceability is sought needs to be produced to
evidence the existence of this Agreement.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>24. MISCELLANEOUS. </B>Use of the masculine pronoun shall be deemed
to include usage of the feminine pronoun where appropriate. The headings of the paragraphs of this Agreement are inserted for convenience
only and shall not be deemed to constitute part of this Agreement or to affect the construction thereof.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>25. PERIOD OF LIMITATIONS.</B> No legal action shall be brought
and no cause of action shall be asserted by or in the right of the Company against Indemnitee,&nbsp;Indemnitee&rsquo;s spouse, heirs,
executors or personal or legal representatives after the expiration of two years from the date of accrual of such cause of action, and
any claim or cause of action of the Company shall be extinguished and deemed released unless asserted by the timely filing of a legal
action within such two-year period; provided, however, that if any shorter period of limitations is otherwise applicable to any such cause
of action such shorter period shall govern.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>26. ADDITIONAL ACTS.</B> If for the validation of any of the provisions
in this Agreement any act, resolution, approval or other procedure is required to the fullest extent permitted by applicable law and the
Amended and Restated Memorandum and Articles of Association of the Company, the Company undertakes to cause such act, resolution, approval
or other procedure to be affected or adopted in a manner that will enable the Company to fulfill its obligations under this Agreement.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>27. WAIVER OF CLAIMS TO TRUST ACCOUNT.</B> Indemnitee hereby agrees
that he or she does not have any right, title, interest or claim of any kind (each, a &ldquo;<B><I>Claim</I></B>&rdquo;) in or to any
monies in the trust account established in connection with the Company&rsquo;s initial public offering for the benefit of the Company
and holders of shares issued in such offering, and hereby waives any Claim he or she may have in the future as a result of, or arising
out of, any services provided to the Company and will not seek recourse against such trust account for any reason whatsoever.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>28. MAINTENANCE OF INSURANCE.</B> The Company shall use commercially
reasonable efforts to obtain and maintain in effect during the entire period for which the Company is obligated to indemnify the Indemnitee
under this Agreement, one or more policies of insurance with reputable insurance companies to provide the officers/directors of the Company
with coverage for losses from wrongful acts and omissions and to ensure the Company&rsquo;s performance of its indemnification obligations
under this Agreement. The Indemnitee shall be covered by such policy or policies in accordance with its or their terms to the maximum
extent of the coverage available for any such director or officer under such policy or policies. In all such insurance policies, the Indemnitee
shall be named as an insured in such a manner as to provide the Indemnitee with the same rights and benefits as are accorded to the most
favorably insured of the Company&rsquo;s directors and officers.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>29. INTERPRETATION</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In this Agreement:</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0.25in; font-size: 10pt">(a)</TD>
    <TD STYLE="text-align: justify; font-size: 10pt">words importing the singular number include the plural number and vice versa; words importing the masculine gender include the feminine gender; words importing persons include corporations as well as any other legal or natural person;</TD></TR>
  </TABLE>
<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0.25in; font-size: 10pt">(b)</TD>
    <TD STYLE="text-align: justify; font-size: 10pt">&ldquo;written&rdquo; and &ldquo;in writing&rdquo; include all modes of representing or reproducing words in visible form, including in the form of an Electronic Record;</TD></TR>
  </TABLE>
<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0.25in; font-size: 10pt">(e)</TD>
    <TD STYLE="text-align: justify; font-size: 10pt">&ldquo;shall&rdquo; shall be construed as imperative and &ldquo;may&rdquo; shall be construed as permissive;</TD></TR>
  </TABLE>
<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0.25in; font-size: 10pt">(f)</TD>
    <TD STYLE="text-align: justify; font-size: 10pt">references to provisions of any law or regulation shall be construed as references to those provisions as amended, modified, re-enacted or replaced;</TD></TR>
  </TABLE>
<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0.25in; font-size: 10pt">(g)</TD>
    <TD STYLE="text-align: justify; font-size: 10pt">any phrase introduced by the terms &ldquo;including&rdquo;, &ldquo;include&rdquo;, &ldquo;in particular&rdquo; or any similar expression shall be construed as illustrative and shall not limit the sense of the words preceding those terms;</TD></TR>
  </TABLE>
<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0.25in; font-size: 10pt">(h)</TD>
    <TD STYLE="text-align: justify; font-size: 10pt">the term &ldquo;and/or&rdquo; is used herein to mean both &ldquo;and&rdquo; as well as &ldquo;or.&rdquo; The use of &ldquo;and/or&rdquo; in certain contexts in no respects qualifies or modifies the use of the terms &ldquo;and&rdquo; or &ldquo;or&rdquo; in others. The term &ldquo;or&rdquo; shall not be interpreted to be exclusive and the term &ldquo;and&rdquo; shall not be interpreted to require the conjunctive (in each case, unless the context otherwise requires);</TD></TR>
  </TABLE>
<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0.25in; font-size: 10pt">(i)</TD>
    <TD STYLE="text-align: justify; font-size: 10pt">headings are inserted for reference only and shall be ignored in construing this Agreement;</TD></TR>
  </TABLE>
<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0.25in; font-size: 10pt">(j)</TD>
    <TD STYLE="text-align: justify; font-size: 10pt">any requirements as to delivery under this Agreement include delivery in the form of an electronic record (as defined in the Electronic Transactions Act (Revised));</TD></TR>
  </TABLE>
<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0.25in; font-size: 10pt">(k)&nbsp;</TD>
    <TD STYLE="text-align: justify; font-size: 10pt">any requirements as to execution or signature under this Agreement including the execution of this Agreement itself can be satisfied in the form of an electronic signature (as defined in the Electronic Transactions Act (Revised));</TD></TR>
  </TABLE>
<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0.25in; font-size: 10pt">(l)</TD>
    <TD STYLE="text-align: justify; font-size: 10pt">sections 8 and 19(3)&nbsp;of the Electronic Transactions Act (Revised) shall not apply.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[Signature Page&nbsp;Follows]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>IN WITNESS WHEREOF</B>, the parties hereto have caused this Indemnity
Agreement to be signed as of the day and year first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><B>ANDRETTI ACQUISITION CORP. II</B></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 35%">&nbsp;</TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>By:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Name:</TD>
    <TD>William M. Brown</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Title:</TD>
    <TD>Chief Executive Officer</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2"><B>INDEMNITEE</B></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>By:</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Name:</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Address:</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>Signature page&nbsp;- Indemnity Agreement</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>12
<FILENAME>ea021383001ex99-1_andretti2.htm
<DESCRIPTION>PRESS RELEASE, DATED SEPTEMBER 5, 2024
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
99.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt">Andretti
Acquisition Corp. II Announces the Pricing of $200,000,000 Initial Public Offering</FONT></P>

<P STYLE="text-align: justify; font: 18pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New
York, NY , Sept. 05, 2024 (GLOBE NEWSWIRE) -- Andretti Acquisition Corp. II (the &ldquo;Company&rdquo;) announced today the pricing of
its initial public offering of 20,000,000 units at a price of $10.00 per unit. The units are expected to be listed on The Nasdaq Stock
Market LLC (&ldquo;Nasdaq&rdquo;) and begin trading tomorrow, September 6, 2024, under the ticker symbol &ldquo;POLEU.&rdquo; Each unit
consists of one Class A ordinary share and one-half of one redeemable warrant, with each whole warrant entitling the holder thereof to
purchase one Class A ordinary share at a price of $11.50 per share, subject to certain adjustments. No fractional warrants will be issued
upon separation of the units and only whole warrants will trade. Once the securities constituting the units begin separate trading, the
Class A ordinary shares and warrants are expected to be listed on Nasdaq under the symbols &ldquo;POLE&rdquo; and &ldquo;POLEW,&rdquo;
respectively. The offering is expected to close on September 9, 2024, subject to customary closing conditions. The Company has granted
the underwriters a 45-day option to purchase up to an additional 3,000,000 units at the initial public offering price to cover over-allotments,
if any.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share
purchase, reorganization or similar business combination with one or more businesses. The Company may pursue an acquisition opportunity
in any business or industry or at any stage of its corporate evolution but is focused on acquiring a compelling asset with a skilled
management team&nbsp;that is ready to grow.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s management team is led by William J. Sandbrook, its Chairman of the Board of Directors (the &ldquo;Board&rdquo;), William
M. Brown, its Chief Executive Officer, and Michael M. Andretti, a Special Advisor and Director.&nbsp; Mario Andretti also serves as a
Special Advisor. In addition, the Board includes Zakary C. Brown, James W. Keyes, Cassandra S. Lee, Gerald D. Putnam, and John J. Romanelli.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BTIG,
LLC is acting as sole book-running manager for the offering.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
offering is being made only by means of a prospectus. When available, copies of the prospectus may be obtained from BTIG, LLC, Attention:
65 East 55th Street, New York, New York 10022, or by email at ProspectusDelivery@btig.com.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
registration statement relating to the securities has been filed with the U.S. Securities and Exchange Commission (&ldquo;SEC&rdquo;)
and became effective on September 5, 2024. This press release shall not constitute an offer to sell or the solicitation of an offer to
buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would
be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Forward-Looking
Statements</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
press release contains statements that constitute &ldquo;forward-looking statements,&rdquo; including with respect to the proposed initial
public offering and search for an initial business combination. No assurance can be given that the offering discussed above will be completed
on the terms described, or at all, or that the net proceeds will be used as indicated.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forward-looking
statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the
&ldquo;Risk Factors&rdquo; section of the Company&rsquo;s registration statement and prospectus for the Company&rsquo;s initial public
offering filed with the SEC. Copies of these documents are available on the SEC&rsquo;s website, www.sec.gov. The Company undertakes
no obligation to update these statements for revisions or changes after the date of this release, except as required by law.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Investor
Contacts</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Andretti
Acquisition Corp. II<BR>
William M. Brown<BR>
matt.brown@andrettiacquisition.com<BR>
(317) 872-2700</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>13
<FILENAME>ea021383001ex99-2_andretti2.htm
<DESCRIPTION>PRESS RELEASE, DATED SEPTEMBER 9, 2024
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
99.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt">Andretti
Acquisition Corp. II Completes $230 Million Initial Public Offering</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">INDIANAPOLIS, IN, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Andretti Acquisition Corp. II (the &ldquo;Company&rdquo;) announced today the closing of
its initial public offering of 23,000,000 units, which includes 3,000,000 units issued pursuant to the exercise by the underwriter of
its over-allotment option in full. The offering was priced at $10.00 per unit, resulting in gross proceeds of $230,000,000.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s units began trading on September 6, 2024 on the Nasdaq Global Market (&ldquo;Nasdaq&rdquo;) under the ticker symbol &ldquo;POLEU.&rdquo;
Each unit consists of one Class A ordinary share of the Company and one-half of one redeemable warrant, with each whole warrant entitling
the holder thereof to purchase one Class A ordinary share of the Company at an exercise price of $11.50 per share. Once the securities
comprising the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on Nasdaq under the
symbols &ldquo;POLE&rdquo; and &ldquo;POLEW,&rdquo; respectively.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share
purchase, reorganization or similar business combination with one or more businesses. The Company may pursue an acquisition opportunity
in any business or industry or at any stage of its corporate evolution but is focused on acquiring a compelling asset with a skilled
management team that is ready to grow.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company&rsquo;s management team is led by William J. (&ldquo;Bill&rdquo;) Sandbrook, its Chairman of the Board of Directors, William
M. (&ldquo;Matt&rdquo;) Brown, its Chief Executive Officer, and Michael M. Andretti, a Special Advisor and Director. Mario Andretti also
serves as a Special Advisor. In addition, the Board includes Zakary C. Brown, James W. Keyes, Cassandra S. Lee, Gerald D. Putnam, and
John J. Romanelli.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">BTIG,
LLC acted as sole book-running manager for the offering.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">The offering was made only by means of a prospectus, copies of which
may be obtained from: BTIG, LLC, 65 East 55th Street New York, New York 10022, Attn: Syndicate Department, BTIGSyndicateCoverage@btig.com.&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
registration statement relating to the securities was declared effective by the U.S. Securities and Exchange Commission (the &ldquo;SEC&rdquo;)
on September 5, 2024. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there
be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration
or qualification under the securities laws of any such state or jurisdiction.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>FORWARD-LOOKING
STATEMENTS</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
press release contains statements that constitute &ldquo;forward-looking statements,&rdquo; including with respect to the proposed initial
public offering and the anticipated use of the net proceeds thereof. No assurance can be given that the net proceeds of the offering
will be used as indicated. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the
Company, including those set forth in the Risk Factors section of the Company&rsquo;s registration statement and prospectus for the Company&rsquo;s
offering filed with the SEC. Copies are available on the SEC&rsquo;s website,&nbsp;www.sec.gov. The Company undertakes no obligation
to update these statements for revisions or changes after the date of this release, except as required by law.</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Investor
Contacts</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Andretti
Acquisition Corp. II<BR>
Company web site:&nbsp;www.andrettiacquisition.com<BR>
Investor relations email address:&nbsp;ir@andrettiacquisition.com</FONT></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>14
<FILENAME>poleu-20240905_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.23a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://andretti.com/role/Cover" xlink:href="poleu-20240905.xsd#Cover" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://andretti.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_us-gaapStatementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="poleu-20240905.xsd#POLEU_UnitsEachConsistingOfOneClassOrdinaryShareAndOnehalfOfOneRedeemableWarrantMember" xlink:label="loc_POLEUUnitsEachConsistingOfOneClassOrdinaryShareAndOnehalfOfOneRedeemableWarrantMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_POLEUUnitsEachConsistingOfOneClassOrdinaryShareAndOnehalfOfOneRedeemableWarrantMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="poleu-20240905.xsd#POLEU_ClassOrdinarySharesParValue0.0001PerShareMember" xlink:label="loc_POLEUClassOrdinarySharesParValue0.0001PerShareMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_POLEUClassOrdinarySharesParValue0.0001PerShareMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="poleu-20240905.xsd#POLEU_WarrantsEachWholeWarrantExercisableForOneClassOrdinaryShareAtExercisePriceOf11.50PerShareMember" xlink:label="loc_POLEUWarrantsEachWholeWarrantExercisableForOneClassOrdinaryShareAtExercisePriceOf11.50PerShareMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_POLEUWarrantsEachWholeWarrantExercisableForOneClassOrdinaryShareAtExercisePriceOf11.50PerShareMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport_50" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport_50" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport_50" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport_50" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_50" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate_50" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate_50" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_50" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_50" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_50" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber_50" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName_50" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey_50" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber_50" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_50" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_50" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1_50" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2_50" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3_50" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown_50" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_50" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry_50" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_50" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion_50" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode_50" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber_50" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension_50" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications_50" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial_50" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer_50" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_50" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle_50" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag_50" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol_50" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName_50" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle_50" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation_50" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm_50" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_50" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_50" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers_50" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_50" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_50" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory_50" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness_50" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_50" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod_50" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_50" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany_50" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat_50" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_50" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_50" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_50" xlink:type="arc" order="57" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>15
<FILENAME>poleu-20240905_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.23a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xml:lang="en-US">Class of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="poleu-20240905.xsd#POLEU_UnitsEachConsistingOfOneClassOrdinaryShareAndOnehalfOfOneRedeemableWarrantMember" xlink:label="POLEU_UnitsEachConsistingOfOneClassOrdinaryShareAndOnehalfOfOneRedeemableWarrantMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="POLEU_UnitsEachConsistingOfOneClassOrdinaryShareAndOnehalfOfOneRedeemableWarrantMember" xlink:to="POLEU_UnitsEachConsistingOfOneClassOrdinaryShareAndOnehalfOfOneRedeemableWarrantMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="POLEU_UnitsEachConsistingOfOneClassOrdinaryShareAndOnehalfOfOneRedeemableWarrantMember_lbl" xml:lang="en-US">Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant</link:label>
      <link:loc xlink:type="locator" xlink:href="poleu-20240905.xsd#POLEU_ClassOrdinarySharesParValue0.0001PerShareMember" xlink:label="POLEU_ClassOrdinarySharesParValue0.0001PerShareMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="POLEU_ClassOrdinarySharesParValue0.0001PerShareMember" xlink:to="POLEU_ClassOrdinarySharesParValue0.0001PerShareMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="POLEU_ClassOrdinarySharesParValue0.0001PerShareMember_lbl" xml:lang="en-US">Class A ordinary shares, par value $0.0001 per share</link:label>
      <link:loc xlink:type="locator" xlink:href="poleu-20240905.xsd#POLEU_WarrantsEachWholeWarrantExercisableForOneClassOrdinaryShareAtExercisePriceOf11.50PerShareMember" xlink:label="POLEU_WarrantsEachWholeWarrantExercisableForOneClassOrdinaryShareAtExercisePriceOf11.50PerShareMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="POLEU_WarrantsEachWholeWarrantExercisableForOneClassOrdinaryShareAtExercisePriceOf11.50PerShareMember" xlink:to="POLEU_WarrantsEachWholeWarrantExercisableForOneClassOrdinaryShareAtExercisePriceOf11.50PerShareMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="POLEU_WarrantsEachWholeWarrantExercisableForOneClassOrdinaryShareAtExercisePriceOf11.50PerShareMember_lbl" xml:lang="en-US">Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementTable_lbl" xml:lang="en-US">Statement [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementLineItems_lbl" xml:lang="en-US">Statement [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>16
<FILENAME>poleu-20240905_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.23a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://andretti.com/role/Cover" xlink:href="poleu-20240905.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://andretti.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementTable" xlink:label="loc_us-gaapStatementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_us-gaapStatementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementLineItems" xlink:label="loc_us-gaapStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="poleu-20240905.xsd#POLEU_UnitsEachConsistingOfOneClassOrdinaryShareAndOnehalfOfOneRedeemableWarrantMember" xlink:label="loc_POLEUUnitsEachConsistingOfOneClassOrdinaryShareAndOnehalfOfOneRedeemableWarrantMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_POLEUUnitsEachConsistingOfOneClassOrdinaryShareAndOnehalfOfOneRedeemableWarrantMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="poleu-20240905.xsd#POLEU_ClassOrdinarySharesParValue0.0001PerShareMember" xlink:label="loc_POLEUClassOrdinarySharesParValue0.0001PerShareMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_POLEUClassOrdinarySharesParValue0.0001PerShareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="poleu-20240905.xsd#POLEU_WarrantsEachWholeWarrantExercisableForOneClassOrdinaryShareAtExercisePriceOf11.50PerShareMember" xlink:label="loc_POLEUWarrantsEachWholeWarrantExercisableForOneClassOrdinaryShareAtExercisePriceOf11.50PerShareMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_POLEUWarrantsEachWholeWarrantExercisableForOneClassOrdinaryShareAtExercisePriceOf11.50PerShareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>17
<FILENAME>poleu-20240905.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.23a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: /qpZs7xRiXgen8uBYXYsWaOIyaPtyJ1x+YkxuG95fXnqLyQpTQr8+iFbjVUGUS8N -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:POLEU="http://andretti.com/20240905" elementFormDefault="qualified" targetNamespace="http://andretti.com/20240905">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://andretti.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="poleu-20240905_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="poleu-20240905_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="poleu-20240905_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
    <import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
    <import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
    <import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
    <import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
    <element id="POLEU_UnitsEachConsistingOfOneClassOrdinaryShareAndOnehalfOfOneRedeemableWarrantMember" name="UnitsEachConsistingOfOneClassOrdinaryShareAndOnehalfOfOneRedeemableWarrantMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="POLEU_ClassOrdinarySharesParValue0.0001PerShareMember" name="ClassOrdinarySharesParValue0.0001PerShareMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="POLEU_WarrantsEachWholeWarrantExercisableForOneClassOrdinaryShareAtExercisePriceOf11.50PerShareMember" name="WarrantsEachWholeWarrantExercisableForOneClassOrdinaryShareAtExercisePriceOf11.50PerShareMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm140056744260816">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Sep. 05, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Sep.  05,  2024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-42268<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Andretti
Acquisition Corp. II<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0002025341<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">98-1792547<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">E9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">7615
Zionsville Road<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Indianapolis<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">IN<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">46268<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">317<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">872-2700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Elected Not To Use the Extended Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=POLEU_UnitsEachConsistingOfOneClassOrdinaryShareAndOnehalfOfOneRedeemableWarrantMember', window );">Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Units,
    each consisting of one Class A ordinary share and one-half of one redeemable warrant<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">POLEU<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=POLEU_ClassOrdinarySharesParValue0.0001PerShareMember', window );">Class A ordinary shares, par value $0.0001 per share</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Class
    A ordinary shares, par value $0.0001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">POLE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=POLEU_WarrantsEachWholeWarrantExercisableForOneClassOrdinaryShareAtExercisePriceOf11.50PerShareMember', window );">Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Warrants,
    each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">POLEW<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=POLEU_UnitsEachConsistingOfOneClassOrdinaryShareAndOnehalfOfOneRedeemableWarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=POLEU_UnitsEachConsistingOfOneClassOrdinaryShareAndOnehalfOfOneRedeemableWarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=POLEU_ClassOrdinarySharesParValue0.0001PerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=POLEU_ClassOrdinarySharesParValue0.0001PerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=POLEU_WarrantsEachWholeWarrantExercisableForOneClassOrdinaryShareAtExercisePriceOf11.50PerShareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=POLEU_WarrantsEachWholeWarrantExercisableForOneClassOrdinaryShareAtExercisePriceOf11.50PerShareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>20
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M%_\;SO$1PNZ_/[&\UDX:?^:+X3]>?P%02P$"% ,4    " !&B2E9!T%-8H$
M  "Q    $               @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4
M Q0    ( $:)*5FW?,_I[@   "L"   1              "  :\   !D;V-0
M<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( $:)*5F97)PC$ 8  )PG   3
M          "  <P!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @
M1HDI6;1F/EUR!0  )Q@  !@              ("!#0@  'AL+W=O<FMS:&5E
M=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( $:)*5G@]#J)J@(  # ,   -
M          "  ;4-  !X;"]S='EL97,N>&UL4$L! A0#%     @ 1HDI69>*
MNQS     $P(   L              ( !BA   %]R96QS+RYR96QS4$L! A0#
M%     @ 1HDI6:K$(A8S 0  (@(   \              ( !<Q$  'AL+W=O
M<FMB;V]K+GAM;%!+ 0(4 Q0    ( $:)*5DD'INBK0   /@!   :
M      "  =,2  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0
M   ( $:)*5EED'F2&0$  ,\#   3              "  ;@3  !;0V]N=&5N
B=%]4>7!E<UTN>&UL4$L%!@     )  D /@(   (5      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.2.u1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>4</ContextCount>
  <ElementCount>24</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>3</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="ea0213830-8k_andretti2.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://andretti.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="ea0213830-8k_andretti2.htm">ea0213830-8k_andretti2.htm</File>
    <File>poleu-20240905.xsd</File>
    <File>poleu-20240905_def.xml</File>
    <File>poleu-20240905_lab.xml</File>
    <File>poleu-20240905_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="30">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>26
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ea0213830-8k_andretti2.htm": {
   "nsprefix": "POLEU",
   "nsuri": "http://andretti.com/20240905",
   "dts": {
    "inline": {
     "local": [
      "ea0213830-8k_andretti2.htm"
     ]
    },
    "schema": {
     "local": [
      "poleu-20240905.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "poleu-20240905_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "poleu-20240905_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "poleu-20240905_pre.xml"
     ]
    }
   },
   "keyStandard": 24,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 3,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2023": 3
   },
   "contextCount": 4,
   "entityCount": 1,
   "segmentCount": 3,
   "elementCount": 66,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 30
   },
   "report": {
    "R1": {
     "role": "http://andretti.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2024-09-05",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0213830-8k_andretti2.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2024-09-05",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0213830-8k_andretti2.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://andretti.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://andretti.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://andretti.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://andretti.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://andretti.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://andretti.com/role/Cover"
     ],
     "auth_ref": []
    },
    "POLEU_ClassOrdinarySharesParValue0.0001PerShareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://andretti.com/20240905",
     "localname": "ClassOrdinarySharesParValue0.0001PerShareMember",
     "presentation": [
      "http://andretti.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class A ordinary shares, par value $0.0001 per share"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CountryRegion",
     "presentation": [
      "http://andretti.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://andretti.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://andretti.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://andretti.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://andretti.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://andretti.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://andretti.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://andretti.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://andretti.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://andretti.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://andretti.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://andretti.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://andretti.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://andretti.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://andretti.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://andretti.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://andretti.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://andretti.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://andretti.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://andretti.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://andretti.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://andretti.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://andretti.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://andretti.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://andretti.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://andretti.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://andretti.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://andretti.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://andretti.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://andretti.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://andretti.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://andretti.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://andretti.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://andretti.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://andretti.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://andretti.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://andretti.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://andretti.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://andretti.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://andretti.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Extension",
     "presentation": [
      "http://andretti.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://andretti.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://andretti.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://andretti.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://andretti.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://andretti.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://andretti.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12gTitle",
     "presentation": [
      "http://andretti.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://andretti.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://andretti.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://andretti.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://andretti.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementLineItems",
     "presentation": [
      "http://andretti.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2023",
     "localname": "StatementTable",
     "presentation": [
      "http://andretti.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://andretti.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "POLEU_UnitsEachConsistingOfOneClassOrdinaryShareAndOnehalfOfOneRedeemableWarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://andretti.com/20240905",
     "localname": "UnitsEachConsistingOfOneClassOrdinaryShareAndOnehalfOfOneRedeemableWarrantMember",
     "presentation": [
      "http://andretti.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Units, each consisting of one Class A ordinary share and one-half of one redeemable warrant"
       }
      }
     },
     "auth_ref": []
    },
    "POLEU_WarrantsEachWholeWarrantExercisableForOneClassOrdinaryShareAtExercisePriceOf11.50PerShareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://andretti.com/20240905",
     "localname": "WarrantsEachWholeWarrantExercisableForOneClassOrdinaryShareAtExercisePriceOf11.50PerShareMember",
     "presentation": [
      "http://andretti.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share"
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://andretti.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>27
<FILENAME>0001213900-24-076981-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-24-076981-xbrl.zip
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M,?+AB0F#1DT@P&YR7.,'K/5-QC1\U?:(0*'$T M&!RD2W2&%L)Q 1- D?)U
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M<9NH7^!"UJ;V@%(ML%CC\\-6]7@3=U8V"<'4G\;(@S%^7P'J%S:L/AS *AS
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M;8=-'P$].M[;"%(Q &,HACJ]GPIOGH-E,3>KPK<2!%@1L;<P;1OR-[Z/R,T
MII,%7 [>1+K9R-I]"R;!POT<M2UK#,DW8QNR4Q'N>CD;%3,J<M*9\3O-,%VM
MS))H]S5F3[&,78Y)XD^"%M8LFT<8F$PNI@)O]'P\[NR+NC0@RV_ R ,7L8T9
M/@0F462P#"5>&88_,&8)H7G:,X.3CW:@J3_2;YNQL=DT81SR#%HP/&\<'V@
M3$\%Z6X[!FB(KB7$6'$G_]6C;K.!9"I6:!OOT2J@8E67T&QF -)O8[I?W-DR
M8[:L.H/.0CZA'UWO&[X=RD)]YN$,3%Z,'.Y/CH>I@2?8(A;*%N05;*&;4W#
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M/U0L08LK>'8P]C2G7_ 3J'2DN+2R2N#6DZ*):[K+#M%E;H6*98<ZFP-7JEB
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M4HW;Q.6Y](?H&;9N:5'%A_Q0+B-R&5>-1H$ZB=OA3P].CLQ/.-6BFMD:9)>
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M@CT3+7B_/%[+;Q4JS=4*=YI0BYZW4[Y6O^6%&"#!^96H6 _$%C^4U37</6E
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MR^LKT%DXKY@A=O*:=D*!45S5V<GYP<6W4';V=;F2!T)]H4=JZJR:QW1N& 9
M]]>SK,WVT*L!NQ2@_/7LDT\%Z0>@"CD"W#(?!79U ]@@##M**5:5ZTZSZ\5B
MZ^J6N<!ST+<)^(9R4R5#4)>@9D2J>A<U;L-LRI5TDO1C8K.U9([PCRYAUD71
M6^="Y^?5C:_LQ:9'W'"&ZV.^OKV,I@?]K2>C%:M647VA#3*1:Y05H+6AVN29
M_ I8WK18T;9[WO[+^?F;D+5+)B?S5(J+D5%,85D,*]E5%>451MYGCST(=^\Y
M?SF^Z8Y53IEXM]60-^=.#V#H!:5+ORE03>])2=9M9\D9)E-%'W?;$".M32P
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MHIS#*N4W[3;(&_;HTO#<YINC[9$CRK%*%\H>'C6,B/!5L7#W\>N$]!3BLGL
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MU+3X:%Q?A?[P0<?@W5^BI%^%6-2)UVCUMVE=1J&L]<('^'_+FEGV3YAE-?T
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MQ_IE'$&*F7SP\4??#*V:LX#+[4X9OUP?^K\B-7CW;<MI$H]--S,9PI5/^5I
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M;3'I*4\<,IQQ^@[IX7A93)^U_F"/@X950URKGDTIEGM$@6G7Y0*'.? =24U
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M/GV$#//P<7+P\3"8*[L\BW_EK"5Z39+&I0"72KN7L \58E5F$V2RG,G62(;
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M\E)[PK/KYS75)<[VS!#;)2AR=G(?%+E]4.3LY#XH\@T3/K "CT-C,W.?:<*
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MLVV)E"N-4G1&>@Z^4BR7^0SE\$(18U"AQF?VB\_Z*LZG50V[!SM")7J*VRC
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M"O&II]3+=X$O7)J7!T6),KL1WCANE<.BG?.#*'%E8DP:# /YA?6CX:0QQ:
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M@U?1PE0FY3[YW$-W%.%A_AH'V1";1U=K/&6(B^:U72S,Q!T>U\@4$C"-V2<
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M'6V*_\W))7D $%_X^R_K$RD8$_C<.DQO"$,+>;FWV?5"'@"O18&AL9PUPAU
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MBJV-T$FF2M/(_'%:<>/YJ/(.'I1C&_4D!IC8!UDH^<V4+,/C7IH_:"!*0,*
M:7;!XVB4%%6:#(T_5Q!7K9X%KL9'@G])'%Q9WM?..,']QBH?"DY4E+;<W+"_
MFA)!)/("9HQUP]D*TK$=EE97!C=[J,"!4OF" ' Q2@J4G[IR>P'U :P6''+
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MCR+O_O_RZ?[QU8>C/S"W\.OYN[>__']02P,$%     @ 1HDI68%^0TF7-0
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M'L9@R47WJ2GT2'R8W?&P)L0]-*X5#T;SJ-FC94A>4W';)I""%Q0()BIM_>8
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M17XEVX/6LM ^F"4B2AC;2((616F<()9>^^0TUY"G&N*)##7&NVYD)E_ZWRQ
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MZ3^S)M=BT@Y"RO36,M)N!X?J5HD&-L>/L[FH3%-<C3LY/^RD-:7F"Z7S6+_
M;+\P7CBH!SD%J)0Q+X$3=!3H)*]C*LYH5Q'S/Y+MBLI,F(VL;;1=GHNV5)Y)
M3D'D5C3S>(O,*M+F(./  IK5RIID0Z92QZM.%GSM[.#= L(7:"@T9<1-!1&;
MGUQ3)!L>D320%[C%@T:VV(DAYM9$B3:HS4D Z9F<TB88S22&Q/+K!=!>C(4
MD#:['>@VK52JT:F]*X<KJQR'6IW=IF0Z=(;?5%W6PK#7/)S=3FTM,/V\="N\
MV\BQ!7 KF#/_]!+6!BY'(&KM3[5<J)QJ=89;'+HQ96:%B>2;2^PDD86AV:RQ
MS6RA;I;2C.O2\N.A9GYXMC'1M-2QC=6RX*S(<K+);J>VW"9@KL:'VCB-NZVM
MW+=>8*AD?]I)3XGPR/N-&5#/F!<VT[UF.M_K3#D)7[^J%&ZHQ+U4F+JY4G6<
MF*X>:_IIY8V:ZJ)YC2*Y]KJASCIIUM:FO6! "^$>.,MOKH1UG>H3ZGYI&:AH
M^R9^78E\KLCD"Q:_(O'(*4$GLU9$R3U9EA*<47<[IKK,@A3D%26E.5U*\T^B
MO:P)A4=0AE;0G#>',H%SMV,5&8=AU#FDB?*;JEA&.1Q,8H)AJ6B[A.^DR3/I
MS.6D&?];$?70'@A28F>5DL&\&=E8YTV?X/Q:9X2M Q-U2@ )\DHOF% U1U-?
M?)AJ9<.5JA2ZB(.T9('AQKE).JF/!)8*0#<MQJ>.* ^AK?=6Q*"O3\BG&9A<
M_[IZ&!.>+9745A/&8\IRHC*['5-\KJ&XEMD(;66BX([)]^:)6"B,0UTPS96Y
MB_1B+ 'H TF4>41-R4"G]!1>&KCR9VZ*Z05T2'0^</)_<!BL2</?HM9B8T!-
M9VW*.64X)WYC6$VM$!%F[&]*IZQ1H,@[C\O9# HE/>&5<T8I* 7G">>TX_!6
MQ9CC5XPY=>K4B^N6=JHPTA($L$#CE]7K+7.'UOGBDPGWIY$I-.XDR\+V(DDW
MQVQX&<?A'_>.PY_#<;C 2?ASAFE^=^C3GXC6@,,9D3$.E.P?##=9?2SFRI;J
M@A"Q%8:'Z2]O?)"8V;.K_>_UK\M%@:<W9@//"=SZYC%>76C5+0F-_WY&PL9(
MNN<ZEDI0&"_>JN_@?.W#L,MS&UFUD]IP5>MY<6CSLOO_&7GYC5F>'V;I*QOI
MC_#TY0!3&_S\G.O1YL;]_>AGN1^MX"K>MO17"H>JX#-W;R-J\1Z?>2-M1??X
MS'M\YCT^<U7XS)6X2*Z$H5G?RCT4\SJAF'_5L9@$3"C8+XC)MG55UG. D[(!
MG70*@^88KS]*X5;1[92Y8)VJH2[*P537Q 5&%! MQ$1-$EC:H)CH*K5PE<!"
MU>B$RK+$YYS*E#5/5Y4VS;!'"0> ;E3\=XW@1Y75>UMM?J";KZ_BWU@@[Z^V
M00\3F9+*P2[B),UH'0/%#D[MN3?.3H;3P>E( JKZQL@1=Q,FN)L5S&I[U==8
M_!_\#ZD"_JE$%W['TFITV(^NK?B^I:7ETLY+6VZ\/H/W:4)@E$)[IITJL2;N
M^PH!JMV.=>'==(#J\MGQE0-4SP.E+H1-U $P>9)S]>!E0U,)REA!7!C":T$N
M<?T EZ-FNE1UMV. ['AH_Q)_/S_^\'YG\_E#_$?HB@C,;Q%DQ*E9-<Q/5_HD
M-J,9"]+_&3K;%PS$ O;<H@'DD\=:"(RA(EB967\+\C A_;"J&IZ$NZH+5E)O
M;L0VU1Y%XL!-(IP0P4$R-948."Q\.94^IN"&&;HO>MPL#"5QX# BDV&@O?YU
MJ%:#([1,^C(PI48Z7$;\=#L#ATD>&2:Y@(MA8X.21RZ YHCO0.9@Q8RE07/$
M-R%S/,PO3*G<#4+[:TY[CJ"%,U0D%N(L/I^'LU@6NN'Z/2@_A<_Z^CW6/YV_
M^JJ]U?>^ZI6NRM5ZJF^^G_K>2WUYI^_Y6^+[YY^G12W_<7'3K=[990(-%F[D
M)1(A-N99L?&AK:YNX\/OG$V%U3AWUQ88^W"<=:&RT=_:KEL'+Y.MQU6X+Y'/
MQHYAZ[&80%OCS,%JF[1C;O2EN8=Z#/M4,HU"- @%&AEZ2?,!5<'AT!"*O*'&
M4.%+14M+_U.-#G'?[FN2)9IR79TWT]JY8H3JYN:]"_9G<<&V0517E<UF[S;Z
M$.^]I3>2!=Y[2W]V;^G-T(Z_[WIBNS'5J"YRM"Z]%$*K'U=^14,BV:P^AODX
M2.49'!<W^'!5"O6M=_5>8]:=S_>NWN]R]3K.!_:^8!I56#L=EHX>&"<RWGW^
M%YMH1R^ZS<80QGXR492FH8Q ?$^1V6S8=\O)<;AAO]NY^FPQ-]X7M_R>7>]2
M3(XO)P 9BU_+N?4:Y?)KH^IUN9QZ&V6>2TQKBD\#K>1%2J&@^(D\(+3&XGM<
M@)S6Z!M#V]=FH:RFY>ZY,X1[[62:+PYI!Z$?D6J[R&G4XA>4^96SUVO6>3\>
M'.V+@\/CDZ,/>R<'[P[A[Y?OCMX.\.^E*L'7K_[<.V#N'3#W#IA[!\QM<L L
M"Z!Z[<SZWI.SS!"C6U77_';;MYN6[14DA%^^Z?S%;30HWYO.;Z0![=YT?F\Z
MOS>=GV\Z=Z"RXJC,GWAO15^N5?#[]"-K/_P1*_J7>ROZBJSHF(]431 2U(9+
MK^9U;9K:IVD(;'<*BX.+90SO& SSS99W"ED0F8+YG?+*:#LG9=$;SDV^OVJ:
MZ5T5JU'HAS+%#+:ZAI^38G)QQ$.9JU6OD0K<Y*S<?IB*=VD0QHAQIY>S[PK6
MZ7:NQ$&P_)"953@(+N<,P RKY^U:MU.FV(UL?G*SS,U]TX3>S-L<4L[H6+,>
M'1KH0-,X8S$2)Z/3J-(#1EP0S\%*#=<6$[@H;HW#XA8%KA&5UB)T> PT00("
MPJ^\+I^+V%D80A!6:S5XBR+]U@8].GZ3)# I;+-B""M!I2!2G(63P[;A[[#N
M'UIZ3%_IGL[636L/.$QICWCW@7\ NRE0/@08SDC7!K&&.E;/C,0EN@QS5M=#
M3>N931=T[$23XMN18H;T$4X<S 6&M;;;:Z2KQCXH2D5@VVG(D6(S$&+H!ZL'
M$.H$TC!PAU_7Z1YZFJ9JW=2=;<_MC2519V$^[XL!'\:Z%TPLU0E&J8!;O&#G
M"Z>6H"EJU <&!5P(EH#BP8("V?:R>=J].^G>G73O3KKA[J1[U]+-<BU5;.A-
M"_K-,[7<?K_/U:26NR"'SC)K!__473N^FJ,B4NO&7[/($;:PKVH$D_.V2PR.
MPXQ:6\B%V9^D_^OZDRJ#O.[%>[C[[L4G(N'7)V_?[/Q_4$L#!!0    ( $:)
M*5D%_8W_!4T  *\_ @ ?    96$P,C$S.#,P,#%E>#$P+3)?86YD<F5T=&DR
M+FAT;>U]:7,;5[+E=T3@/]QQ].L@(TJTN,CNMOP<05&4S1F)Y)!4^WDFYD,!
M*)!E%:K0M9#"^_63V]UJ 4&)LD"HNB-LDP2J[I(W;RXG3_[\V]6[M[\,!S__
M=GSX&OZM\'\_7YU<O3W^Y>?O^=_PU^_ESS^_.GO]A[J\^N/M\7]^-\W2\B>U
M^WQ>JJMX%A7J-+I3%]DL3 /^1: NHSR>?@=?A*^>/_1[+]4LS*_C]">%'WW^
M4I71Q_)9F,37\*L\OKXIO_OEYU>_''^\B4=Q"0_<V?OY^U<P[/,O\<)QE)91
M#F]\<W9ZY3[YV32<Q<GBI_N>39\MXO^.>"@T]K^GHV+^DD>-SWU2@[\X_O7D
M\NKB\.KD['0XN#CY];>K2W7XZ\7Q\;MC>,L7G%6<3B+\_O.=%W'ZF+/2^]$Q
M:G=)_ZR*,IXN^"%K.)6KWTXN85></5*-+=HJ;^)"_3V9_+O*7L*._OS^E\/K
M/(IF,*2?OW__"V[AWW/ZZW:@)F$93518J&P*;YV7T6P4Y>I%H/:>[QTH>- L
MG$0J3">*I T^&Z=EID:+X0!_&<ZR]%H=II,\*LM8'8[_7<5%7,99JHZR?+ZC
M3DX"%:JC< '34R=% E\J5/0QFLWQO>-L-@_3!8XY\H=\Q']I#MB\ZW*>I466
M#P<G)^KMVR-\S>LH">_"/%))/(OQ^4D<CN(D+A=+WB3/:;[IU=7)KP$^NN5+
M%]$\CPI8DK",;Z/Z=WEM\$L52$)>@&S!8.9A7L:PW4E<X-CH3^JW+,%_P7KA
MQ_&385G!#.;A-7ST!E8<5GLK"L<WJJC@'_B014 ;@M.9P]/ANUF.VX/SO+O)
MZ%OA%'9K.!A%,'%X4,A?5/ P$@\C$6I>Y445PG_ GW UHC'N'I^9%ZA\W_^"
MLN%_"Q?;6P^>1FT=:)3C+$GPF;=1 C+36$C^8E%?P9TGJ#J?N-X_.KDZ?'N)
M=L'34_&KK?Y3TO0PH]]_.[XX/KS$*05\<D0IH@J.4(_"D1V#\JIF,]#B<-K@
M#Z![PP0.]2B)QW!NI_!X4-!T@,WW_YX7>,@*4$%Q6;1HMY/SLZ8Z)!V$WQ@.
M\*6@Q.3)1TE8@&Y09_DD3L-\H2YO0 <'J''4;9A4D?K;\YWGSY_OHK92!?ZQ
M_D[_JX7_8G_PK/NR-'IV$R;3X0#^"C\HN)E -86C)%)P ^2HT+9J.NIW_GU]
M9KB*HTA=9[=1CFIZM*#7R:<=3<F?\Z_!J+R+HM3?'1S?$>QGG.+]D*BBS,8?
MU!4\K8#M4'\/9_.7\",(H#.GP@P;%#\.OK$IC0$U=.9P<(Q[!%= 8L=/]T("
MLH</O.';!D8.:G]\$Q81+5[[#JJP1)F"RSH?Q_#)>1Z/(]R-O^WN[KQX3KOI
M?Z/;R%K?4_8MZ TQ<51VEQ:XI>$UR- UZ@S8S1?!CR^>!W ^N[0$20<OTRNP
M-&3#Z1P7#SKE(,1O,C)[A@-]T&MGL9JC<#H#NKN)4:3C),'#5U1Y'N$#X "2
M*6-/W13FE[(^C.$#(=F@DV@.'R<]Q086K+T<97HP+P\-Z2X'BS$O]"* "K22
M#[^(8?5 08 8)%E)ZB";XRLVPZ_X1LZ!2)_<,@I%%.0%MK6,\>(@E5Z[B@(M
M.2 <LT(L6A IW/L"5&)V"]*&MT'KT0EG**T3^AH\K$1G:SB81;,,=/.DFK$=
M#Z\?HX8&T8.3EHUC$EZZ%&;A N5^6N7P^-P\;YIG,U7""M I@'_W8KBV,Q(Q
M#-BR%FE"MYO\M&P:J+KQX*KLF_"V9G.,05Q#D#?]B?,\OL6GG2?AF V5]V36
MG>L;WEHP=W%YX]LJG>[P Q[;-!5=GY(5N#NE$+\(Q\"U0NJ7TH'< (Z%"F.S
M [UGE"P_[^O6:_NGZ_8L6D0U2^@AR]1QL[E6JVH:K6*N#0</>95\J?FRK3@=
M)Q5=?')-ZHOO)BSIY];+#-48K$7*,8#A .7%W(9Q82[$R39^,D2+D$8T-R,J
MT<H-Z>LJ&X_ANL8Q%/&L2LHPC;*J2!;*/':<9(7CGL!;=I1CPIH(3^?,VZU;
M/E<-*[>^IV'[,NM'TZ=:(CN/9Q0_,476JV96S7[L;XF&KGWP/HTZ'/B:6BU7
MU ]\>J>^YGEEUQ%9&/:*>/A%P,OE#?(S;I'AH/T:J<T;1H@/G$04946KCJX7
MM>QVV6O>+DN6MDW_R"USST*J%=8QT*^F.V[9HK6L$-UJ*PF"^H0[[MX'MUYU
M$OQ^P#IH2WL%Z5G]<AT.FK?KI\RQXXY]Z&8/!_I!*\VS^V:'A[.3O+_+0AQ/
M5[W0G</]=2[T^\_5%[C7:SN\['IGT74S%BV;M>QY#Y02_[LM[S)689?<KZ<Q
M\I4,#\]4\',FGS>C+QJ8B#%])U'9*6Q5.HY:8PGN21QG!5Q<S<--5V$1A7 Z
M*" FX0K.$- 1GKII@E<5G-:H*/!=(W@U6_U;(5ZG,!0,AD=)=K<=N%(;T$O"
MZ31.8CB\A:+W++JBAQE\<(R!-1S+),YAM%G.@8TD@['4PW@5)C;"PG=3\=-Y
M].\JQKR"B0JR'OS;;O#BN8D74I(4'VQB)XT(3SCA\ TL0)<!\'N6?T ]=A3.
MXS),AH/6"YB.GWOH, !*AZ[V?;Z!M><UUSN!/R44SA0MV?HUN;AQ)8>#E>[M
M^F,^RR/M?OYPH%_0=5L%+)21DY6H#<W7]^2O/E3AH\ NG_]2CVY==6B[^Z-5
MX:?G5UK'N(KCI=_Y/YX]4V_B*)G\I,[#Z^@E//C?501:"]ZOGCT3O-G/KT_^
MI0?'3W]69G/XR-Z\U.][-LK*,IO]I'[ WXU("YK?O0*;X(."+8 A%5D23V (
MGSE=3IR;M]-XGK<,A_4TS/?G[V$6+1,:Y5'XX=DH A4+LY[3*K@/_:'EH3AQ
M=PK>]6*WU7NEL]3?XUKS\CXZH,"(01]">,0DO0X7",*%/-2< O8DAGP7U6$U
M[2ZO?F0!JCI1UZ3,W$?K@ -XN'!3Y'*/$YJR8!4,^G\.-Z]RHA-%!-9\3(BD
M1H8=C8@2+0@T*=+:*+NQ.4]L[S9/&D_/?@<IO$*9?'-V<4Q2*6:BDQ65[<X=
M1P;^'L"G;J,4[W%.2^G]+O#K*#)@#^*-'*>,P=""E)%S<YUEG.?"9# :$!)6
MUV\-Y)WC*)Z7],&B0M,PAJMC86TZM&CP)2,X0.,/:7:71)/K:,+?U@@ZAL4%
M@H.1*/<(C:EK."!@]6&>+Y#G@%.',T&AGH)GE]T5/SU!?-:3!I<=7ER='+T]
M'@YVOR2 ^$O. *S*U\=O3DY/$'-+(#FV(GO RQK,:'=G%T8/.X1.*V?F]?[L
MJ"N3N]<^K;[0$!C-J7>U2S!7NEX#=IP3!-'E\ZS0UZ-_3U/0GQ4:7:P8"9I%
M80JZ"%Q7>WF2_]RM;Y[20F\0C'XE<#QL(YE;9JME?]4U;':J$1_GX K,X+;;
M#*-H4_?X59*-/X!AE(>3>@! +=UEL"OB$O<:'E)4HT)B;7L[^SN[[=#X7A#6
M;2J>(&1A/NDXZ+CS) (C_!#NK U7^AY2O\?K-A5OCR6J/1PX8>WV4T];3@'F
M*+^.<O!K9F%R'<[$8V$4:_1Q?!.FUQ'ZQ7BSA[;(27]$AR<#L >R_!HTR'^+
MJY4/!^P?%3%,+<S52,?<QW9P[*-C:!-,CUD&#]2?XO Z14=C7( XO<V26QTG
M[<5Q3:=2JV2;Q471E,&&WGF_<[D#SS1A&722CT7XE'U,O]WK-I7["Q=[8_)I
M3\7=X=<1?&5"";#VLL?:W:)+/'-UG6?5'&T)"=P&@L?4 ($(<0=4UC6)"_0]
M\;,7$M3%G)RC'$"24'["%.-;&MO$A1B8Y"U5$H5%J?ZV]X+W 2:>,*J<8\>$
M'A>SYKTN@"A!%GEZ@=2GAN;]=%%=(H2]43<*$W4?,1R<2>%9+\CK-A57D(]A
MERATP=;2.7PGJQO'R]VCAF,$;E'O&#V5J7BR(';&<' X;B!$:W:*HX6,>0+?
MPBW?_>?^ >6/P&L6_$5GS4HO$.LV%:]2CZ!(,8)?CK(*0^K$(/!YZJ&/FSRA
MJ:Q>MWFO%#!N>XQH'$-J02E ^AXH"40=,6B;*U?X.;5:/ 7^CZ06JSFAX!#9
MA2Z1A@KU0K1N4VER?0P')_"V61I/8]CQ<R(P>;! ^6KEH+<ZGLY4EJ@5]38;
M?W@&+M(R4]28(5&8)S$Z5E.U%6_S$A7Q1S6#5][H9+\.E=51L"U0583B=N-B
M7Z(#MQ6;%Z'T(>ZMU C6%=ZP%'@;F.HCA'FVH'\LU0?R^;AP8/XL+&"5,"P8
MUPF&0&A@7-D; 0J)TTB)2T0'$1I)FW!<Y<YU_9B^' [&87$3.$"A -> PYGS
M/)M'8 _TYVO=IG(_NU(?C'K:4_&H>AAB-1R\C<IR:2B*0DT:LY70IRW&RR>"
M:Y1!CAC.R&QO'E30*^Q.)U*2]J!:@,T0L(U$UFA1,Y101H/@+#_!ZO^:>[W>
MV/F]E^J,*D.*GW  PL/W4OT+0[KPYTV"UCO+H!?@I;I:S&&>AWDXBL<OU6DX
MBWB13C.<^IX'AM??PK_T0/W^KESMKGP7?HQGU6PX.*V(Y90H3[5M^[F!K=V=
M@]X#?1I3\60B+@J=TUJ2GP_T?38..2O7E1=#:+RJTC*O(F4>S%] SRU'[V\:
M8K <[26524X?'3'Z>.-S4O;(?#DC>>B$ UZ(Q$?:LV@,OB3&R> CL_ #2ZQY
M>Z$_K-*L5/#") HQ?<DH_L:\SO.,(*U5T3H78ES\U,G8D;I5KTN&;-8](7=5
M[,IQG(^K&7P:K@!PVSE3:1SFA;J#[Q)Q<5";<G\6UVTJ[EG4X=Y'C#+W&[YN
M4_$V'$\YYI>851+UFD8.]"C=;U@NSN/KZ\4H1,BV>\M^KHFVUTO#4YF*)PU1
M/D-<T80 _$2B''5=#@9TU2#&IX+:; 8FB<9C=4*K0#3F^IT4W=?4S4@N846R
M]JUY'F>YI=N;QWZU98U[U,]T!"W$0_XG#,L&J\Q$_CB7KX>%M>(8=Z$!7,3#
MPT%"Q3'"0,*[#Z'U\EH&2/,!C6P.Y_,D'M-RF'BB9L9F/@Y9<5T1[3%Y4R9X
M8=8XBMCTH_X%_;E<MZFTL%8-!UTR>T_^CF57207O_G,U"1=(+%.*U&++CB1:
M(9TV'+3ETWKA6;>IW",\O='_K>Y\*YMBO_$;,)55-GX%BM)>%C9@*O?(0A?1
M9K_W&S 5?^\S<*+",NQ3+M_J_DN"X;Z"R+GYI(8%4[X"_<7.[$L!+B<XI/0C
M=W/29%SX:.>)]F/"=V3:=0P']6]E1?DLTM4R_#'[1<NU3X/7"0_X=9;/LSR4
M8>01NK>8M([%+;:#Z05VW:;B,_Z:@,]P(!&?CD(($MVM4$"B+7$?'0-I@[9'
M%.71('=%&'=!EFJ<._&W+H8#_ZF!VAHYK^QD&N^FWNYFH*81UXF*M\;R.@X#
M527FXN@(U.?EAJT4IC++A0:4+KPV%0]<$\/7R2NBXV*U-VS7(@=@'R2L$TQ,
MR@>\-:X2FL"84[ VQ(=#:I+OXE-:R0<"3DXRM1!^*KS-X@DQ_2++1%:-RD $
M2)<_X&#KZT'D:;>1/P$.<MJHB8/;(QK=$&M)RSP>5310KL)R0'L=),))#'.>
ML'IEM%Y19$G%L]F:V.UO):T%$6E0Z&K9Z6!G%4%;1MU:<,1P*W+>WBY8M5TW
M@C0<&$FJTR(2OR)JY1J]+JSU7;C@U#B3/8QY;);B07Y?S).X[!"-T*5[H!2Z
M[I\&F^H]+S!<%(CW1G26>8W/+8&H/%X'W84*55)@?GN3W46WC CE.F..$O-,
MB4EO7"5AWAK/7@2\%@Y')(OG.$(_C9$('7'PNYL(M/36H=ZDK@+BV@8P>681
M)I&A<6Z\G4Q#;FFK['5LX]S.*+ >D4D&ESP(X]-PB@(3?89#'@P'4GQ-%#"8
M0!" /-L>8[C5^>C2!.CY[3-\J;9>F6J!Y:,@*;ZC5G/>2%*XL!"R&T_C,>'^
M48'4'X80AU$4$C%_B!R(D70;R^,Q]7O0W<-L'J/V^DF4P$+FMOFERV%J*QVP
M(P?U%?4T2N=NX;@$O>(QDW9N&"S8T?T+1B)HX##.W0-??]WQ=2E%Q<VF;8-O
M^4-RJ]DOJB3BQ^P>'*"1-JN2Z]"V;/8'3@6SU)9!- @B7/"PFJ>X3["Y#6>I
M!3:S#;=X)><BS=0MJ-M99"LNS(YBXSGX+?6XIM$7VV Z8W7*<<?T?7%72)U)
M%U&>5=<WV,MYE&<?4.5,(CA_1%7@]$24UA!M6V^J0?B/A;,J3GU*#_KM OWN
M]_A>P??N]_C>'M_[2'Y:"U;$"RV$ONYG2X(OOWD>S>4FA:L/6US0I>I]WH%U
M6EJO23:NZ'=D_,W %+0V O.$TD5(40.R_YK77V"<0R>CCM=((?U#K\%>,WU'
M_2N%U'6@,_-\(7<,6FH V8P"C\G848T+Z:_1V[UD/TRRAX/CC_,H+99"8*C1
M2%4^RZ;/YMGX0U0B(H6^U 0O!S:"%1CKR%H7#!<QU;0]F>V:364KQ*Z4L/'>
M>7?4UQ2[XCFA%OJY[O[R9PL#-Q<?#T'45HD93A!UDDY@67**PZ)6RN _#RL0
M'8JZ<!\M4D16PYDZ8Z^XN1[C0$<:?I^" !:@W39CBS9)VD:PNR1!N,6N4JG?
M>FY_"?!VD)BL^+!027CG22-8<$66TEUG'@M.Q@@<,@G.T[,K>$UBXF?OK7="
M9?N->(MYW;\K6%CRGMEOZ@+];6_&]FR2I(U!TN9@BY5T,<V0#36EP%@9)='\
M!NE225@X>+$PPK@9T]^DG9QL8S?.3SCG$H?:C&78I!V-5MU1SFE,HGE$8Q$C
MA6*-$C3"B&J5EJ%\P8O;I]AP%#Z*9@II<>SNTM:DO!F&!0GR:"UU8<EF;, F
MR=)TFV/_3:O"[']'LBVQ#8U=3$ M(8$N?N@'1*TMFJNP*C-,VD^& _"B2G&7
M%R"D,VNJ:C>_<*L$**E4CYCW]NM:3V7K^GYIJVUI6SH/?IUG(1+897=J*L'_
M5GU34!/@C5B[31*#FXX+S/5HT,+<VI6<"O46,P9*053-("M_9F"@8LLQEAG#
M#6UZ\W&-0LDAQ5:F99;'"PQYLSK37^4D;3SG;Q/PJ5W&&KT&F]]4IJ:N%OM!
MV),)-_8XI'6;2G<4\+*#MJ!>"=<1!N[,FC-/%+:3+P1;VU[N)AE32L0*6.\V
M+K2776^8Y2-]SMN!?4O"UH&+NG/"!SXT;SBPG]J6[+5%^2$MP9+ N$;[11]O
MXE%<"E9B\E!4G]^$TSR^/UKK-A7_:-E>F+?U%E$]7][3GDKW1@\'JY?!]G4)
MO6CT=6J]'/25JKT@]#5KWYPH:.]\>=.GAQ2O[??%:T]C*JX@U("_JW?*L0UR
M]@.GUJQOB[/^4_'V_R9*IH]+2]7WKG@R4_$D@0NH^EC!IN]P'R3H96)EF= "
M\+/ARB?=WLO!!DQE13G8B.C >M=-'?1U4U(W==#73?5U4U].E_4!KF]%!JH"
M@2]<7W3["98LQT;0I>4EVN_)F9[*5%PY<"HKEI=0.DA(J1J_N\D0%4(>4;$,
MD!D267**^*3D7E@3L@B$C&C25 /# ;_1\,#"<GV(RF>SD+A#L.C\EM[4B]JZ
M3:55U&#/AP,&PSWQJ'J_[0_=]N7]'D37>,#^V&"R'8BW7S= ;#S,=.$I%\UE
M,8WS&=:KS>*26]H8M@NJC\QRG^9" ]RH7F$S=,J&=RL4L_6I=RSL]_MA^RTD
M8\ZVJW[7OX%=]\+O_<YOL/$@_(##@28(W(A@:[_O#][W'HKY36Y['X_\QG?^
MKU#XCY*3X,S/7V_-K>_@#R^N3H[>'@\'>^J)S@"!H,>_GEQ>71Q>G9R=7J)3
M*>G^+S.9WC-XR(SV=G9A].T\@%]%V^]NBJY_Y(D0YI&VBN"4JKYA.^K*C>:A
M=U<(A366WX,^G\;3$OELMW9?2'WV2+> :W212XMJ-@O=/G)M[>*D#%N_]"Z&
M^Z0JJ O=#*GF0Z0><2K&H^DTR[E(=!HG#DF:Y4]46V'9VK>NR!)\<%&Z)>?;
MM4"G4^%K6%-T_2S<@$24K?EWF;$Z=N?8D7O9"E43S]K8 .=JW>Y/SAI-!$_.
M'IV<8\/;N?STL&6THB2/0_S@$DYSI@7T"=BI74I-\K$-2\;_-F]"=E7,S4FK
M4'-"I8NCIBNLR:___AUU68W^%,Y"IH Q+-C# 9SU,H23+5WM_0KTLK$H/ /*
M5#:/ 7*_T$*$\WF>S?,8@1%>Y3BLVLS)/,C4AP/3_B/4O.5(/:X)(UH8UDWS
M#O,%;C_[>4?=;(N00NRHDZD*>;HE2%D]KV+W&/79I%6AN33I]82_!;+#NKL5
M^5A"K[M52*N"0NE<;YJ!0$1Z-_6J$ <!M?2&STQ(-,UFP:PE/2ST4K T.CN\
M;#4,T8#>V*X60I]Z#5!%!W$"&\Z!YHM<K1X:8OHT0M9XI,&,D;F*F!E@ROP*
M>H:9-*Y4^"%2<\3HM'4DP.'#T9JUT##TJGR-)D+):E+EK> 'UN0U;>=S;'3U
M0\,39T]G 7_Q?J^1.=PD)N"&0G7B&I+,&0I::,[JA#XC=$<=D U70SQ<P1"7
M9UV@NQ7-%@RC,[>L6A$%VRVWH[$J2[(HGXLV1D/24'7733CJQ3,W2J>-UX=T
MVW014,::<\L!*RQ2Y)JK1_?/F,BWR"0,;=?LNQONC:+[1N1<BD@JQW0+8C48
MJCDH([<I!S_#C+JKX;EHQ.5;2DPOS<_Q;-46<ZPY[;Y)B3_^:$E&NH>+[2PZ
M2C=5:^7FMMRY128;YNZWOWE:3.XRM;7G2<F6QQ4%OU/QM*:XXX(NK]LH3^/K
M&R*/'V'_C;)]'MN.A:2%S;O0M>C)#8IUA)X+LZ/>8[.LVG>UX ME'@W1O8LU
M52[7)89-6JJM8CO0UUKS3[R68'K S9B6<9DPD[0.S,5YMPC6:(#N5R]=HKBC
M#G$["2AF"+' A .KB>]/ ^ZX9TS2(&79>#2+$FQN%Q1)5H3B46C0$"3% YR$
MIMD84LW!I07W!Y@"9%\:)>F 6&B=M3UI.@*U#[#.2V:7Q"$FZ_[^CCK-2AR#
M:?#&9/!@"&=T)/PV6X36RT9P_7)K F.VS3+B121**I@O3/B:VK^2#,/LU=:^
MG)UV$CUOXY<N-W5D[!Y(U\6%O8U6?(-H@10<#>QA]T_WOG ##PD+')VTCM7=
M #/F'GOL"]:+//)$ZE-84G[RHB\_D?*3%WWY25?Y2>_W=/L]!Q*GGU1C;0 N
M<8).V-"!AX?7J%%=/*=+\\RWVHJ^B?\A[0"1O7>=97"OAJ#FP9B<@,,5%;Y-
MV,KT&:@.&D^\D:1-&OPHW=O(.J+>;/ IMW&J;I1I(SY^<\L6N"L9VK6+V+O[
MM.'M64_8Z AC6GJ9,'B&\;DJ3!3E6J]UMR++L-TV@:V83,EMQU*V(YID"=(F
MAS.D^,:OI=5LQ+9K%UMSY[3KOICV+4RSDA5MR.CC.(HFA<C4QWA6S9KCU'^P
MX[U_/,R<"9*E6PU*XKE]&+K3#D@8K&J4+,!VH*"9&%ELLE(72BV_.1CZ+&9E
M/-/F%_6KM&#E602/G2@AT(>'C$!S)](45=H3&H?+/'J+?GS :M1:# ;#@4<D
MRZ/T_+!W\HQ3\PR[ZW67+& .[6;(5DOR<A>0!L,=BXJ?;#OF:9P7I3ZF[<(W
M[6#QW8*%5'!<0C4*"XXA2G!V+E'X5L$V[:)C26"Q9]\(MMR$A2/-JXNR:1BF
M+>I5A]$^2W+3/F4<6[J?N?;HXX*94:63$$8OXI2VI=X*7EW JM;W?[MYEO1Q
MX=.K#\DRH7II ^L@J!DJ=PZC@3/VL:1DAEZ*98^AS4FIQVJ$[C1LH-<*U#A#
MZ#",$\J@@,CIOKM+9*V+^!G;<?.Z2./HSU^(L6D/'N=F'10O P[CRZQ#H1="
M]VNF^"/L"B].K?<3]3#]U"MO$A4QWIITLX&BX)/Q"3)$6MU=.PINZ8;7TPQ[
MZ=86\(O)44'))%XLNW ZC@N;VKJ.#[ <=#OT;O,$I^9GQA_5N%#+;0MW%RFH
M](DG8#.P?AL*VN%\=CL_?0_?6<.)P)8)?,?9-(QI%Y^0M(+_?TK2*L;$5<FY
M*\IF<\L?&WZ;A!S>-7K+ (%0K[1#@+S/B_W-N CSW24!1(S$(BM4=I?JID8X
M)-W+ROQJBK9L'MW8_$_=N6RS?!'*6L^::SO<N JA]$1"!Q>3+%,7 ."",APD
MAK8QY)G\-F,SP[TZ!M^"EU(< M+*BSF_WS$L/2=,\%2<P8>AL5^"H6OXEN>Q
M:",V#6>1'K*9T2I./TJ#HK7ST!3DW'2M!?YW-D=SM4KQCG0N,KVJ][JJN)XV
M;<7)?+&>76>8X\4PD'K:2&U5:8(R^%F)(I&8>@)JFT(9Y&Z,D:),)P\I&T1&
M3B/W [N_U41&U-)IR_7TTBQK+;1"8*/AP'MC/0/3[M>WCX'[/1BX$QY%!Z@Q
MPEUI0)W<N-)PL"RP1&USC5BVNT'P6 >YTS$GQ[_R\#GUCAHM&8@]R7LWEZ6K
MOXMV5 L\6XP*P55";RAF/1LR54.SP54CO/&0;?!7XAX,TS()(*^Q!>&R@EXI
M^:ZPZ4#5F@W4Q[X[-]Z(%:Z2_M-[)5"S+Y/]XTOG_O2?3@EO@/&Q45;47C,.
MWJU?'R\0SO ZK5X=W>$3VZX2#&^TGNJ^+AM-J?!K[=,EC,=#@LF%\7P_.W00
M$+X.61^N(U0A$O\V%A&ITY5?Y]@F] ;;^;I]:S!(0 $"A@-1FTP7?O,PQ[K-
MIV853+GXU?8-U2AIK,#:5A1%ZS:+S$0[[R4S3WL=MB7@:\ OZRHX$:V(F(D^
M:S_H#BB$762%S6D=- QCV>[,S4)X*.*<'"=J-T<;L]0W<%,7R^(=;'RG/WT5
M-;DY)8Z//I6M>'LX.&F!#)XYQC^=-=9!M3[(!ADGOF0;J-W)D!B 5X?#NG78
M3(Q\>BSQ?KW:&<O&@/P#@MFO6J/ZGQ^,%1Z@[JC^X2I1?:-1<QO8[U2#-4"]
MM2"' V-"/GXZ@!3HT9*4@%G$X>#Q4P*'+2F!5_>$LD%"OIYB;U/GP\%CZ/-'
MV4[,FWQ%[?@5F()W5V<*_J&':@E4ZX<>JM4)U>I-EB4FRRHVBU_VH8.@H\6C
M>" V)CX<?**QH^JVSB?;.7C/8%$;_(<.73D7?<MT@X[Y/IKV_V+VT'T@!\<<
MZG0&'\L>4JN90^RL/Q@>L9(MM/H"4FOQ+V8+K6Z*V^.RNBW^<$/R];W8"$X%
M?2E+,G!6S6 CCCX?8]*2N%N.D_"CY368A"[A_ZQX3A=0XC/VT\6&]?'A-9H(
M*KS])= (]3ML\"0/[\*$H\.'('6")ZS1(9%/0HZ,?$57=W4\F2L\%Q1BS22)
M!IH51+S(HEMX?H659:UE8[5";AT=7A:I-@!B.& W,:S(#7\($WB4YM$/UJ,?
M#FCXRW)0\SS.<CT8JMU.I:-!6\%F=[43C N3M]?V47@\J4X;E=I]# ,CAHC"
M:8WQ7M0:Q1OJ,=-_4 E<18#)F-1 *A>?R0%UA<K-7&-1$RP4RY-35,K4G_<U
MF@CNRH'4@Q.K!4A"AW2[8)LW&5TI#%4!X8;+$:2:L!"+6BHX[P+$$^Z\GFI8
M&H)G\>8+6]'UB.B3XI-J+W0%L1D&"VY+V3?S;4E:=U, <)L(Z>-[ZU62@>1>
MY2$2?IR1Z7249620X3:;XLX>Y+>&$X%-Q /7<B%J*UC#^@S/"&SY(:9XX:;;
M8^M[5"$%BD$#WH_O"WR&FG2BZ]ICVR 7;-V(DMN&9*:+9P)M\+23GHLCQLUB
MC+NXN&%7*4JO,105IS;[BSCDRE5>VJYW"W50+\;I;9;<LK,K *H\"R?%3787
M:-9*369#%DJ6)@OU(27T8&&_-*)#5.(ATE^K<WC1.1L.Z* UR U ZUM^(4.7
M(<X*-T[1ST4HB<" VF:ER^%#-<JS#Y@.1E0/#/4ZXG2\B[X9#NC7Z)A0%IWF
MI#]HNK\$30J/;CW1+!)R 6[,S@"#*S.D"\U,EHNJIEP6*N1;&^NJ<'*. IT=
M,'4T@?K;W@M>-%B01(-#4T/KT) :C&Z0BTUF+P@8'AGA9?!]\17RW/M\%EPV
M#7/CUA@J\!S.YF6R,.1V5NOB6C?6TX$O@10DL"Y(R *':*N=2L\SI9'9HH%6
M)( LF]C&X&_2CZ%UZK(H49"DC4TO'&.]&CK%]*;[YF/DXZ5FEYJH)35.>32'
M74*G@H[F+/PS0WO)H-TZXEBH%,0/L%IAE>6V)M#*3&QD?MUE^0=/:QE_"O_M
M0Q-S.9&%=R3I#W/3RDU^1SPM#9*4-S#8% <$;T)C+D>PSJ)^XAQ?0WHMN?%/
MC[O*V458;PIR.(QE7L:LL-1;L(%44%>Y5;-&U";9N,+/B=^31XD.KCQH(WHS
M8XTF@F;&'G4>M$K&)P*T1:7F'H7-A,W%O=17ER,X=+^8GQPNMJIH]ZU#5W0H
M0-@M.X&C,F!)*#Z1H^QW5H[6:596%M-&)_&.*,[#GMH:VU&KA';$*:R5P:\4
MV,&SW*YAO.!/260\K2$?.]7A8/6#_I!PCGIH-(>QMY\6S@D?L&'WAW?(V?+B
M._OLIO>:;HTF@KNRW^I0K2R2]T=C4%DN. G[ #M0=!27)+1X1,MI/[]JQ[VV
M/?L:B)15\2@_]G@4P:/\V.-1>NJ@AZO0@^'@JL70XB*HASIC3=N**VOJIDVQ
MQ(09#HP-8XIQ5A_'5BV&P9TM:7!8=!JS:8G%?4C#@BQZX$U5)9G#7+4J3N0X
MNTYAJ298.G$+%BF9O*,P_5#T#.[K-!&4X1?#P6&K!'LQ**HG%<Y=,-4MA2("
M+=36@41KO"C[4F%KLBAR#X:VZUP05>5=E&!H:%?7K<Y@/@1!B+,))Y]HS+=9
MS 5Z6(275:.2\T\/<'8:2:C[PF/=.:@'$Q4WD->:ZK%/-:WYC/8,E1R&GB6U
M@!G2]G0I99FPC,ZKYNJ@/_H<'KE&'+1>)H<MBBN.^L%3LA'V+3!@!6Y+C&>I
M<N\@:C62ST#=VU_3=RA"]M(+]5/$^1$GIIQYR4AM92!(RN3:15>\RL)\TH1C
M.B['758E$VZ, *JD*A)4=;"%%-]+NF D_%RX& GVR<7+Z)-7B<#T8DKZ1 4%
M>/DY$^2AHF_KPAK2-QJ\V4&L)=3]F&_2D7^WFKX9')A6>1H7-X:8V&PT6-*Y
M1%%@MG"PG"80-R'L)Z:4_'4K0UOXN.IBP\P?MJ;PHZDTDLA*![R71Y!&80ZS
M+*M<1_G->J-:)XM\A9572Q<>#F<JE #1;4<8IFFT\8O\O,24&<;IHL)WXCUA
MKU $>F+T:=\E[[4)A$#=9'<8#@L<<BQ_%/@\?B]Q?C#4SQ2:Q,@&D:91[KPS
M2\=1R[WZS+M2GV!7M,UH2K?_A)O2'9V].S\\_6,X.+\X.SI^_?[B^%+UG>G6
M:$;[PI?T:P0J 93C>9Z-HPEH4H3<\CYU-&VZA\5$6,V;K"U=8"^*XC\6-4=K
M[QG#S#%/"-_02LH1<%\@:W!P3\ZFGJ5R/LS8$U\)W6E(7Y05C*@4KA$';V[3
M15^G^KEW>ULGLL\M_S@7+,B>KK9Y#V_>U]UJAIXO-*W:-NMF+H!1?<E.:?Z1
M$6*)%IRCXWO2F'*PO6,'[Q1(X1/9.9PL13/8YOJ[6EO%4]MJ*@"KK(P3.(B@
M:CH69(PL5&RO+ILJ6614N4&5!VAYY=B81"59>HV)P:HT^8XM7<, UDX+2[!I
M:X=;#!<:?:Z.0]B$ [%1)WMOQ9/-#?6P3QH7M= =D!7E,WM$G+^*8N\29J+[
M(AIJD^,O3)+ZW$   J?/FH,"ZZ3ADOQX+;'M/H. 7N9[>97@\N31=96$$H#(
M,0H+8ZXD(N%@&&1\S4Z"!$^H=^G)]6^<0WDX)A =O5?4@WUU:=A:B)'D0Q3-
MERRBHYI(&:C/UP4H YK\O*'K[K</BJC$Y2AO#,M8QWO\/GN-75^JA#;AV&V4
M_MAWD&7F0NO>>/=PRW$U:J,N&&Q8!B8^H\OBQC<P17,<W5P/08#:<ST^TZ2G
M-3KIDQJT>:L59: .<<+GCKJ35PH9C$JBZS"A^'<1@;D\SN92R[CTE!:6RY!9
MP*@G7\ A+KN8\%(,Q[CG;-ECO6R68Z00!=['FWB$[HRV]7%"&M)'RY3E\RS7
M, 2BCZ>,<,GL\=O"*.J<\2W[!GHKW$%8.4/UGO9CVW;IQ,<Q+PV+]DS?2COK
MM!1]Z-;2"[R-,[BL%D;1^IW5 ;3DY5F]%71VESKJ7%[IQL :D2_JAHJ!+S+X
MZ(*R<2_T*_FK5!YO5KF9T)'Z<<U"%]Z&<4*#R]*:P6 (CXY?_WIXH8H%7-BS
M35!Z&Z6]#QSM[9E.OM1WTSNLZ'.9I(VII89W_KN"=6)(?*=?YY@N2VPAMIIJ
MC4WP%9Z#,DHJ,' ^U+'1*@GOC-8=#OZ$KQ<3G9 RW$-4U$=O-+KG<R\07_DF
MS!@L6$K44$N,K6V/L=CC3C9) :&4=CH4MSN_2U?<IY6L^\ANL0E9B:@)L>GV
MK:.>6'-?$RNRY#/""FYRRSG8:*4,7[V-\[+2I-+#@2EL(' Y^*#:7O<+__EB
M4@9OG^B6K; 6^GZ@=#IIL,9[<?A(E*G-?6GC[&PVY7L^<[=]5O(6S7]/Z*Y%
M3MOR'\U+P$N[&V<(AJ-/XC4'.1F'".MH5EUR'^X[L3PHAYTQV2OJVXB+?1<7
M4=<;4-50:V+<H;'!"C/CEYL'LZ5G,BA,C=T*=?H<@[!%P4_[&!K>47,+-P<J
M^2X<).4$[4B+3+_MZVGU=<8]_J/'/0KN\1\][K''/3[<R'HQ'/"U&VHV\Z6<
M^4E,L:U,_#''H(D^@NN;7E/.!Z[0;$8>%]@P7%<E1K8BE4=@Q!9F>+#.JV:T
M*J1,=Y3*RS=AY3=*A'Y .YTN>"R3S<.T0/B"J<J]([XA*12DJ*G;ST\"C21Q
MW-3D/D'$T%M8NLQG)MHX'%![EGN"%%T.]";LQT8)UH_@\1,UO%8V2>)TB>SR
M^DSA,N?[P+1BTY)ZE-R:QO:8FF9X'!;')]'D.C)99&VYHS[B,+/N:P^7HL1(
MK)*R68AB'MENYI&;<EI!)CF(S55]'.;!%N;P@336[;X7=-(T[Y:!A0M/"Z<]
M].Q7R/+/<P)#>5-5S9FR!RZ+Y5>+@<K6/3OMYXL;;2BS/M\$<=RH<_4/T)-5
MKN742XVJ<\F@ZKAVB.X@)I(B!$C.B0Z 3J.MIFTP G4$U1LQ=8J(KQX%;GV8
M"0?ZS2>ZP[[4+*7QFN&@,Q-0TR?T53MY^M%&?MNRD^BKKZR_:$V8TX "N(\1
M.%6?%C>%H?2!TZ<V$3S?_QP.'$(/@QAV&'"8ZL8]3L1Z(/6BRPYA7'BA$SAJ
MDRB).2IG>35=>3[\FK&+7D+:(5//,?VVI)UBO42X19[$1KH!:]XU41A@[4'H
MX0^Z;<L[T",6)? 1)*P0S!YY>!1]S'.#/?0^CGWQW#1^'>'D]W+<A*W:+)G;
MI3 HF<:W4F?053(2^$67Z"8N9<] .P+QIE1GWD$)X1/DUE5<H-&KH:7R"0G!
MXG=X;-!3. 3*'2\VJ51#UM%>O!+X4UY2W6G>2)/V.B0WY^5""\C\*LLL3R-.
M*# ',:U*'J&!WTS=UO@WR*XP+;<B8E9C\\:2"!LS 5G'(F:N,&18+;P]2RRQ
M!N@*VPR:'HOU!C;9= J^'>[2)$8MDDGB/9K-DVP1<1B++,Z%8J)W-&UY+&T@
MKN$ )4H'[GW!"-Q5"3J1'>W+W47&ZJZ$8_H-!W[BI&4X]7VBGSLD,K)M ]&Z
MCR=<7(.\U:9M8$$;1A RQCF,F'G,X=>"98%7%R#?,,5%K1 H\!F^P+Z($+S!
M?&[C)"NPX$<[FQ7U5#%[L0DJ;[-T]QXX QP 0(=PAG>P2J(2Q4@ST34.(XX'
M R)XDIU<[+P"'V7LG 63R+[_6@!3X8O="^V6[Y9C)M%?S5.0><]]#)U5H^)M
M=9X$<]S3VJ%M:H'OU1:2^YCJE:S5AYI'B#?)Y(:U;J#<N?56" QP\' *2\?$
MHZ;,^DL@0VX:7H1A.&!I,/B#UF:2[;@C'03NU"H>-]:S.C>6U__1%*=NPLG;
M+!6RO][FG\0Z3'_WKEJ.W/5XI]EJ-IC6G: )YG&*O^)4A> ')V1((<NVH/8\
M-DDWXJ.YP5QJ[I;WA9-)CC6SIHK);Y)J+3L&]ZV*2FWOCN[K#H8?:@U2KY-I
MX*3B5/^9@NR2&R1H#J\41AQ&$3X>6]6G6K^T3JC+"JN;L!WX1[*0"U"HN:_N
M&M@9&1JKVQ19-:C$H ";AF+HH@OO56QL,K?.9#A8:2J;H!TV2\T=K*[FR"7P
M%1U3BRQW_3Y3U?GM@K5BP48Y"/Q"UZ#1JJC+6/$-(G\0#IAX.+#<MEXU?8!.
M6';7ZE)W/)9=%FQL[9@Q@J1T6"V,X3.I$,$&TH/!?P%52M5(32W)2O0XJS:<
MU3][G)7@K/[9XZQZG-4GW LOVNZ%#E#[P^S?1S%_G9 0P0BBG'Q#GX1$FDCC
M<(RNI3H<'32RD4EXW_A& CZ:/-QD$[#+4550+S+T/3UW-+#!L%8?4@S@+NMH
M6N-KD==O@AAMUGGX83B8$=C:E.D(%[$  L$DT48])GZRC$Q_QQ*98S\["R-3
M49BG!)^W&2/CF9#'8#A[3'\"ILL9#FH\=.APP%I04LL((S7X5%N[1;E-[0I\
M<+^Q-_ACTPJ)%D'NTDE(M20YBJXE(+#UL1JPMJR<09PB<AZX*6 ]7>?EP79W
MMT)-?%TO\,7S=E'!8N^^^(=;U+MER\00O(Z.(18"$_BA2J3;('Z<Y]  /_6U
M\^LT$3I@/Z*.;6# '/A7[?B!Z8_Q^N@C2(PD%&KM/[W$CQ](]&J9L"$-HL#N
M:L5,5,UO0J!^G<NR>*BK_J60HAW B>*] =NW67+XC^' U+-0^-ERSF'LB.NE
M/ &XHS]1T,G4BUE1"S7Y0:..=10U9<=$AM#FJ&?<&G;07T/)^41EY3&'7:.K
MYS"DZ<;;1L_74AG6!F^CV(&;UJUQ3K(%V46Y'-=)!!FOUV%LZN;"!%TAGIHT
MG.EJPUITP:'JZ(P%^7UIB''9]/KRB#UJ'1&7S:D&N.\Y9]=V1M2PACAG6]I^
M6);9JWH$W>D,8H0.C5R'<H45INDV,D) 0BW9N*-.&/TY-G!X1C^XD"\#0-6_
MT(\,<X%3C/-(RF@1[4H,"GIX+L(0G\$$<=W5VUPF7'B!03&S49-KRY.#\(@I
M0*F'[W'/*HQ]3"-\CA_XQ\9T.(AQ5G"Z-)!C1]4D=8@9982B*<'R&:YB#1T?
MM&(WZM4OMA$?E1T8VPO'PW 4O282!/ I&QK)'UGM_NRN[8SVI37I!=].?!%A
MKN[<)G<XV=6J_)WC?9H)ALKT85^0F5.SO#MM8&X?=&\3>H^2N9Z1<[JV>"D"
MXRU6:8*U @[BRQFM[6F) 9]"^M'KHJXZ0$Q_S?S&'3,?P%%8Q(5MPB>S]P-0
M;DM[M\C?&3_#3 T5 6B0>1*5YD2BUX,_H.-N;$TR)F%1TA![, 9JGMT)+D+#
MN@)"9\Q245H8M'M6S3T857NHK.#QL/*Q;_1(9-I]H]C'6H->F]D\<.>R?$WM
M\14R&_J4KY#;V'W>)S<DN;'[O,]N=&4W^IMPM9N0.R=<4C&D[N-\B1D ]Y)[
MY/YY=(<D[!5N'6KN=3 X%U1/A5R0<VQV@U_>BN7O?-$ES4+-Y05M6[%^0!)6
M*>4:EF5RA+H,R^PQ_D%\:(P'U)&*1D&6,UNZLE[)^QAI&3LMJ\M,WPB>64Y.
MJ=RZ.F.S6*W>3:H]I9:UI9#5U,C&;%&DX+([-:MU:EVI"!<ZE08/)5*T% 0N
MCB=QF!.)#-SU4D;+: C.EZ&SG8VY]Z%N:.2\.ZB].7>)_KF5@1<I2F+X.U[.
M<[8RN-28ZU]KU'?,^Z+7.9P0970*GW" S+6)Z9X[UNE?K:9QBDD14/$HEEX0
MHU[Y=T/U-2,8AD+XMB7#T;7 : 4B2R?[.A;C;;!<:98^\Y'80G23+LU%^ ,V
ME#BZ^;5!^3MNSR1"$T53*KO=)>SRJZ[5)_/1 OY7&A71U\6)-)">2T31W0UG
MXKEKLF_92H9QG(,EQIAWPAU[(6Y'O1VCG#6HA%?B/$+[CAL^).&"&2;YV'6Q
M5 ;8TM8]JAVQI-3M27&7X<$)R5D.2##L'XOX(YKL/SPW5G%:2/S?YJ^PB46@
MW.\-!RF(&W[SG_J;W!^]]AV/MU%JCI?VJ5#OYP2.'D?QW.3(W;:Q3NMS:]B3
MGJEO"<HS4KEWR0QKXF[E2QU?3)X.HXK3>E6;^]+A@-_:7N/&RR =N=@Q8G&P
MMU')Y;SQ;!9-T/_"-BL8U< X0"7->-A9X7RZ"9T0$M6MN&253V_\U+DS;:^]
M4S1[0N$0@89.[39L/2KK&;/"61D=#K::6#,]_\S65@O-\S8OBM0 %J9RY!9'
M.7/6E:NNO!"0&:&("3V)?%V/"1J.LJ$A12W:(%//C']K:;BH_#%NNL2Z60TG
M(N#ZB1SX@;M9=(_'=J\1@I8@3#9.G19-?BD.++%[!S10J+5C85')M4$V9N-0
M30\'27C'FF<TSZ(TI#9612;U4XV'!9Z=07.0]];[ &4Y'?\:JRPX0JQ]\X@F
M-<$&6]DB8+IX*ULDO(ZJ,YG\;N:YVINPET-$XK%,%\>%7S(_'.CI8*$2#Z[1
M!]=8F#Y*TBNVSOU4!1?74?',W*)47,[9C_:9?&D)2M&YM>AF-)3@&7+MPQ4Y
M?69_(5W*ISSQ,/%O-S1>%\;X;739<.T).(_/2'512,EP!\ T(FZB/0>/=DSO
M,^8IC9PVL("QP+RIYV6>I3!\I.W#Q$4^OHEOA2]/JD4\A<K$4?$8<1$PGI"B
M*7W@<VUG1$TG*? YSW**.9U9M)AU^ X+HDOGQ-5"WRE\KK!&M"L'X&D>5.?P
M^9)&R9>[(?<9H5['R+F,8FQTGPZ3'6M^LL-QR34+:2C= *BO #X6S[;E!:)C
M76BF59//<QIHF(8$#7M_.+C.P[$&'6U+)F!.T(L:?P+?Q77.,P,5(H"0O-.]
ML'W(SSY!?G*U^V)K8K _>LK$P;#C=0*:5CD''NTZR%7&ZVD3[_J3XL'Y.]A9
MT)4D#0@Y3WHX:/5BA<S4J3MFK4DNK$Z-TN7%=*1+,D>P6$F]B-G0L^>>#]Q&
M6$$P*6=/D?F[]%R7Z&,$1@O)A0E*P^L85G5PX&&F.M_PV8 KMUF+K3VTV21=
MHR(F-5M27.<B9C4O34M$Q5Z"?M=!4-7:YJB5-Z(Q.*FPJ)K)<_\;8QQ<BTT%
M.UAQ$)$8Q:64&L 5%^M<N90SVZNJU_AK.Z-]Y/L#C?_6.1?W-$;M#/<Q W\]
MZA>@4R3>OL?$H-UE.(#Y&'0!!X^H7:-&)HM6+-3>SBZIZ+V=/2=QQ8=IB@_;
M>B$$_A@G4EL_;JM%%.;4<844/7PF@:$89[,5LEF'?V)QO+,0U@V$']X@GOKR
MV6Y@G(%5YJBZID@S=+M \A7V&)T>/SG9\F513?=D<7;[+([.XNSV69POT17S
M'JS=FH[:[49Z\(2[D9Z<OCY^=WKRYN3H\.KD[!2,VM/7Z@C><7'RZCW^IN]-
MNDXS.I#>I"<,C]"VHK$*-@#>O#$X[0/NHGG5&J,5?,MT4:\*9L(LB1$FX9T?
MY%Z"[*.BLB934V!IF@)A_J7?$G$T&68>WU&@9M%LI,.LW*B)L4AW-QD;DUE2
M>/[+EN/7S:)0L]8UW;-MM37.DL28@8Q/]C) \D@CWACVIM<7]5P03"#$MGWD
M%2<4E@R0=#.>X>S#&<P/D4,Q7.:);1AJ,(*V&Y5#O109 )()>!IT(7V^$.JR
M&@2QXUMY7-!:5(95)<+(L[3]U/%8!\!ED9B>;4H!U3HOWP%W'MV6.!]1%Z-5
MC6+FYDH"Y)"/YLB-5633,-=4#P68-Q10I30@21LGFH6OC-LBVN X)V!MX%RH
M;/F/&AI5BU;S,S%#'8$'/#41VLY=5N@DD%;#T"8FU:J"6V6A2]-KMS6:R %W
M$CUI,JXM 7K$J>&LO$^A$6+!)?$(/-GA@)H(H6DDZB %M$C66="8CP3TY"2\
MC6U7.?W-9MRMT'+8QBYG>-96@X$0,OH^?2^MM-&%YLX\Q(<"WNN?69R6B05'
M3FM)I*X;8#BP5X"Z]P98KOC=M7J XA=ES<WF/D=;KZ!V'ZBLAX//U-;J$94U
MMKW"N$:R4/4TF* <C-Z>A9.(0^BP;,0QG\K<-;DXICM)2GU"1K]@0)^GS-/H
MP\&GJ?0V_:VT^@:%CWTF&'DD$7&*!?.N+PQQH10Y\#.' QMI&D7JFMC[N61Q
MAL4)RG2L2*-2"9-_H1/7C9BU"3TMKY1H<$]U8G>N8RHFRC&LI".[L6^>.]G0
M_@Y;HXD<<#?;0X0SL*YS(8_U392X*@NNP>,C?Y8@+NK8 3DZ1EM34D$3*J"@
MDP+T"MOH)C.]T8HH^E TQK%E\B-&*2 P"V%7V#O-&8^,PV;:8SC$,:=(:B4#
MI,-:9NV>/E\C<1Y+7JR+]C3.CL$G?X+*'G/*I645MOTNA@*HT#B,V#$.Z>-N
M--@H<WC#-=-8D])+8B[3,FR&HZB\HU;W]4>RIJP-"<\]AHHI1]\H.&0 &VV9
M4+SE4:.8@"J;^-+R.!C<)3!3$C0-DM_%4VJE4+)^HJZ$!A%)7Z=6)%U/7) ?
M(Z6)0KGL3=F1/:Q-*0A4(W58.%JCQQV1M)532YEI&[/: :M0MW"0IV,)'+US
M$G0=":\>U:$')8/!W!"F\6Y4EM+?@NY!R>0UQL)P#[S3N?L#47&!S%6R/OHW
MWMNKM%8VC;G/[1UUF+8-',TC:3/H: ]"]A%4@_Z$YSKH6/=0%MT;@]P84I(;
M\O1:2]W\;(77H1@>I\7:61DJ0.R2CFZA#Y0]H34LJCF%HM>:@MY^/!&7JT];
MYTF5!PC/MJ[F;?\<SK1[!E0'UISS<" 6MQ8529L5,J-6P0K,)[16! /9*':[
M(+G/ >1)+NOY<9CRGL,XZ&_L;I/12I,HM'2#&.A5GF5(?KUE>F7SSS%2NL#'
MXDG]0#@[[.,3ZY5.=GC;!/(7EA0[Z$G&8$"-G).RZ2I% CFCL>"9!M.!+Q$C
M249%NQ'R\LP31.N!^FL:3_80TRG19-=L.6/4QZ@%%TE24]0*_8G>]EJ[B1QP
M+^HK]W")@6/L&W(@K%=E@;2Z]]B,FF>ES Q$SAJK1\HJ(RPES">)4W\2I[=8
M>BC 1'USX&WN>33ME[5</>)A6P?;1EB-=QWHOGQU<GL.KNI(&WC4Y.CH:L\I
M]@_I5'\\Z:+*;]'$HZ.KVP+BZ36NR]<3\W7F6MS=ZS/9.I.]UV>R>[;%AZOK
M%V38E\LT]OTQ,#12-)80K<(J+YFC>S8G&+3?R)O!G%7J>CX81&Q1D36BCD^*
M,U)#.P&1LKM/_DK:84L%Q#Z9Q%'%5JWS]PZC4:)>2R/ ?#7$X*,8/T\B7639
MH<T4+KCU9,/K$2>PC@!G#O$'+X?VQ6%["0+,2-58R #F>1R64BTY303%*_%%
MK B9AO+V#D-4U\RU+!.\Y0XQJH*+9:/?E*P0#P,M -K@('?"Q<)@7#T 1>\G
MVW') )IR9,I?=85=5)=5W".O^R'Y=C.$8FO6$Z2?" P\DTK_O (F&J3.!-O@
M+)7^Q$[0LBUVE"_SD=JG:F,GK7.V42"]=NBAH?UB:&L"+&R@2E5_Q,2V,$?I
MJ-)8,TESKS&JFI!@+['.C._IO],:#):PK:]8L+15TC"DF$BQF(TC<+%EZ9?#
MD^G*VI8@L76)Y75U3NW6**\9*PM>]R$-5>NII/G2H31@[.' /8RN.@I'V6WD
M"F<TTV%*\L,"56L]9R'6S0YO=OT*6D#2S '^1=)Z^#-NK?QFGQ:8AA"X:&C-
MKL6<0.,;N(]X,HY&-9$4&"C5&1OA-GJ[+:OFF>I<;VZ:]/)Z:X<?%34N$'H'
M!G#/-;023,&KE36;T1SQU*I9NL'J57LM4L;+<A?E==T (U,YEM8@\;IM3B-=
MKGB)9J *A"C5?$A77!N?F@H$I/.,R4)U:#N,@UKQT#7]'8?#I<"YKN*$S]<T
M#ZM)E41<!ECKI=.1W:N3HDZWC8JM)_U:B00>O.HD>B9;YN0D[R3FS/.A47!,
M>LFL'@/(^U>C]%9 L:WOX U(\L43!DF^.[D\.G[[]O#T^.S])6N!'A&Y)C-Z
M(8C(4\IUN=5QZ<+I2H_4=E6J_976H-*LHC"T"Q[!.X,;Y(P<"JY)-,^*N-2!
M\/<I61N4$2XPI!TG';V"%N+/Z,+G@*JHT<6E2NUX(B77IOX<!\XU098 LZQR
M6\MO^$X"FTB3,J,%.2>62(S:BH%^QBQ]E-_*NE (&V-@\(V4<H X?G4;A]RS
ML^*KQ_YY'.;XC!H+@:V5BM"VDY;W=B18T3K6%:T8M=)MO$?4R;, 6R6A\6!(
M+]E1Q_CDKMW3/;7QHSAS6Z.--"O\=/*G].T5@GE!A<=CN'G0VFLWIHH*0WMQ
MA" ;WO: 2VHG :V3[CS$-J,AY: %P)@\#4=&79C>5R!E^41M[>>3;4LH,D$.
MG6F&?5JTM\@%,*G-_CHSK+U)7N$7I]<V-U W1.$H6T"VFK?'5/K)R :J%T3/
MCEYJGZH-:)'EB&T"R5_)<PVK!!?D&605K0A^*[V.<JJBU!TV]=O,(ZC[]111
MB(8;T[Z2N$S<*SS0*)=[5Z0I6$%C$#QEJ1?$,/+"E2 #+#/C^0R]8E0"L_S4
M^GJ6V4_JQQ]V7ZC_@\;=;9P@O4T6PH=/TDD<IB'6AB.62WY4!S_L_?"/@"%E
M_#QK;)HB1&_T=; .3Q\[38>Y2>LYE?%:$9G^: Y49CAPK#WMDO++]=LLU1Z<
M/+A.PM('B]9<+@?C)2>'OX3P @PV:D-_F[= ,D/X!BE!)C2?O!M'+)OD=FBG
M\N)&I>RH088BZR9--SP_(U FZ2;OQ;"]?J]6*37V"]0!R.NRKWE=D,A%ZN;L
M"97=T>/VV1E;8VHOV'/K"SO7=D8OA'_XL$!I1GWP$EVQ*[H4SLDF>!6E$=X[
M1-355W*LX41@$[F2P]/K.MS&\$\P0RH3076;^]0X8BV<2A>ECJC)(2P#&S"@
M#Z+K-J98 D]GJ'J)C)WT4B\F:S01%).]'203<UIT1Q_GL=^7_4TF)<<W(=P9
MZJV0VYY+)QW=G3V^18/P/ D%@>Q_+M# =;* ^)X-$%UK.23@5B*Q<H7*O7%]
M[)\58.+JJ#>GJE,H:F%45A:=2A,GHJ<)=[QD=0?FMF81$(ORN<F.7,D#(B3F
M$Y"T;BW0^BE;;<47,EB7N/3Z7)D!(10IC\<MH5)_UF!XV%Y#G[6M(",/VE<'
MJ(V_>KQ]11ACR\;&M8T5X[(T:]OKG36:".J=_<[KR>EI)8 LV[(@9NH(\K$L
MQ"1.!4N,7Q^1=6(+(-S^X+K:HC0>5)9+CHD^8PXE"ZRY"TW[&$&7R5L93]9V
ME+\BIJ67MU9Y.VC(FX6O(M13V'&E- ;#3RQ'!9>IZ$!^82'0^,VZJ^4WD0"=
MBTY6LK!*6MH_M@A^J[>T]]6\I5Z6NF7IQ7!PFHF.F$D\,M0NOD[O:>^XEK!>
M;GM;8[M=Y]DK,>(D?8W=$9]G23M]@NR;\#:R548F.%R+).AA.[.K.?8M/CVG
M&!Q*-!/;Q6'H-SC]05FMBA?!_<!"ZOMY'WC?"3]Q#QO7/D)@,&MSOR]B[;P)
M%ZG$>C![B2Q45$A&&XE!F2B=5#,GG#T6MA\L:32E)>Y3)<JC+0[R>9PU).BF
MKQU6");L^3B!%%&C.+W;+)[TG1PZD9/[/7)2(R?WGSAR\HE%SQXU]?WU";@H
M'L@]C9QN<EX;,C]SP"I5VNB09IMA^? \X4(?_0 W=NXE/<Y?O_$^N!T8(YZ4
MMI2^.#DP+"."2S5.D1.7BFZ0*E+3V)?9-2/:^&L(2"GCLN+;DTN3L<P[K]B7
M-&XZ5B:9A\ -1>SVH+ GU3AJ:-Z^\\@:G< 7TGGD5TX>@H"]#>_@/HC2*G*X
M",^N?C^Y^NWRZO#T]<GIK^KJMV-U_O;PZ%C]_MOQQ3'\?'*I#G^].#Y^=PQC
M>W?XAWIUK([_Z_CH_=7Q:_7J#W5X^H<Z>\-?1,S(\:7";UZ=!>[OAH/C_SJ_
M.+Z\?/L'/P[^>'A5?_SE;X=OW^(+?CW[U_'%J7X!\5I=7EV\AU^\/WU]?$%/
M?GOX^Z5^,XS_ZAA_.#W^7?UQ=O&_U"$\]_S\[0E\Y>K,O@(&<OCN#"9J/@B#
M.GF-?U'P#QCX:W5RBM\XI2_"6,Z/+]Z<7;R#/\ '3BZ.80:X9">GYAD!_>+L
M_14\[-?#"_HBC@I&_>;MR=$5#@Q&J\XOSOYU<GD"<QD.X%>7[X]^4__S_<7)
MY6OX$/RZSP:M[8Q>"+'SH2;+9Q?C738Q6'KG-C 4LX8?UB]*-*Q2$F_1-.EN
M,_80YOAGEDN1G*F+QIQE+:/K!F(%C$O94?B:;MAF37UY)*6V=>"F;/)NZO"L
M;0Y _2XF3GDYH1RD.0O=-Q.D,#?A)_^!VX%PW#K\ZJGI&F^]%)>*&A]J:A.7
MQG<YFPPWTUW(  ]3\65@\"W/YUHN_7CM!4G/!C/=:/+TV@EW K73&O4LU2;;
M-L,DD[8=A/CO.2]KKDQ9* 9^>+>1Y(:2Y2X/=D!]#0@XK&X(^G##I7-4RAW.
MPW&L,=4WADR([!".P/NG1)QBP0)9")'A*ZB5X-O\OSY66P(*QZ93_/)M4XAH
MNT4Y9]02QEB2%9XF&#V8!4;(3B%(J9 J 745M(-\E\R!>]@-T$.7>]@U)AIR
M(67@_$"XT'@*_"P7G+<_FMC9B2!7DU[;\!U22$]0-;2E@[09J;N.TY[(;@N,
MO^5)/L#?'PLM#PZ#[5B*"V)3,<W?V_E42S_N6=(."'_)4*E@P2JS^MND#*4Y
M$QMFXEG(3[:J@'D1-N46V\1[F>FWSVB'E])N7WED87(Y\2US1YU!->M_J@'W
M7AC;]G%M9T!S<56!'_>[L=>[<U),*-2\W0?58^.?**?6"[_S)YQC,0DY.\/
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MQ#6M]0<QB6O4$24>"',_,-<0*P[9#8H0S&UF^5X%&)9$;.60!^!%HL+!A$,
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M;F?#WHSX-"GAP'5.IS^!DZ"%UC9Q8MXYK=YI7.C;"(B\_FT%5!\I.XXPC^8
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MB<QP<="J!/I5C!H]NSJMHROPSK<R0'+$C-P81!OR3X7J)@(8%BGP1S$%X#*
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MK?#7T*S=IY;3,,-DO%)R.2O/6.Y[^8DANC%%6V-[><91'O6C]>*G*MW0'*B
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MM&%7]/,1H@P.^:$WA*6.G<ZEP[ZL&U:,$!E<[ )JG/:OQG"9X(S557\(YXK
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M2_#:ENT=W-DP 8[6F"F!'W4[MG\K!;K4R]T?[:M9N,X=[W(+R]\H8+VPC"L
MSG +M)SZ)< JS*RF^+Q7E;3J&D!U2]LEGCO:_YC"M-0\1X(D.<JDZNM#];-(
M7S>-?XQ:D/H"]Q^;T!F[;1,YT/@<&Z^:Z"5G?1N683_!RJ9R52GAA9:/X8#
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M9F$BOBD1U0$"-D&7,\RJ)RQ#Z%F]P)8IA2[)WTAY.$%5)[F7C/#:-B(9)#.
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MLS1;.EGB\YF-?ODX=I!YS-E\1I&&QO5&O"/DZ/MO(4</#SGZ_J\<<O1%T?:
M6Q=>$(T6P_;GGN,+K'T323S:.V"[FVR'.GXE,3(*&P7OR R<S,PQ_'=W7&4)
MG:3[2@EPXI$P*#:"^Q)C>AW6<^+:;2;96,A=SA&K)G*?A8J<Z#(6X@^GU'W
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M"9=G/^,E?_)V_.[\U?\#4$L#!!0    ( $:)*5DF9A9NQB<  %+!   ?
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MAP\8WJVUA*-1SIC?DK.\:OI!!?#N^BAH&) 0#M8ZFM:'E'BZ:WH\_6A!:EW
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M#X$E78A/6\2$A3QZDRBIU,6EB0EG>&#9V 7)AP:?I%.U0K'"GSB)U?HS03%
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MT8[W+J*DUU5/'33RX@I;0_E(8IAO)]8+@.+ST7L;3$091UM"6[RWJ<\G-:<
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M@6-C/E9 VH5TU&-%CTLJ2@GV%]2UB&CZ^DQ?CAA/VFQY<$3:M[)13.HU*[7
M%,BPL*>G\IG^DB9EL)HI*JLVW0\S/NQZ&T4:MFF_:)G671\\@3'<R';S)]4L
MN(+%*[D#W=(N\\J&7\>C;O+I8(.G.^T%^K/<IR'JM>_48')2>4$OQKX6&(*5
MXSZKB\R4\VY3,[MQ;5DA_7[;(6*?FT-53$6MK4984ST]'VHK8Z2-2"[-"^&8
M20V2ZY$7 -GI3$ J2F>)4?SNHB#2Q+&%N$IN,&LKE_V88AK8E%P@$71K8T Y
ME&RGE5ZH!SN[.,);5S^ISK;^/FE43 [EE YL![#?$@?*(@!!#6V!:\[2W@-_
M-ESB:+BT6]JB)NS844& X,USRHD/HH;[8O-T@HYVE.'!J<N4X$_<825U,B()
M9M9 -*Y3Y411I^ MF'0+=%B#R>@<CB?)*W\ /I=V>RC!%A_$'PH]*S UV#><
MX4+C)25<44IMLP6CNWL(E6&_FP+M;_"Y3)B%/<&>K>UU4S])JA:BG!@T]@TE
MQ6"M,<Z;Z@@WY:(V*8D-7B_V"=&41F*RRSPE*4<M#R:45-&\.VF%?1FB+,:#
M$LA1DE,@"I-4P&?+C'1VD7).:FT\V\1/E?1DE6'!"L!WW6K+YMTQ?1M,%4P9
M]9"5M.8HXV;C/JM9>J $756>!-'A#$-878W*O1YBUB.VK,LEYVCG7%R5IK:!
MMFBO<[/T<#1$/H9L\H0_AAI*T)V;XFY10BU!AEY-@7PR3AEJW/X#U&VPZ,J!
M2!M3Z,O\G4[NLOA9GZVQN]-(UPAN70EWF'+Y6+>CFY% \RE\TX%+D\M!:&KH
MKHRMZ=S'&^%()(25>W8LTOQ9:V7A@QD*J->"!6A) +]"=W0L3X:5)]8@%0\%
M$:UTR[)?;4Y4^PH> *E]DQU5KS==7!-.;-+%);6R#^MJFU471+5X]%RM+3/[
MGI;YK3>'.D9*%P<I1:9N6%FTZ!4C3<CD+IO!JM_& O_?Y%G<+"CRX'M01((B
M#[[-H,CGBM"U&7;_[46[V^JH<5D:IY$W@N)]-GTK0FZ+0;$/"3DVV92/%A'H
MN0LQ\)N&/3?'J_@J(>YH8A^Q7JIV-D;@INLMCZ4$+:L#M3D6Z0H%W^A@7V;)
M3'8XB.4G[!-NK+T97VDW#PD6[6,ZQ]W,Z)YHAO?+]/D$>Y(UK0>W=<-??XQF
MW?;@V#]*=O%0%&J#'%.4@_MP_9.F>\'G?PTFX/MJ#Y=]OVGOKK2Y?<-A(HIB
ML1/X&B38@-+P?K'?;%\2C)U)XM>]_ZCU4\]";8_(P7J#ZU?KXC3#RS77K[?O
M;M V<;;SBBT)+&U"Q=(-)Y>;=FC ^MW;3]X2:OBRH1ZS%8^O+TFX%,=]TJ@*
MFDGU@5NB^\7?Z/FCRZKW:X,O']I4^\%EP"[=?!UDK%'Y-^>J(8XX$;4'@9Q_
M2CN5HSF-_(WB:YI:Q_='#3S1=%A$AU:ZK?FOH9,@1;U3JUXUBO ;ZCA^8;O^
M2'"AV9X@=+1= P(7F*,-RKJO7/:HL'UEP""Q3%P,P]*YPON*"R@X$J5K(M"M
M^UOE/@ ,DY"U>=EAO#:UJ7<EXY%;"N8(R-37=R^S!DFW@YEJ-C"3VNQK>IB-
M1SU-S.P<']K(S 96?+D+.;.O;V?F>WL&CKBP5H8&^N0F9^YVVJ.XNJ:)61@;
M7]_%S)MJ'O9)Z!8 )&'^'$!<K#Z\OQ4GS-Y^?RL/7- U2@TVC0+MX!.Z1G$7
M_7C3M=V0EE$+[0FUIW.4&FP<1:X7VSDJXLY1TSOM?-^ER_CZ['O<:NXAS 6;
MB$7,<(X:71FY*97-7Q)R0?HQFL,I5!O1;L=I':S<X%8N0A9O';K[-%[O@L>2
M-=7&))B$84$HQ4GE139&7*;L8: K[+O@3%RPB%QVU%"Y5<BH5^R[U-:EB(6!
M\E OZ"Y('5 5QXK0J4(GFQT50\@.BE2D(F[BVR+2Y472-9>J@EM-:3"^6A3<
M$DU5P+I]V$07!36@<FTL"!=QC6:,BU&Y_B94U.MOMR]!&!)TKC<(/H"[TD"H
M^-R;>S\>R>9W[TB6M)N@:QIY=-KQ@M*V5MEJ=UQ=N;2H-A[O]$G=Q\8G4BLD
MR*6[($OL"6=K90.TC$='85J"L'-*FJ &,Q/7*(=#RD')55,*W:AQJOCJ>??!
MLJ<K:PM4FZC]#0&YD B*.$2M.M7(;]O=][H0=CLF8@&+F3@WUH42EW!M6O@:
M1ATVAA2G."+%"@"Z.0G512K8LD?9P2>/:SUT/!U$4[G0,6^HH9-6(GKS8N[F
M-04@V+"=#V:WX1DQ]GH#@H#_[@UZWVG2?G MXB_0"N+^E*STDW@J; VJ]"8B
M2ZCO#M0PQ^:L$C,48?YG7KSSWO4+[LLD:@(GKLQ L^!,3"S*@S.0Q0948EL$
MS_D2TKA(M$7Q&(<&@]PZ1R1@@;$!KC \Q]&&E@"E7G78[\Q?Z"U!0?8\^1"5
M] 3D1I9T\X!KE8_KDW">"\PUQ-MDP-'OB9\2-*H.PME&K(O*J[<='*LTCTD.
MVJOHJ.<3#/0,C;)5<SN.<TX%@2]?1ADLMXJDH0,6L%[F,?<2JJ=P3%QL/<0B
MD\BESOPMF.'/ROT:%'.^C].ZM"8_>>-(UC+?))DO2J2TR[*/#PQ,"@$Z%>36
M#$1/T+F!$A(IJ3HSFKN>UXL[?<8/6"APJZ:)%Q]\%:7<@HHG'6_?8T6\)Y'2
M]H$#%BE7";I$FR&EP.]QT.')2Q'J7)N1\B/W*\!Z3-K(R[3.$]Q&+#Z4+H&4
MM(IMO%@]H]<VI!S?=J>2Q>EDDYZ><P\%:^A@!G5,TXCN*$;A7::$:P*N#QNR
M(%1BY.9FE(Z9U!.2VMZL+65-WG?288*1ZCK7:Y.$0K<GH7CMNPEM=!M&7[OJ
M88*S<'F ^R\S[^F1TKG;$P6>I/H $3T'VJ+T[7TLA=_9>W##BR0"->O@NN-2
MUD#BK*_,0TQ]KACH5U]"=O ]6BK1TH-O,UIZ(PJEF<Z/CE^<J&<G+UZ<O3EZ
M=OKJY[_<V[E'G]\</7]N/W\P-%<FJ>:/Z=9V1T?8"29:EH!1^]<]0L3A^5L[
M ?6(CZ/4T@=@^YY%UOES]>PU0OGJ+_?V[@TRY?4L^PPT&5!4T]5$6,/A_?/G
M?@:'(?@3_O/6PM</0_CTM4-\L24>'C\]>O7\[<GY^:DZ>_/ZU=GKM^KT5+UX
M\0P]\!^[;)E-]O7@/_L7WWIL_X;//=QI/K<>AAX,LMS_ "0=KQ[W8L)Q@&M8
MWQ.U;A\_/=GA?GE?_6K2U$0+]7);'1?Y5<;LX^/V[39P1KS5SK@&=[<Q5W?M
MGT2VMP'2.?ICUE/-;4SS$AOSHV[UDO2F#UCX?>+E3V\]-X:%-,!]ZN8]??J9
M\G""N?[G[/3G5T?GO[P]46^.?CY1YZ_5"V!J)V_5T<]O3TY>GKPZ_]\O ,D?
MDN[V\+L")PK<PV]3@>O3U;X:;6V]NG(;3!!TF--79Z?/3]Z>/?X4K>6CP?L0
MS>Z&<N"&JM-':1YN=-*X/HL6\K=M=0:V_;3(\W==3>0/5^B(;WPQM:2)C"^@
MFJRCF#^(HC\#&7\+"O1MT.B;/C5@IRMT/UK+?B.@??#_/@"T4*1^0T3YTL3S
M2*>(\Z,L*715F:^"+K^08=>[_.\,].NDU7]%[S"%Y=E=XY]K9^DL^CMU?IW4
M^;<(W_AU6_U=K["6XUL@SO::OTW:_$ H/]*D^L"M09)\%I4EV 5%I,ZVU0NM
MOP*WY9>ARS]DX5\A97[]7/-G741IHIYOJS=UE46+;X-O=E?]G3Z_3OK\6S[/
MT+]"SVNP3[\- NU9]LTHU(=]0K>S0^Q7&;917SQNLS[<\N/W<(N$6W[\'FX)
MPBV?/NR1KR7AU#C*74L>WV8\\=@!?WQ[AZJ91W+T[+]_.3T[/3]]_4H]>_WV
MS;8Z/;WEZ5IQUJ\NTO4!O+X1Z_D#\E"^0#1HV*7^=42"OJ>I?&Z#;V[T3)U0
MM1WFWK[F)D7?TU6^G-[S&7)3;I)J;W60#YWD&FWET6=.L7E;IWK+*@VA\A*(
MA'N-'T*:#]0[6D:/;F=QA_J*_#?45QKS?Y[MNG_\^OD_R23XZ_G+%T__#U!+
M P04    " !&B2E9&_>)I>$*   J-   'P   &5A,#(Q,S@S,# Q97@Q,"TV
M7V%N9')E='1I,BYH=&WM6VMSVS86_>X9_P>LILG8,_(C;NS=L17-R+:2:L:Q
MO;;:G;33#Q )B:A)@@% *]I?O^<")$U)]",;V],V[H=4) '<U[GG7H!TYZ?A
MQY/NZDKGIW[O&/]G]%]G.!B>]+N=+?]_/-TJ'G<.SXX_L<OAIY/^N]98I7:?
MO=G.+!O*1!AV*J;L0B4\;?L;;78IM!RW,!%3S[]VW@%+N)[(=)_1T.T#9L47
MN\%C.<$M+2>1;74[A]W^ETB.I,6"FWN=K4.H??X4 @.16J%;W=?IR&0'3RP$
M9O5.CR_ZP^& ]8[^_?/@<C <G)VRH[.+\TTV&#R#G?_<>[/+?I4J-=<RC@76
MX>$3BQRDH>0ISU0L,:^X8F_W=O;^]7<(ZJ7(K$A&0K/=-MO9WGG[:/(>W8!6
MMY>&6E@KV64&""@-T+&3DZ-'E/"D 'L>,"WY?=@[/.FSH_[)R7GO^'AP^N%=
M:[OEKB_/>T?E]?\I=,.JS FN;HR4M2HI[DUE:"-:;_L5"&1X48JY%MK*@,<E
M'+'*/#[_R(V5XQG1=&=X7$XKEMO>W)7I_/A8C(EYWY^=#NNF;!CY7^'M:74O
MQ'YGBT90%3GNUM9ME'SW8KTPD:DT5G,KKP4YY5H&\%=OHH5(D%UU452MAA?T
MFV+1_98HW^/PXAZY8]Y/,@T%2=I>]%QE[Y/R32%E41E2L-4]X:'$NCP-V0?<
MC\E_^\N*-*[W;=J5BNR\W=REJ#ZR#_R_MWB\V1?#2!J@V8*=&2^QQ$8SYYV1
ML%,A4E82X>I*+_B<2R,M*(L=*9U1(69K-A+L=1Q^SM4!JG9GT#U22<;366=K
MT*4R_5J[9^MNT5M8M6&5"N3G6EW+4.C%]=JK*RK7S/B%VK<O/;^L?[BT& NY
M%2'CAJDQ(V7HFD5""S5N@UKBF 4J'4N=,))ZXRT;<0M5 I7@,I#IA,$[U0+T
MPX@@U_":J-8N/,2X%@Q+&LO T22^F'K*3<@_LP^Q&O&8?>3Z2M@&%YU@$@D\
MAJ0&[V2Y-CDG%17C[$),"@:!D$N+*4Y]7+Q7,.IRXXT+4*:5R41@<P/-8J@T
ME39R2OV\>;D)X%6VT.C^ER#BZ<19E$AC:.UE/>NB5U<JV8T @9-A4TYFY?@5
M.]&"ZU@"HX7[,,;D2>)- 5KK+L40GC*PI95PW2@W,A7&8$HRDJF?06(P976E
MF/-:&Y*/3)# =^@'K<D48H.(!=P(@D4H3*#E"!Z1/DC-#EUG:R;'M%+E"D:0
M/J8\TV(LM,8R%!7C%9GSUE#HI%2U*;)_"[+Z"I):D^ML&-6J7DD(S$0<:9GP
M*P3HFLN8CV(X<PVI'_ <45-PKF:9T : (7_/#UVG6S7LM!FWK*DIJ[JGIEZ*
MD3Q"'L(.[8AX8A446"\ NZ0Z^"9 5\(!)34>XQ%HC >BS7) _B:]P!R@-*X)
MRG3-Y_L DV>9TI9@E/ 9"!O@XK 5QLWP$V FG(UFJRLU*S=9S^"A3$:@AY+"
M@,\Q<6@]D[QW,SYK-H&M%7G4\,C1I1:!("TI1P76&CMW2&M$/&9.F/<^0DY*
M8 /KHD:6UP-7Q:VRMHS?<O@,2Q4\)&I"B1!<0M;77/<> 8G0XQ]VVKO;V_2(
M)4!SA)D :EJC\CK1+K*4FQ+/O!-]BM\0UV(N;WYWN7MK\I*[P-T27'B-? %D
M5U>F'( Q+IL<W E%=,P!K$AT:FU0+_PK#&X46"&Z#RI6#V(N$W\32US)U!5T
M#BB:/$:M0R6G9-5H8BBXN;]EF[H@\ C1/T"UT-R0B*7*17FL@<>VUWM1?T*J
M$>**LLE77:\A3Q2P@MJ2.S C!6YTPAT-UZZN\""@40QFPTO21,CI,4G#D)%(
MQ5C:LC!F.08$E+E:1"J&FY=;CI0*&(1-(XFL,/D(RZ94+(%A4KA<2JM B+"<
MOUPLRQ);R 2- 2KPJLM]4%$H,H5>$<HN-P1#LHSUO&'+K1CIN P/YM$!A\ ,
M%P9R&!%?Q$$S154>YS;70(HWSP^;JCP. 8(P)XI%EY:[0PCXT)'"5%*%#[%-
M!#7!"; DL#Y]ZWJR@N>1\)+4**<#8D984RHP-\?;,LZU'TC@(HZZ 01(4A$/
MM^<IN7V#%)0Y\(<9%S OD.,-XQ-4$,+(/<JRA^CJ0$5S?!&!![DU2L MWQMK
M-6^+J.L$#>56&%^WD#7HWVN,0;'.4\HZI%3H**9()JY=32=04YZGQ$C493-?
M$2D-_Z!+]+1.*-7^G&J5"(D/J0YKJ?3\ZC"T$NY"K$6&=7'E"@X@B@2BF ($
MDP8]D"1HY5%\'3PTCQ=+,GX2&F*J>C)UV)A2.^ '+>CLMTJL(":T**GQD#6T
M.0)O)UGLME@^LU\P11XF]B(Z %]RW @%>LU$A7(L1>@8QG&>JV*T74  7 B#
M/.::*/I:TI8+G/8E$)G?N5=!)6;0N1,COF#;9ETOV("#[RT4I\HY8%:F(P4!
MO(B)3$C'DK6. %E=1:O@QR)G764W-SV)9UD4PXE//[>\2UBWAZ;*[@LK)7(9
M))Y1%'E5=HLNE=0[\ %VF(C4E(BX34S/[2U==\V.QI:&5 6K*W3.T "_28S+
M^?+$I#1PKOTF@2&8+K#QK.UGEI>DCE;Y!-UUZA9-E!;>(8G 'DE+"A=EOU:Q
M\9-->1T[/)8WO:/H% 4RBQ'.;^U*NUN]B!@MN/%FKT,IDVO:.+@T(N^X6,+\
M:ZEB7A95YS$X!-[B651L?I"6UTJ&1=,D7&.0%WLQ/X*25\%3[JQ'P1_$>V/?
M7!2Q((^6&''T2*UL2:*+NHFF+<+3I\2?C1=OJ;6N%E%N13*K-M>+1:WLP&D?
M/2G.B(JCS/KPM6DD',XG0# Q+T'" 0]EB[*"<@.EEI1HLYA/*7:TI[:S]1MX
M3!32,B6R)B@[M77NUZ*^78<\Q>;>G:$5G;?0*-(4\/KQ'"D&$56W[HZ3Z(+\
M_4GIJW:%_HF\ILY"%%VJ<EP41(H.$13VV&X9I$<:R"P6YHGA]'C0N>==0]/[
MQ-_H/!=W.+7\[)Q/!'L/7E%30WN*W__,;Q>KI?ZQL<'>2Q&'^\Z  XS_G&.+
M0N]^V,9&\45"YWCP2RFS[JXW.PW^VJ-[(V!/Z.K>8<R#*_:&2B\S*I8A5%BP
M(E4Z ;<]Q)CE8#PHBM[LSA:,:;!KA'W'U<:(#J)@?.:<45]TKV%1LK]N2<W+
M]:#-B:QY?,MAQGGY:5^&UE]^+KX<_6JAM?><59P#X)YG!HXK?[6<O7>_!FV5
M/AD>LZ,STO+T76MG3J6Y]Y!WOZ7\1>@9'5I@#SVC36U[_JUD*>BVZ:7SZ&TI
MO< LU&]6L3YZ:>G&%[X/E?=L[GK8)RZ/Z\'Y5]N[K^[V8S'LQ_O&/<3?%6SW
MME]]A:8/"^7=CCZ<[=_IQ_NH\H#=A85O9XTML\7^(^-8\H1]W&2'6DU3SUH/
M=';+O_-_#E^>8INZ7T;O#I\^AJQEGWRSP&?%W9 :_;NA]QABCB(IQJSOMOCT
MON7,O5#23^6MZK.2EXKYS26@]^&BWS]FPS.&2H B<-0_'^+Z\-/=J'DIG8>W
M?Y[W4C1?BN9+T:Q\PEZJ9J.8CSSE$SI(^>B^2/YK5,O.H)(RN/7S=X-=?+P1
MH*(]VL?X@^YO"^<L5GE%;ODR=76E^C3U][MT?3P%[_?+7U#6\_RI!9E1,Z5V
M/G*1QV*C/".IG]7,?VI=>U#/BMHQE#O :3B#*@VDXYGBW_KQS)S\9X_I%OVM
MC__C'_H;H?\!4$L#!!0    ( $:)*5E4_].@04T  +B> 0 ?    96$P,C$S
M.#,P,#%E>#$P+3=?86YD<F5T=&DR+FAT;>U]:5/<6)?F=R+X#YJ*>-^ "!D;
M;[78[0B,TU4Y@<$#N*IK)N:#,J4$E952EA8H^M?/V>ZJJ\S$QFX[AXZ.MPQ(
M5W<Y]^SG.2]_.W]W]&I[Z^5OHX,W\-\(_^_E^?C\:/3JY4/^+_SUH?SYY>N3
M-W]&9^=_'HW^XX=95;:_1/N/%FUTGL^S)CK.KJ/3:IZ4,?\BCLZR.I_] "_"
MJ^_5>VWV3_L@*?*+\I>HSB\NVQ?1/*DO<OCQT0^O7KY^-?KG,I_D+0R]]^/+
MAZ]A(N^](=;]M#4R/ JC_[N<-(L7=S;@B\A>S#0KVZRF);P].7W'WSIY&XV/
MWXS>'8_/_XP.?CT=C=Z-CL^_TK+LV?W5-6T^NWD1??)78%WGOXW/AM83[;27
M>1/]NTC_[JH7\/#+\:N#BSK+YK O+Q^.7^%#_Z[IK[O;6_#H/$FS*&FB:@9?
M7+39?)+5T;,X>OSH\=,XFMQ$29E&DZR]SK(R.BC3.FO;/#J8_MWE3=[F51D=
M5O5B+QJ/XRB)#I,;6$,T;@IXK8FR?[(YC)E&TVJ^2,H;G%[FSNZ0_^+/+=[>
MP@_CXUV99G4#^P?C[#COCN$O\S)OL\Q_?>\[I-?3T>'X_.#H[-N^;C35/WX;
MG8X.SF(BN4O@'\4-'7'6PG*B!1Q753;197*5 >G '[)H7M595&=%-VV3LMW>
M:JNHR6KX^Z*;%/FTN'EPF16*3G*8#9!DFM?9M*UJF$DUF^53&#:JZB@OHPKH
MHHZFR2*9 @W"TUU99$V#Y ($"U]:U-55G@+!7.?M900D_G>7M/3K%H9$JFTO
MZZJ[N(0[4#9=G933#,?63^9,6O#5A!Y/+A)XL(7?5W6:E_A(G3<?Z=Y,BR2?
M-W11$AJ\T8_#A.8P(;@JY454=2T^#K_+:UH]+"F"C8 7@=KAS2M>#'QNDETF
MQ0R?;KKII=F6+\Y?OAH7$Q)""HKIFK^NDCK%%;]1QRZ;%1T.,@]ZI\_6+I%X
M@!;K>8Y,H[U,VIC(I@9.0CO>MC5L.!T9,#0XJPB.O8#CAL?AZ.$D4OBYB9WO
M7^=%@:\B3\-1YO >O8OT@?][4>$Q3Y(FAS<3H/*\;:*F*C)@A(NL;+(X*O)D
MDA=Y>Q,9NH.AA##UU2'J@+'LS^-D<<"S;M+D:0Y4!3N^0TN=T3HG65%=[T:S
MNIH#7ZEI:NI[FTL[UY<Y;#!NU $(.;SSN%&G6=,F*'G>9<!ZX#?=G'Y_4+?
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M]=IQUDYTJ8JJ!"601C1M@@$UX\\@)5ZC#'B(-\ZPY -E31.#B6#<%QB(8-"
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M8<Z)4"_;;4$E0_+L4:8E.L:%KV!\;99<^6(IX)GQ4P?WHO<6.GU@YWI^;!7
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MIN1NP1U27XLME<'9#)Y%P@VD @LF/N!0D5D!J]B<L8UP#Z:?3YNE2R2'?>^
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MTK]5+DH@S\1/10FEJWRI7)1HK504P9<PZU/)(V+^![---A@YW''"]B@0)*E
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MRA5-"AGB!>T2_,\I'\Y#(H-7]U3W:50W^2RJ$PM3ZC'%JB1JDK^8A%SU1T4
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M,HG@=\^B*OB%*$-2C(>PJN--!MTD2Y;UEA,?[O7_/7@0_9HF6?Q]]-J<)S_
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M*J!_Z@*\0SUZ.58'6C!.3);P+_D K39P]<I&/_TYC=)U+]+%*%U:TH\3KG[
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MJOP+VP;<\S#D.[T'')T(UU%+3D]?!JO!L8(<!5R;ZU_ECZ;/,)WP0X0\/YS
M8WX1/,'@B.+JY3 ^++]F9\+K_&2+"]K-U6:.04A:X':/M/ XDP8$MB%EJ0W4
M[(NU:<=V[;H]C/@)I:ES>Y@@4,^Q>9O99I +SJH3=MA"8#]C3@KE\W>_HN:6
MA(/.N1U&6G,;6T$:CHB6+P+1TNY4L<V^(NI8C[9#K;Z@#0PR?7$+=J(JE]TJ
M(XS9\YW+Q$#$3%<FKHU!LF@X\C:L8K?\*KZL:!=*KLDB*/+U(C-S;/=H_>/%
MH4?S_-D_F-JBKX=OA7J270,8ENZYQXG]74QA2.[O\<,Q]Z>YO^_^GKD_^?]M
MPG5@FG2 \3T\[&\6"VQ*1- C;0:M]#>.#<ATHQF%=@VFYNC40VE=<Z_TSE7.
MUIQO9GY%AW\X2QLFX9CQ;7A4J6D.^I.+(\6&1-X@UPT,%&C;'3AD^^Z@8P"/
M;Q,#>.U) @C!& C8*R%X_'A@(  .,.M4.](^K)HQZECWN/R19"9-]%=3E,T*
M'3S)JS$NRV/O17XA\%;+F(@'/2.,@Y&P3%@>"9Z%'8(L-\G@4,,@CC)SU!89
MP<IUH20=BLT%9?B 8@6VC3I>B+%*\D=-4U^ $8J1Z;"U.K6EDRBV/KX^U4%K
MLKV7WX%%:KK:&)!A NMT;=AAZ)Z>\XWTON0RLB1+UA<%MW&4IHC%:M7DPIQ'
MC)CIFE,TU"G3,,C1<572F4@3J+R[LUP'<:V%R;W!I6Z.LO5TXQ.P)NW5++M&
MGXQ:.G1.=(T!:60*'!\IT#.ZD;C5N!9Q2E'ZW^&4WGO9'MI;UP/+'J6Y;1G2
M4R=V['>5A]]&(M:4DR+&ZJ1$ :V.(^R]SO%*%/L<,TE*)]D3Q]%$N.2)VAU^
MU7KTK,]\6\RG$UH\PJP>C^DI]8IT\C:U#BOH'J#F3JC7:OC*PW[ UB!SEJ;%
M+),X><3$+ 5&XI5+8W\:C&AB;;6R6':2O*V<9!#\Q+L@U&7<;+O<;,,R_F?+
MP)I!WT?-$6EM2YL$U#BE+6QFE]%+G,R')=?MXOPU4ONHC&><# G04!&102+!
M/ R:M_I38ZY$D58PY>@J2=YK((Q^H,BIKQ6V+I@#+W$1(ZRL^SLM> X1,1;6
MSC@PM+8$BV#G9S,K]_>NW"MIORRKA'3TT43;JYTUO-5"(&>SH'LBT6^IW-]F
M-\G/O+@&1XX7-2KT%@[L1LWM 4R\.H^"A'MEWB>N:;F'W%%$FKW53%*$,^OL
M]  S'"\9$4V%<U549"?)RCVX2VF_S3\*[NQ0+3*4 $68\J.]0Q\]HU9;"$=R
MW15N\_H+,CJ;'%F2Y4MX]>T>W<'.G4ZXS3O9)DLYO24E(!G=+GIO-%CW8*</
M:Z-PAE%(UQ0NY>8%3C@Z^Y(DMG7) #F%?7Z[4W?+0;*X* I,98WB^(6)XS"V
M_W<M.# =/19_:!M/48,I-6MJ=>Z[D:WHR,%)0&RK0JC7J8]E@),_5H,I$,J>
M%L':.)B-,L3:,5)F3CT!!D7F.J89G#RNEB0 S63)L@:%O20B)P>:">;G2/YE
M8&DI5KSGN>VUW.\O1?CC1V.R5).ES_^>R=)1LP_1[,,Z*?P'0=%=DQYTM5.'
M:!,H#EL"83,O3-7OUH: 1P+F=T$OEA?,VN:O:F422_T"KGE?<Q/K1_@AL^Y4
M]EK1'KP8/A]H[\Z<^[JUQ;DN=%IYC:*5<Z;7-540K*M\TAXQ8*":.84H$[ ^
MJD69\$W0F$EC/O5K05RFJS6UZ5HPO4D#2UJE)8'^M7DAUP$0?A,SL7WI?+42
MV#+AJ%$'Q-N"IMIPL!8&]GFT;4^1$CA%5:_1'.\#\Q(]#]LV.AF9",:U:!XA
MYC;<[ - R/ ZL!,VEG/TJ!88?+6NLXV@;'$Z6::>Q<ET,C"5JL_HE,XV>VW;
M6Y79=M30J#%VF6Y_^)$GEY.+ 2=75XAV=')U9W(BS8 IQ$7E0? \*RP<GJ^P
MY:_SUNUL>@N%83<B4XLD;/2:;;?K!!F=+NE)GK*7@[!YD\&FCS<,7;>#CUMI
MIUMI8 V+GZU;-Y:0B-*-K;(2NSOB9$$'!$9:8;VSD<YUMTL]&.519)EWJA)+
MM3 %^"$>CLAP$;<F=)NL=FK3'\55KW /4&R.W":GZK&&7(B$AKLRR <%+S8>
M]<:.A6DHK(+63==,^T=2:B+5;%$K3$WJXJ\FJ>POO.A82RSAJ*HO,,QX@CUN
M._>B9!-9?':\MEQ+"@A1M[,M]!@]D>FVJ/I[ 4ML-LZR#"Q.N%VSQLIL"7S2
MC&U)F9LZ1>>Q1R$,3D%!ZG8OR"M&@T;KA%L;4C+)O/?R;*.NW?GV& B$Z!;Y
M8%]H+."!/_%P[4J@%>"@ZBNJL!\*20Z,1C*)EQ^T%!PT0/S);0#B_T.2PNWW
MT$,>$>&[50!/!B+"/7I/"A%1FS3<PV <U66Z8&2LJ6NSN)"-;MN3( >512E6
MQ$^!C6?@A#EM<VA/)\R"GU#MN/0S]@#@UMD4@"NK&"HS1J>.C'QT"OEZ;H)K
MH;F@GS:1$48+QJ(?M-;9>]$;9N:WCIX_"=ZCI01MUPX$)2U*^1H;*T4(.,5?
M&OJ=*Z5OE1-@QS_$^Q/ZM!TC&5I=,!M67A!I=<'QS .O+1;)NI:>.V1Z?H!-
M4WE>QZ7J3@J3T!2"ES%3.I:4*VL]ET80?):/@!*&! ZV;@MV*+"CRXC3"2,1
MY7TH;R[K[R6'./=Y!^UQZO?QF/J5U._CAV/J=SPCMIT10[UWL15 ,S5Y532@
MM$#AQ3,A;?$2:W FK#CJC2K0>K0K$R?:X6P!3GP]4P*"/QO0X3&;.)1QRYK<
M+#8S<G'I[+$U!P@OPV@V'#-2 @&'R0(."$2QS8L\K6;N^-#31RAE^ $L\Y>4
M7S@T&]T$;":9G'7?&?)YXXT[]_5G3X?17FOR@Y?S86XX:,SKG&NMJ;FF.-,:
MP:7CSL>,A]U N08]L9L;4]2A1<U6MXR54^:8BST1,0G_Y7=$ 7GC< !6R6PH
MM\Q;9-7:BU+SZ6B"L"/J*(>[E,-AZ'V00VZ($P0J2T/&KJDTZ4(AHF7JFC:@
M8**0EFC=@KF[C:*+6O,(]F4ZN3;<SM8_388W05HI,5DIQK\47;%32+_';&:<
M5C#OXJJ+>;0/1%E&9B^VCXO$AC'54,:-8.-[FQ]Z3%SN!6&SPM(5]/C1,CB7
M*LY$5<%+75(R%.>_*'+R""X/.UBV]UMD&.R=(UW""(>1SBA)O?,75G<3%+(?
ML:5R.[\3O-9;E+4[OQ-D6A4^SE"+9AQ7*493;(&]+2WC3Q S5 :EI&E>U66#
M:8]J&T^3<>B"_U#!BCUQY.95[]WQUFYT?"E^6;[/1NY(I/A4(5,ML/M08U!Q
M-0^1AG1DR8>D7"#D@1.$3&5*+O>XVW:YVX:A^JTX*_-7*$P<"<PQ&86JG[:C
M"ZF$@L*F?-CTE:3_RFRF$\G5E6$W3\IZ$5NN-:N-AA_!=BI6W-X;11;M*!E<
M% *:5]1RV:"D$Q&O/SCBV,R\HN9$A,:'X0G1O^4.(9\&\99787,FC ;94(^W
MNV0G.GYDV"8(5>3]XEP17P' <=C2 #>^@G""?;O4&JGNGC>_*R(,W/*R[G,J
M!ZT.#CI3]?265$8?P(T9$U2[/0">#DQ0O=NJRDR;R<?CQ/"I@(4?W^HWBH-3
M1W"I"^ A4>45I3LHP-8IP$W9=&PO=YN97T=LAZ'"A*T67M3.+'0F!0;.C18?
MVGG\]/;LFSO3ZZ UV=[+]7!:P%:=? M-3[PB+,R;7@?:8>O9Q3!YGTD]G7#A
M8U-W2*N#IC^<>(6?.!=\X+Z+DW51I;5XXQ9];_\B7_J(F%^X/AUM< \"OZ6\
M5VMZ]6E\3[[O-: 5Y*'U:(YL[U?'86C!/1?8%D,>["229"68($FN93P2HV7D
M%>YS2WWA%G;8FL(T.D]SW9I&6Y?T3LNVOMA4*/X9"(N$3#H=.%N4NT^_HUJ*
MH'7(#67:V]9,USE8(^L 8_K2)BJ])X.'@>DGE89']UKG[7&^\LF8K]1\Y:,Q
M7SF>ZMM.]>$=S%HD! IO2BY)(==B7KIZ/HP-9PQ?HA3/-7$Q"V.G:%RK"X-W
M6IWV#\+E@DSAY+1_V")CC8@2+-PAJ\*5SK")F=C9VCX00IL63D'/I8"RQC/4
M.0"_SRK[X 5Z6&+R9O=+(N$BY4W5< $JGNH%P>-7% +W6,KHLW;C1TR_4"RJ
M+"Z38[(=9>3D WH^E:W=H')6X=]L0!0# \-Q9*P<:GV)7TFR*<,X=YUBP=EE
M\;ZS66XR"+6&A)&/0I-=7#&'#*/G\6:(W^*WD"\:,N3X.QEU1,?O6/B'94,Y
MU6,;"75S@5[(]2:]S86-H$7Q4D+?23@6 8K2(BY.# Q+AG]E<L'@LS.CO?X(
MF7M9N,RK\W5L\$+#!K6F=-I>$18Q:5!$">;A1,'BY:7KU\&!U2VQ4Y=KX=<C
MJ $M?G>1&+A(N])A&R%]LEGP&&6D-Y].<'*"=6FW68JV.B>>%]+G-G:*T7M]
M$>M_I* &J(E1<WY!P?6F2MQ#'_3./>@X\;/;Q(E?2  O&4L:]F+9'S\;VNV.
MD'[#6.-EOWLX*;786[H>0[)(NU&G-26E,$4?%PO.C&D KA4A(KUG^["A+@LK
M3BG,:R-%=IKG8 "5%"2:%S'FZ30(+ ,*<R1V]D8X2OX>;*=E6GNL>]RT,T (
M"'AL*QVF1K3 MJ_\.AY76ZOXM,*/2G?0:N28!"EW!AB@B50A",W13[.R=NOD
MY>7LY&T!I/>[1=' %K/WX)YS5P0]R+T& ]/)& S?_98=6 J"F)@7V)<2A?-?
M!9ZWA)NI*VZIG"1'U?&QTH<'V969OWUG* OD2/1MFHJ),FIL]%Q%'[]GNC_H
MVT(MGAJRM71ZQ@/:]8!>"!VFPUV3S";T"SUHZQ&D%:/=L"?12V-?QW02;F:7
MB0J:1V[!O&WM!NF-B*H3H]3+IB35EN![R!VQR1)>?D7Y_3;BM:M"I#2-:J.W
M:).;)4C(WWU%>B4JQN%FIQ,I,U(=KG#6)',6Z8VW.FB]<]!FXC>W,1-%-FAK
M_PZ*YP].Q:+K.+#+Y0XMQD\LB_;MB&VDJI,#G24JC3P!_RWEU%-QE7==OH"E
M"!,]X+&RT<0X2SSP^:]96Q\[$(!<SITQ8@['<.F<I2\HL#D;JUUB\P:U9;UT
MA5P) )\)P>"MG'R^%_FY%VY0[NCIF#O2W-'C,7?T.7I"'O2Y\^UMSAT;.-_[
M0^; ?9QOAP/92L]\-GV](HC8LU)G(D1<$':>35;K4%R (7RI/*#>J<G)%#A)
M7VFS9M<["E,7R 2:<"PY;A9L9&?I"BU8!:Q8U+V=W4$;M'LO9'=!E3E?+65Y
M07PB+&^9).Q6)M7WX,F@?WDVTW^<D=VD?YQQA\<><: Z#'(\V4/UVV[EX!R!
M>4940M2AKJBJ=)XE)]&_UT+ 9>)B[><PQ+^L9L*1(-N@\S!!$(WN# ].1+6K
M*LDNT4RK>IX)9-T^DB?2]'#R1>=>TJTI #09ROA@3C(M/;Y<V7=:Y8L!N1)A
M['G>=!DO9^)!RM3N[[9*P13>UA%A:BBOYTU\_+VIZ^>6)S[!7V-6ANL;^@>X
M_I71O&H6N/[?<+*7VH;,O =S#\.]LHBYK,:BO.G$_8JK]#B;1T_JJ^J^UX$N
M N>>*%I!5\B#\9N06_%[[YVO[7"2EC;MO**FJB^EB)(C$V]K4R,%M(T0GZ[7
M&2@6K+_]S5Q1O(N^(&;7$MM8(H>LQ<S!7=(5/$A]A3&:_LE0_!DT2FD*.3(Z
MY9D5U0-[P#YORN$Q)O4:'%59%9<FD]:PMK L^"V'@J1WC!:3FH7)%QB*Q[U-
MY?%YSC!+D(4X3CD(WQK(79DZK[-[SOK$1=@A@Y[*7<<LDJZ)AWL,\@S=+9?$
M==94R4RQ"C*6^+!*8&/@ZS\Y(6NYIY'M-E1P]06GF5FLX"DS#)Z=7W@V@/8I
MF4Z.B(=R2=PO\IRJ08]G4G](H;,BZ[O;282,O>W=3[3@(M4,DF!=#,+MYYO3
M4B.0U%+7IL#E2EP(>W5:\D:H*N\V-E[H=A9>)%7%A,EP38*"_8OO%QE_1#K"
ME1*Z<DXT8[^M\]QF@#PY-&YL47I)>9E8J>:7%;L\^+*!W^B>]S$KMK2W?4,J
M)- [>L^\D)ZM%%349]CZN@:_K4.VRP[:X?ON5G5+$O3V%-#H^NW6*O_N]B1[
M?=D5>\+;[F5%"3N\6=G#456[;;>+S6>U[*!2$GA0^=U6P3RFXX(-DUC6QH$7
M:\[=R1481G2XV80,7F!1;^T!3Z(_"K!E,E"7 4+)>R90;,'C:'=#5T8A3;<8
M)$K=O;&1 G7>,+:4-Y@BYL"N*"WLM"5=#4[*4L+-;DX7)G9P5B)]*,2%=G,(
M?D/O%P^EL.&OE_?SS)!K>HJQ6QZ\27F+\IE'J3+ZW?NQPP=2EB-;S@5&?:L9
MM0Y)\03?H CA)W$)MC[\[SPE0ITELJ1<8.L1V@&"3DG.BSHE"?#P</1W0,-
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M)BK#N3M.OZH(SC<:@F#216MP-ZP<:-L.,_%P8'MG:65A-5I8P2Z,=$YC#X:
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MI_!>M!^D8&;A5UB+N]C8TVW;C2C #O_)L7)W;JJ48"WVP/BK24N;ZTI7C!;
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MV%.$EX,/B4%KVEDKF P5[ABE",'@"*S;!K;ZO2Z;/0WA/%HF:2T>G:4DA(U
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M.O&C9)AY-AE1Y%47\%OX^[PLFK4[76R9"9.X(^T('6XPG:*4T\<=1=V&4%]
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M<))\ (FOCL>%W^7"#ZL!%GVFKL/2KKB"L+%S&IRB<VUU)N*!>L_4%RTYF;D
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ME,1^YKL?]AI"H@51+HLSLPJSMV0RT%F3X7MK-SIHM?K@A6Y8F_J6S&V14X!
MZ>F4'&9GUEM,US^^^<4-Y$ 1RHO\2? CI"#%-T$CS25;UW_'&>?JST,'HI5+
M)RQC34X<=U6@N]\".J+PPG.Q2'86TA[KQPB%(0\WBO%>*\+#ND?/P@E'K#4W
M*4U/E9Y'?\L2A+@:^HJO.OG:!&*2R_IO)7V-R*[61RY^W(+-EAH==I[=O6"S
MX[,'F0&Q!K#;3)/%;2OT]=3*T$J^#(,<.<(B%#O9IBJM;6?R'HJ,'SZ>MWZS
M]O"FI"<);HBI-/ :$0&$"2ME8:B:K'9=<-@D<YDF$*DY8+-_UJI878 -E14\
MZ"/_H$$_SW<!_?Q<U)@7'6$_^U7RSP?"?N1UM:9S:ON]4K7"I]P<V8%.MTFI
M9=P=]PD:X1*>(5$K-=)-)VG-;?Z@F[$PC6QLH*]M9J_C:&&NJ5ME:=+,=6S*
MA0,>-/[$]U $%&@7Q56N6JF/3>V(2'\LN_ (7<?G1D?*/1K?W*\8N<PD(<O_
MI+<+.4J#91WC6!"Z*J&GLHI@F=3%3%_]/@-'J@0/<$Z6J,E%,1*['!.[MYVF
M3VP#<0;L;:"%&<]SD]TI^EF(?K,SM$8/6N$?_/$?"._B#JC('P?BX)C=_'U\
M>1_KY6DR<-L+/#+'@]Z?:--OM!ZIVD'>9__,)6YT9J64V"REVE7[A\0Z)A=W
MJ61N<^NYIN<Y<'V,HAJ(G25*0!]2AY#OFGR+<_P2I&C',9;@8,J?JV8&3C7B
M25/\Z+B=0*<KH<;TO8ZRX"NP ?(LGMM3=^=CRO+)*,G;)7DV3)+1';B[&'.S
M+V+;V$93C+,JK9);4%\=W($<$0-A+3;04NNN)-W\W>)H9RE?I LPV3M+^72B
M8MX_2K)?^*->V<>'L\DHZ?N4]/DP22>7EUARS/6]2CP+KKK;DJZCR^TLT41$
M@_*F\XQ0Q@C.QS/E1D';IZ EPP2-HQ8':=H4?]Q=!IU D,#Y0.G6J(E31S6S
M'(#LI2LW,N5/BRE(OD6Z.D+_UVT6@!9XI4V5L(A:Z\=4YOQ#7EQE-CD/TI*Z
M5B)7&@_!'@^!'>A7# U7=S@&7B#U-$PGF"._ '^3&83#"X3=[&2JL;\_V6?P
M_.=D:Q]+& 2=>#%")Q0Z\?P10R<>L^8<D!@:UF=RIMKKE@2PX#\KQF3S7U40
MHNA7+TPEQ(;))5%S(&Y:H:K$66=D) -&2FZ"-9'"BO JM)1QWUB<RC^4S:KF
M'C-'\)X&KH$?&<8N4"[9;EY?"-UFFS^=\'-R@8\*G3SBNVK[)N+3N$S#$G>&
MR=<]PP@]&RZMM"MDLR3JJ$N/BDW ]3 5HL;1%Q'N=6U#U(?3"]*D[?0#_JJ:
ME^F*4;FUM-JQAU4U6)$44B7RB'2DCZQ(7P\1J N%YHPFN>F;X,(@7[98N9E_
MX9N<T;R.=LRL@[5DO],P2.470:AG;S=YF]/-;Q09,=%I*^8T9BL9D\G[U!G#
MFGBD^@'R0NV(:P!1=WSD[;=D9IVUQQT]["BF"S(1-$FDJ(BY*4M)\(1DF );
MP5@A"N-@\;G@GPI*2];6TTWJ*H5AB".*+6-_..#I.HE5@QA:BF9 NEN<HN&O
M6S. ME2M"(=/SRY*EI"Y-&F'CN@5;%UUD:ZXL44T:&)IMAQ1CS)G"!*5&DKT
M9_8<WH@6Z3JJB0Y_. 9B@XIU=33]  =^2D254C?W^H%F1MRU_@1^1[F3'+RH
MO D.X?)"=+=LP(8^A_ Z3&+'PC>=R-4.&Y \X@^VX ].=\$?_":\K>]7(P1A
MOV;C=" $X<>^;BDXX%>(.P*%QP7M+ 5'+3&^&92)K<G_D1FX[>L@PA:T6K5@
M3"-I2":J+LI*PFWVA-9'S!*E=L*>(_U#<'<B?$:84XTDE[,_A-.3[$HXK%3\
MJW!:*5J\Z"J5!&VS&HNLGT615=Q4G7>]D3P^I#EW%CP U@2^ =FLE6'YQ=';
MMNMGNX204+$S>[YP8L="8LTK\ADJ70Q^OR 7)D81SJTIF?>!HSDY406R=?A?
MSXHRUU!A.@GH[@.F=HWX3"E3H,-I>E5KG-XW<(0.-XGU"*1[8.'U?J1[R;1S
M)H\V2#G6[(ML(QUNGY1K((HX6LP A'R@HD6=>:@@TLV:#6>A9^4$NKJ;8 ];
M%JS(V0:<?H;<&30]FEMQ,2KG:]-*^FB<A9I8)EDF#287F&6C,]RR0_B/+Z[)
M:? ="%-6M;#+!YQ7_KR/Y !W:!@DZS9WJ.L-T5#!:A='A D(',PPI%*!$!+D
M$,';O^(PZR;DX@B[S3UVW/VZVR,LC+PQS3Y);*_Z2,$M^Y *L[CH!QE&;4IW
MJ/K]NR,E5EXWA9@U3+ESE<ODM<,W43:*;EE0.O!84:[*,A-DS5@1T".+<L3!
M)XZWX:*XXO15R@,[@HX;4Y:8AT/B-,I[UE>6F2/"X;Y)NEC (0?E,<^(."L(
M_+^83M[UO&;WSB@5J%L?1Y=6-K9W#\,-PEP#Q_<5YQ*8J@\_JEQ1U \;X22'
MRT94'>';O"+>"YY?#I>**44@/DGD>:/]EB'T-)-P'JD15K7?>5II /HJ":EH
M'/_\.&[QCA6SK\:*F5;,3A]QQ6S?H>*#SEZ]V"5[]2-L]#(GUB&P-3]"R%AB
M3\"8RMJO[_9B8"J+:8!<OW? L8/N"EHO-;'FLD@39<Q)BF96QP%4B1&D\"UE
M8VG[/L?8\EN<L_M#%IAK!,C" Y^T[B^?N658@\Z Z]+\QVN5.6PECMY0DOT?
M7[[^5EH4C\,$AO\>>C9:JNQWSW3$.A<NQ4['TF!,,ZKGUO(4'DK"@9]HE]3R
M/"\J9!Y/S!(47>6&V%2<05-H+1<RW+^@=V#JJL"-" ;$=*=>8/X#KM&4S(G*
MW8PZX-#,:X9EIAF-RRGH$ZQ":Y4)'YMJ'#B64'D-:S=>C><%NJ?U;.DZB/LF
M6$"+?XPOBBU,<$ODO5F4\.[1O<H6#<B$/<\LKTX^2>S"P-*QY2A:?X'\TJ83
MI(5/-\6(]&8*)CWCS>:5!3Z\>YG!9CF_.R$QBXC7@/\^5B%H;9AXD:U-D_FO
MM"]^OPS6__#3LFC.)3C9:3N<M[N^);A3TTFWB+2@H$HA7=JPF^QZ6\4+@%<J
M54M]0HK%:X1!4C<"K3#H-?ZC@4=&^E4?/]!*B*O"8"^M'W6)<V,(;G;0WNZ#
MMP3#9P*U0WB37)*^QVJVZ151T0=T7B%TQW3LC:M4+*R 4+1ENY* 5%4@YI'D
M]#)P)I=)/BY$ VE5((VH.U+%58/QF5?(?*(QI$S/M7<<"\I4PN\_7*1/A+1*
M/1C,,&0$/YYKZ;?"8UW3D,_N^FA!LD.R/GVP" ,^.F&<ZMND[I#[:HXS@(P
M>&KS@8')8;)=;D))P2:ONXH1-+8##1/F,R0FP-;V#-YQ<LXY/T56\^<F(89T
MWC(ZKMW=FDYDO0@#13L?UK"=>94KK)JR:HRNT&L6V+YM:S0[K!+U<L\RHQU6
MV1UM1]?2>XLM;YOP&DDTA>V@U/F;U)#;=3)VO;:?^\GOF![?;5-IZP9GG7;?
M^-&54-PK.\\Q#93JE[11]>Y3]=YA<D[<'E0;O/B8?#$=?-CFT$\U\.I)B;4H
MG6@6F_K6O2XOJ\48C^9E6M:-4V_8W8U_9\COS^B88$(U96Z=T(O;TBX4$"\0
MN"3I.6KU&&$WY(W O4JR,!A9--*W[3ZA5)^O,X275ZAGDV;U#=\L,V%UQ,^[
M?;B'X$'G(K[:)1?Q@R-R^=V:@:7</:8@/OKLY?<:L[2X,-V112#=O$QGRI[O
M>7!PC&D_)S#-;L^CYR=P)+^S<P=@IL-*/Z.(N-T&JI<#=Z\H5P631L?.T,$3
MX37ADM/)OTW>8+=3>,G]3:O^Z/<;E//^>LQY:\[[Q9CS'B*WHTG98E*^WL6D
MO,.&T86EY-=OYH8)C)&1K"$E=O VYH%[V%_?#;$)L:FCG28:C@4%HP)K=S@
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M550U^+NP<M"":V^TU<*)FZ\$G(1QL&Y;3;2T06=-]#XG[ 9.UX'SX2>SP^:
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MT+K_X<C%EZ]_^>YW5(M?_N^[G_[S[?\#4$L#!!0    ( $:)*5EE.+CM7&X
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M^LU(LY/JM_<OF;9=FQ]Y,#NJQX$1;9Y<4W*@5^%!FI-.BLCJ#G@?H$Y5\Q0
MWW%YR$9T")K*3/G?1^9>P.,^NQE7Y<1B-$KW0F<X.A(EU&==H7[OIISE([K#
M7+A%OO J':;('9/ -K@J,&];!5P%!!GZ<T71*5*\V@WJNCG\:T:87_0#_Z=]
MC;$HU2028.8"7M$KI;NO EL/>T&?/?H%[2ZI9-[/A9P@5+U*SHT([VE8 H5&
M:)6"6EZN5C6K[Z)-/V(R)GE,$3U#26/2XLB-FJ$-E56@2:WM;*ZCE@8?'ZLX
M%M[T/"7[QXT;L?DQMU!:5,1.  1C:':MTPKP*\NUHF*%6O(-,/^FS+V@OXZF
MV>KFKZL;]["AY&>/G5WHUJR;2OJJI1&;)#I=9@]/Z3RZF"Q87;)/5D<RR4!I
MG:2*BPN%W_.#4?A[Z#%6@]-/*&,+JP+&!0L I5)/SI^L_TH<- D8E> V2N'R
MEK<IOR7IV'JD[SH;9CDWXI&SNG02I/(&15AW<YV-9DD>(T^\S,8-Z2&)1=H2
MM54/:MK59JZZ#>Q73(#UP@>9T'1$G"MQM$)XK_'[/?Y ["!G!%[5,QB"5@F2
M >-P-KC*BH(?G((?.>?K3@J^!LUDAK^Q1R!/;HB7(3:"*B@9H8L[N^!:,;(H
M1FG27&EZ8@_UBE8>G%:>_I5HQ4HR17;W+_AC-LY2--_@0[ QZ&E2!8CH.WF^
M2@E=#ED\LJ<$F(3"":P3]!^BT!!CH>:0BP>Y*6A/E,1Q@T46!K)00R=:L%U6
MADH03"'!2MLF+6JK$K.!98PK#(7YM70@S]"?.YM,2!(F8<L),U;"L WZ9?G:
M73886'@$/D/)+Y<8ME.^'HHEX4\PB\;"=M36UTV*)2N29@GZ@-JFD5R=\ 7Z
M*X9]/NE*+)+U9;YSU\5IC>:Z/O#B/'O\>U-&5=(DC@BUW&UB8X 9U39Y-@C*
MNJGM9%:Q<&++OH%KA,#SRC!W2P'T%Q8SYEH@QQH7W[FW;/.CRHBD/BJ',THN
M^R+\_O,'7"3A9F>56R.Y-3O?9V[-U\-4'U#/^.FS*AELVR*R30L2UM2((U)]
M.$2$+\1_7(<.FR-93?DIEGY@.7RZ'O'YX/(RB[]+ZOGYBQ@O''#O<"SFV;]F
MV4B2M:8JKRNH] 5UO95%LR1:^>71'=U6C0JH,O!#.<H2.7I5-UX)*N4M0[.#
MSD:*'.5KBPVAT_UT.'2*C4CJFG+C&27PQ?N7PSR9(=PP.?4IN4BJ4/!'8K7T
M1\IM[B:RS]2O[Z4^2P!B\PL&("3+2-K5M#+T$:0')[.8#<?7:;D,J-M()."M
M;Y5Y?.D<7R#3K<5R_C*_Q"6V*G@Z18&V__N];K1J1;,2SJ7\*TO<Q!V Y\:<
M4LX0&TF;709@_\URKHNCA--QOR=)5%6JS+ZKY%KEBA%Z'.4MJ6]PQ,M+GN+[
M5%_%5ILI,QNLTH"S!/,;&)2JO8BCJ_(&$]ZHH(/R:MEA8WL-%^9VG"HK?_F%
M(O8P3FT"T1A5"X"U(G]M4$L\-\^UNU.1'<199(FN$DK<QAU.2C;^)+B>%PCY
M@(DI$O363!XS4ZI,JHQ:J$@ZVLY;:#],<&)28RC[!42BVWJPY\ON=Z<S"%2<
M75K=)9-2CMF! 9P?J_3*E +!6P<C?95C?"?+^6GA'.-NL'%,)!M(WE<@1\/*
MXIB3C-*9WO(=IR?>5P%]?!2&<XVW-K!P?E> 74M/8FNC,RS_L%6]QPE& KKA
MNB2-DJYUJR['Y%M98/8<7K QM4)%.3X>C.EMAC*PG#46^&P,1/#^):E$K(#L
M;.QL[+*PMC'XM?]:QUR<!$U/TR"<=ZD!PB)?5=?4B=C?[WFK-+#]5B$HR%&8
MK-0^1D\UWABI;$;,)C5L,6H#&G0BJ^T7=UA%X:1>!$)4ZH8N9**#TTTAZFA6
M*RGN2'^!XTCMP(_=7--J*E>0YD5@9K?1-+GU@"9=+[ZNJL!W<JJT4!5)NM>K
M[!-%R1HV01N%ID9&Z+K5["#3$\3@@=H:)T+EG: @=NGPE!PA:(!P(6P( JMK
ME)LE+> $-2;U@@F-^&>X^3AP#CJE6QE%&TYM'9"T\!..KV;P<9H)]L@!A?@"
MO46I.@LW(BL%U@CH'!5W#LS=P*IOH[7MS76GR 3T38%?,E@@TJ!E9&5G2LD$
M)XZQ$8#RVM*CC7I?A.)^W%"R;CB_,IE.<^"!Z##(DQOL$JGU;5V&[Z9-J^KW
M!!>%! [Z=0HDM@.*+Z:7JMY>O&U*^Y6*,L4G8$TSZ356MCE."SN:P0+U[1O/
M*I7YR>?DC@F[T59:6'E-#!J*5E:^W<C1TU7D2")'3U>1H^]&RWI\\+V#F8&C
M<LLX][1<F6#!I -EAS"HT6BF._R)P&A[';2>?D)/M$H)U_;6T?4S$50.5733
M40/ 7-HJ AAG%7!Q+ORT)4;(JQ3V09&-3SVPD\:: 5='UJ1(E$.03[ _OT9K
M']>CW5^Q3=9T8[(1>_6>)'%#*QAC"L+:[GIT"\/:TU]DXM15=%[3-Y#CM^L2
M!M1^LR"4_=J_UP,X2%8'%5M]LE0]Y8U2NC1N0138 =%K9 M.S;BH;H0ZF2>=
M:NFSC6U;,0T1EJ/,M-J!89S*][X9M<!N$],&=B6(5$>1KN%+]5B\B_*.I7X8
M]&\J>;41P$.6P38Y[6@/ L!4A>KW>)UV]GU")8WA)V$ELLED)Y"%<4$..8T0
MQ.Z2?@]L%HT?H!9,D$36M6:@8$*B#:B,>G^ /-/HNLRD/0>5I%'S#9X%QV^\
M7PA-F98IO:6Q]YRT@PH8!$,NOFT,M<VY;MX\%]6AT2+ OHI\&6=NSP*MP%T@
MO$2>Z/:MWL>>?XK>:2G2R-)45+6M<FH5T63R/9S::<:TL*^UV@G[IO?$J*!?
M7/_\:^D!R]0&'M_!UNE66WX8<$5*#Y\BL!. 55T^$9VP8X:UR+,NOYON1VO[
MW>[E=(LZ?6Z)K;H&09A/+=P?UU4H[!ZQYB2L94^240Y0K2.P"8'?YT(DA!%-
M*L8X,FB8<W%W#" =5Y%8)=K.M&-&,?'J#.[$V9LW9!"S7PUG@B@MC5TDK@(!
M;2&5JF:Z#*<9[-*D/)D.A!^#?DL#;"Z/$6P@0F92:$9!'.\V)"![6E%#P-_@
M_\8,*8K:59YJ]XWVS+H @ /K$=70N!TJ]9Q]?@:QHV.:8GZ.$.=&Q=<-S[@E
M5HM E2M;;SQ0IFYPV._=06&?1#=ZC@:P5Z9EH:&Z:+]2O. >@TX@@P&'*2@3
M"N@)S@(.0WEP8:#QK.7=$G>F1HWUFM?6G%SD^0@)V,?0.*F@ AR&RHNELS?)
M1T3^G:5=]0P=K21C^5$Y*MTY2U%%)UZ-#>-,1.X^%]O-KE82,2 1/UNM6DO6
M'SN_,D]N@+XC4*%37;N-@"% H-2 M^;.:9=E.2(LJ6A4)6.R\NA/@FD*3P^O
MTN$'O#9,P<QG&&\GR&<Y4'*352[4LPT;96'I8JOU;[UT9G$RNJ,L9NWBT<G(
M2=/M\MN0OT%[46P?2A;P,VD&_>D]?:A;#LE4!65#<9]^CUKD=!BGE&4E[-5%
MXB5$+2]P!Y>BSFH=M+M ZQ4AMT:I=D :1)Y2C%P.JY*6Z?'B%$LPU>V!$9N,
M]O3"8)E3\28.C0X_45LQ0*/6T1FR)7]&?NO/*N[W)K.\R4#X&%&*^">UWAI9
M\NLDJZ)W2?4A;3C^(8N.(\M[IF*H;?UWB\@25>#R.A0<I"Z:REW8^M9&=%;F
MR!1P$Y7V9<=^.[ZF$M*,\VY'8M]W+TP%O'3\-T%@N$N"\R\KI*EA7A*>FXY[
M!P*MJI81?2=K6YOK&EJ-_,5I8:,'HC]Y9#_ X3X-+-UVRAIOC'7GLIIBP(J.
M.B@][O2I6E?S.3#JE;!?BK ?KB_(W8-,EYB1RX7F^*Q_VK"3*?SF ,L[QT>+
MR>ZN8K(2D]U=Q62_#@[R  ZTQX_)'EI&HB?H@,TH'RWY9?N]/8QLE R02-B!
M;-Z:(&-7K$N9I,,\32J[M1 9 M0\P618M>WRM6QL#'@,8+ARKJ4J).OK1BGP
M&C\0 *0(TH#CPT_0L]M=V$5%5O,'1+:J+7/?@%1WZF[:G7"5QM0[43?G4$B-
ML=?+AV;%S7PJZ:.4Z*0O5J2E<?E5-HE1+O"8TJ'>6Y8!Q#2MUHTG0WPDU"0(
MR*MK!YR>=]ICD=34[7CQO;"]*XM/$J$SHW%ZHS$[O7"1<G?*IMSEAXJXX$.[
M0!.#>*[CM(2B(903[DOD>J1BNR-1OW>?ED2)[?PB?=QJRA';O47PDQ=)'FK7
M!9/$Z5%\EFXH8Y^I56Y$1Q[0.UU(D!>7)?PK='D$A5#:V+,-)FX[NNZ+>RD1
M\\-F#J;+*5:3R0?$*\H-<%S:T$.I5HQ=X6L5]4VQHZM*_=L;-@*P; 7# ZJ^
M9V+YB*R4,)+:,73R_:'.I@#!&6Z'WZ>V*X@;RQC..D]86P.^H<R9 /1Y0GS5
MNU*;JD5+(0R'ZLD[[6Q.9G7TX;1:4#2T3]/@/O,6,X</-M$)D0/S5W\?L;H[
MZ*-6Y]?>?/2N O50B2:^'CY^PQD,NXPMW"-$(,0 S\B$)&!? IL"#\I;W.#&
M$(Z3-&K7QQ.1L:56,Z]1OP3EBA/,[NCD9+5V%R=,<U/:/C0,WJ=#AEY7:<&F
MX1,33*9ZRX5:D,66!=F2=LZQVIC!00<** 2'%H#Z39:[&.<75F(NC%& -4XI
MU7*?;3%O>)*=3('234:P;5[O&M+U"8S9[=U1SIT.<UEL*P9GOL I)+5)Q4D#
M8>L(DVGO<B6Y^VYK1RV89@L3VOZ<O?EQ%Y0S1K"X2Q\%3=Q;]>GXSO&="DT+
MY;G?$YCGE;]A.=;"X^=L_$["1=D,?$OV@(8\:F ZX-EH2N9 7X<8X+@8]BG#
M="N)BP4RM8#(2,#EM[H9,ZJJ6*$A_9&+LG@"D\&^=IB/MOQDDA5=/S1=^Y"*
M]W.D8:*Q"&9%J%9%5[!3$TFKN^V\*&#FM2A?,4&F5]6!2'NXT5K3"HEH+Y3A
MZ(H'MB\Z(K=.XF^H>H5LB-""=(,4ORUA'-U@,JD*=4@X>ZY1?I,PL""8.94%
M?V871A-&*9D'MWHI3DMU/UG ^M$R*2WT=FJO8X_/'3_4O)U9$R(O/4?]4$AE
MHWB^CD]R.V8W?=G;.FD#&DXMJ5**&" 7LD!6#:M:Y*1#YZNTP5PZ7*G^/>K@
M"Z![NPE/FQ#""PVM#)_#?D$;GQ.##3VRB)?WV<K+*U[>9U^YE_<KCL]_9G2>
M<@$?71-[EWS,)K,)UKH@;<*9B#9FVQ@ZM4[UD("W'5YG);LY0?^LX3"[4NR[
M*YH]S(Q@[)8R)9]3MH -3H*FHS79.PHCND=6/@37EXKMG6M)/9<4.[3H./=1
MY^5EM>E'*)/I;FA,!0S<:"J4M,6O:^^-\8BB?\MTO5'Y[]JQ2?Y$ P@3L+1C
MKWB8,^O)IW>9$:B,FE:IDNVE^-B12VM->9E2:CXIV&RC\6]ZUJ8SPKKJGR!F
M[248BE-ES&K8>UN8<0MV@V5O0>+'VLA5S>016O^&%#%.3J#LB:<;O_P'CO/+
MQL__$:VIY$SID3VA)$_4P=07D:I1\0"R7F^GD(2NB)]@&HKPN]4K3@+3 EN^
M@1W9O(P&RZVJO39,9LGE)?8$;P*F=;\GVH"_9^QKM@^67/SVUM>Q.CPZ-7-<
M\]]R3TSHE/.BT_GVO^NKZTAG;'FE# F-4ET8QZX6Z>0FA>\8].%*(]8XL7D?
MWTD@'IJ=[X_ &Z+]*N[L,-'&GZ%VE<? 34PD!--"VF4Z.)>'.Q)=(:,A[>:>
M"J6TWIH5$"XQ<&',U+6F:J\"\34+?J1Q%T7Z+MTN&V#*U8<76BO#7=V/_N8N
MU,)BB(,)^5RY2&LB'#]@IW1U*^>O8.YPNR36B$D'OA&OW;HM8!)K<%2E[1VU
MG!9)D>3E93G3#>RMM[0H[/<81F,C&K#EXM7IB0SU_;AQ.!<*FQE>5LGT*K:.
MPFK"J\4E*#S#62Z=&=OITLJ]N;6S-M*<SPJ*#%2:\1XGGVW]LO.43=X)VE;A
MBEMY!1DKO.9V#U5! V,R8[SE<J8;$&@Z$[ &CW6J$M"0_+F2IL>8RL5[:&UO
M<*7V\KAYO96@/7=:9B53+4E@<G[#+=OL8V8F!P$\J\".S A:AV$!"]I,*D<U
M.,R=,]^(S@.:@)&''U+>%ZW@>) BW5I4[%2%+$WOB190>XS:*II=UJ@\*'WO
MW'E*V66HEB)VW I<O(I^!!(%"^E0"'4S5XF*/E.'LC=I/O=7+1TY1-.E2JF#
M:2M '2F-GZ#OF#@R9XLZ%*]9C^7)[2"[L+JD:0CK0F5L%84U.H@U;;\(P@ES
M<1P)=ZGH'B&0E@"R0W*-,TSU7 \&:2=EW5 @!HFQ*&88@?&Z\VYM/OE''/W7
M+$$L?IA&^^?_BN=U]C6(CQSY0M*0,C6/5:E>\.A1Z_<X.R2.UK;7D82PT%HF
M*@-)RV!VL/N=#2O$JK$T!,E,;3^&_U0XCXIOI T9E<22F;%TJH[6&3 QX+ 2
M<[/PA:R8F*I<QM@@QJD</A0LH=$-WHD'L4*!_/"FI,UQ\(5BBD1DL/<E=],6
MI"IE*+L]3.\(BU$#;7N!AZ@NP42&Q)H6IL:0;.FXG1)'#FDO\ T,IS:WEKJG
M:R.UON<(M8"1 'LU3(T3EL$P+4ZVT()NN%TWI5UO1*]@1[QZ=#<GP@];NU67
MK0H\+.:LJ*B?$@#DOSMXHEVH50JS5X=;6A? DOYL=&9V:A;->@X4:^26P^L)
MNC%WE4EB=RFMLX_-[1.&'UE[ME4W5,=OY?2H+<MJJXC.W;]O&+WIIY4/67S(
M/WWE/N1O,T9ZWPCH(S>4 X:U9Z ;5[BFGWAFCP]]P+7)@D0LO4!7Y[>LO 0\
M8?^,[YV7<#:[>(+U?JB8J10S'Z)+>3W8>IX#)&L#JVYPB9? /"VL56*V@N@A
M(PZ!<-QXZ!"5+@(&7<>WLKCJ-\&9ZI6%='P?09_"3#13.'*5ZJ;3:-W@?F!*
ML??!T, +.*L]5W7:@OPEY['>(2Q3J$KE/E5V@-;DQ+'7O=\8G1. JA+66BE_
M-JF9.37Z11,97F[8J@^4M?KUI90QB /IKN\6TD0[K2"1TD8+9]4X]=YD=5-6
MA,?454(90E;STQTZJ(BT]LXS<0IEK1)8!6[273XP;&:T6:"E&77<WV:,)9DH
M@*2**,6^91/-'XL5^2IU',W4Q<#86ESEWLH/6E>(%(AMDI)/ 6RY&1OMICQX
M;!4#*X1B%Y*"TMVZ)D@EQ7RC5?WMO*,-N6!:#AOB?UQ4@T<B63C^ES,NC[5V
M\OY[%'3ZR#X((PJ]A"=I0..B)OF0%M);0N!A)&* N=J2]"WYLQ8.#"^(W-XW
M*8)XU(SI,>*T; ;(Q<'45+QXEQ.*T6?M.,WG'847H"3W-A/'=9G/P*Z]27&"
M>,FD='E>I;)E8ML FJ'"986JZ94O^X7+ZH)V8F%Z[H\*N9L,9IG9=F>5K/7K
MA#8D%J<\QFMN30C(\1JK_&?KZ*B8H<MY(JEY2>/R/SB$*7R'>ACYI;2+JAOW
MZ]MTKW23N1!FCS!9O/J/7Y@X^ C4 S9Y5B#&T@&QM&)4:[7)=@Y1[UX-1 [D
MZ)8"<(&$+9?Q9F*$=)I1O8@@)Z)319AG05%3C*=$;F-8!0P?;,F#A8!UREDS
MG0+=\5;6X;I+"]$JE!^X9O0I>2782X_<G480,S?L@#JW^/1Z+(/3_5A+UMG#
M;\61.D0#]T8# 7&Q'AVKD]N'S>KW]/D%% AX8;A.ZA37.TE 7J,?:"%SQ[Z%
MNE*SPL;*V]S^4!AO6](4K"90P,8;]C)24#484%#A5J11+,.@@.XDG91P6*/9
MA&O,\';G?/ P@7*8L4!;L\*U 5BR5@!WG_L#M_'&$"L97IN4(Y4R)H0\)*8-
MPY&8"+=P=,OW$D28<M LPAA8_BCZP'3VZ]#M#4X" '5.,@\[9*!DK^B."HB%
M9/0[_,NQUA%;VR.51CQ4>Y,RUW$^*M.:'+D*;8U^#?8C5_&'*PUGW<H/D*.A
M.,RK ):RTEXQS //84Z 91^:NL/2:4*FN@XH@L8N8NF3^;W3T29#_1AGDJYW
M'!^&]O4)FR(MNP"0%(<DRV=5ZE$.]X.73;L+A%H#K5EMX6P.30$-"EDP+Z9O
MX[]MR.HU[8C'>A%)(AI)]B-G&NG,$4S?IGP.U@;]%(B0F/)IA8/KA1.YYBQZ
MRW@2,S.V#.%V,':.H1R>2JP".JRXTNY0&1YLXX\2O1NC'LIJEW1R7'.#NC($
M@3*1?DY@8?!:<[6N\HA"+>KD",A:03U98^OU>\J2,5#-=RQD83-EF\T4YY@<
M<61K$\XYP5TBA9LL!7S05@;D#Y8J0*(TYNH"YDV,:YU8+66X!M!P.?,+GP>S
M<%0+:,.&)"U'6EHBK;<^;#8TP/ L17_GV>Z33MW>%&@,0<EV\^[4]RF=REDR
M"1AR%_/%L,K2\UL5,&?FQ#><;E3M7"8X<5%>]+DYQ^FV"Z+D,KZ@.'OG6.K@
MN4CV'[=DE(R$PNI/Y*>0\$4TQDV7J\&J2)[C.%HW<@"S,>#[?]O$UDEKS%5V
MM:#21K-CPK%\\D33.B4\4B.$8-FZV*0RA,DI76BSM.<%?C9F$4VZ$Z0KR_.9
M*IV.?4$8LZ/I$W7Q*75=\*_?&">TL\OU/55ZG96SVE3]F243>X-'GVY&BL_=
M>9F6<8\DC,R3'FE6W"$$J'2Z0P9@I>-]I(#W24*_@+]M[[)^DUQ0B_54^+RJ
MULJ0TBA:>)$V-UA/#^_\I-[1!&4(C6#S%]I>/"-B).3J5#XK=T]M].7 *MAM
M)O<(9P3S21J^H^@IXU]49NR<*5/>Q8)SCN9/V3A$0A->_X8#[C^O NX2</]Y
M%7#_3H)_C^__VA,.)GJ9LD']H"&V*?K,J*%Z]SYA0RVI./R';G6\LTHA&-JN
M%84BSFJO'[BK4&[6M4G/?:CHH8A@=VK1@C.+ _/ZM" CB+Y%HHQF0\-11IW$
MEA7S(HRKT/_][_;CPVA8"3=XGHXRN,K@6!H3?_0&)7\ @TH5.'(GIY!P/3.+
M(/"/8S]EQ@*/ PBQ0<=\6;F,?]MVU[?L$0L$3-OZ:QXV$.I6Z\C\!6SZUD>4
M$-/&MEU<C=DRR$F&* @C%?ON]V#',%);5E:"L8[O+KBC820E=T,7F&+,)4/*
MO  =OZ1JQ?O/K2Z=Z=D?IQ V2?8.!O#-0>-_9NG]TP!DZOW"J(<FU4+7Q&.0
MN+9#_FUUA#-&GN19\0%+"XWG<TP^%@ZW54G&8.+*<=(1^%"@XT*7\WW?Z%P3
MD+VI\EM9_F+[A['MSOEE8WLSD$>R9HJ8%AJ4X0#<<A_C"W;\Q-P5SH=XT?GO
M"G=6^(I:M1VL<&*%,M")QE9<E]J3K'+J3G6B0/*!80V\#!!>_RL3H%0QU79B
MDZKQ,VEH.O(7^K*'#N2R$KW>=I0)[AE<_D/.31 =P T?8(BTY=BXA)V0;C?I
MJ.9PG_.IVL#]</$/4<(S$RIK2B13R7Y2 PE@K,*0(YY$-9"F>0<L"W%[E7ML
M+L%Z7K*&BU/JV62BM?T[QUA#Z,#21L2OUTV7T7G9,2J!95Z6C.7H@RL2R(D!
M7;MJ%LF*P3^4X0ZKLF*IS@RODDL)<::!2.V<+*%U5 F(9*UK7ANXOXZ TQVB
M7? RE7-X:\MXKJ]@ETVAE3TS72G;IFF>R]^V?M[8M&9HQX6;*KN\Q#H;FJ>?
M<. WB.4%?^IJ?M[\O-4\'N+^(SGU?EDY]<2I]\O*J?=5*(^?W_7T:0MI</FF
M_VDZA3N1*E@]"W^!#)73M*PNDT*EN?=[:3,4IU_A*%$A]U3EO*SCC-V.O#4K
MSRN))"=S6.HN?(XY6?=[5A(P_*1C[1WFI?2"4DV2:@XE)J17LAS469<=B6[K
ML94A*JM'0PRLSK2ZY.08Q[_GYY60=DM#4,J,I'MCSORMEZOKO4B9'L[CWE[9
M7^7H%L\HU/E*@,()("0K9A3&EG:>*I\EXX@Q%5+4&1B$C)CHS8$A*QU-=)0Q
M&D!Y4W ;K'DYA[XAXZZ9XESVFY3VA?B8QA_I6LO2O9M.CK &V8)G6YD.7<?"
M.1K/L?B'H=X0<;!]D6"$OD(O-!SOK;(R_..78#EGJ)@2>T*I-;\[!$'O5BD3
MC[?+[N^.J2< +$&Z&(&V7N;7W-"[L[63Z#G&01" T-!5'YPX2)G15M$\):+P
MR>B_H14G,5 #/.[4-KN1>RZ$S[-TMB!%^<Z-ID2"H08>V@-BICO?7R,I:]JF
M24<\YH44AX.Y)TTX=<2W]N,'=HH28:_P61NL(0H&K[?FPPGF'M'&'LG&75R)
M")7Q1N2\.9F&FV\2>H6VBX5X-72GU><]B&]0"\H5T8.N9U#]/N25JV1DM?>X
MPH0DW2!$ [:LU9C2V.D+X]2XMO6ZEP,5H0D#WS? T*Z!XI3%:_DAU?&J4TO2
M2&4)XT7,KWNZP6*/($)](C<"(RT*#B;1L#%$)&5ETXBFB9@S 5K)W$%B\,2.
MXO]6BD>('KN^I=@0C@IKFJF6$9&UN_V>[M6#%CASDV PB5!F[2*; ""MN"E;
M%K-LMS]Y35E3W!A);;L-L:QV1O2\_8H$RA#Q-A))=Z&L>P>X43?RI<*C!"M8
M1H2&8Q>2./FG8XTW9#I$Z%([7-80@;G2T6*+<&6_?%U7L9#X;WU=P4IZ$M9W
M +:3S+77R7$XM:21=ON/M13L]ZRDX82;HI#451S4R=#UUNA/=1Q(G@\[+A"C
MS+#DDJ_OO-D3*#8F#H+NMR[5>,.L&LXFG&%>:RU*Y)?D!MLIBGP(7$VFVR./
M%7HGDE!%$Y'0MH/9Q&!*M=(7&*)NS<K)5JAB\,#I#.[/UL[HR>[:Q3K6ZYF&
M,@Y@VIH UQ J,[!XH AX<WV=-%8+'(5FQIA.V,!=L,6<Z=$!:Q!-.DK.\#=J
M,H\R=\K;%T^V Y/M]^;.5N56>UM$'^W"+>R8J[5&1*=RX*IDYDPJH=W>N?<^
M6QY.XZFZ+HF33LL;(SA;U0HVBE2[%-32#?P<?-)2E(PIK7ZVZ]UP-::]CB6\
M=!^/FJ]Q2*;&<_FUD3&=Q4E&M77;;<DL68W0U;3(-A'G,BW,3(FEV-4L?ENQ
MH+IANR ==RFE?":+W6H0QHIC,R0L\5A&>Y=&68V%QM,UCF1G5[#E29-(ETV^
M=#H%N[.ZQVW8E%@Q_#5ROM/=T>F9OI=[[KRHQ H]EK#S2(+ &%/&N@7^6V=6
M!V[KLP(>Z,B 0 :UHWQ%XUF%JS2(1)D=)OK)N$5#E;*D3+0D)M_BMMRGZ5I%
MG]<"RF_!"> CV/2#"9?#9G53#C^0@>6,9"Z\&' \>RSK(+_OF-KJBFN>CIG%
M$XYH+H-3>5I3R;7.$,=:JPL8[0JS^.%Z/8'//I$N=[HHE=\35.S2^K@."^ \
MU+B6-JV5?4N=ULWY<('MIE%\87/3<ZAV+I/F_AG9,#N;Z]R"V#(KR,G"E3A@
M>&"@T2J^"5)HZ\ \O<#NF93, ZT#F2!]J(0^+#S-.5$)6/YL*&EEA6)K:U@1
M#JM*@+6Z2 %6XO(:YLAG5D,J0];_3JMRG5+#%9R EZ2@>KAY-@]-AK:'J_1)
M Z72.(Q$P@D)!HMS50*!1'G[E>0UD%?\R=D0VRMI\TM"#NVWN2>6VQR]>X Y
M%>3*T::%48>YUQ6C:Y,&Y:N)N>[.:5*.4JJ>MT!IY4@Y%DNXOJ@$)F"CY%A#
M4%RG*ATD*2AV*R!\/)F\25C J6M-]2;#\A+,[Y2"="HB26Q!1YZMZ/0_9Z-+
MNY^)E#.9;G&HO!KK0TV=D&G=NL#PT8?WWH)+<'DJ)9DW9=#VT/51M8*-K1GJ
MNF8;20MZ5_C+O.NK=JC?MJ$*M^)(P65V1%%1SGP)D $WHU/C%/IDR/FPBSD5
MD[PNQ2BJ&9M7Q$$+VJ;3#2Y><(7IEQ:M;";-R\@$[.Y5VY&>52L'NCC9=W3;
M>T^\XTRD4QUR"#?/MZ4*2,-PGIPDLJ+?$G;S5A@>RM>,W4C.1M:^IZM6KJY:
M^5F-;8]J4I+;>J=R97'7PW:_0)<76S( 9N7BU)AX@0D@FSS;>=#S&W9P:YDA
MGH=)W/K4?CI;FZLPKH1QMS:_\CCNUYO6MT!D]L[$OL?OJ'-$(*IL]Y%0L'.S
MF<V^GR+73:F?F<7P759CU9->?5+'#*]7J]NM\Q(9M$#E4@^9C+%X*=0:PD:/
MQ=:71X7_4^O:]J19-)+NI=/)K(6J?)@0NBZ7@5+Y9^;#;,])STV:R.0]A8,_
MUGXXN-)<.HXXT332*&V2+%<NI>:J'+&6I)4X/?UQ,E2X )8?Q'XRJUFYY2/G
M0.20^S8/=9R1Q9@3+K.D..D)EAAOBW26^B*8[SIK=7XJ+.K,Q@K08"@DL>#D
M[4[;L6HL!\?18()KA=+5($]H%"SEWG%K596!&AM_,C4I'(GKKZVS.47@&_W>
M:T%_@$E>:MPF7IAN& +&CS0:0,@%A<U#P7'3@B!/+^$&<QR6^H%*1-=LQ*J$
M8DDI,\^^ &..7NOVQDXAG-? GL.H6@\.]"8S[62-G0OJ:77;U>V><Y]-=^5@
M9W./8>GV%75'"VF+H[9,A);>K@V-^S>/MGHTE MVCX[<YM%6%JFS-[$5"36]
MQCH[26,$Q+22GB\<0IVDHU4CZ:7>Z9\>_4Z_%J>OHUZ=6]Y@[:(J$$)#X/'9
M6$=J'R8SD_!CW:<%KA)J 58Q%2,"&BQ]YW+>LJ8D(4U,A7+U):51T$_=$*54
MM"5(7GY2C816=4/K]A(TT^(6BNWV A&N2Z>)J(N*L[=A\:1'#J;AD3.XXH J
M8]QADKKVA#3M<XC\X;F["*%O61@P43OQRY+:!D),!V95O-%\1F<XR7:0_X]\
M\#50$2[[YHJ#I=SOQH3@:7A*GJ#<&E0GG/0Q]0WEF+@AIL5-4IQE)U2E)<2V
M8CI+8CH_/SK3.2:R&1 B$;<$5TFUECK/30])OQ;:52Y-*_E"1U +A/$5+==W
MP#D]WA:".L)<R@882R...2DE0@B\1C[(XAX[WV2((17"->*LOE:5(_I#I:<)
MNJ23ZU*P<T9<!)_!ZH:-\LHZ27_D-6;5?J;9(6H*8A-*A5OGRE2I?B808,I-
M'5(M<.%EA@.+_W\,KXW2*49.K<Y%'$7 &89C!R:S2L48]'!6U,"$"(5)Q$XM
M)QDIR#3+*;!IG4BF&%!9,8=S1! %AYMPOJ+$TNQ2WB)%KRNF^Z+EIK<XNN<.
M2[$=G?FMJ<_#D^*208M,[*_&+L5X$I!%LG<\].M\0M,M[R08PRYBN_>=)[;Q
M2":"6ZEB^++G#/M&CG^DV$1,WE$YNT"#5L^((_%WZ=-HE?]L.<*5EYZ"BNP(
MI]!(6VS<#UO!<6NVG9I?B.%;['[Q,8*"P7/E+3;2%&MJBTN]#3^W'7\O7A\?
MG3M.PG$RR?+;7^\:NQ-B&0=\V>V$_ O._.G&+QL/,F_;)QV0B?SI3ZLH>[#%
MDGW/*S2H&"R<Y]W[HNR.N,T5@ZH*Q<V.=!@DSZ;=28W"MEU99*JL6,-62O9*
M.V&ZHP"Y#2^+LZ#"E7;]N3<S)S+;+FT.#&)D,8MAEV5J]%E#AP\6-UOB'7\T
M#?T!AGNTPLZMK55(4(4$M[[RD.!?\<I]*7OU,Q68SU &EB7W=Q]&ZG?9OP\I
MLE6[5YXD&B@#D\^JA2UY]>PU+8<S+YFXOPMWS.X7:&#'\423 :Z(BK6_<Z.U
M]7MV-_)*PI J>4S*Y +M#L0]'/(!ZKA-.[@ID0V,KDJXQ8Z<]'MCISK/KS^U
M>HVG(Q-N,:F\Q:BL:LF,C="EF30S"HJK)RYG";Z32@L(]'2@JIE)!J5QMJ+?
M _9O)FXE>UX2M]8E&F:^"=C^-WK5VCG!0,R26VLP9HQ+VZM$M9KI(#XWA:1S
MO5[ST!#U]CQO^3XX-X$2PNSM"VU>'?L:O#6J5=DFC6\)\+CU):\=;J!C,!V[
M=)1>^7R7Q&0>'T;U!&&-1IAT@/?CS+[6VK&#_,8$;55$0+, TTS92ZSQRK9:
M?<G'3IV'S34D;E2E/A]R61U'GZTX![^$XY+?N>*J)^M&2SXN?=]<NG9I0=LL
MMM<;(\+\?3G#G;VO$0Y_2D4M.OQBJABEPP;7L> -?566'YX,BJ:ZU4<3[1OV
M@$\>8)Y\1MDF@2=BMF_-.*&'Z"3FCR/T0,4E='P5);WGMURE6$H)._U%Z.0@
MG99UUK!_U2 /$&9@JN,%_E-6B<N(?RKQ)TZ(3M3;E <=?C98Z1,Z"1%:DC%$
M'F+#NBVRMT4*;$%2B=>$8A14DIRGEXC/CU4+GB2D$HDJN\8=/-&0)TY8@2BP
MK,A?+WUL]0/K<8")F[P,E@">9&8@#;PRSHUHW1^8G>FN[G[A*E'UWB3:M.,?
M95,Y*VKXYEC\+]HMWB2-+CS "1E*4:R$W%*,GC"BG&HL)I0@ J=)6-.=H'N=
M$M5QQ]T-CWB_5_)I2?+I\:& K<PFQVRR]5^F387**KD0$@(<F;B1%$&X2K4F
M15L6V3$N \Q"(2<%,4!,YD:^;ZEE%&F_0)Z:$D\EWJ,#[@;$U7X_ME@_EFLJ
M]D"]3E:TO"1:?GQL*WCZ&K-BT'E\:7+THEK^/J2_6^C"Q!?'DOCI8CET4;&E
MMJT(9SF$\_BI]XK/#3ZFPYE.U=XW:3]D(Q,]]7LMQH@!;08"BI)9<U56%-JG
MEG)Z (%94&8BV>UH65<<6-)8O%;0R,Z\\DQ0Q7LIUF],83^(,K\B:S>V"KNL
MYDDW"C1<<_B00:L2H^L9%G"Q!>[N"JU)3WDTXSIBV%^NV;Q(X?UQ")J#\_$Y
MX6!UR99TR1X_C?H\P$.919]859?]WD':@-U$VOH!F5&DR7/:C6\C.R:143"T
M-63;QTKB&X@\!SLB,[TZ8W8JT1A*V[828%*5E:4 X(9E\<]984!UT,L5U'N4
M+P^GL1&]9@,)36BQ%6TQD]!3U+V#:QW$Z^ATUE2#*;<8NO#(JD3U'3=4#>AE
MR)B>I-9\O&QVE8^87I:X5BGFG\]2I*.+A7Q4:.U0_($A41JIKIH:O<(C@F^X
MF]76]BH^JN*CV]]K?/0O+8#N*UP>7[2<:F"Q5?>:I>D,SUHANLYBVKO/R>'^
M*&.Q+RYK WM8WH,)Q^AH,/7W5/43 &7U50)NR8U [(Y[E(JI"C+_UW4=8JGG
MXFC =M6"!2DQ4,5,)](S4HTR'EN5D9Z63 YV529;AKWAK2RQ.-3QW@#0;QL
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M*5XE+DQO=U\-0^_[ 6U1^'DU(-NZFRNO;MWGWKK']P*]+6NP;\^:,D=XB7=
MI@0U'7-V,)!N>8N&LQON/G0!M!!"GH:I99B),\Q(#>-B5>C\52?G8L(=8+6>
M4@MB!")83,#NNZ7T.9/^K!P1^!XK85EE@_-D$PIZKUD)>X&2$SUA4V\B(69Z
MT"@>PE36$3*#\F3=:A 8+,\^6-W-F5G O\3!1L9FXJ+0(PC^(MO'3A1V69AO
MJF0PW?@HE1YX\@_&9Z.F%%%Y 020V*:TG3/C.TY@U/0R'>6WBTW/))F;EK*6
MZ9&B:CQ,50,$^'M9K%2T93&2QS>+3U-,4M3$Y;J-=$*N[\)%"D$0:YI"14-P
MM.M#FDZM&$5BV4R8+&*EJ6&@;59( ID/A4<9Y8H<ZQG&N3(%,3-%0Y-)74ME
MX SC64[M'KM03.Y&&?N6<SUV5KD>*M=C9Y7K\1?DI_?GE7Z:]R<D!;BYUBX3
M>DZ9 >1^TJY#X$H^_,FQ\1RN1*$ZM*W/%H1/_P)EV>TPBN4@UNHP2@^16 2?
MR&!I4RH'812[J-6?)VE44T4['J/C(@=>) 7T.&D3EQG<S'XO%$<!!5A)3L0)
MS:BUYF2"])MPXQ@-&YZ.$?R:M'1L661R54W#(FP9!CKD$Y,$D2!6F86YAS%F
M:]?.5%H$HUJ3PMN1-Z'R2LE6-SWOK+[@>T-)/[=K<^9D6<QOA%&',-WNL4<,
MO$IF1<+5TZK?J-F<0G72R8QO6?],1Z42<3NWU:\!J<V.WB-+A*K\.''6;C;G
M=>OTDW.#A0&!Q%NC,2F3,K0F;R5@\.BSQV)#KN;",# V74$'D'E5PA=U]A$(
M >:Q]FRSN7(OB-56S+LC=X4:P0:<WVS:[3 =VYE8$@*]@'45A16KQ)G>/N'T
M@K5G6W7C339TF168Y&)!40,[?7_2@?E2"#6TT>T>963O\I*- TD6?J-Z_'H9
M'4F6Z]B^HGZN(UTX?RK<3&_!!"H[H&0GU\^+)\4JP'*A2[#T-/3K:X%;H6-W
M:\GZVB_K:C8NY^KJU\E^.6G(_E'NXKHDPH ,87N):IV]O7#:OV&?O8P._4+V
M&E9!?DP\M[6/Z^KN8A\W-<-.G&9BO_FMHG*]K\#*L"O&-,],,0Z&>6I]=18)
M7OGI@-=N68!J?P12\):GW1H-9.X9P]?A/DE%A%,(8 4!27G@".!=L_/2/51K
M49U7H2ZKRJP(TNCG]P&C1(>UG1=G[T]>5J/U%S_B?\S/?!!\4Q/>-*:P5<<=
M! 1A!) K&U;?NS+<'=UJ'GE1E1^D;3I:9]0ZK[H5S\"(PZ/.;/P+IV:G@^)W
M33*<1Z2CS/Y;@AY! 6J_T;1%IIWS(6^B6^K3#?XO*!.QRGH*3$1AO2Y21F_[
M.,G[QN#=.'">W#!X+V/FF /!'T"P S6A[;KNEN*O9>M*](?YY:=E+<R[:@2M
M6S9.;38B1U0FO-.EXAF<Y0[^K^+I3L\%LUUCT$5RJNX9L:2@[V!A$;Q(^FC=
M[XU3;#Z8>UM8&X\F)FRK16#.M^[L/"_ZSDV;GS[M7EM+","6J.[8OE<]EAV'
M<\QO[?8O7LU[-S@"8I&I:G.5D,<9O=Z9<4L>072Z\H!&*9V#P49G!5$&GA#C
M1B3L8W.(R>2>F-;'9<5_)N73CR!HQS>0["Q5I:3BY%8%K!/LSD=TEU'=J6V:
M:7=X;>T\*U_-%9!#1*C3Q7"^B"#TFX?I6O?5V^-W="4CFGET>_R^_I=^[S#<
MJ+-*5<4$A314%ZM0IRU.^.7>QG?W4F;&( G30-CP;#T6E7HDV#K,_!6SE=Z:
M9C#%<)F0E6JY]?/:Q?K:UCUU2^>:49\*JM)@''?V#JC,K%!6%K+ KK2LEH+M
MU\4ND+?UX*ITH%8E*)Q8PJQ+_)#ZV'GI:W4I:>Y=[9 \'DP.$T2A4I:^::2<
M=!DZ)M?=_ P\N-OU,=_;<9=)5'A%M; >S/"]#+:$8I)5/:%P9=POUQ52.H.C
M#NR ](T.NRX<42<>LS+H?4&=(>1^T67(\$WN6RPU^XEDDMQKFWSJ-8=@ND_T
M>Q=8>E1_N&5=05[E#H*44(@ZFN66DH_@'KOC*TU;M??]*-T-C &H50\5.?N6
M8U%/5[$H%8MZNHI%_045J/N&*_R&/O>.1.V#D9M6A>=_$5,8I1>G6[ZC+*YZ
M%6QZX+R+G[] L.DDN54M=,^3CU:JA:M\@(W6 FP%VPZD!I95H6<9TS!P *(3
M!IJ2<)1J\$6I5".#_&ME"+:IK9V-J*(OE,$E,$*W(2=BJ(6MJY-<S)IN_<HQ
M &EI-F@'KS$K4#]PIF>[K4@'<:>U2E6:S\X^\^(\OE5XFC(N%IDSP#A)ULL_
M@03>I7 !V'_N$/8JZWQ)L7JD@<=GGWO<*TVQT#-M&;HPV^C*>?_RW.=RNN>R
ML2@Q5[6)3!-&:<:&OBODHQ51'5DKHQF9:,AN+[BA)#'=$3O6*1PFA3'FR7XO
MST %S-FZ(_QCLCCX6Y?9-;7*PR BQCJYN%A<',JKCJ 2:!URB87%12D(B_^>
M P<AL>JZW[M.AOC7"[4D'1G.BF$R38;83QI3[X=^N\@VWU;]ZJR9V?"\+;DR
M13!<F9[).E6.^W'@"RJN2*TZN46;=>Y2LIJHJ K[^MP";>FHR2%G<E+B=JJN
MY3)MXA9BOW;M23!*@8B@MUXLQ;B2UM"A(H$#=N#;7;_KV06F,8(E'D><P=OO
M(7FIM\?T?1)U.!NWHH]=/87_:2NYFYJ@(D*>HI:SV11+71%<T "1GBEC%N_C
MGV7U 3^K0L*S@GN+V[\I&]F^?-V'[B():)_=L*P;G14=>E'G-?=[^A[Z-8V\
M]US@ADN*K0@*_*6:EB;K0<*M6'>"+UXFW 21PNL?LYI(U[@ ;&O_C+O@6KM
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M_VKV@=?<G!2;")!_6P);05CHI'8(">F,D,4Z8,5T-,9^B5[03!$.9007MD8
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MI?1[@_\>O#LAR^+UZ?$[^>[I'OT%-G'O][W#MS@*V!Q'$=I7^ LLZ?VK_V\
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M/-#"%/SAI3*()PTB[I9D?KDM8Y)6+DJ>E [@_[H5JN281C?(D)Q8N"H'V7)
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MRT-BOI,U6_DOZ0<'S2\0Z(<*_P902P,$%     @ 1HDI64Q4*1$2!   @Q
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MULIL E&X#G+-/ *]%9HNK1 "H]8(*[N&RYY=MIRR6ZRXE5+.['4[%X,%BXI
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MC'$RK/2\MAF#0HU%Z8^Q90(C!4*YGVN=F@Z8BV/:9.KO LEYY'0HVTN$-IK
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M7V%N9')E='1I,BYH=&U02P$"% ,4    " !&B2E9:*TK)82R   *P , '@
M            @ &](@  96$P,C$S.#,P,#%E>#$M,5]A;F1R971T:3(N:'1M
M4$L! A0#%     @ 1HDI68%^0TF7-0  U%,! !\              ( !?=4
M &5A,#(Q,S@S,# Q97@Q,"TQ7V%N9')E='1I,BYH=&U02P$"% ,4    " !&
MB2E9!?V-_P5-  "O/P( 'P              @ %1"P$ 96$P,C$S.#,P,#%E
M>#$P+3)?86YD<F5T=&DR+FAT;5!+ 0(4 Q0    ( $:)*5EMUF.!=1T  +JA
M   ?              "  9-8 0!E83 R,3,X,S P,65X,3 M,U]A;F1R971T
M:3(N:'1M4$L! A0#%     @ 1HDI63<7MJO5,   N.L  !\
M ( !178! &5A,#(Q,S@S,# Q97@Q,"TT7V%N9')E='1I,BYH=&U02P$"% ,4
M    " !&B2E9)F86;L8G  !2P0  'P              @ %7IP$ 96$P,C$S
M.#,P,#%E>#$P+35?86YD<F5T=&DR+FAT;5!+ 0(4 Q0    ( $:)*5D;]XFE
MX0H  "HT   ?              "  5K/ 0!E83 R,3,X,S P,65X,3 M-E]A
M;F1R971T:3(N:'1M4$L! A0#%     @ 1HDI653_TZ!!30  N)X! !\
M         ( !>-H! &5A,#(Q,S@S,# Q97@Q,"TW7V%N9')E='1I,BYH=&U0
M2P$"% ,4    " !&B2E972+JJR*9   3G 0 '@              @ 'V)P(
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MSS@# &5A,#(Q,S@S,# Q97@Y.2TR7V%N9')E='1I,BYH=&U02P$"% ,4
M" !&B2E93%0I$1($  "#$   $@              @ %(00, <&]L974M,C R
M-# Y,#4N>'-D4$L! A0#%     @ 1HDI65AZ3[Y6"0  6FL  !8
M     ( !BD4# '!O;&5U+3(P,C0P.3 U7V1E9BYX;6Q02P$"% ,4    " !&
MB2E9\7DQLI,,   1E0  %@              @ $43P, <&]L974M,C R-# Y
M,#5?;&%B+GAM;%!+ 0(4 Q0    ( $:)*5DQ1Q.5F@@  /!E   6
M      "  =M; P!P;VQE=2TR,#(T,#DP-5]P<F4N>&UL4$L%!@     1 !$
*[00  *ED P    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>ea0213830-8k_andretti2_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:POLEU="http://andretti.com/20240905"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2023"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="poleu-20240905.xsd" xlink:type="simple"/>
    <context id="AsOf2024-09-05">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002025341</identifier>
        </entity>
        <period>
            <startDate>2024-09-05</startDate>
            <endDate>2024-09-05</endDate>
        </period>
    </context>
    <context id="From2024-09-052024-09-05_custom_UnitsEachConsistingOfOneClassOrdinaryShareAndOnehalfOfOneRedeemableWarrantMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002025341</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">POLEU:UnitsEachConsistingOfOneClassOrdinaryShareAndOnehalfOfOneRedeemableWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-05</startDate>
            <endDate>2024-09-05</endDate>
        </period>
    </context>
    <context id="From2024-09-052024-09-05_custom_ClassOrdinarySharesParValue0.0001PerShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002025341</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">POLEU:ClassOrdinarySharesParValue0.0001PerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-05</startDate>
            <endDate>2024-09-05</endDate>
        </period>
    </context>
    <context id="From2024-09-052024-09-05_custom_WarrantsEachWholeWarrantExercisableForOneClassOrdinaryShareAtExercisePriceOf11.50PerShareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002025341</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">POLEU:WarrantsEachWholeWarrantExercisableForOneClassOrdinaryShareAtExercisePriceOf11.50PerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-09-05</startDate>
            <endDate>2024-09-05</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2024-09-05" id="Fact000003">false</dei:AmendmentFlag>
    <dei:CurrentFiscalYearEndDate contextRef="AsOf2024-09-05" id="Fact000004">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:EntityCentralIndexKey contextRef="AsOf2024-09-05" id="Fact000005">0002025341</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2024-09-05" id="Fact000010">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2024-09-05" id="Fact000011">2024-09-05</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2024-09-05" id="Fact000012">Andretti Acquisition Corp. II</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2024-09-05" id="Fact000013">E9</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2024-09-05" id="Fact000014">001-42268</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2024-09-05" id="Fact000015">98-1792547</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2024-09-05" id="Fact000016">7615 Zionsville Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="AsOf2024-09-05" id="Fact000017">Indianapolis</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2024-09-05" id="Fact000018">IN</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2024-09-05" id="Fact000019">46268</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2024-09-05" id="Fact000020">317</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2024-09-05" id="Fact000021">872-2700</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2024-09-05" id="Fact000022">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2024-09-05" id="Fact000023">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2024-09-05" id="Fact000024">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2024-09-05" id="Fact000025">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="From2024-09-052024-09-05_custom_UnitsEachConsistingOfOneClassOrdinaryShareAndOnehalfOfOneRedeemableWarrantMember"
      id="Fact000026">Units,     each consisting of one Class A ordinary share and one-half of one redeemable warrant</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2024-09-052024-09-05_custom_UnitsEachConsistingOfOneClassOrdinaryShareAndOnehalfOfOneRedeemableWarrantMember"
      id="Fact000027">POLEU</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2024-09-052024-09-05_custom_UnitsEachConsistingOfOneClassOrdinaryShareAndOnehalfOfOneRedeemableWarrantMember"
      id="Fact000028">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="From2024-09-052024-09-05_custom_ClassOrdinarySharesParValue0.0001PerShareMember"
      id="Fact000029">Class     A ordinary shares, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2024-09-052024-09-05_custom_ClassOrdinarySharesParValue0.0001PerShareMember"
      id="Fact000030">POLE</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2024-09-052024-09-05_custom_ClassOrdinarySharesParValue0.0001PerShareMember"
      id="Fact000031">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="From2024-09-052024-09-05_custom_WarrantsEachWholeWarrantExercisableForOneClassOrdinaryShareAtExercisePriceOf11.50PerShareMember"
      id="Fact000032">Warrants,     each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2024-09-052024-09-05_custom_WarrantsEachWholeWarrantExercisableForOneClassOrdinaryShareAtExercisePriceOf11.50PerShareMember"
      id="Fact000033">POLEW</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2024-09-052024-09-05_custom_WarrantsEachWholeWarrantExercisableForOneClassOrdinaryShareAtExercisePriceOf11.50PerShareMember"
      id="Fact000034">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2024-09-05" id="Fact000035">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="AsOf2024-09-05" id="Fact000036">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
